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Abstract 
This Joint Roadmap for radiation protection research is established under WP3 of the H2020 CONCERT 
European Joint Programme by a working group including representatives of the six radiation 
protection research platforms and specific CONCERT Programme Owners and Programme Managers. 
Within Europe, many organisations and associations have important experience in radiation 
protection research. To face effectively future challenges and make efficient use of resources (at both 
national and European levels), we believe that a common and shared vision for radiation protection 
research is required – the Joint Roadmap provides this vision.  
Future challenges can be addressed and answered if we have a clear path forward both in terms of a 
common programme (R&D and implementation) and required capacities (maintaining and building 
future workforce and infrastructure) clearly set out in the Joint Roadmap, presented within this 
deliverable. Additionally, we need to develop the structure and governance to manage a European 
radiation protection R&D programme, which is another expected outcome from CONCERT.  
This Joint Roadmap defines priority areas and strategic objectives for mutual cooperation and provides 
a vision and role for a European radiation protection research programme to 2030 and beyond.  
The Joint Roadmap presents a view of the research challenges in the context of existing and potential 
exposure scenarios, relevant from societal and radiation protection points of view. Within these 
research challenges, the joint roadmap presents ‘game changers’, defined as research issues that, 
when successfully resolved, have the potential to impact substantially and strengthen the system 
and/or practice of radiation protection for man and/or the environment through 1) significantly 
improving the evidence base, 2) developing principles and recommendations, 3) developing standards 
based on the recommendations and 4) improving practice. 
Within the first half of 2020, this Joint Roadmap, and the associated game changers were sent for 
consultation to the research communities, end users, decision makers and other stakeholders for 
evaluation and further evolution of priorities.  
Due to COVID19 pandemic a final consultation round within the time frame of CONCERT and approval 
by the CONCERT consortium to produce a final version of the joint roadmap (JRM) with strengthened 
priority setting could not be realised. But CONCERT do not see any reason for any stumbling blocks 
that the JRM will be basis of future R&D, resource and financial support planning since  a next version 
of the JRM to be prepared in the near future (2020) will be taken up by the MANEES and future project 
in radiation protection in Horizon Europe. Within the course of 2020 the joint roadmap will also be 
presented within and beyond Europe, aiming to build cooperation and collaboration between 
research communities on a global scale. The joint roadmap is a living document that will need to be 
updated on a regular basis, considering advances and developments that affect the research needs. 
The implementation and timescale of the joint roadmap will depend on the availability of human, 
infrastructural and financial resources in the Member States, on the EU level and progress with wider 
global integration. The availability of a coordinated funding mechanism would benefit the 
implementation of the roadmap and realisation of its goals. A long-term commitment by Europe of 
this sort would allow for the implementation and realisation of this ambitious radiation protection 
research roadmap shaped by societal challenges. 
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1. Foreword 
Since the HLEG report1 about ten years ago, a remarkable reorganisation of the European radiation 
protection research landscape has taken place. The report on European Low Dose Risk Research 
subsequently led to the establishment of the MELODI platform, an association of European institutes 
committed to low dose risk research and openly sharing their vision and Strategic Research Agenda with 
the multidisciplinary scientific community. The mode of operation turned out to be very successful and 
several other research platforms in radiation protection were set up soon thereafter, addressing 
research on radioecology (ALLIANCE), nuclear and radiological emergency preparedness and response 
(NERIS) and medical radiation (EURAMED). The European Dosimetry Group (EURADOS) that was founded 
in the 1980´s as an expert group, also prepared an ambitious SRA. The newly established SHARE platform 
has further consolidated the expertise in social sciences and humanities in radiation protection research.  
All platforms have developed specific SRAs in their field of activity and continue working on specific 
roadmaps. While the individual platforms have brought together European scientists and consolidated 
their research strategies, there is also an increased collaboration between the radiation protection 
platforms within the integrative work packages of CONCERT to develop priorities and the joint roadmap. 
Also the research projects recently funded require the collaboration of scientists from the different 
platforms.  
A Memorandum of Understanding (MoU) was established between these platforms confirming an 
umbrella structure (MEENAS) to further foster and enhance European radiation protection research and 
support collaboration. The implementation of a Joint Roadmap for Radiation Protection Research is a 
key element in this MoU. 
The scope of research envisaged in the joint roadmap is in the context of various existing and potential 
exposure scenarios, relevant from societal and radiation protection point of view. The key aim is to 
provide answers to open questions related to the exposure of humans and the environment, for example 
to reduce uncertainties in risk assessment and to provide sound, applicable solutions for risk 
management. Research and development are needed in every step of the radiation protection 
knowledge updating process, ranging from underpinning science to principles, recommendations, 
standards and practice, represented at the international level by UNSCEAR, ICRP, IAEA/ISO/EC and IRPA, 
respectively (Figure 1). This joint roadmap aims to provide an instrument designed to support the 
updating of knowledge. In other words, implementation of the joint roadmap for radiation protection 
research should provide the knowledge and expertise needed to improve the radiation protection 
system and its execution over the coming decades. 
This report describes the joint roadmap for research on radiation protection in Europe. The Joint 
Roadmap is prepared within the European scope but will be shared on a global scale to stakeholders, 
researchers and research funding institutions, to assess the possibility of research programming and co-
funding, research cooperation and collaborations beyond Europe. This document is meant to be a living 
document, to be updated regularly to consider advances in the state of the art and future societal 
challenges. 
                                                          
1https://cordis.europa.eu/docs/publications/1070/107087891-6_en.pdf  
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Figure 1. Role of science in the process of updating and implementing the radiation protection system. Research 
and development are needed in this process, ranging from underpinning science to principles/recommendations, 
standards and practice.  
 
Implementation of the joint roadmap will have impact on radiation protection of humans and the 
environment in many ways (Figure 2). First, by consolidating our scientific knowledge the joint roadmap 
will support the implementation of the European Basic Safety Standards, to help cope with the new 
requirements and harmonize the practices throughout Europe. The joint roadmap addresses both 
human protection and protection of the environment. The holistic approach covers both risk assessment 
and risk management, as well as development of tools, methods and best practices to cope with the 
issues related to radiation exposure, thus making a major impact on society. Research is needed for risk 
prediction in specific situations and for foresight, to anticipate potential exposures. New knowledge will 
contribute to evidence-based recommendations at international level and informed risk communication. 
Research on risk management will help on risk prevention, improve the resilience of societies for 
emergencies, help to set up action plans and work on the mitigation and remediation. Guidelines, 
recommendations and regulations are needed, along with good practices and reliable methods for field 
and laboratory work. A graded approach in risk management is needed and research will help in putting 
exposures and risks in perspective. Technological development comes up with new standards, 
technological innovations and improved capabilities. 
The research foreseen and the derived recommendations will enable consolidated, harmonised and 
robust decision making in the field of radiation protection throughout Europe and beyond.  
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Figure 2. The research ecosystem ranges from basic research to applied research and from risk assessment to risk 
management. The societal impact from radiation protection research will result into improved risk assessment 
and risk management, both supported by technological innovations. The regulators and competent authorities on 
protection of health and the environment rely on the output from the research and technological development 
processes at all levels. 
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2. Scope of the research presented in the joint roadmap: exposure 
contexts and scenario groups 
The goal of the joint roadmap is to identify the research needs and the development of tools that will 
further optimize the existing radiation protection system and advance radiation protection, considering 
the societal needs and concerns, and to plan such research. Implementation of the joint roadmap for 
radiation protection research will deliver the knowledge and expertise needed to further improve the 
radiation protection system over the next decades. 
The scope of research planned in the joint roadmap is to provide information and tools for radiation 
protection in the context of various existing and potential exposure scenarios, driven by a societal and 
radiation protection point of view.  
In this Chapter 2 we present the potential exposures of humans and the environment in a two-
dimensional approach, with on one side RP (radiation protection) contexts resulting from man-made or 
natural sources of exposures, and on the other side exposure scenarios that may result from planned, 
existing or emergency situations. A graphical representation of this two-dimensional approach is 
available in Table 1. 
2.1. Radiation protection contexts 
Exposures to ionising radiation for which radiation protection may be required can be grouped in the 
four following contexts, from which the first three result from human activities, whereas the last one is 
inherent to the natural environment on earth, in the atmosphere and in space. 
I. Human activities related to medical therapy and diagnosis using radionuclides and X rays, 
electrons, protons or ions: medical exposure of patients and the consequent exposure of 
personnel and the public due to medical procedures, the production and manipulation of 
sources/radiopharmaceuticals and related radioactive waste management. 
II. Human activities related to nuclear energy applications and other industrial applications of 
ionising radiation not related to medical applications 
a. Installations from the nuclear fuel cycle: uranium mining and milling, fuel preparation, 
exploitations such as energy production in nuclear power plants, spent fuel 
reprocessing, waste management and decommissioning, research reactors and fusion 
research. Site contamination due to normal operation, incidents, accidents potentially 
resulting in legacy. 
b. Industrial and scientific applications of ionising radiation e.g. welding control, security 
screening, irradiators and particle accelerators. 
c. Military: former nuclear bomb testing sites, weapons fallout and nuclear-powered 
vessels (submarines, icebreakers and nuclear powered satellites). 
III. Human activities related to the use of natural resources, containing naturally occurring 
radionuclides (Naturally Occurring Radioactive Materials or Technically Enhanced NORM) 
a. Mining, processing, waste management of natural resources containing natural 
radionuclides (NORM) (e.g. oil and gas extraction, NOR-rich ore mining).  
b. Use, processing, recycling and waste management of technologically enhanced naturally 
occurring radionuclides, including decommissioning of NORM affected industrial 
facilities. 
IV. Natural radiation as source of ionising radiation: telluric and cosmogenic radiation, natural 
events leading to radionuclide releases 
a. High natural radiation background areas, potentially resulting in radon and thoron in 
indoor air and/ or in natural nuclides present in water/food. 
b. Exposure to cosmic radiation at high-altitude or in space.  
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2.2. Exposure scenario groups 
Exposure scenarios cover a wide range of potential exposures of humans and the environment. These 
may originate from various anthropogenic or natural sources. Six exposure scenario groups related to 
the four contexts have currently been identified as shown in Table 1. The six scenario groups are 
presented according to the ICRP classification in planned, existing and emergency exposure situations. 
These scenario groups cover all the types of exposure situations potentially experienced by the public, 
patients, workers and the environment.  
Each of the six scenario groups cover very large ranges of exposures of humans and the environment. 
However, the exposure scenario groups presented below provide sufficient information to deduce the 
joint research challenges of the joint roadmap. We have provided within the exposure scenarios, where 
available, indications of (collective) doses and general uncertainties or knowledge gaps to allow 
individual stakeholders to appreciate the relative importance of the scenarios from their perspective. 
The research challenges presented in Chapter 3 were developed according to these exposure scenarios, 
and must therefore be interpreted with the exposure scenarios in mind. More details on doses in specific 
exposure situations are available in UNSCEAR reports2. 
The relevance of exposure scenarios may differ in time and may vary strongly from different end users’ 
points of view and values. A changing societal concern regarding protection of the environment may 
shed a different light on the relevance of some of the scenario groups. A new nuclear/radiological 
accident with radioactive environmental contamination may also impact on the societal concern related 
to radiation exposure. Global geopolitical changes could lead to uncertainties in responsibilities and 
emergency management. New reactor technologies or new sources such as floating reactors may induce 
different threats resulting in different accident scenarios. Climate change may alter environmental 
exposure, for example in legacy sites. Other external factors that may change the relevance of exposure 
scenario groups are an increased exposure of patients to medical radiation or an altered global health 
status, or exposure of humans and the environment to a combination of various stressors. Finally, 
progress in information technologies such as big data, artificial intelligence (A.I.), availability of human 
health data for (molecular) epidemiology and progress in emerging life sciences may positively influence 
the progress in radiation protection research. 
 
 
 
 
 
 
 
 
 
                                                          
2https://www.unscear.org/unscear/en/faq.html#Levels%20of%20radiation , 
https://www.unscear.org/docs/publications/2017/UNSCEAR_2017_Report.pdf 
https://www.unscear.org/docs/publications/2016/UNSCEAR_2016_Report-CORR.pdf 
https://www.unscear.org/docs/publications/2012/UNSCEAR_2012_Annex-A.pdf 
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Table 1. Exposure scenario groups related to different exposure situations categorised according to the ICRP 
classification (planned, existing or emergency exposure situations). The columns represent the different exposure 
sources (anthropogenic/natural) and contexts (medical, nuclear, NORM - TENORM and natural). Within the 
different exposure situations, various groups of exposure scenarios are identified. For emergency scenarios it 
should be noted that the first phase is classified as emergency while the recovery phase on the longer term is 
treated as legacy which is an existing exposure situation. 
 
 
Scenario group 1 – Patient exposure from medical applications of X-rays, electrons or other particle 
radiation including the use of radiopharmaceuticals 
This scenario group encompasses the medical exposure of patients to ionising radiation, for diagnosis 
and therapy. These exposures result in the highest average exposures to humans related to man-made 
sources of ionising radiation at least in developed countries e.g. in Europe, where the annual average 
dose of X-ray and nuclear medical imaging procedures is 1.1 mSv per caput still with a large variation 
between the different European countries, from which about 5% is due to nuclear medicine imaging 
procedures3. Dose ranges are very different amongst the various applications. However, there are body 
regions with low exposures in therapeutic applications while there are also body regions in e.g. 
interventional or cardiological investigations and repeated three-or four-dimensional imaging 
procedures with high local exposures. Thus, the scenario group will encompass all types of medical 
exposures. 
The exposures to individual patients may vary substantially depending on their health status, the 
national health care system and the type of equipment technology used: For example, the average 
annual effective doses per caput from X-ray procedures in Europe range from 0.25 mSv in Moldova to 
1.96 mSv in Belgium4. Each specific investigation might be performed within a large variety of parameters 
and settings within different countries, regions, hospitals or even departments. Many individual 
                                                          
3Study on European Population Doses from Medical Exposure (Dose Datamed 2, DDM2) Project report part 1: European 
Population Dose, page 9. Contract ENER/2010/NUCL/SI2.581237, 2010 
4DDM2, table 5.13, part 1, 2010  
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members of the public may not receive any medical exposure in one year at all whilst some patients may 
undergo several abdominal CT scans each of which has an effective dose5 of about 10 mSv.  
A slightly increasing trend of average exposure per caput related to medical applications of ionising 
radiation is seen during the last few decades, and the awareness of adverse effects has pointed out the 
need for optimising imaging procedures in terms of a balance between an improved diagnostic outcome 
related to image quality and a reduced radiation exposure. Improving the quality of medical images 
usually means increasing the radiation dose to the patient, which in turn increases the radiation risks. 
For this reason, the objective of medical imaging is not to deliver the perfect image but one that is 
diagnostically adequate for the specific health problem6. Balancing image quality with radiation dose 
requires a special approach, since too low a radiation dose could be as bad as one too high: the images 
obtained could be of unsuitable diagnostic quality. Clinical auditing, reference levels and safety culture 
are among the means to improve optimisation. In addition, it is expected that technological innovations 
based on artificial intelligence will surpass the image detection capability of human eye after being 
trained by large datasets of image information. The distribution of exposures resulting from certain 
procedures like interventional or fluoroscopy-guided procedures can show differences in orders of 
magnitude resulting in local doses in the range of a few Gray. Exposure related to radiation therapy using 
external irradiation or radiopharmaceuticals may result in very high doses to tumours, of the order of 
multiple tens of Grays. Surrounding healthy tissues may also receive significant doses in the range of a 
few Gray, which may result in secondary effects such as acute inflammation, or late cancer / non-cancer 
diseases.  
Especially, young children with higher radiosensitivity undergoing repeated examinations or 
radiotherapy may develop secondary effects. Like age, other individual sensitivities such as gender, 
disease-related effects, environmental risk factors like smoking or weight and genetic background are 
important to consider. Unravelling individual sensitivities may ultimately refine the system of radiation 
protection, especially in the context of medical applications. 
Besides the development of direct radiation protection optimisation in terms of medical outcome per 
related risk through personalization and harmonisation of practices in diagnostic and therapeutic 
applications it would be feasible to study the secondary effects of medical exposures.  However, it is 
important that assessment of secondary effects resulting from medical exposures takes into account the 
health status and drug intake of the patient.  
Such research initiatives are only possible when regulations are adapted to support the harmonisation 
of medical practices and protocols, and to enable the use of relevant patient data for research, while 
respecting patient confidentiality. 
 
The ultimate goal of research related to scenario 1 is to provide information to policy makers, national 
healthcare, health practitioners, patients and comforters of caregivers on optimisation strategies, to 
allow informed decision-making, and to adjust protocols to optimise (i) image quality and dose in 
diagnostics and (ii) target dose and healthy tissue dose in therapy. 
 
 
 
                                                          
5 The meaning of effective dose in terms of medical exposures might be questionable; it should not be used for individual risk 
estimates. We refer to dose concepts in Challenge 2.  
6https://www.iaea.org/topics/optimising-image-quality  
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Scenario group 2 – Exposure of the general public and the environment as a consequence of industrial 
applications of ionising radiation and the use of NORM in normal operation conditions 
This scenario group covers a wide range of human activities. The operations linked with the nuclear fuel 
cycle (from uranium mining and milling up to final radioactive waste management, disposal and 
decommissioning), with industrial activities making use of ionising radiation as well as with the industries 
handling material containing natural radioactivity (NORM/TENORM), may lead to releases of 
radioactivity to the environment, which need to be controlled in order to minimise harm to individuals 
or to the environment. 
To assess robustly the transfer and distribution of radionuclides in the environment from source to target 
(individuals and environment), fit-for-purpose models are required capable of capturing the required 
uncertainty. Uncertainties linked with exposure assessment may be related to the source characteristics, 
physicochemical behaviour and transport of radionuclides, transfer to biota, dosimetry and dose 
assessment in humans and biota. 
In some cases, a full understanding of the bio-physico-geochemical processes affecting radionuclide 
mobility in biosphere, geosphere and atmosphere is required. This involves the development of models 
underpinned by dedicated laboratory and field experiments and studies and the development of 
dedicated data bases of parameter values. Special environments must acquire additional attention due 
to climate change. The representative person and reference area for biota should be adequately defined. 
The human and environmental exposure and impact assessment, both for predictive (e.g. newly built) 
and operational situations, need to consider not only the radiological component but also societal and 
ethical aspects.  
Potential (health) effects to individuals and the environment is expected to be negligible given the 
generally very low dose rate/annual exposure.  
 
Scenario group 3 – Exposure of workers in normal operational conditions. 
Next to patient exposure and exposure to natural radiation, exposure of workers in normal operational 
conditions results in the third highest effective dose to humans. The description of this scenario group is 
based on a summary of data from the ESOREX7 platform, which was developed to gather information on 
occupational exposures in Europe. The information gathered by ESOREX included how personalised 
monitoring, reporting & recording of dosimetric results is structured in European countries. The ESOREX 
platform also collects reliable and directly comparable individual and collective exposure data in all 
occupational sectors in which classified workers are employed, i.e. in the medical field (e.g., diagnostic 
radiology, interventional radiology, radiotherapy, diagnostic/ therapeutic nuclear medicine, dental 
radiology, veterinary medicine), in nuclear industries (nuclear fuel cycle for civil and military purposes), 
in industries using radioactive sources (e.g. industrial radiography, X ray fluorescence, industrial gauges, 
electro-beam welding, radioisotopes production and conditioning, industrial irradiation, security 
screening), in NORM-related industries (e.g. ore mining & processing, handling and storage of NORM, oil 
& gas industries, coal combustion) and in activities where employees are exposed to natural background 
radiation (e.g. air crew). 
The type of occupational exposure varies and could include exposure through inhalation (e.g., of radon 
or radioactive dust), external whole-body exposure (e.g. in various sectors and to air crew exposure to 
                                                          
7ESOREX platform: (1) Establishment of a European Platform for Occupational Radiation Exposure –Highlights of 
the final report Contract n° ENER/2012/NUCL/SI2.636456, Rapport PRP-HOM 2015-00010,2015; (2) website 
https://esorex-platform.org/ 
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cosmic radiation), or external exposure of extremities and eyes to gamma radiation (e.g. in the medical 
sector), all of them potentially resulting in different health effects. 
The mean value for monitored workers in 20158  for all categories was 0.27 mSv/year in European 
countries that provided data to ESOREX9. On the individual level, occupational exposures may be higher: 
From the data available for France in 2015, the annual average dose to measurably exposed workers10 
in NORM industry is the highest (i.e. 1.94 mSv) and originating mainly from Rn inhalation, followed by 
workers in industry using radiation sources (1.38 mSv), nuclear industry (1.17 mSv) and medicine (0.34 
mSv), mostly as external exposures. To complete the list of occupational exposures, we include the 
annual average aircrew exposure in Germany in 2015 (which was not measured but calculated with 
suitable codes that include flight route and the field of secondary cosmic radiation in the atmosphere), 
which was 2 mSv, with individual aircrew exposures up to 6.5 mSv. Annual collective doses in France in 
2015 in NORM industries, industries using radiation sources, nuclear industry and medicine were 38 770, 
17 990, 27 450 and 15 380 manSv, received by about 20 000, 33 000, 70 000 and 200 000 workers, 
respectively. 
Although protection against radon is primarily based on measurement and optimisation, dose estimates 
are required for workers if, despite optimisation, radon levels in a workplace remain above the national 
reference level (ICRP 126). The EU Basic Safety Standards Directive 2013/59/EURATOM widens the 
application of radiation protection practices to previously not affected fields such as exposures to radon, 
thoron (including their progeny) and exposures to NORM, and demands that they are regulated in the 
same way as artificial sources. Many open questions remain regarding dosimetry, effects and risks of 
radon and NORM when occurring alone or in combination with other stressors. Further knowledge is 
needed to significantly reduce scientific as well as technical uncertainties in all steps of the radiation risk 
management cycle for radon and NORM exposure situations. Effective doses arising from unit exposure 
to radon and its progeny have been calculated using either dosimetric models or using the so-called 
‘epidemiological approach’.  Both approaches give consistent results within their associated 
uncertainties (ICRP 137). Taking account of both methods, ICRP has recently recommended a single 
reference dose coefficient to be used, in most circumstances, for workers in buildings and in 
underground mines.  Reference values are also given for specific situations of indoor work involving 
substantial physical activity, and for workers in tourist caves (ICRP 137). In special cases, where exposure 
conditions are non-typical, where sufficient reliable aerosol data are available, and estimated doses are 
likely to be high, site-specific dose coefficients can be calculated using the dosimetric data provided in 
ICRP 137.  This would require a careful analysis of the European workplaces with a coordinated action 
with an expert group performing field measurements for dose assessments. 
 
A large number of workers are covered by all these scenarios mentioned above, and hence efforts are 
needed to improve the assessment of doses and to optimize radiation protection. 
Awareness of and integration of protection culture into industrial planning and the implementation of 
the new BSS plays a key role for an optimized radiological protection. 
 
 
 
                                                          
82015 is the most actual year for which most countries have provided results in the ESOREX platform 
9ESOREX data including data from France, Germany, Greece, Switzerland, Finland, Slovenia, Spain, Lithuania, The Netherlands 
10There is a difference between monitored and measurably exposed workers: compared to “measurably exposed workers”, 
“monitored workers” include individuals not having received a dose above the recording level, which is mostly equal to the 
applied method’s detection limit, or which have received doses equal or lower than the limits to the public (1 mSv). 
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Scenario group 4 – Exposure of the general public and the environment with regard to legacy. 
Past development of commercial and military uses of radioactive material and material containing 
naturally occurring radioactive materials (NORM), led to the development of many nuclear or NORM 
facilities worldwide.  In many countries, these facilities were built and operated before the regulatory 
infrastructure was in place to ensure proper emission and residue handling and end-of-life 
decommissioning. This has led to legacy sites worldwide, contaminated with long-lived radioactive and 
other toxic residues that may pose substantial environmental and health concerns. Other type of legacy 
is that linked with former nuclear bomb testing sites, areas where ammunition of depleted uranium was 
used, areas impacted by accidents of submarine or nuclear energy-driven satellites or orphan 
radiological sources. Legacy sites are characterised by a large variability, complex and heterogeneous 
features and cover a broad range of issues. These legacy sites may cause radiological (and chemical) 
exposure to man and wildlife and may entail health risks and/or induce ecological damage. To robustly 
assess exposure to man and the environment and propose remedial options fit-for-purpose, transfer and 
exposure models are essential. Justification and optimisation of the remediation strategy should involve 
a multi-criteria approach in which stakeholders are actively involved in each step.  
Exposure of human beings and wildlife is generally higher at legacy sites than at nuclear and NORM sites 
under normal operation. Impact assessment for individuals and environment is hence generally more 
crucial than for scenario 2. Since public exposure is sometimes in a dose range where there are 
uncertainties in the effects, scientific development is essential to predict health effects at these ‘low’ 
dose rates and related total dose.  
Proper site characterization, human and environmental exposure and impact assessments, safety 
assessments and evaluation of remediation options (in terms of technical performance, associated 
exposure reduction and social impact), constitute the basis for decision making and need to be based on 
robust scientific and technological developments, as well as on the concerns of the various stakeholders. 
They ought to integrate uncertainty estimates that would help identify the priorities for scientific 
research to be dedicated to the most uncertain processes/parts of the assessment and take into account 
at the same time societal uncertainties and ethical implications of decision-making.  
 
Scenario group 5 - Exposure of the public and the environment to the natural radiation environment 
Radiation emitted from natural terrestrial sources is in most European countries responsible for about 
half of the average annual dose to humans. It is largely due to primordial radionuclides, mainly 232Th 
and 238U series, and their decay products, as well as 40K, which exist at trace levels in the earth's crust. 
Their concentrations in soil, sands and rocks depend on the local geology of each region in the world. 
The average natural radiation exposure is 2.4 mSv/y (global average)11, but may vary strongly from place 
to place (from < 1 mSv/year to 100 mSv/y). Indoor radon is the largest contributor to the natural 
radiation exposure of the general population and the link between radon exposure and development of 
lung cancer is well established. Notwithstanding the recent recommendations of ICRP, there is a need to 
improve the knowledge of factors modifying the relationship between radon exposure and effects, as 
for example the interaction of radon with smoking habits or the radon-related risk for diseases other 
than lung cancer. 
In recent years, several international studies have been carried out on the effects of background 
radiation on human health, but they are not fully conclusive on the specific radiation effect given the 
low dose rate, the impact of confounding factors etc. A more comprehensive dedicated international 
                                                          
11UNSCEAR 2008 Annex B Table 12; it must be noted that different countries apply different dose conversion 
factors. Therefore the average dose should be regarded as a representation of the order of magnitude of the dose. 
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study is required. Another uncertainty concerns the possible relationship between background 
irradiation and cancer incidence, particularly in children.  
High background areas might be regarded as ecosystems exposed to long-term low-dose radiation. 
Comparison of such ecosystems with other ecosystems in areas with much lower background radiation 
levels might reveal important evolutionary information on various populations. 
Information on scenario 5 is important to inform public and legislators about the effects of natural 
radiation, and to assess the eventual needs for countermeasures to be taken to reduce the exposure of 
the general public and/or the environment. 
 
Scenario group 6 – Exposure of the general public, workers and the environment following a major 
nuclear or radiological accident or incident including long term consequences 
This scenario includes all types of incidents or accidents in nuclear installations, medical facilities, 
transport of nuclear material, military installations and operations (e.g. ‘broken arrow’ incidents such as 
the incident at Palomares, Spain), lost sources (such as the Goiânia accident in 1987), satellite return 
(such as the SNAP-A re-entry event) or other events involving uncontrolled exposure or spread of 
radioactivity.  
 
The impact on the affected population might range from local (e.g. a lost source) to worldwide (e.g. 
Fukushima and Chernobyl) and is not limited to individual health effects but may affect the environment 
as well as economic and social activities, e.g. all possible living conditions and lifestyle of affected people.  
This scenario also covers accidents related to the medical use of ionising radiation. This includes among 
others accidental and unintended medical exposures, overexposure and incorrect treatments of 
patients. 
 
The timescales may range from days to decades or even longer, thus appropriate means must be 
developed to deal with the related challenges as defined in Chapter 3. Preparedness, supporting 
scientific tools and engagement of all relevant stakeholders are some of the necessary scientific input to 
deal with the consequences and mitigate them as much as possible. 
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3. Deriving joint research challenges and game changers from radiation 
protection contexts and exposure scenarios 
“Joint research challenges” were developed, based on the scenario groups (section 2.2), taking into 
account the priorities identified in the strategic research agendas and individual roadmaps and 
interactions with CONCERT POMs and stakeholders. An overview of the joint research challenges is 
presented in Table 2. The term “joint” refers to the fact that the joint research challenges cover many 
disciplines, requiring collaboration of research communities of the different radiation protection 
research platforms. Table 2 summarises in the last column the different platforms needed to tackle the 
challenges. Most of the joint research challenges are relevant within various exposure scenario groups. 
For example, a better understanding of the human health effects at realistic low doses or dose rates is 
relevant in all exposure scenarios, even though the specific dose ranges or dose rate ranges and radiation 
qualities may differ according to the exposure situation.  
Table 2 Overview of joint research challenges derived from the exposure scenario groups, addressing research 
disciplines available in the various radiation protection research platforms. The main platforms involved in the 
different research challenges are explicitly presented in the last column. 
 
 
Within the joint research challenges, various “game changers” have been defined as “Research that, 
when successfully executed, has the potential to substantially impact and strengthen the system and/or 
practice of radiation protection for man and/or the environment through 1) significantly improving the 
evidence base, 2) developing principles and recommendations, 3) developing standards based on the 
recommendations and 4) improving practice”. As such, the authors estimate that funding research as 
defined in the game changers will maximise the potential to address the joint research challenges 
derived from currently realistic exposure scenarios. 
It is important to notice that the proposed challenges and game changers are a current snapshot, 
sensitive to the evolution of the state of the art, or to future alteration of exposure scenarios, and 
accomplishment depends strongly on the resources available, as discussed in Chapter 5. Whereas the 
joint research challenges have already been presented to and validated by stakeholders in 2018-2019, 
the game changers are new and will be presented for priority setting to researchers, stakeholders and 
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end users. To include this information, the joint roadmap will be updated in May 2020 as the last version 
within the course of EJP-CONCERT. The level of detail provided in the research challenges and game 
changers is very restricted. More detail is available for specific topics in the SRAs of the different radiation 
protection research platforms in Annex 2.  
3.1. Challenge A – Understanding and quantifying the health effects of radiation 
exposure 
The central aim of radiological protection is the protection of human health from the harmful effects of 
ionising radiation. Risks to health are the prime consideration in all situations of radiation exposure that 
include humans and are therefore of relevance to radiological protection in all occupational, medical and 
public exposure situations, under normal or emergency conditions.  The ultimate goal of this challenge 
therefore is to have a comprehensive quantitative and mechanistic understanding of all radiogenic 
health effects. 
Figure 3 summarises the current understanding of the relationship between radiation exposures and 
health effects (UNEP, 2016)12. In the context of the Joint Roadmap, low doses and/or low dose rates refer 
to a range of acute and/or protracted exposures of ionizing radiation that are typical of those 
encountered in the workplace, the environment and in diagnostic medicine. Moderate doses refer to 
doses that may be encountered by normal tissues in interventional radiography or in radiotherapy or in 
nuclear or radiological accidents. Doses below 100 mSv in a year may be considered low, and doses of 
the order of 100 – 1000 mGy are considered moderate. Doses higher than 1000 mSv are considered high 
and may cause symptoms of acute radiation sickness if received during a short period. Low dose rate 
means relatively low rate of dose accumulation. In radiological protection context, annual dose rates 
below 100 mSv may be considered low.  
 
Figure 3. Relationship of radiation doses and health effects (UNEP, 2016). Dose ranges are defined in the text. 
                                                          
12RADIATION – Effects and Sources, United Nations Environment Programme, 2016,  ISBN: 978-92-807-3517-8 
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It is important to distinguish between observations of early health effects in exposed populations from 
theoretical projections of potential future effects. For both situations, it is important to consider any 
uncertainties including those related to radiation measurements, statistical considerations or other 
factors. Currently, health effects can be reliably attributed to radiation exposure if early effects (e.g. skin 
burns) occur in individuals, e.g. after doses greater than 1 Gy (for teratogenic and other developmental 
effects possibly greater than 100 mGy). Using epidemiological methods, it is possible to attribute an 
increased occurrence of delayed health effects (e.g. cancers) in a population exposed to moderate 
radiation doses. However, there are no validated tumor biomarkers presently available to distinguish 
whether a cancer has been caused by radiation exposure or not. Where the level of radiation exposure 
was low or very low, changes in the occurrence of delayed health effects may be observed in 
epidemiological investigations; however, there are statistical and other uncertainties and a lack of full 
mechanistic understanding of the pathogenesis related to ionising radiation or other stressors. 
Unequivocal determination that cancers occurring after low dose exposures are caused by the radiation 
exposure is rarely possible. The LNT (Linear Non Threshold) approach suggests that epidemiological data 
from the higher dose range can be extrapolated to lower doses in a linear way. Understanding the 
mechanisms of radiation action helps in judging the biological plausibility of cancer induction by 
radiation exposure. Such mechanisms include the recognised DNA damage/gene mutational pathways 
and others such as potential epigenetic mechanisms, and disruption of mitochondrial function leading 
to persistent elevation of reactive oxygen species, amongst others. 
Exposure limits in radiation protection are based on knowledge of radiation cancer risk derived from 
epidemiological studies and assumed risk of heritable effects in humans. Epidemiologically derived 
health risk estimates are limited in power below around 100 mSv; depending on the cancer type, the 
applied models for risk inference can be linear or linear quadratic. However, for risk management 
purposes, it is a linear non-threshold (LNT) model that is applied, justified on the basis of a biologically 
plausible argument that relates direct damage to nuclear DNA to mutations in specific genes that drive 
carcinogenesis. The mutational action of radiation may be modulated by other processes, some not well 
characterised throughout the prolonged periods over which cancers develop.  In addition to cancer risks, 
there is increasing evidence of risk of non-cancer conditions, notably circulatory disease, cataracts and 
cognitive effects at lower doses, more than previously recognised. 
Refinement of risk assessment for both cancers and non-cancer diseases can be improved by further 
large-scale epidemiological studies with good exposure assessment/dosimetry and integration of 
mechanistic biological understanding of radiation-induced disease processes.  There is a need to further 
characterise organ-specific sensitivity and the distribution of risk within the population (evidence points 
to age, gender, co-morbidities, genetic factors, exposure to other environmental risk factors and life-
style/behavioural factors as risk modifying factors).  Information on the effects and risks associated with 
internal exposures, exposures to mixed radiation fields, co-exposures to radiation and chemical agents, 
differing radiation qualities, and inhomogeneous exposures is needed.    
 
The major issues (‘game-changers’) to resolve with potential impact to the radiation protection system 
and or practice in this area are: 
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Game Changers 
Potential impact on the radiation protection system 
and/or practice 
A1. Define the risks of non-cancer diseases at low 
and intermediate dose levels (100 - 500 mGy and 
below). 
Priority with highest potential to advance 
understanding in the short term (5Y): circulatory 
effects at near-field / out-of-field therapeutic doses 
and dose-rates and following interventional 
radiology; 
Long-term research topics: cerebrovascular / 
neurocognitive, metabolic and immune diseases, at 
progressively lower doses  
If present, these risks could lead to re-consideration of 
calculations of radiation detriment, dose limits and 
reference levels; there would also be a need to re-
consider tissue weighting factors and potentially 
additional protection measures. 
A2. Integration of epidemiological estimates of 
cancer risk with a more complete understanding of 
radiological disease pathogenesis to improve cancer 
risk assessment 
Priority with highest potential to advance 
understanding in the short term: defining processes 
contributing to cancer development after exposure; 
e.g. role of epigenetics, metabolic status, in single and 
multiple stressor at low doses and dose-rates 
Long term research topics: definition of target cell 
populations and cell 
interactions/microenvironmental effects  
If a dose and dose-rate effectiveness factor is no longer 
needed, or requires alteration, this could lead to 
reconsideration of dose limits.  Should a signature that 
unambiguously identifies radiation-induced cancers be 
identified, this would have impacts for compensation 
scheme criteria and programmes. 
Developing an understanding of all contributory 
mechanisms for radiation carcinogenesis at low 
dose/low dose rate, and the associated dose-response 
relationships, is essential for the development of risk 
projection models and predictive biologically based 
models 
Knowledge of the nature and size of target cell 
populations for radiation carcinogenesis is critical for 
further development of biologically based predictive 
modelling 
A3. For deterministic and stochastic cancer and non-
cancer outcomes: Characterisation and 
quantification of variation in response and risk 
between population sub-groups/individuals due to 
genetic factors, sex, co-morbidities, dedicated 
exposure of disease areas in patients, 
environmental and lifestyle factors and the 
interactions between these depending on dose 
levels. 
Priority with highest potential to make progress in 
understanding in the short term: Evaluation of 
potential predictive factors and correlating them with 
health outcomes.  
To improve the understanding in the difference of the 
dose response curve shape between males and 
females, as observed in the LSS cohort 
Longer term research topics: Integrative 
radiobiologically oriented systems biology, setup of 
If a robust (specific, sensitive) predictive metabolic 
status and biomarkers or radiomic markers for 
radiosensitivity (tissue reactions) were found, this 
would allow more individualised cancer treatment. 
Knowledge on the range of variation in susceptibility to 
stochastic effects in populations would be informative 
for public health and development of the system of 
radiation protection.  
A better understanding of the mechanisms involved in 
long term effects of ionising radiation may be 
integrated with mechanisms resulting from exposure to 
other stressors or from combined exposures. On the 
longer term, an integrative protective system could be 
established to cover realistic multi-exposure scenarios.   
A confirmation of the difference between sexes in the 
shape of the dose response (males: linear-quadratic 
and females: linear) may lead to changes in levels of 
exposure limits. 
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adverse outcome pathways related to ionising 
radiation and in combination with other stressors 
including diseases. 
 
Seeking biomarkers of individual risk through 
cellular/molecular and systems biological approaches 
as well as radiomics investigations 
Moreover, a better understanding and validation of the 
impact of life-style factors on the risk of stochastic and 
tissue effects could contribute the reduced risk by 
modifying life style. The dedicated response of diseased 
organs are of primary interest in taking care of patients 
since in diagnostic as well as therapeutic procedures 
mainly diseased organs will be exposed. 
A4. For stochastic cancer and non-cancer outcomes:  
Define how the temporal and spatial variations in 
dose delivery affect the risk of health effects 
following radiation exposure.   
Priority with the highest potential to make progress 
in understanding in the short term: Addressing the 
difference between risks from acute and chronic 
exposures through the integration of experimental 
and epidemiological data applying biologically-based 
risk models 
To improve the understanding of the effects of intra-
organ dose distribution through observations in 
patients exposed to inhomogeneous dose 
distributions and experiments with organotypic 
tissue models. 
Longer-term research topics: Addressing the 
difference between risks from internal and external 
exposures through the integration of new knowledge 
on the effects of chronic exposures, intra-organ dose 
distribution and radiation quality considering energy 
deposition at different scales (from intra cellular to 
organs).  
A strengthened evidence base may impact on 
judgements on dose rate effectiveness factors and 
radiation weighting factors (potentially including those 
for non-cancer outcomes) as well as in the introduction 
of new weighting factors accounting for the effects of 
modulation of intra-organ dose distribution. Changes in 
these factors would lead to reconsideration of dose 
limits, reference levels, conversion coefficients and 
dose coefficients for intakes of radionuclides.  
 
 
3.2. Challenge B – Improving the concepts of dose quantities 
 
The dependence of biological effectiveness on radiation quality is commonly believed to be related to 
the differences in the energy deposition pattern on a microscopic scale. For charged particles, this 
pattern is called the particle track structure, where for heavy particles, such as ions, the energy transfer 
points are concentrated around the primary particle trajectory. Identification and quantification of the 
relevant statistical characteristics of the microscopic spatial pattern of interactions (e.g., spatially 
correlated occurrence of clusters of energy transfer points) are an essential prerequisite for 
improvement of present dose concepts. Micro- and nanodosimetry have provided experimental and 
computational techniques for the microscopic characterization of the track structure.  
The overarching objective is the development of a novel, unified concept of radiation quality as a general 
physical characteristic of the radiation field that would allow separating the physical and biological 
components contributing to the eventual biological effects of radiation.  
The comprehensive multi-scale characterization of the physical aspects of particle energy deposition will 
enable a quantitative investigation of the impact of track structure in terms of biological effects. Track 
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structure has been proven to show a strong correlation with the induction of early biological effects, 
particularly the occurrence of DNA single and double strand breaks. As later biological endpoints also 
show dependence on radiation quality, there should also be a correlation of track structure 
characteristics and the probability of inducing these later effects, such as chromosomal aberrations or 
cell death. The ability to establish these correlations at the cellular level and investigate the response at 
supra-cellular organization level will form the basis for the comprehension of the radiation damage 
mechanism. 
The major issues (‘game-changers’) to resolve with potential impact to the radiation protection system 
and or practice in this area are: 
Game Changers Potential impact on the radiation protection system and/or practice 
B1. To improve the understanding of 
spatial correlations of radiation 
interaction events by improved 
measurement and simulation 
techniques. 
Understanding the physical interaction between radiation and matter 
is a start for finding the low dose effects for different kind of particles 
B2. To quantify correlations between 
track structure and radiation 
damage 
 
This fundamental knowledge will have a direct impact in addressing 
current optimization criteria in diagnostics and radiation therapy and 
radioprotection, such as “biologically weighted” doses delivered in 
hadron therapy, dose calculation in inhomogeneous irradiations such 
as those of short-range α- and β- emitters used in nuclear medicine or 
in the case of internal contamination, risk estimation for low dose 
exposures, etc… 
 
 
3.3. Challenge C – Understanding radiation-related effects on non-human biota and 
ecosystems 
 
The need for an explicit demonstration of the protection of the environment (or wildlife) from 
radioactive releases was recognised during the last decade (ICRP, 2007; EC BSS, 2013; IAEA, 2014). Also, 
human health is in the long-term directly related to the fitness of the ecosystem. Environmental 
exposures at low dose and dose rate are relevant for many planned exposures situations under normal 
operation conditions (scenarios 2), existing environmental exposure scenarios with regard to legacy 
(scenario 4) and natural radiation (scenario 5), as well as long-term exposures after accidents (scenario 
6).  
The current knowledge about the radiation effects on wildlife was used in the last decade to develop 
appropriate radiological environmental impact assessment tools and to derive the associated protection 
benchmarks. For example, dose rates for reference animal or plants within which there is likely to be 
some chance of the occurrence of deleterious effects (DCRLs, derived consideration reference levels) 
were suggested from 0.1-1 to 10-100 mGy day-1, accounting for the variation in sensitivity of the 
considered wildlife group (ICRP, 2008).  However, most of the available knowledge used to derive such 
benchmarks is related to the risk to individual organisms, whereas populations, ecological function and 
structure, and the preservation of biodiversity are more relevant from a management perspective and 
should be the focus of future studies.  
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On the other hand, there is considerable scientific disagreement on the actual extent of the radiation 
effects on wildlife populations in contaminated areas. Many studies have reported no significant effects 
of radiation on wildlife (e.g. in the Chernobyl and Fukushima exclusion zones), whereas others reported 
significant radiation effects on different wildlife populations at very low dose rates (below natural 
background exposure). This questions the robustness, the representativeness and the scientific 
consensus of actual diagnostic tools with regard to the long-term consequences of radiation exposure 
on non-human biota and ecosystems. This controversy has major implications for the robustness and 
the credibility of the system of radiation protection and resolving it would be a major game changer. 
The robustness of radiological environmental impact assessment can be improved both by the 
understanding of underlying mechanisms that governs the sensitivity of wildlife populations to radiation 
(link with Challenge A for radiation effects on humans), and by an actual understanding of ionising 
radiation effects on key ecosystem processes under realistic conditions, associated with a robust 
exposure assessment (including internal exposure, heterogeneity, differing radiation qualities – link with 
Challenge B) and considering other stress factors.  
To achieve this, the major issues are: 
 To identify the key factors determining the vast variation in the sensitivity of wildlife populations to 
radiation. 
 To characterise the influence of exposures on the populations currently living in contaminated 
environments (whole exposure assessment, including past exposures). 
 To identify and validate biomarkers of exposure and effects that are relevant for effects at the 
population level. 
 To understand the impact of multiple stressors - contaminants and other environmental factors - 
on the effects of radiation. 
 To determine the effects of radiation on ecosystem functioning. 
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The major issues (‘game-changers’) to resolve with potential impact on the radiation protection system 
and or practice in this area are:  
Game Changers Potential impact to the radiation protection system 
and/or practice 
C1. Resolving the controversy with regard to the 
effects on wildlife reported in the Chernobyl and 
Fukushima exclusion zones  
Short term priority activity. This requires to: 
- characterise the influence of exposures on the 
populations currently living in contaminated 
environments (whole exposure assessment, 
including past exposures), 
- identify the key factors determining the vast 
variation in wildlife populations’ sensitivity to 
radiation, 
- - identify and validate biomarkers of exposure 
and effects that are relevant for effects at the 
population’s level. 
The re-interpretation and achievement of robust, 
consensus-based data on the long-term ecological 
effects attributable to radiation in those emblematic 
contaminated territories would have a very significant 
impact on the confidence and credibility level of the 
radiation protection of the environment (e.g., 
robustness of ‘no-effect’ benchmark dose-rates). 
C2. Determine the effects of radiation on 
ecosystem functioning 
Longer term priority activity. 
 
If an increased sensitivity of ecosystem processes (in 
comparison with the reported effects at the population 
level) is demonstrated, this would strongly question the 
robustness of risk assessments that rely only on 
population-effect data. On the other hand, if it is shown 
that the functional or structural redundancy of the 
ecosystems brings greater robustness against the 
effects of radiation, the conservatism of the current 
assessments would be comforted. 
 
 
3.4. Challenge D – Optimising medical use of radiation 
 
Medical use of ionising radiation is the largest source of exposure on average for the population in 
developed countries as in Europe. However, there is a large difference in radiation exposure due to 
medical applications between different European countries and there is also a difference in the medical 
use itself. Therefore it is of great importance for the system of radiological protection to optimise the 
medical application of ionising radiation and to harmonise the practices throughout Europe especially 
with respect to the protection of human health from the harmful effects of ionising radiation and with 
respect to the potential benefit of the use of ionising radiation for the individual patient. The ultimate 
goal of this challenge therefore is to optimise the use of ionising radiation for the diagnosis and 
treatment for each patient on an individualized approach in a standardized way throughout Europe. The 
corresponding research needs to include the basic investigations as well as the transfer into clinical 
routine. 
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The European Commission summarised the different use of ionising radiation between different 
European countries in terms of the average radiation exposure caused by medical applications13. The 
existing technologies are not used or available in the same way for all patients throughout Europe. This 
means that patients in some countries will benefit more from the use of ionising radiation than those in 
other countries, but also that there is potentially more detriment due to the more intensive use of 
ionising radiation. In addition, there are many new emerging technologies in various fields of medical 
applications such as targeted therapies based on ion or proton therapy or targeted radionuclide therapy, 
new technologies for interventional imaging procedures and molecular imaging approaches. 
Optimisation of existing methods can nowadays be achieved by hardware developments as well as by 
data processing tools. One aspect of these data processing methodologies will be the use of artificial 
intelligence for optimised usage of the existing data. Thus, it is obvious that sufficient data structures for 
research and clinical use is a prerequisite for the optimisation of the medical use of ionising radiation 
and the corresponding optimisation of radiation protection. For all new and emerging technologies and 
technological approaches it is necessary to: 
 Develop potentially optimising methods and technologies depending on requirements and needs 
of medical specialities. 
 Optimise and develop accurate individualised patient dosimetry for all organs (and even at sub-
organ level) 
 Optimise the protocols for performing the diagnostic or therapeutic task related to the individual 
patient. 
 Characterise such methods in terms of related exposure, but also image quality or physical therapy 
quality 
 Evaluate and describe their potential benefit and risk taking into account individualized patient 
parameters 
 Transfer such optimised approaches into the clinics 
 Harmonise its use throughout Europe based on evidence. 
 Foster an improved radiation benefit-risk dialogue with patients and the pubic 
This shows that the main focus of challenge D has to be to allow the harmonised use of the most modern 
and beneficial use of ionising radiation throughout Europe, taking into account individual patient 
conditions to guarantee the best possible radiation protection of patients throughout Europe. To 
establish a suitable way of harmonisation it will be necessary to rely on various methods for 
characterisation of the technologies which will partly interact with other challenges. The characterisation 
of exposure is essential especially for the patients but also for the staff involved with a practical 
diagnostic or therapeutic procedure. This has to take into consideration the individual sensitivity or 
susceptibility of the patient. Finally, there has to be a characterisation of the potential benefit i.e. the 
potential accuracy of the diagnostic procedure or the accuracy and related potential beneficial outcome 
of a therapeutic approach. Thus, the characterisation of the procedure is not only necessary in terms of 
exposure but also regarding image quality or therapeutic quality measures. 
 
The major issues (‘game-changers’) to resolve with potential impact to the radiation protection system 
and or practice in this area are: 
 
                                                          
13 RP 180 Medical Radiation Exposure of the European Population, Part 1 
https://ec.europa.eu/energy/sites/ener/files/documents/RP180.pdf and Part 2 
https://ec.europa.eu/energy/sites/ener/files/documents/RP180%20part2.pdf   
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Game Changers Potential impact to the radiation protection system 
and/or practice 
D1. Development of new medical applications or 
optimisation of existing ones depending on disease 
related applications e.g. interventional procedures, 
CT based approaches, targeted therapies in nuclear 
medicine and particle based therapies to improve 
patient protection relying on corresponding 
improved dosimetry procedures for individual 
patients. 
Priority with highest potential to advance optimised 
use and corresponding radiation protection (5Y): new 
interventional procedures, CT based approaches, 
targeted therapies in nuclear medicine and particle 
based therapies 
Long-term research topics: molecular imaging, 
theranostics 
New methodologies or optimised approaches can 
reduce the radiation exposure to each patient while 
maintaining or even improving clinical outcome and 
help to allow similar conditions for patients within 
Europe and require new or even potentially additional 
protection measures. 
The development and characterisation of such 
technologies will need to rely on improved dosimetric 
methods especially those suitable for personalized 
patient dosimetry and quality metrices predicting 
clinical outcome. 
D2. Application and development of AI methods to 
improve patient protection relying on suitable clinical 
data structures and taking into account the limits of 
the use of AI especially in the medical field. 
To make use of the potential of methods based on 
artificial intelligence to optimise and better 
characterise imaging and therapy techniques and to 
analyse patient data.  
Priority with highest potential to make progress in 
applications of AI in medicine in the short term: 
development of suitable data structures to be able to 
use the generated patient data for AI methodologies, 
to understand the limits of the use of AI especially in 
the medical field and develop corresponding test 
configurations 
Longer term research topics: Ethics when applying AI 
based methods for decision (support) systems 
especially regarding radiation based therapies, AI 
based optimisation of individualised procedures 
AI will play a major role in optimising and 
individualising medical applications in all fields. 
However, it is of major importance, that there is a 
profound understanding of the limits of such 
approaches in terms of reliability of results but also in 
terms of ethical implications. AI will allow further 
optimisation and individualisation of procedures and 
thus influence the corresponding radiation protection 
system dramatically, but in the field of medical ionising 
radiation it has to be controlled very well, otherwise 
misleading results might result in detrimental non-
helpful exposures. The European radiation protection 
system has to define standards allowing best potential 
use of AI and thus improve the system for patients and 
industry. 
 
D3. To transfer the (optimised) technologies and 
procedures into clinical / medical practice and 
harmonise it throughout Europe Investigating key 
challenges and problems for the transfer of 
developments into clinical practice, evaluating 
conditions leading to large differences throughout 
Europe, defining standards for justification of 
applications depending on individual patient 
characteristics and benefit-risk evaluations of 
procedures including a dedicated education 
guaranteeing the best possible radiation protection 
for patients is of great importance. 
A strengthened evidence base medicine, a better 
justification as well as a concept for education and 
training together with a clinical transfer concept will 
allow harmonised practises in Europe based on the 
optimised and individualised medical procedures 
using ionising radiation. Therefore the radiation 
protection system for medicine would be harmonised 
and allowing better patient care with harmonised 
exposures throughout Europe. 
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Priority with the highest potential to improve the 
radiation protection system in Europe in the short 
term: Investigating key challenges and problems for 
the transfer of developments into clinical practice, 
evaluating conditions leading to large differences 
throughout Europe, defining standards for justification 
of applications depending on individual patient 
characteristics and benefit-risk evaluations of 
procedures and including a dedicated education and 
training programme 
Longer term research topics: Evaluation of newly 
developed or optimised procedures regarding benefit-
risk outcome (evidence based medicine) Development 
of a framework for clinical transfer and harmonisation. 
 
 
3.5. Challenge E – Improving radiation protection of workers 
 
Exposure to ionising radiation continues to be an important concern in many industries and applications 
in Europe (e.g. nuclear, medical, air travel), including various and often complex exposure scenarios. 
Consequently, radiation protection of workers is a major issue that requires continued improvement.  
Internal exposure assessment of occupational exposure from incorporated radionuclides is still subject 
to major uncertainties, mainly due to activity measurement errors, individual variability and limited 
biokinetic and dosimetric models. The resulting overall uncertainty in the estimated internal dose is 
acknowledged to be generally higher than that for external irradiation. In vivo measurements, for 
example, can provide information on the actual radionuclide activity within the body of an individual. 
However, there is no standard procedure for calibrating the required detection systems (body counters), 
and the anthropomorphic phantoms needed, such as those used to assess the skeletal activity of bone 
seeking radionuclides (e.g. plutonium and americium isotopes) are scarce.  
Furthermore, biokinetic models for various radionuclides and individual parameters (which may also 
include changed body metabolism of patients and effects of decorporation therapies) are still limited, 
and their predictions would benefit from the use of available databases including human autopsy cases.  
For external exposures, monitoring of individual workers will benefit from real-time monitoring of all 
limiting quantities (e.g. whole body, eye lens, extremities, brain, heart) including well characterized 
active and passive dosimeters, or computational approaches using Monte Carlo (MC) techniques.  
In this context, neutron dosimetry raises particular problems. Some neutron applications in industry 
represent well-known but as yet unsolved problems such as the inevitable existence of photons which 
might interfere with the detection of neutrons. Others imply newly evolving problems due to strongly 
pulsed radiation or very high neutron energy ranges, i.e. radiation fields around high-energy particle 
accelerators and during flights at high altitudes or in space missions.  For external exposures, the 
challenge is to assess relevant dose quantities in real-time. This should include all radiation qualities and 
in particular photons and neutrons, static and pulsed fields, and a vast range of radiation energies up to 
GeV. Appropriate neutron reference fields will need to be developed. These efforts, together with 
improvements in procedures for dose optimization and improved protection measures, will significantly 
contribute to a safer use of ionising radiation.  
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Leaving the Earth’s surface to space, humans have to cope with numerous stressors, such as 
environmental changes, disrupted circadian rhythms, isolation, microgravity and heightened levels of 
radiation. Exposure to ionizing radiation has been one of the major concerns since the beginning of 
human spaceflight and represents a critical obstacle to further progress for long-term space missions, 
because individual doses are usually much higher than on Earth. Radiation in space is a complex mixture 
of all particles and energies. The particle energies range from a few eV up to 1020 eV. They are incident 
isotropically and are very penetrating in matter, hard to shield and of high biological effectiveness. The 
radiation field in space is not constant as the energy and fluence spectra are modulated by the solar 
cycle by a factor of two to three with sudden increases due to solar particle events (SPEs) mostly 
occurring during periods of increasing and decreasing solar activity. Moreover, the field is modified by 
planetary atmospheres and surfaces, planetary magnetic fields, spacecraft construction materials and 
lastly by the interaction with the molecules of the human body. Production of secondary particles in 
nucleus-nucleus interactions prevents adequate shielding against galactic cosmic radiation (GCR). The 
challenge is to provide accurate information (energy and particle spectra, dose rates, and 
microdosimetric quantities) in each exposure situation. 
Radon is the most important natural source of ionising radiation with the most important health effect 
being lung cancer. In some cases, this is of relevance for workplaces (mines, water works, spas, caves). 
Environmental monitoring for radon and other radiation hazards needs to be improved according to the 
recently published ICRP Publication 137 on Occupational Intakes of Radionuclides.  In addition, radon 
tracer methods should be included in environmental climate networks such as the Integrated Carbon 
Observation System (ICOS). 
Finally, a key aspect across all applications and domains involving workers’ exposures to ionising 
radiation is the development of radiation protection cultures in support of improved decision-making 
processes regarding the management of exposure situations and the involvement of the relevant 
stakeholders in the identification and implementation of radiological protection actions. 
 
The major issues (‘game-changers’) to resolve with potential impact on the radiation protection system 
and or practice in this area are:  
Game Changers Potential impact on the radiation protection system 
and/or practice 
E1. Development of biokinetic models and 
personalised dosimetry that will lead to the 
improvement of the assessment of internal exposure 
Reduction of the uncertainty of internal dosimetry 
towards the level of external dosimetry 
E2. Development of real time practical individual 
dosimetry of workers by harnessing the 
developments in new connected technologies 
Real-time practical individual dosimetry of workers for 
all organs 
E3. Development of a practical neutron personal 
dosemeter  
Reduction of the uncertainty of neutron dosimetry 
towards the level of gamma dosimetry 
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3.6. Challenge F – An integrated approach to environmental exposure and risk 
assessment from ionising radiation  
Faced with environmental exposure situations (all scenarios except scenario 1 and 3) where various 
environmental and human-population related factors strongly interact, holistic approaches to risk 
assessment are increasingly justified to ensure sustainable and safe use of radioactive substances and to 
protect both human and ecosystem health. Concurrently, integration of scientific, societal and economic 
considerations is needed, if more integrated dose and risk assessment approaches are to be developed 
to meet societal expectations, better inform decision-making and improve risk communication among 
stakeholders. 
As a basis for more robust exposure assessment we need to further improve the understanding and 
associated modelling of radionuclide dispersion and transfer processes in the geosphere and 
biosphere. This needs to include the dispersion and transfer assessment in marine, brackish, estuarine, 
freshwater and terrestrial ecosystems (agricultural, forestry, natural and urban), covering the watershed 
continuum from the source to the ocean and ultimately at the global circulation level. The goal is to 
produce advanced environmental modelling to improve human and environmental dose assessment. 
This goal will most efficiently be reached by collaborating with wider environmental sciences. Models 
should be improved, or developed, to allow for the interaction at the various biosphere interfaces at the 
local, regional and global scales.  
Specific emphasis is required on integrated and holistic assessments. There is a need for the 
improvement/development of innovative methods to characterise the source terms to delineate the 
multiple-hazard footprint (e.g., geostatistical interpretation of environmental, radiological, chemical 
data) of a site in space and time. Innovative modelling approaches are also needed to support decision 
making and to identify the most significant sources of uncertainty related to the impact on human and 
environmental health.  
Such scientific advances would help in the development of improved international guidance on the 
management of legacy sites (e.g. from past NORM activities or accidental exposures); such sites may 
represent relatively higher exposure scenarios. Such sites often represent complex “objects” to be 
managed via a multistage process including site characterization, definition of objectives for 
remediation, impact and risk assessment, and evaluation and selection of remedial options. Each step 
comprises an associated uncertainty analysis, which is of both technical and social in nature.  
 
The major issues (‘game-changers’) to resolve with potential impact to the radiation protection system 
and or practice in this area are:  
Game Changer Potential impact to the radiation protection system and/or 
practice 
F1. Deriving a robust prediction of 
radiological contamination in the human 
food chain, for an integrated dose and risk 
assessment of post-emergency situations 
If successful, the resultant models (largely improved/developed 
based on a thorough assessment of available data and models) 
will be applicable in any relevant environment, to its time-
evolution, to any human/animal food.  
They will especially include future changes in European 
agricultural practices, and, since NPPs are often build on the 
coast, and since in the future more NPPs built on floating vessels 
are expected, we need further developments in marine 
dispersion and biota transfer models. 
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Models developed will be transferable, meaning that they will 
already include the necessary amount of processes that allows 
model applicability to different scenarios. This will result in 
optimized management in the emergency and post emergency 
phase with respect to dose assessment, food chain protection 
and control, remedial actions, economic and societal impact. 
F2. Identifying and quantifying the key 
processes that influence radionuclide 
behaviour in existing environmental 
contamination situations 
Implementation of the new Basic Safety Standards (BSS), 
applying to the management and clean-up of existing sites, as 
well as to the licensing of future discharges and large quantities 
of NORM waste, developing the modelling basis for accurate 
dose assessment and establishment of remediation approaches 
is of important added value to society. This is especially 
important as NORM legacy or operationally impacted sites are 
often close to human habitation. 
F3. Integrating risk assessment and 
management (consistent exposure 
assessments for humans and wildlife;  risk 
integration for radiation and other 
stressors) 
 
An integrated assessment and management approach will 
enable ‘radiation protection’ to make more balanced decision as 
it will take in the ‘whole-picture’ rather than making individually 
for human, wildlife, radiation, chemicals etc. It also represents a 
more defensible approach when communication to stakeholders 
(including the public). 
 
 
3.7. Challenge G – Optimise emergency and recovery preparedness and response 
 
In nuclear or radiological emergency management including accidental exposures, medical follow-up and 
long-term recovery the radiological impact assessment is of prime importance and demands the 
improvement, development and customisation of several new methodologies and advanced tools. 
Among them, we should consider advances in atmospheric, aquatic, terrestrial and urban dispersion 
models, food chain models and dose assessment models, individual monitoring of internal and external 
exposures and dose reconstruction and finally monitoring of the different environmental compartments, 
food and goods.  
One of the future challenges is to develop and combine different modelling and monitoring techniques 
(including data assimilation techniques) to improve the predictions of the impact of an accident. Besides 
advancements in operational monitoring of dose rate values, nuclide-specific information and data on 
ground and air contamination levels, another emerging challenge would be to integrate measurements 
or assessments made by the public. Medical follow-up of (potentially) exposed people, depending on 
the received dose, requires further improvements in biodosimetry, internal and external dosimetry, dose 
reconstruction techniques and methods and optimised measures to reduce contamination and health 
effects.  
To manage the radiological situation in a holistic way, and in order to better build and implement 
countermeasure strategies at different time frames (preparedness, response, recovery), there is a need 
for improved understanding of countermeasures. This includes the development of countermeasures 
and countermeasure strategies as well as their lifting in time. Important issues to be addressed are 
among others development of radiological criteria (notably, Operational Intervention Levels (OIL)), 
effective decontamination strategies (human & environmental), and waste handling from an accident. 
Improved mechanistic (process based) models will aid in better predicting where countermeasures will 
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be required, the effect of some countermeasures in different geographical areas and also the likely 
length of time countermeasures will be required. It is also evident that countermeasure strategies have 
to deal with indirect health consequences, economic, societal and ethical aspects including the 
environmental characteristics. 
An inclusive design and evaluation of countermeasure strategies requires the involvement of all actors, 
including the public in all phases (preparedness for and recovery from accidents), especially those with 
off-site consequences. However, the stakeholder engagement process as such is a challenge that 
requires further developments in the participatory processes in emergency and recovery situations. 
Furthermore, nuclear or radiological emergency response and recovery requires decisions to be made 
with high uncertainty in some critical parameters. This needs advanced decision science, situation 
awareness informatics and the use of big data. 
Effective communication strategies during the preparedness, emergency and in the post-accident 
phases - even with uncertainties - are a key challenge for the success of any measure as they contribute 
to the development and maintenance of trust between experts, authorities and the population, helping 
to better implement countermeasures and manage the recovery. 
Many of these topics are region-dependent. Therefore, preparedness should take into account accurate 
local environmental descriptions of the potential sites of nuclear or radiological emergencies. Models of 
the surrounding environment describing e.g. the population density, biosphere, geosphere and weather 
conditions should be readily available as real-time dose reconstruction and impact assessment will be 
needed at the time of the event to provide decision-makers with recommendations for 
countermeasures. Harmonisation of models across Europe, guidance, including in the availability of tools 
and expertise and preparedness, especially in certain areas of increased environmental and health 
vulnerabilities, emergency response and recovery and lessons learnt during and post the incident, would 
decrease the negative impacts when accidents or incidents occur. Mutual benefit can be obtained by 
collaboration with relevant security-related research. 
The major issues (‘game-changers’) to resolve with potential impact to the radiation protection system 
and or practice in this area are: 
Game Changers Potential impact to the radiation protection system and/or 
practice 
G1. Change of radiological impact 
assessments, decision support and 
response and recovery strategy by 
Artificial Intelligence (AI) and big data 
With AI and big data, new methods for radiological impact 
assessment, a new DSS and improved response and recovery 
strategies can be developed, allowing for example the end user 
to define his or her objectives/goals and the system identifies 
the best possible strategies to achieve the specified 
objectives/goals with pros and cons. AI would also allow all 
stakeholders to evaluate the results in a more comprehensive 
way as all available information – needed by the AI – is available 
and can be searched by big data analysis approaches. This new 
approach requires research in the following areas: 
 Use of AI and big data in radiological impact assessments 
and measurement strategies; 
 Development of a new DSS that uses AI and big data 
capabilities to better guide the end user in countermeasure 
strategy definition; 
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 Databases with historic and scenario information as starting 
point for decision making in new events, needed for the AI 
to learn; 
 Improved communication/dialogue with stakeholders due 
to better information availability; 
 Development of methods to combine uncertainties (e.g. 
Aleatory, Epistemological, Computational) with AI learning 
mechanisms. 
G2. Further development of risk 
assessment and risk management 
approaches, technological capabilities to 
cope with novel threats and accident 
scenarios arising from new and future 
nuclear and radiological technologies, 
including further development of 
monitoring and dosimetry techniques 
With the evolution of new civilian and military nuclear and 
radiological technologies and changing global and regional 
threats, risk assessment and risk management must evolve as 
well. In this respect, event scenarios, improved early detection, 
source inversion modelling and new methods to develop 
countermeasure strategies – based on indicators – are required. 
Research areas requiring attention are: 
 Event scenarios, including assessment of potential source 
terms and evolution of events; 
 Inverse modelling, data assimilation; 
 Monitoring strategies with mobile and advanced monitors, 
relying on citizen science approach and providing early 
detection of threats; 
 Combination of monitoring (including citizen monitoring) 
and simulation of an updated operational picture; 
 Development of indicators for strategies that can be applied 
even with little information on the affected area; 
 Establishment of dialogue/communication with decision 
makers and concerned stakeholders to challenge the 
proposed approach on risk assessment and risk 
management. 
 
 
3.8. Challenge H – Radiation protection in society 
 
Significant progress has been made on the inclusion of social sciences and humanities insight to the 
radiation protection field. Work remains to improve further integration between the technical content 
and the societal context within which RP operates. Therefore, research and innovation in radiation 
protection needs to be better aligned with the values, needs and expectations of society in order that 
scientific research can inform decision making more effectively and for innovations to be responsive to, 
and acceptable by, societal need. The character of social science and humanities research requires that 
attention to the Social Science and Humanities (SSH) research priorities is essential across all scenarios 
and is of relevance over all previously stated Challenges. 
Without effective means for RP research to reach societal actors, (stakeholders, policy makers, publics) 
RP knowledge and innovations will fail to generate societal benefits. Concurrently, without openness to 
inputs from societal actors’ values and perspectives, the RP knowledge and innovation communities will 
fail to address social concerns and political priorities. Thus, meaningful interactions between the 
technical and societal spheres are essential. Core SSH research concerns, therefore, relate to: defining, 
building and maintaining effective, two-way communications structures and cultures; development of 
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the processes necessary for relationship and trust building; formulation of new approaches to inclusive 
governance; and development of novel forms of engagement to reach all relevant communities. 
 
The RP community has to consider the social and ethical justification of exposures to ionizing radiation, 
under all circumstances, and, accordingly, to develop appropriate radiation protection cultures. The 
organisation of radiation protection research and the formulation of its policies are shaped by multiple 
factors (economic priorities, cultural values, institutional interests, stakeholder negotiation, the exercise 
of power) and these require constant, critical examination and for reflexivity within communities to be 
enabled. In line with global calls for Responsible Research and Innovation, radiation protection culture 
should support a reflexive, inclusive and anticipatory stance within the science, technology and 
innovation communities of the radiation protection field. Core SSH research priorities therefore include: 
characterization of existing structures, cultures and processes; development of novel methodological 
approaches to take account of socio-technical integration; and advancement of an open and 
transparent, anticipatory research culture among RP communities. 
 
The major issues (game changers) that would have a substantial impact on the radiation protection 
system are: 
Game Changers Potential impact to the radiation protection system and/or practice 
H1. Better alignment of 
research and practice in RP with 
the values, needs and 
expectations of society. 
This will be achieved through:   
- Effective research 
translation mechanisms;  
- Development of systematic 
approaches to inclusion of 
societal dimensions at all 
levels of the RP system and 
- Methodological innovation 
enabling transdisciplinarity 
in radiation protection 
research. 
 
Effective research translation mechanisms will ensure generation of robust 
radiation protection knowledge that aligns societal and technical 
dimensions.  
This will result in new theory on knowledge exchange mechanisms 
between technical and societal spheres to underpin new practice; 
empirical evidence of the effectiveness of, and limitations to, current 
communicative structures and cultures to identify areas of action; and 
highlighting novel forms of citizen engagement, including advancement of 
innovative technological interventions. 
Development of systematic approaches to inclusion of societal dimensions 
at all levels of the RP system will ensure that RP research, policy and 
practice are responsive to the values and interests of diverse actors. 
Development of mechanisms for integration of responsible research and 
innovation within RP communities and integration of models of 
anticipation into RP practice will enable development of reflexive research 
cultures within RP and improve radiation protection. 
Improvements in the research, governance and practice of radiation 
protection will emerge that are based on advancements in the co-
production of RP knowledge between science and society. This will inform 
RP policy and practice, through consideration of the ethical and social 
dimensions of the RP system, including attention to cultural diversity. 
Methodological innovations will enable collaboration between different 
disciplines and between different societal actors in transdisciplinary 
research environments. Development of social indicators will support the 
evaluation of the alignment of research and practice in RP with the 
values, needs and expectations of society.    
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3.9. Summary list of game changers 
 
In Table 3 a summary list of game changers defined in the different research challenges is presented, 
together with the radiation protection research platforms involved and the potential end users 
interested in the execution of the research.   
Table 3 Game Changer list, involvement of radiation protection research platforms and intended end users 
Game 
Changer 
No 
Game Changer title 
RPR platforms 
involved 
End users 
A1 
Define the risks of non-cancer diseases at low and 
intermediate dose levels (100 - 500 mGy and below). 
MELODI 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
A2 
Integration of epidemiological estimates of cancer risk 
with a more complete understanding of radiological 
disease pathogenesis to improve cancer risk assessment 
MELODI, EURAMED, 
SHARE 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
A3 
Characterisation and quantification of variation in 
radiation response and risk between population sub-
groups/individuals due to genetic factors, sex, co-
morbidities, dedicated exposure of diseased areas in 
patients, environmental and lifestyle factors and the 
interactions between these depending on dose-levels. 
MELODI, EURAMED 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
A4 
Define how the temporal and spatial variations in dose 
delivery affect the risk of health effects following 
radiation exposure. 
MELODI, EURADOS 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
B1 
To improve the understanding of spatial correlations of 
radiation interaction events by improved measurement 
and simulation techniques. 
EURADOS, MELODI 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
B2 
To quantify correlations between track structure and 
radiation damage 
EURADOS, MELODI 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
C1 
Lifting the controversy with regard to the effects on 
wildlife reported in the Chernobyl and Fukushima 
exclusion zones 
ALLIANCE, MELODI, 
EURADOS, NERIS, 
SHARE 
UNSCEAR, 
ICRP, IAEA, 
Legislators, 
and regulators 
C2 
Determine the effects of radiation on ecosystem 
functioning 
ALLIANCE, MELODI, 
EURADOS, NERIS, 
SHARE 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
D1 
Develop new medical applications or optimize existing 
ones depending on disease related applications e.g. 
interventional procedures, CT based approaches, targeted 
therapies in nuclear medicine and particle based 
therapies, to improve patients protection relying on 
corresponding improved dosimetry procedures for 
individual patients 
EURAMED, 
EURADOS, MELODI 
Health care 
providers, 
legislators and 
regulators 
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D2 
Application and development of AI methods to improve 
patient protection relying on suitable clinical data 
structures and taking into account the limits of the use of 
AI especially in the medical field. 
EURAMED, SHARE 
Health care 
providers, 
legislators and 
regulators 
D3 
Investigating key challenges and problems for the transfer 
of developments into clinical practice, evaluate conditions 
leading to large differences throughout Europe, defining 
standards for justification of applications depending on 
individual patient characteristics and benefit-risk 
evaluations of procedures, a dedicated education 
guaranteeing the best possible radiation protection for 
patients 
EURAMED, 
EURADOS, SHARE 
Health care 
providers, 
legislators and 
regulators 
E1 
Development of biokinetic models and personalised 
dosimetry that will lead to the improvement of the 
assessment of internal exposure 
EURADOS, 
EURAMED, MELODI 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
E2 
The development of real time practical individual 
dosimetry of workers by harnessing the developments in 
new connected technologies  
EURADOS, 
EURAMED 
Operators, 
regulators 
E3 Development of a practical neutron personal dosemeter  EURADOS  
Operators, 
regulators 
F1 
Getting a robust prediction of the human food chain 
radiological contamination, for an integrated dose and 
risk assessment of (post)emergency situations 
ALLIANCE, MELODI, 
EURADOS, NERIS, 
SHARE 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
F2 
 Identifying and quantifying the key processes that 
influence radionuclide behaviour in existing 
environmental contamination situations 
ALLIANCE, MELODI, 
EURADOS, NERIS, 
SHARE 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
F3 
Integrating risk assessment and management (consistent 
exposure assessments for humans and wildlife; risk 
integration for radiation and other stressors) 
ALLIANCE, MELODI, 
EURADOS, NERIS, 
SHARE 
UNSCEAR, 
ICRP, IAEA, 
legislators, and 
regulators 
G1 
Change of radiological impact assessments, decision 
support and response and recovery strategy by Artificial 
Intelligence and big data 
NERIS, ALLIANCE, 
SHARE, EURADOS 
UNSCEAR, 
ICRP, IAEA, 
legislators, 
regulators, 
local 
authorities 
G2 
Further development of risk assessment and risk 
management approaches and technological capabilities to 
cope with novel threats and accident scenarios arising 
from new and future nuclear and radiological 
technologies 
NERIS, ALLIANCE, 
SHARE, EURADOS 
UNSCEAR, 
ICRP, IAEA, 
legislators, 
regulators, 
local 
authorities 
H1 
Better alignment of research and practice in RP with the 
values, needs and expectation of society, through 
effective research translation mechanisms, development 
of systematic approaches to inclusion of societal 
dimensions at all levels of the RP system and 
methodological innovation enabling transdisciplinarity in 
RP research 
SHARE, MELODI, 
EURADOS, NERIS, 
ALLIANCE, 
EURAMED 
Radiation 
protection 
community 
and society 
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4. Graphical presentation of the joint research challenges and game 
changers 
In order to estimate the type of research needed and the time frame needed to achieve the goals, the 
joint research challenges are presented in a graphical way. The game changers are accompanied by the 
number as presented in Chapter 3 and in Table 3, to show how related research could be planned when 
resources are available. 
Some of the research shown in one particular graphical presentation may be strongly related with 
research in another joint research challenges. Non-exhaustive examples are studies related to individual 
sensitivity in Game Changer A3, which is also relevant in challenge D, or challenge G that strongly relies 
on new knowledge related to various other challenges. These examples show the need of concerted 
actions and strong collaboration between the different research fields in radiation protection. 
The timelines of the graphs are different, according to the ability to plan research in the different fields. 
The timelines should be considered as rough guides, because the implementation of the roadmap 
depends on the resources available as presented in Chapter 5, and on external factors such as advances 
in research outside the radiation protection area, or on changes in the society or the environment. 
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5. Resources for radiation protection research 
5.1. Human resources: More than 200 organisations contribute to the European joint 
radiation protection research 
 
A rough estimate of the research groups currently active in the integration efforts within radiation 
protection research in Europe can be obtained by counting the members of the European radiation 
protection research platforms and the research groups involved in EJP CONCERT (Annex 1). However, 
the list in Annex 1 is not exhaustive, and in particular many additional universities have research groups 
active in radiation protection research. 
The platforms succeeded to gather most research groups active in their fields of research in a successful 
attempt to combat fragmentation of research and to pool a critical mass. More than 170 organisations 
are members in the six thematic platforms (associations), and more than 90 entities are involved in 
CONCERT. In total more than 200 organisations contribute to European joint radiation protection 
research. They have joined forces to create and update the strategic agendas and to carry out RP 
research. One third of the organisations listed in Annex 1 are universities (72/210). Within CONCERT, 
organisations have been mobilised in most European countries (25/28); only small countries such as 
Cyprus, Malta and Luxembourg apparently have not yet joined the European brainstorming task forces 
permitting an inclusion of their national research activities related to radiation protection. 
In Table , a summary of the number of members of the different platforms is presented. It must be noted 
that the membership structures are different. Overall, the institutional members include research 
institutes, universities, National bodies, funding agencies, hospitals, associations, SMEs, International 
Organisations and a few individuals. 
Table 4 Members of the different radiation protection research platforms. The institutional and university 
members represent groups of researchers active in the relevant radiation protection research disciplines. (*) 
Included in the category members representing multiple researchers are research institutes, universities, national 
bodies, hospitals and SMEs. 
Platform members representing 
overarching associations 
members representing 
multiple researchers (*) 
Individual members 
MELODI 4: ESR, ESTRO, EANM, KVSF 40 Europe + 1 Canada 9 (7 + 2 honorary) 
EURADOS 0 74 620 
NERIS 1: CEPN 
54 Europe + 9 Ukraine, 
Belarus, JP, Russia, 
0 
ALLIANCE 0 30 0 
EURAMED 
5: EANM, EFOMP, EFRS, ESR, 
ESTRO 
7  
SHARE 1: CEPN 21 2 
 
 
In this first attempt ever to provide an overview of human resources available in Europe for radiation 
protection research, it is not possible to obtain an exact number of researchers. However, within the 
different domains together, a few thousands of researchers devote at least part of their working time to 
radiation protection research.  
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Whereas the EURATOM funded projects have supported the integration between research disciplines 
and collaboration between the different Member States, Table  and Annex 1 demonstrate through the 
existence of numerous research groups in institutes and universities that the majority of resources for 
radiation protection research is provided by their Member States. Therefore, it can be deduced that the 
sustainability of the research community is mostly provided by national funding sustaining research 
infrastructures, supporting lifelong research positions and running education programmes. 
Annex 1 demonstrates the broad range of entities engaged in radiation protection research. As 
envisaged by the HLEG in 2009, the initial idea was to bring together national funding bodies, for the 
establishment   of   a   trans-national   organisation   capable   of   ensuring   an   appropriate governance  
of  research  in  this  field,  and  a  scientific  strategy capable  of  structuring  future  research  in  the  
most  effective  way,  taking  into  account available resources. Since then, it has become clear that very 
few of the national academies fund radiation protection research. Such funding is mainly channeled via 
the institutional budgets and via special budgets of the responsible ministries. While there are 
arrangements and dedicated programs for nuclear safety research in countries using nuclear energy, 
similar funding arrangements often do not exist within the radiation protection research area. Not all 
Member States have a national funding organization or other national programmes covering radiation 
protection research. This is a serious problem which is jeopardizing co-funding activities on the European 
level or is even inhibiting participation of research partners from specific countries to participate in this 
kind of European programmes.  
5.2. Future resources needed for the joint roadmap 
The practical implementation of the joint roadmap for radiation protection research will strongly depend 
on the resources available. The different Game Changers defined in Chapter 3 are graphically presented 
with timelines that are subject to the availability of funding and other resources. The joint roadmap is 
therefore a living document and will be updated by time. New challenges may arise that need attention 
while some questions may be solved sooner than anticipated. 
A. Needs based on game changers 
The game changers were derived from the joint research challenges from the perspective of the societal 
benefit, i.e. protecting the people, the environment, the society and future generations from the harmful 
effects of ionizing radiation, without unnecessarily limiting the application of radiation for the benefit of 
mankind. These game changers are highly multidisciplinary and require a supranational coordination and 
collaboration. Therefore, funding at European level is essential.  Next to European alignment, the 
integrative approach may benefit from national networks, such as CORES, PEPRI and the BCRPR. These 
networks can strengthen the efficacy of the nationally funded research groups in the different types of 
institutes / universities, which are the basic foundations of radiation protection research, in need of 
continuous and predictable funding to ensure persisting engagement and attraction of experts and 
responsible for keeping up to date their infrastructures. 
Whereas EURATOM is the core funding programme of nuclear and related research, the research 
proposed within the game changers has a broader societal perspective and some areas are strongly 
related to domains outside the EURATOM programme. For example, medical radiation protection 
research shows clear links to the HEALTH programme, topics requiring artificial intelligence would 
benefit from collaboration with ICT and HEALTH programmes; the radioecology related topics would 
benefit from collaboration with ecotoxicology or the consequences of climate change; and emergency 
management and preparedness may benefit from security research programmes. Similar analogies can 
be found for the basic research disciplines involved in radiation protection research (e.g. bioinformatics, 
physics, earth sciences, cancer research, etc.). Therefore, it is proposed to allow funding on national and 
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EURATOM level as core funding, complemented with coordinated co-funding to reach out and 
collaborate with related RTD programmes outside EURATOM.  
B. Development of the research community: the need for education and training 
The Joint Roadmap lays out an ambitious programme of radiation protection research over the next 
twenty to thirty years.  The subject has been developing in breadth since the beginning of the use of 
radiation for medicine and then power generation.  The early science of radiation protection was mainly 
limited to the physics of radiation shielding, and experimental radiobiology.  The new research has split 
into six different areas represented by the six platforms, and has embraced new technologies including 
bioinformatics, powerful computing, and big data.  This places great demands on the skills and resources 
of the research community.  But, as well as changes in the scientific domain, the demographics of the 
community have been changing, both due to population aging, and changing pressures in the work 
environment.  Pioneering researchers are now retiring; the subject is no longer as fashionable as it was 
during the infancy of nuclear power; students are struggling to find secure career appointments against 
competition from health and environment research. 
All these factors point to the same directions: to carry out the research programmes called for here, 
there must be a coordinated and strongly supported built-in programme of education and training to 
maintain and develop the human resources. This programme must be broad in scope: attracting new 
entry-level students into the topic area, providing project opportunities for MSc and PhD students, 
continuing professional development of researchers, support for researcher career paths, and 
knowledge management to ensure the researchers of today benefit from the experience and knowledge 
of the previous generation as well as current developments. 
Over the last ten years, through the Network of Excellence DoReMi and the European Joint Programme 
CONCERT, the EC has funded an annual programme of short courses giving students a free hands-on 
introduction to research topics.  It has also provided travel grants to enable students and early career 
researchers to present their work at conferences, attend courses, or go for exchange visits to 
laboratories.  A firm long-term commitment for this type of support will be essential.  Support should 
also be given to EURAYS (European Radiation Research Association for Young Scientists).  This is a 
network for early career researchers in radiation protection that was originally set up in 2013 on a pro 
bono basis and is now being restructured to provide sustainability.  An essential part of sustainability will 
be attracting supporting sponsorship to cover costs. 
Next to education and training of young researchers entering the field of radiation protection research 
there is a need for lifelong learning programmes to enable researchers to enter emerging research fields 
within the course of their research careers. In addition, the education and training programmes within 
radiation protection research are part of the dissemination needed to bring results of the research to 
the end users. In this perspective, we also need to link E&T activities in research with E&T organized for 
radiation protection practice. Education and training activities are therefore inherent to the 
implementation of the joint roadmap, providing research for an improved radiation protection system 
and practice. 
C. Infrastructures under fair policies 
Inventory of European infrastructures and future needs having revealed that most necessary 
infrastructures are already available somewhere in Europe or other countries. We need to make better 
use of existing competences and research infrastructures in Europe. The current challenge is to facilitate 
their access by increasing their visibility, to favour their sustainability beyond national short-term 
economic constraints and to support exchange visits for their use. 
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Next steps will rely into further harmonisation of quality standards, practices and protocols in relation 
to the use of infrastructure including the implementation of intercomparisons. Huge efforts will be 
dedicated to sample/data acquisition and sample/data storage with the aims to re-use of archived 
materials. We will propose trans-national agreement on a strategic work plan for maintenance, updating, 
mutual use and new needs of suitable infrastructures. Meanwhile, education and training actions will 
promote the use of European research infrastructures the advantage of using newer, larger, faster, more 
powerful infrastructures although not at the bench of each user. 
 
6. Implementation of the joint roadmap: vision of the joint roadmap 
working group 
The implementation of the lines of research described in the Joint Roadmap and the graphical 
representations in Chapter 4 call for coordination of resources and timely investments.  The members 
of the RP research platforms represent a major resource of human competence as well as research 
infrastructures, focused on joint objectives. Based on the obvious success of the radiation protection 
research platforms and the SRAs, and on the experiences on integration of research within FP7 (mainly 
within the DoReMi, OPERRA and COMET projects) and H2020 (mainly within EJP CONCERT and 
MEDIRAD), we propose a long-term call planning system to turn the joint roadmap into reality.  Efforts 
to integrate the research community on a national and European level should be continued and 
additional efforts should be devoted to international cooperation on topics of mutual interest, in order 
to bring together the critical mass of scientists and knowledge. On the other hand, the implementation 
actions should be compatible with the different financial structures in European Member States, the 
European level and should allow sustainability of research activities within and outside Europe.  
Despite the success of the RP platforms, joint planning between the national programmes and the 
Euratom programme have not kept in step with each other.  Requirements for national co-funding in 
EURATOM research has been a major issue due to the incompatibilities of EU and national rules, and the 
highly variable national rules. The funding rules of the European Commission and of Member States 
should be made compatible in a way that discrimination against research partners solely due to co-
funding problems in Member States is avoided.  
Open, competitive calls to organize research in radiation protection according to the joint roadmap need 
to be pursued. They pave the way to excellent science and to fair chances for research groups from all 
kind of research institutions to participate in radiation protection research in Europe based on their 
scientific merits. Scientific excellence should remain the major and most important criterion in peer 
reviewing of proposals. Further attention should be paid to the preparation of call texts and conditions 
in order to address special European requirements and needs in radiation protection and the added 
value of the European integration efforts.  The management of calls by an administration that is isolated 
from the research community like in EJP CONCERT should be favoured. Evaluation of proposals should 
be provided by experts free from conflict of interest but having experience in European radiation 
protection needs. 
Whereas EURATOM is the core funding programme of nuclear and related research, the research 
proposed within the game changers has a broader societal perspective and some areas are strongly 
related to domains outside the EURATOM programme. For example, medical radiation protection 
research shows clear links to the HEALTH programme, topics requiring artificial intelligence would 
benefit from collaboration with ICT and HEALTH programmes; the radioecology related topics would 
benefit from collaboration with ecotoxicology or the consequences of climate change; and emergency 
management and preparedness may benefit from research in other accident scenarios or security 
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research programmes. While recognising that there are budgetary constraints to realise joint funding 
between programmes under separate treaties, this aim should be pursued anyway, for the benefit of 
science and society. Supporting research on medical radiation protection should not come on the 
expense of other RP research fields. 
To complement the research activities, a strongly directed comprehensive programme of education and 
training will be needed.  E&T is an essential component of the research process.  As presented in Chapter 
5, an actively supported programme of E&T is needed to develop and maintain the research community.  
Further to this, all research projects must be required to allocate a proportion of their budget to E&T 
activities.  Horizon 2020 has set a minimum level of 5% and this should at least be continued.  The E&T 
activities would include provision of project opportunities for MSc and PhD students, as well as hosting 
seminars, workshops, and courses on topics in the research area.  E&T is an important element of 
dissemination and impact creation, providing an outreach to related professionals and stakeholders, 
both for communicating new knowledge and for seeking feedback.  For such a comprehensive E&T 
programme to function in a coordinated way there must be top-down direction and support.  This 
requires dedicated funding, either as part of an umbrella programme such as an EJP, or as a separate 
call. 
The establishment of a sustainable European radiation protection research programme could be 
facilitated by (1) co-programming,  (2) by a strong European joint programming consortium linked with 
the wider research community and allowing open calls with co-funding rules that do not exclude any 
potential partners, and by (3) an institutionalised permanent joint programme secretariat suited for long 
term challenges and priorities. Beside strong institutional partners from member states responsible for 
running national radiation protection research programmes and/or funding such programmes, the 
platforms should be involved to sustain and further improve the network of the radiation protection 
research community and assessment of state of the art and priority setting. These options need to be 
investigated thoroughly and the best option selected to meet the needs described in this chapter. 
Essential elements are open, competitive calls to organize research in radiation protection according to 
the joint roadmap, the implementation of an independent call management unit operating behind a 
firewall to restrain undue interference by potential applicants, and inclusion of E&T activities, such as 
project opportunities for MSc and PhD students. A long-term commitment of EURATOM would allow for 
the implementation of an ambitious, integrative and sustainable radiation protection research roadmap 
shaped by societal challenges.  
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7. Annexes 
7.1. Annex 1: List of Platform members and EJP-CONCERT partners 
Organizatio
n  
Acronym 
Name Organization 
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te
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E
R
T
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E
LO
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N
C
E
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R
A
D
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S
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IS
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R
A
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S
H
A
R
E
 
AIST 
National Institute of 
Advanced Industrial 
Science and Technology 
Research 
Institute 
Japan         1     
AIT 
Austrian Institute of 
Technology GmbH 
Research 
Institute 
Austria       1       
ALLIANCE 
ASSOCIATION ALLIANCE 
EUROPEENNE EN 
RADIOECOLOGIE 
Association France BEN             
ANR 
ANR - Agence National de 
la Recherche, France  
Funding 
Agency 
France BEN             
APA 
Environmental protection 
agency - Portugal 
National 
Body 
Portugal BEN       1     
APHP 
Assistance Publique 
Hopitaux de Paris 
Hospital France TP             
AWE 
Atomic Weapons 
Establishment plc. 
Research 
Institute 
United 
Kingdom 
      1       
Berthold Berthold Industries SME Germany       1       
BfS 
Bundesamt für 
Strahlenschutz, BfS 
Research 
Institute 
Germany 
Coord/ 
BEN 
1 1 1 1 1 1 
CAATS 
Centre d’Assurance de 
qualité des Applications 
Technologiquesdans le 
domaine de la Santé  
 
SME France TP             
CAM AC UK University of Cambridge University 
United 
Kingdom 
 Subco
ntract 
      1     
Cavendish 
Nuclear 
Cavendish Nuclear Ltd SME 
United 
Kingdom 
      1       
CC UOI University of Ioannina University Greece         1     
CEA 
Commissariat à l'Energie 
Atomique et aux Energies 
Alternatives  
Research 
Institute 
France BEN 1 1 1       
CEH 
Centre for Ecology and 
Hydrology (CEH) 
Research 
Institute 
United 
Kingdom 
LTP   1         
CEPN 
radiation protection R&D 
center - NPO 
Association France LTP       1   1 
 
CERAD-
NMBU 
Centre for Environmental 
Radioactivity (CERAD) 
Research 
Institute 
Norway LTP  1 1   1   1 
CERN 
European Organisation for 
Nuclear Research 
International 
Organization 
Switzerla
nd 
      1       
CESNEF Politechnico di Milano University Italy       1       
CIEMAT 
Centro de 
InvestigacionesEnergéticas
Medioambientales y 
Tecnologicas 
Research 
Institute 
Spain BEN   1 1 1   1 
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CLOR 
CentralneLaboratoriumOc
hronyRadiologicznej 
(CLOR) 
Research 
Institute 
Poland     1         
CND 
Centro Nacional de 
Dosimetrica 
Research 
Institute 
Spain       1       
Collegium 
Civitas  
Collegium Civitas 
Research 
Institute 
Poland             1 
Controlatom VincotteControlatom 
Research 
Institute 
Belgium       1       
CRIEPI 
Central Research Institute 
of Electric Power Industry 
Research 
Institute 
Japan TP       1     
CTU 
CESKE 
VYSOKEUCENITECHNICKE 
V PRAZE Czech Technical 
University 
University 
Czech 
Republic 
     1       
DEMA 
Danish Emergency 
Management Agency 
(DEMA, Denmark)  
National 
body 
Denmark BEN       1     
Dialogik Dialogik 
non-profit 
research 
institute 
Germany TP       
DIT 
DUBLIN INSTITUTE OF 
TECHNOLOGY, DIT 
Research 
Institute 
Ireland TP             
DMI 
Danish Meterological 
Institute 
Research 
Institute 
Denmark  LTP       1     
DOSILAB DOSILAB AG SME 
Switzerla
nd 
      1       
DOZIMED Dozimed Ltd SME Romania       1       
DSA 
Norwegian Radiation and 
Nuclear Safety Authority 
National 
body 
Norway BEN 1 1 1 1     
DTU 
Technical University of 
Denmark 
University Denmark LTP       1     
DurhamUni UNIVERSITY OF DURHAM University 
United 
Kingdom 
LTP             
DWD 
Germany's National 
Meteorological Service 
National 
body 
Germany         1     
EANM 
European Association of 
Nuclear Medicine 
Association Austria   1       1   
EEAE 
The Greek Atomic Energy 
Commission 
National 
body 
Greece BEN 1   1 1   1 
 
EFOMP 
European Federation of 
Organisations for Medical 
Physics 
Association 
United 
Kingdom 
  1       1   
EFRS  
European Federation of 
Radiographer Societies 
Association 
The 
Netherla
nds 
  1       1   
EIMV 
Milan Vidmar Electric 
Power Research Institute 
Research 
Institute 
Slovenia         1     
Else Nuclear Else Nuclear srl SME Italy       1       
ENCONET nuclear research institute 
Research 
Institute 
Croatia         1     
ENEA 
National Agency for New 
Technology, Energy and 
the Environment 
National 
body 
Italy BEN 1   1 1     
  
 
 
page 51 of 57 
Deliverable D3.7  
ENSTII 
EUROPEAN NUCLEAR 
SAFETY TRAINING AND 
TUTORING INSTITUTE 
Association France LTP             
EPA 
Environmental Protection 
Agency 
National 
body 
Ireland BEN   1   1     
ESR 
European Society of 
Radiology 
Association Austria   1       1   
ESTRO  
the European SocieTy for 
Radiotherapy & Oncology, 
Association Belgium   1       1   
EURADOS 
EUROPEAN RADIATION 
DOSIMETRY GROUP 
Association Germany BEN     1       
EURAMED 
EUROPEAN ALLIANCE FOR 
MEDICAL RADIATION 
PROTECTION RESEARCH 
(EURAMED) 
Association Austria BEN         1   
Faculty of 
Medicine 
Faculty of Medicine, 
University of Osijek 
University Croatia       1       
FANC 
Federal Agency of Nuclear 
Control 
National 
Body 
Belgium         1     
FCT  
FCT - Fundacao para a 
Ciencia e Tecnologia / 
Foundation for Science 
and Technology, Portugal  
Funding 
Agency 
Portugal BEN             
FEERCObnin
sk 
Federal Environmental 
Emergency Response 
Centre of Roshydromet 
National 
Body 
Russia         1     
FMBA 
Federal Medical 
Biophysical Centre 
Research 
Institute 
Russia       1       
FMU 
Fukushima Medical 
University 
University Japan TP       1     
FOPH 
Federal Office of Public 
Health 
National 
body 
Switzerla
nd 
BEN       1     
FSS-Uni-LJ UNIVERZA V LJUBLJANI University Slovenia LTP             
FU Fukushima University University Japan     1   1     
GIG 
Główny Instytut Górnictwa 
(GIG) 
Research 
Institute 
Poland BEN   1         
GRS 
Global Research for Safety 
- non profit organisation 
Research 
Institute 
Germany         1     
GSI 
GSI HELMHOLTZ 
ZENTRUM FUER 
SCHWERIONENFORSCHUN
G GMBH 
Research 
Institute 
Germany LTP             
GU University of Gothenburg University Sweden         1     
GUF 
Goethe-University, 
Frankfurt am Main 
University Germany TP             
HMGU 
Helmholtz Zentrum 
München, Deutsches 
Forschungszentrum für 
Gesundheit und Umwelt 
Research 
Institute 
Germany BEN 1 1 1       
HU Hiroshima University University Japan         1     
HUG 
HôpitauxUniversitaires de 
Genève 
Hospital 
Switzerla
nd 
TP             
HZDR 
Helmholtz-Zentrum 
Dresden-Rossendorf 
(HZDR) 
Research 
Institute 
Germany LTP   1         
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IAEA 
International Atomic 
Energy Agency 
International 
Organization 
Austria       1       
IFA  
IFA - Institutul de 
FizicăAtomică, Romania  
Research 
Institute 
Romania BEN             
IFIN-HH 
INSTITUTUL NATIONAL DE 
CERCETARE -
DEZVOLTAREPENTRUFIZIC
A SI INGINERIENUCLEARA 
"HORIAHULUBEI" (IFIN-
HH) 
Research 
Institute 
Romania LTP             
IFJ 
Institute of Nuclear 
Physics 
Research 
Institute 
Poland LTP     1       
JSI Jožef Stefan Institute Research 
Institute 
Slovenia BEN     1 1     
IMP 
Nofer Institute of 
Occupational Medicine 
Research 
Institute 
Poland       1       
IMROH  
Institute for Medical 
Research and 
Occupational Health  
Research 
Institute 
Croatia BEN 1 1   1     
IN2P3 
National Institute of 
Nuclear Physics and 
Particle Physics (IN2P3 - 
CNRS) 
Research 
Institute 
France     1         
INFN  
IstitutoNazionale di 
FisicaNucleare 
Research 
Institute 
Italy   1   1       
IORH 
SERBIAN INSTITUTE OF 
OCCUPATIONAL HEALTH 
Research 
Institute 
Serbia       1       
IOV IstitutoOncologico Veneto 
Research 
Institute 
Italy TP 1           
IPCESCOLA S 
 
IPC-Escola Superior de 
Tecnologia da Saúde de 
Coimbra 
University Portugal           1   
IPH Institute of public Health 
National 
body 
Macedon
ia 
      1       
IPOP 
InstitutoPortugues de 
Oncologia do Porto 
Research 
Institute 
Portugal       1       
IR 
Institute of Radiobiology 
of NAS of Belarus 
Research 
Institute 
Belarus         1     
IRA 
University Institute for 
Radiation Physics 
Research 
Institute 
Switzerla
nd 
  1   1       
IRSN 
Institut de 
Radioprotection et de 
SuretéNucléaire 
Research 
Institute 
France BEN 1 1 1 1 1 1 
 
IS CAS 
Institute of Sociology of 
the Czech Academy of 
Sciences 
Research 
Institute 
Czech 
Republic 
            1 
IS Global  Institut de Salut Global  
Research 
Institute 
Spain LTP 1     1   1 
ISS 
InstitutoSuperiore di 
Sanita 
Research 
Institute 
Italy BEN 1   1       
IST  Instituto Superior Técnico 
Research 
Institute 
Portugal LTP 1 1 1 1     
IU School IU School Association 
United 
States 
TP             
JCU  
University of South 
Bohemia 
University 
Czech 
Republic 
  1         1 
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JRC-ISPRA 
European Commission – 
Joint Research Centre 
Research 
Institute 
Internati
onal 
        1     
Juelich 
FORSCHUNGSZENTRUMJU
LICH GMBH 
Research 
Institute 
Germany LTP             
JYU  University of Jyväskylä University Finland             1 
KCOR 
National Centre for 
Radiation Protection in 
Health Care 
National 
body 
Poland       1       
KIT 
Karlsruhe Institute of 
Technology 
Unversity Germany LTP 1   1 1     
KNMI 
The Royal Netherlands 
Meteorological Institute 
Research 
Institute 
The 
Netherla
nds 
TP             
KU  
Kingston University, 
London 
University 
United 
Kingdom 
            1 
KVSF  
Network of Competence in 
Radiation Research ,  
Association Germany   1           
Landauer Landauer SME France       1       
LARUEX 
University of Extremadura: 
LARUEX 
University Spain     1         
LEGMC 
Latvian Environment, 
Geology and Meteorology 
Centre (LEGMC) 
National 
Body 
Latvia       1       
LUH 
Leibniz Universität 
Hannover 
University Germany     1         
MarkkuLeht
onen  
historian/nuclear 
governance 
individual Finland             1 
MBS AC UK 
Manchester business 
school 
University 
United 
Kingdom 
        1     
MED LU 
Lund medical faculty of 
medicine 
University Sweden         1     
MedUni 
Vienna  
MedUni Vienna - Medical 
University of Vienna, 
Austria  
University Austria BEN 1           
MELODI Association Melodi Association France BEN             
MERIENCE  
Promoting dialogue to 
inspire solutions for 
complex environmental & 
socio-technical challenges 
SME Spain             1 
MET.no Norwegian Met Institute 
National 
body 
Norway TP             
MetOffice MET OFFICE 
National 
body 
United 
Kingdom 
LTP             
MINECO 
MINECO-Minesterio De 
Economia y 
Competitividad  
Funding 
Agency 
Spain BEN             
Mirion 
Mirion Technologies - 
Dosimetry Services 
Division 
SME 
United 
States 
      1       
MP 
Medical Physics, Lund 
university 
University Sweden       1       
MSKCC 
Memorial Sloan Kettering 
Cancer Center 
Research 
Institute 
United 
States 
TP             
MTA EK  
Hungarian Academy of 
Sciences, Centre for 
Energy Research 
Research 
Institute 
Hungary BEN 1   1 1     
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MUTADIS risk governance R&D team SME France LTP       1     
 
Nadia 
Zeleznik 
psychologist/nuclear 
physics/president Nuclear 
Transparency Watch 
Individual Slovenia         
 
1   1 
NCBJ 
National Centre for 
Nuclear Research 
Research 
Institute 
Poland       1 1     
NCRRP  
Ministry of Health, 
National Centre of 
Radiobiology and 
Radiation Protection ,  
Research 
Institute 
Bulgaria BEN 1           
NCSRD 
The National Center for 
Scientific Research 
"Demokritos" (NCSRD) 
Research 
Institute 
Greece LTP   1   1     
NERIS 
ASSOCIATION DE LA 
PLATEFORME 
EUROPEENNE NERIS 
Association France BEN             
NIPH  
Norwegian Institute of 
Public Health 
Research 
Institute 
Norway   1           
NIPNE 
Horia Hulubei National 
Institute for R&D in 
Physics and Nuclear 
Engineering 
Research 
Institute 
Romania         1     
NNCRK 
National Nuclear Center of 
the Republic of Kazakhstan 
Research 
Institute 
Kazakhst
an 
    1         
NPL 
National Physical 
Laboratory 
Research 
Institute 
United 
Kingdom 
      1       
NRG 
Nuclear Research and 
Consultancy Group 
SME 
The 
Netherla
nds 
    1 1       
NRI UJVREZ, a. s. University 
Czech 
Republic 
LTP             
NRIRR 
Frédéric Joliot-Curie 
National Research 
Institute for Radiobiology 
and Radiohygiene 
Research 
Institute 
Hungary BEN 1   1       
NTUA 
NATIONAL TECHNICAL 
UNIVERSITY OF ATHENS - 
NTUA 
University Greece LTP             
NU Nagasaki University University Japan         1     
Nuvia Nuvia Ltd SME 
United 
Kingdom 
      1       
OBU 
OXFORD BROOKES 
UNIVERSITY 
University 
United 
Kingdom 
LTP             
PAAGOV 
national atomic energy 
agency 
National 
body 
Poland         1     
PDC-ARGOS 
software system to 
support the emergency 
organization 
SME Denmark LTP       1     
PHE 
Public Health England- 
Department of health 
Research 
Institute 
United 
Kingdom 
BEN 1   1 1     
PHI Public Health Institute 
Research 
Institute 
Bosnia 
and 
Herzegov
ina 
      1       
PRI 
Institute of Radiation 
Protection 
Research 
Institute 
Ukraine       1       
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PSI Paul Scherrer Institut 
Research 
Institute 
Switzerla
nd 
      1       
PTB 
Physikalisch-Technische 
Bundesanstalt 
Research 
Institute 
Germany LTP     1       
RBI Ruder Boskovic Institute 
Research 
Institute 
Croatia LTP     1 1     
REC 
REGIONAL 
ENVIRONMENTAL CENTER 
FOR CENTRAL AND 
EASTERN EUROPE -REC 
Research 
Institute 
The 
Netherla
nds 
TP             
RIKILT Institute of Food Safety 
Research 
Institute 
The 
Netherla
nds 
TP             
RISOE Risoe National Laboratory 
Research 
Institute 
Denmark       1       
RIVM 
National Institute for 
Public Health and the 
Environment 
Research 
Institute 
The 
Netherla
nds 
BEN 1     1     
RPII 
Radiological Protection 
Institute of Ireland 
Research 
Institute 
Ireland       1       
RSC 
Radiation Protection 
Centre 
Research 
Institute 
Lithuania BEN     1       
RTU 
RIGASTEHNISKAUNIVERSIT
ATE 
University Latvia LTP             
SCIENSANO  
Institut Scientifique de 
Santé Publique,  
Research 
Institute 
Belgium   1           
SCK•CEN  
Studiecentrum voor 
Kernenergie - Centre 
d’Etude de l’Energie 
Nucleaire  
Research 
Institute 
Belgium BEN 1 1 1 1 1 1 
SERGAS  
Servizo Galego de Saúde 
 
Research 
Institute 
Spain   1           
SIS 
National Institute of 
Radiation Hygiene 
Research 
Institute 
Denmark       1       
SL Seibersdorf Laboratories 
Research 
Institute 
Austria LTP     1       
SMHI 
Swedish Meteorological 
and Hydrological Institute 
Research 
Institute 
Sweden         1     
SMU Slovak Medical University University 
Slovak 
Republic 
      1       
SSM 
Swedish Radiation Safety 
Authority 
National 
body 
Sweden BEN 1 1 1 1     
St James's 
Hospital 
St James's Hospital, Dublin Hospital Ireland  TP     1       
STUK 
Radiation and Nuclear 
Safety Authority 
Research 
Institute 
Finland BEN 1 1 1 1   1 
SU  
Stockholm University 
Centre for Radiation 
Protection Research 
University Sweden LTP 1           
SUBI 
Southern Urals Biophysics 
Institute (SUBI) 
Research 
Institute 
Russia TP             
SURO 
National Radiation 
Protection Institute 
Research 
Institute 
Czech 
Republic 
BEN       1     
SYMLOG Symlog SME France             1 
TECNATOM 
nuclear engineering 
company 
SME Spain       1 1     
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THUNEN 
Thünen Institute of 
Fisheries 
Ecology (THUNEN) 
Research 
Institute 
Germany     1         
TU Delft  
Delft University of 
Technology 
University 
The 
Netherla
nds 
            1 
TUDr 
Technische Universitaet 
Dresden 
University Germany       1       
UA University of Aveiro (UA) University Portugal     1         
UAB  
Universitat Autònoma de 
Barcelona 
University Spain  TP 1           
UAM  
Madrid Autonomous 
University,  
University Spain   1           
UB 
University of Barcelona 
(UB) 
University Spain     1         
UCEWP 
Ukrainian Centre of 
Environmental and Water 
Projects 
National 
body 
Ukraine         1     
Ucrete University of Crete  University Greece           1   
UEF 
University of Eastern 
Finland 
University Finland BEN 1           
UFC 
Université Franche-Comté 
(UFC) 
University France TP             
UGR 
University of Granada 
(UGR) 
University Spain     1         
UHasselt  Hasselt University University Belgium             1 
UHCZ 
University Hospital Centre 
Zagreb 
University Croatia       1       
UHL 
University Hospital 
Limerick 
University Ireland TP             
UJF 
Nuclear Physics Institute 
ASCR 
Research 
Institute 
Czech 
Republic 
LTP     1       
UK University of Kragujevac University Serbia       1       
UL  
UL - LatvijasUniversitate, 
Latvia  
University Latvia BEN             
UL Lund University (UL) University Sweden TP       
ULg UNIVERSITE DE LIEGE University Belgium LTP             
ULISBOA  Universidade de Lisboa University Portugal   1           
UMB  Matej Bel University University 
Slovak 
Republic 
            1 
UNEX University of Extramadura University Spain TP       1     
unibremen Bremen University University Germany         1     
UNIMI University of Milano University Italy LTP       1   1 
UNINA2  
Second University of 
Naples (SUN) 
University Italy   1           
Unipa Universita di Palermo University Italy       1       
UniPavia  
Uni Pavia - University 
PAVIA, Italy  
University Italy BEN 1           
UnivDublin University College Dublin University Ireland           1   
University of 
Exeter  
University of Exeter  University 
United 
Kingdom 
            1 
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University of 
Valencia 
University of Valencia University Spain         1     
Univmainz 
Medical university Centre 
Mainz 
 
University Germany           1   
UOA  University of Antwerp University Belgium             1 
UOWM 
Universtity of Western 
Macedonia 
University Greece         1     
UP University of Porto (UP) University Portugal     1         
UPC 
Universitat Politècnica de 
Catalunya 
University Spain LTP     1       
UPM 
Universidad Politécnica de 
Madrid 
University Spain       1 1     
UPV 
University of the Basque 
Country (UPV/EHU) 
University Spain     1         
UROS  Universitaet Rostock  University Germany   1           
URV  
Rovira I Virgili University, 
Laboratory of Toxicology 
and Environmental Health 
University Spain   1           
USP 
Universitadegli  Studi di 
Pisa 
University Italy       1       
UT  
UT - University of Tartu, 
Estonia  
University Estonia BEN             
UTA 
TAMPEREENKORKEAKOUL
USAATIO SR 
University Finland LTP             
UU Uppsala University University Sweden       1       
UZH University of Zurich University 
Switzerla
nd 
TP             
VIN 
Institute of Nuclear 
Sciences - Vinca 
Research 
Institute 
Serbia  TP     1       
VUJE 
nuclear power engineering 
company 
SME 
Slovak 
Republic 
BEN       1     
WarwickUni 
THE UNIVERSITY OF 
WARWICK 
University 
United 
Kingdom 
LTP       1     
Wiv-ISP 
Belgian Scientific Institute 
of Public Health 
Research 
Institute 
Belgium TP       
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1. Executive Summary  
 
The Multidisciplinary European Low Dose Initiative (MELODI) is a European Platform dedicated to 
low dose ionizing radiation risk research.  The challenge is to improve the quantification of risks 
and reduce the uncertainties in the risk estimates, as well as to develop and validate risk models 
that best characterise health effects at low doses, drawing on both epidemiological and 
radiobiological understanding. In 2010, MELODI was founded as a registered association with 15 
members; membership has now increased to 44 institutions.   
A major activity of MELODI is the establishment and periodic revision of a long term Strategic 
Research Agenda (SRA) for research on low dose risk for radiation protection in Europe.  MELODI 
considers low doses to be those where there remains substantial uncertainty on the magnitude of 
health risk.  The SRA is intended to guide the priorities for national and European research 
programmes and the preparation of competitive calls at the European level in order to fill research 
gaps and test the hypotheses on which the current RP system is based. The ultimate goal is to 
provide an improved evidence-based protection of the population. A key priority for radiation 
protection research is to improve and reduce the uncertainties associated health risk estimates for 
exposures at low doses and dose rates that are relevant for the dose limits for occupational 
exposures, reference levels for the exposure of the population in emergency situations, diagnostic 
reference levels for medical exposures, damage to normal tissues during radiotherapy, reference 
levels for radon exposures in buildings and occupational compensation scheme claims, amongst 
others. The approaches have to be multidisciplinary and innovative to provide the best 
opportunities for advancing understanding of low dose and low lose-rate effects. Incorporation of 
expertise outside of the conventional fields of radiation research is essential to widen the prospects 
for broadening approaches and adopting novel methods in health research in the assessment of 
health risk relevant to radiation protection.  MELODI is also concerned to ensure the availability of 
key infrastructures as an essential basis for research activities, and to maintain competences in 
radiation research and health risk assessment in the long term via an integrated European 
approach for training and education. For these purposes, in February 2014, MELODI established 
three working groups (WGs), one on the MELODI SRA, one on Infrastructures and a third on 
Education and Training.   
 
The SRA is periodically updated by the MELODI SRA Working Group (WG), systematically taking 
into account results of recent research and emerging radiation protection research issues. Open 
consultations via website and the annual MELODI workshops are regularly conducted, the results 
of which are taken into account in the revised SRA. Prior to calls from the European Commission 
(EC) or EC-funded projects in radiation protection, in addition to the SRA, a short MELODI 
statement presenting the top priorities is developed by the MELODI WG SRA and an open 
consultation process initiated.   
 
In recent years, large parts of radiation protection research in Europe have been organized within 
a European Joint Programme (EJP), CONCERT. The aim of the EJP was to bring together relevant 
funding agencies from the EC and its Member States to integrate European research and to 
administer calls for research proposals in radiation protection on behalf of the EC. This activity is 
built upon and aimed to promote integration of the SRAs from six European radiation protection 
research platforms and aims to establish interaction and synergies between the different areas of 
expertise: MELODI (low dose and dose-rate risk research), ALLIANCE (Radioecology), NERIS 
(Emergency management), EURADOS (Dosimetry issues), EURAMED (Medical associations), and 
SHARE (social sciences/humanities). Research findings arising from projects 
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funded by the CONCERT calls have, along with other developments, contributed to updating the 
SRA. When CONCERT comes to an end, it is not clear how future integrated European radiation 
protection research will be funded.  Some follow-on project(s) to CONCERT may emerge, 
alternatively the EU EURATOM programme may directly fund research or substantial national 
programmes may be launched, either way the SRA aims to provide a guide for these funding routes. 
 
The activities of MELODI can be seen to be complementary to other co-ordination activities 
elsewhere such as the IDEA initiative in the USA, the Japanese PLANET initiative and others.  Most 
recently the OECD’s Nuclear Energy Agency Committee on Radiation Protection and Public Health 
(https://www.oecd-nea.org/rp/crpph.html ) has been working to co-ordinate efforts on a global 
scale. 
  
The current 9th MELODI SRA for the year 2019 describes two research topics and two cross cutting 
topics (which are relevant for both of the research topics) in low dose or low dose-rate radiation 
risk research.  The topics relate to the diseases of concern, (1) cancers and (2) non-cancer diseases.  
The cross-cutting topics that are relevant to both of these disease categories are (3) individual 
variation in risk and (4) effects of spatial- and temporal-variation in dose delivery on disease risk. 
Each if these is considered in detail in the SRA. 
  
The research required to improve the evidence base for each of the four topics may be grouped 
into two categories:  
1) Research to improve understanding of the mechanisms contributing to radiogenic diseases 
following low dose and dose-rate exposures  
2) Epidemiological research that integrates, where possible and informative, biological and 
molecular markers to improve health risk evaluation of radiation exposure  
 
The current and former versions of the MELODI SRAs and statements can be downloaded from the 
following website: www.melodi-online.eu. The current SRA structure is outlined in Figure 1. 
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Figure 1: Outline of the structure of the Strategic Research Agenda (SRA), numbers in 
parentheses refer to the SRA section dealing with each topic/issue. 
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2. Importance of low dose radiation health risk research  
  
Exposure to ionizing radiation is unavoidable. Everybody encounters exposure from a range of 
natural and artificial sources. Medical and natural sources are the largest components of the 
average dose received by the general public. Exposures to artificial sources can vary between 
individuals depending on their occupation (e.g. employment in the nuclear industry, in air transport 
and in medicine, particularly interventional radiologists), medical exposures (diagnostic and 
therapeutic procedures) and in somecases due to environmental contamination. Exposure from 
naturally occurring radiation involves background from terrestrial and cosmic sources, and internal 
exposure from radioisotopes such as radon and uranium, there is notable geographic variation in 
radon exposure.  There are many and varied uses of radiation in modern society. Nuclear power 
generation is viewed as a carbon neutral and efficient energy source; industrial radiography plays 
important roles in safety assessment; medical uses of radiation for diagnostics and therapy are 
extensive and rapidly increasing.  Long distance air travel can lead to exposures, typically 0.08 mSv 
for a transatlantic flight though altitude, duration and other parameters can affect the actual 
exposure level. Other sources are exposures to ‘NORM’ (Naturally occurring radioactive materials) 
in the oil extraction and other industries.  Broadening access to space travel is anticipated, with 
both longer exploratory missions likely as well as some commercial space travel under 
development. 
 
Not only is exposure to ionizing radiation unavoidable and variable in the population, but it is 
known to damage health at certain exposure levels. At very high doses  radiation exposure can be 
lethal, while tissue damage can occur following more localized high dose exposures. Whole body 
exposures at these levels are very rare, but for localised exposures, severe tissue damage can be 
observed in some patients following radiotherapy for cancer.   
  
Evidence accumulated over many decades demonstrates that radiation can cause cancer in 
humans following acute exposure in the dose range of a few Gy down to 100 mGy or less, with 
children often showing higher sensitivity.  There are indicationss that these more moderate 
exposures may also be associated with other conditions such as circulatory diseases, cataracts, 
cognitive impairment, immunological effects – collectively described as ‘non-cancer diseases’ and 
effects on future generations (hereditary or transgenerational effects). The risks to humans in 
terms of cancer are established down to around 100 mGy in adults, for circulatory diseases and 
lens opacities down to about 500mGy and about 200mGy for defects on brain development and 
cognition after prenatal exposure during neurogenesis. The risks to human health below these 
levels, especially following protracted or other non-homogenous exposures are less certain. 
Currently, the system of radiation protection aims to avoid tissue injury and minimize the risk of 
cancer and the possibility of hereditary disease.  For radiation protection purposes, risks of cancer 
and possible hereditary effects below 100 mGy are regulated on the basis of an assumed linear 
non-threshold (LNT) relationship between dose and incidence. However, there remains 
uncertainty about the exact dose-response relationship for such low-dose exposures, and the 
impact of protracting exposures over long periods such as during a working lifetime.   
 
Striking the appropriate and acceptable balance between the benefits accrued from activities 
involving exposure to radiation on the one hand and the health risks posed on the other is 
important. The regulation for protection of individuals and populations comes at a financial cost – 
there are, therefore, disadvantages to both under- and over-protection. This applies in all 
situations – existing elevated exposure situations such as high radon areas, occupational settings 
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such as the nuclear industry and the medical sector, and accidental situations where difficult 
decisions on countermeasure implementation such as sheltering and evacuation are required. In 
all these contexts, it is critical to utilise robust and accurate information on the magnitude of health 
risks posed by given radiation doses, ranging from high to low.   
  
The main uncertainties in radiation health risk evaluation are in the magnitude of cancer risk at low 
and protracted doses below 100 mGy, the magnitude of non-cancer effects below 500mGy, the 
variation in individual risk within the population, and the variation in risk with dose distribution in 
space and time. These are therefore the key areas requiring further exploration to provide better 
and more reliable evidence for appropriate decision making in all areas of radiation protection. 
Accurate and reliable low dose human health risk estimation is an essential foundation for a robust 
and acceptable system of radiation protection.  
 
2.1 Dose and dose rate ranges to be considered 
For the purposes of this document, MELODI considers low doses to be those where there remains 
substantial uncertainty on the magnitude of health risk.  For low LET radiations these are taken to 
be those of 100 mGy and below when considering cancer risks, and 500 mGy and below when 
considering non-cancer diseases as recognised by international organisations such as the 
United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) and the 
International Commission on Radiological Protection (ICRP).  In the context of cancer risk, 
moderate doses are those between 100 mGy and 2 Gy, with high doses being those above 2 Gy. 
For non-cancer diseases, MELODI considers moderate doses as those between 500 mGy and 5 Gy, 
and high doses those above 5 Gy.  Low dose-rates are those of 0.1 mGy min-1 or less for low LET 
radiation, or one-track traversal per cell per hour for high LET radiations. These definitions apply 
both for organ and whole-body doses.  Note that units of Sievert (effective dose, a radiation quality 
and tissue sensitivity weighted quantity) are frequently used for cancer risk.  Effective dose, as 
defined by ICRP, relates specifically to cancer and hereditary effects, it is therefore not appropriate 
to use for non-cancer outcomes. Sieverts are also not directly quantifiable and sothe absorbed dose 
units of Gray are generally used in this document; furthermore, these are the units used for dose 
quantification in experimental and epidemiological investigations.   
 
 
3. MELODI  
  
The purpose of the MELODI Association, as given in its Statutes, is to constitute a European 
Research Platform in the field of low dose ionizing radiation health risk assessment and its 
application for radiation protection and to coordinate and promote research and long-term 
competence on effects and risks to human health associated with low-dose and low-dose rate 
exposures to ionizing radiation. 
MELODI currently has 44 members including national bodies responsible for defining, funding and 
implementing research on low dose risk, as well as universities and research institutes committed 
to contribute to R&D efforts. It is a research association that contributes to the definition of priority 
objectives in low dose risk research, fostering of research programmes and initiatives to achieve 
these objectives, assessment of results obtained, and promotion of communication on these issues 
between the various parties involved as well as sustainability of key research capacity and 
infrastructure. These functions are performed by organizing scientific and stakeholder workshops, 
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promoting the visibility of the research area, establishing working groups on specific topics and 
facilitating collaborative research.   
  
To achieve these goals, the establishment and regular updating of a long term (>20 years) SRA for 
research to improve protection from low dose health risks in Europe remains a major activity of 
MELODI. It provides guidance on the priorities for national and European research programmes 
and the preparation of competitive calls at the European level. Furthermore, MELODI supports the 
availability and maintenance of key infrastructures as an essential basis for research activities, and 
the retention and development of competences in radiation research and health risk assessment 
in the long term via an integrated European approach for training and education.  As the primary 
aim of the MELODI SRAs is to provide Euratom, national authorities and funding agencies with 
scientific research agendas to guide the preparation of calls and areas for prioritization, the 
significance of this work should periodically be evaluated for its impact on the content of calls and 
research prioritizations, and advances made through funded projects.  Ultimately, the research 
guided by the SRA is anticipated to make an impact on radiation protection policy.   
  
Following the recommendations and roadmap established by the High Level and Expert Group on 
European Low Dose Risk Research (HLEG) in 2009 
(https://cordis.europa.eu/docs/publications/1070/107087891-6_en.pdf ), and supported over 
time by DoReMi, OPERRA and CONCERT, the latter moving to integrate SRAs covering all aspects 
of radiation protection research in Europe, the radiation protection research community within 
Europe has been progressively more deeply integrated over the past decade. 
  
In October 2010, the first draft of a MELODI SRA was published on the MELODI Website and opened 
for public consultation. The contents were based on the considerations and key priority issues 
formulated by the HLEG and DoReMi. In February 2014, the MELODI Board of Directors (BoD, now 
re-constituted as the MELODI Executive Committee) established three working groups (WG’s), on 
the MELODI SRA, Education & Training and Infrastructures. The MELODI SRA is updated periodically 
by the SRA WG, taking into account recent and emerging research results and radiation protection 
research issues. The updated draft and a short MELODI statement (usually in years where an EC or 
EC-funded project call will be launched), presenting the top priorities, is posted on the public 
MELODI website, usually before the annual MELODI workshop - now European Radiation 
Protection Week (ERPW), and an open consultation process is set-up via the website and the 
workshop to seek input from other scientists and stakeholders before the SRA´s and statement’s 
revision. The updated SRA and MELODI statement are also sent to the independent Scientific 
Advisory Committee of MELODI for comment.  The final SRA and MELODI statement are prepared 
for approval by the MELODI Executive Committee. The current edition of the SRA will be the ninth 
version. 
 
 
3.1 MELODI in the context of other radiation research platforms 
 
Currently, large parts of European radiation protection research are organized within the CONCERT 
European Joint Programme (EJP). The EJP has brought together relevant funding agencies from the 
EC and Member States to integrate European research, and to administer calls for research 
proposals in radiation protection on behalf of the European Commission. This activity builds upon 
the Strategic Research Agendas from six European radiation protection research platforms, 
MELODI, ALLIANCE (radioecology), NERIS (emergency management), EURADOS (dosimetry issues), 
EURAMED (medical associations), and SHARE (social sciences and humanities), and aims to 
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establish interaction and synergies between the different areas of expertise.  Integration across 
the different platform areas is being fostered and developed through the drafting of a roadmap to 
guide all research related to radiation protection, and further integration can be anticipated in 
future years.  CONCERT will come to an end in 2020, and it is not yet clear if any similar cross-
platform integration will continue to be funded.  
 
MELODI’s activities can be seen to be complimentary to other co-ordination activities elsewhere 
such as the IDEA initiative in the USA (see Cool, 2019, Int J Radiat Biol. 95(10):1358-1360 ), the 
Japanese PLANET initiative and others described by Cho et al (Cho et al, 2019, Int J Radiat Biol. 2019 
95(7):816-840, Repussard, 2019, 95(10):1354-1357 . Most recently the OECD’s Nuclear Energy 
Agency Committee on Radiation Protection and Public Health ( https://www.oecd-
nea.org/rp/crpph.html ) has been working to co-ordinate efforts on a global scale.  Furthermore, 
MELODI aims to be responsive to the key challenges in the system of radiation protection as 
identified by international organisations such as UNSCEAR and ICRP. 
 
 
4. Summary of Developments since last SRA update 
 
Recent advances in radiation epidemiology are starting to provide evidence of risk to health at 
doses below the 100 mGy level used to define low dose exposure.  The INWORKS series of pooled 
occupational exposure studies suggests that significantly increased risks of solid cancer and 
leukaemia can be detected at doses of 100 mGy when delivered over a working life.  Though the 
subject of continued debate, several studies of cancer risks associated with exposure to CT scans 
in childhood suggest significant increases in leukaemia and brain cancer risk at 50 mGy and above. 
Likewise, some studies have shown increased risk of childhood leukaemia from natural background 
radiation, though the evidence is not consistent and dose assessment often not based on individual 
measurements.  Thus, this SRA edition is being written at a time of strengthening evidence of 
cancer risks at 100 mGy and below, even when exposures are protracted over time.  Much of this 
evidence has been drawn from European cohort studies. 
 
When this SRA was last updated the research projects running under the CONCERT European Joint 
Programme were starting and results of the 2017 and 2018 EURATOM calls were not available.   
The research areas covered by these projects is summarised here. 
 
The 2016 and 2017 CONCERT calls have funded nine projects.  Those most relevant to MELODI are: 
• LDLensRad – an investigation of mechanisms underlying radiation-induced lens opacities 
and dose/dose-rate effects at low exposure levels.  The project relates to SRA topic, Non-
cancer disease, basic mechanistic investigations. 
• LEU-TRACK – an investigation into the role of micro-vesicles and their ‘cargo’ in radiation 
leukaemogenesis.  The work relates to SRA topic, Dose and dose-rate dependence of 
cancer risk, basic mechanistic investigations. 
• SEPARATE – concerns the effects of partial body irradiation, particularly out-of-field 
effects, and how they may affect health risk following exposure. This project relates to SRA 
topics, Non-cancer diseases, basic mechanistic investigations and consideration of 
spatial/temporal variation of dose delivery. 
 
In 2017 EURATOM ran a call for research in medical radiation protection that resulted in the 
funding of one project: 
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• MEDIRAD – is a wide-ranging project with elements of epidemiology, real time organ dose 
estimation from diagnostic and nuclear medicine procedures, testing of multinational 
image and dose repositories, experimental work and modelling, relating mainly to impacts 
of therapeutic and diagnostic medical exposures on cancer and non-cancer diseases, 
including consideration of individual variation in response. This project relates to SRA 
topics, Dose and dose-rate dependence of cancer risk/non-cancer diseases/individual 
variation in risk by mechanistic and epidemiological investigations. 
 
 
In 2018 a further EURATOM call in radiation protection resulted in the funding of one project: 
• HARMONIC is a large multi-disciplinary project to contribute to improvements in the 
understanding of health effects of medical IR exposure of paediatric patients, focusing on 
two distinct scenarios: (1) Paediatric patients undergoing modern radiotherapy (including 
proton therapy); (2) Paediatric patients undergoing interventional cardiology. The project 
will explore potential effects at very early ages, exposure to a wide range of doses from 
photons, protons and secondary neutrons radiation. It will also build European cohorts 
and registries for long term follow-up in the context of very rapid technology evolution. 
The study will use state-of-the art dosimetry, complemented by non-invasive imaging and 
molecular epidemiology to assess: endocrine dysfunctions, cardio and neurovascular 
diseases, societal impact and cancer. The project will also investigate radiation-induced 
cellular responses in samples of blood and saliva, and the mechanisms involved in the 
processes that may lead to cancer and vascular diseases. Ultimately, HARMONIC will 
develop tools and allow definition of guidelines on optimization techniques to guide 
treatments toward reduction of patient doses in paediatric cardiology and oncology. 
Relates to SRA topics, dose and dose-rate dependence of cancer risk/non-cancer diseases, 
individual variation in risk and consideration of spatial/temporal variation in dose delivery 
by mechanistic and epidemiological investigations”. 
 
Additionally, MELODI has sponsored two workshops, one concerning individual sensitivity to 
radiation and another concerning non-cancer disease. Outputs and recommendations from the 
former are currently under review, in press or published (Gomolka et al, 2019, Int J Radiat Biol. Jul 
26:1-17. doi: 10.1080/09553002.2019.1642544, Seibold et al, 2019, Int J Radiat Biol. 2019 Sep 20:1-
16. doi: 10.1080/09553002.2019.1665209, and further publications submitted or in press). Key 
recommendations for research from these publications will be considered here when available. 
 
Beyond the activities of MELODI, there have been documents of relevance to this SRA publushe 
dby UNSCEAR in recent years – most notably UNSCEAR 2017, Annex B - Epidemiological studies of 
cancer risk due to low-dose-rate radiation from environmental sources and the UNSCEAR 2018 
White paper, Evaluation of data on thyroid cancer in regions affected by the Chernobyl accident.  
There have been no publications directly relevant to MELODI from ICRP since the last SRA edition. 
NCRP have publlshed in 2018 its Report No. 181 – Evaluation of the Relative Effectiveness of Low-
Energy Photons and Electrons in Inducing Cancer in Humans, and Commentary No. 27 – 
Implications of Recent Epidemiologic Studies for the Linear-Nonthreshold Model and Radiation 
Protection; and in 2019 its Report No. 183 – Radiation Exposure in Space and the Potential for 
Central Nervous System Effects: Phase II. 
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5. Strategic Research Agenda  
Radiation protection is one particular area of health protection concerning the prevention of 
radiation induced non-communicable diseases and tissue damage, notably cancers and some non-
cancer diseases in the general public, patients and workers.  The health impacts of radiation 
generally concern diseases or biological effects that are multi-factorial in origin, with both intrinsic 
and extrinsic risk factors.   The intrinsic, non-modifiable risk factors, include age and sex as well as 
less well characterised genetic and other factors, all of which, in addition to being important risk 
factors in themselves, may also modify the health impact of radiation. There is also, a wide range 
of modifiable risk factors affecting the incidence of these diseases, including ‘lifestyle’ factors such 
as diet, tobacco smoking and exercise, as well as natural and human-made environmental factors 
including co-exposures to other environmental and occupational carcinogens and medicinal drugs.  
Radiation protection research therefore needs to be viewed in this wider context where any 
radiation exposures and effects on health are rarely, if ever, experienced alone; rather individuals 
and their disease risk can be influenced by their genome, epigenome, exposome, microbiome and 
other factors. This wide range of influences on individual and population health risk can pose 
problems for discerning the impact of radiation exposures, especially when exposure levels are 
low.  As stated earlier, radiation protection is but one element of general health protection relevant 
in public, occupational and medical exposure settings. 
 
The MELODI SRA is based on the key policy goals defined by the HLEG (www.hleg.de/) to address 
the robustness of the current radiation protection system (see Figure 2).   
 
 
  
Figure 2: Key policy issues in European low dose radiation risk research defined by the High 
Level and Expert Group  
(https://cordis.europa.eu/docs/publications/1070/107087891-6_en.pdf ) 
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The key policy issues identified in the HLEG report are:  
  
▪ The shape of the dose-response for cancer;  
▪ Tissue sensitivities for cancer induction;   
▪ Individual variability in cancer risk;   
▪ The effects of radiation quality (type);   
▪ Risks from internal radiation exposure;  
▪ Risks of, and dose response relationships for, non-cancer diseases and hereditary effects.  
  
For the purpose of the MELODI SRA, these issues were restructured into two topics relating to 
disease types and two cross-cutting issues (Figure 1):   
TOPICS 
(1) Dose and dose-rate dependence of cancer risk;   
(2) non-cancer effects;  
CROSS-CUTTING ISSUES   
(3) individual variation in risk; and 
(4) effects of spatial- and temporal-variation in dose delivery 
  
  
As discussed by the HLEG and confirmed by MELODI, research at low dose-rates or low doses 
presents significant challenges in the investigation of both radiation-related health effects and 
underlying biological mechanisms, because the magnitude of health risk and biological effects is 
expected to be low. A multidisciplinary approach is therefore essential, both epidemiological and 
experimental studies will also require sufficient statistical power and sample sizes to be effective, 
nested case-control study designs are likely to be suitable, as well as “meet in the middle 
approaches” for example.  
  
For these reasons, discussion of each key question is sub-divided below into two categories:   
• Research to improve understanding of the mechanisms contributing to radiogenic diseases 
following low dose and dose-rate exposures.  
• Epidemiological research that integrates, where possible and informative, biological 
approaches to improve health risk evaluation.  
 
5.1 Dose and dose-rate dependence of cancer risk   
Current risk estimates used in radiation protection are based upon epidemiological studies of 
exposed populations. Radiation protection standards aim to avoid tissue reactions and minimize 
the incidence of the late developing stochastic effects of cancers and possible hereditary effects in 
future generations. Thus, it is of fundamental importance to radiological protection that the health 
risk estimates are evidence-based, robust, and credible.  Most important among the 
epidemiological studies are the follow-up studies of Japanese populations exposed as a 
consequence of the atomic bombings of Hiroshima and Nagasaki that provide risk estimates per 
unit dose for cancer and, more recently, non-cancer effects.  While the Japanese studies remain 
the main basis for the cancer risk estimates used in radiation protection, they relate to a specific 
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population and a specific exposure scenario. The exposure was essentially an instantaneous, high 
dose rate total body gamma ray exposure with a small neutron component. Information about 
cancer risk from the A-bomb survivor studies is, to an increasing extent, complemented by studies 
of occupational, environmental and medical exposures, which allow direct investigation of effects 
of fractionated or protracted exposures in current European populations.  
 
As noted earlier, epidemiological studies provide direct evidence of dose-related increases in total 
cancer risk after acute exposures with doses of about 100 mGy and above.  Recent studies have 
provided better evidence of risk at doses below 100 mGy and with protracted exposure.  Some 
reports indicate a possible increased risk of childhood leukaemia from doses below 100 mGy due 
to natural background gamma radiation and from paediatric CT imaging..   
Nevertheless, there are major uncertainties concerning (i) the magnitude of total and organ-
specific cancer risks following specific exposure situations such as protracted exposure 
encountered in the environment as well as in occupational and medical settings, and when the 
dose is inhomogeneously distributed more particularly after internal contamination;  (ii) the risk 
for individual cancer sites due to possibly different tissue sensitivities, and (iii) the best evidence-
based models to infer risk at doses and dose-rates that are lower than those for which direct 
epidemiological evidence is available. In this context, there are also a number of ethical questions 
that need to be addressed, such as the use of the LNT model for extrapolation to very low doses, 
and whether other risk factors may substantially modify radiation risks.  
Classical epidemiological studies will need to be continued to refine the knowledge of risk directly 
in human populations, particularly in the context of low dose, protracted and non-uniform 
exposures. Accuracy of risk estimates can potentially be increased by more precise dose estimation 
and outcome assessment, larger studies or pooling of data from several studies. Mechanistic and 
epidemiological approaches should be integrated whenever feasible to address cancer risks from 
acute whole-body exposures with low-dose (<100 mGy) or from fractionated, protracted and 
inhomogeneous exposures resulting in low-to moderate dose. Studies also need to address the 
impact of different radiation qualities and effects of both internal and external exposures, alone 
and in combination. Knowledge of health risks from low dose-rate exposures is of direct relevance 
for radiological protection in emergency situations, in medicine (with children, who are known to 
be more sensitive than adults, easily receiving doses of several hundred mGy to the brain from 
multiple brain CT scans), and in occupational settings, with the current dose limit of 20 mSv/year 
averaged over 5 years with no single year exceeding 50 mSv.  Radiation protection in the medical 
context is particularly important as exposures have been increasing, and novel radiation modalities 
are both in use and under development.  Clear and coherent principles for justifying the long-term 
risks with more immediate benefits are needed.  Radiation protection in the context of long-term 
space travel, where radiation exposures have some very specific characteristics and differ from 
terrestrial exposures, is likely to grow in importance in the future.  Beyond studies of specific 
irradiated populations, there exist some major cohorts established and followed primarily for 
reasons other than the assessment of radiation risk, some consideration of the benefits of utilising 
such cohorts and adding radiation exposure information may be of use in the future. 
   
Research line: Health risk evaluation  
Quantification of cancer risk at moderate dose or dose-rates from acute or protracted non-uniform 
exposure, and at low dose or dose-rates from acute, homogenous exposure are key challenges for 
improved radiation risk assessment. The large size of epidemiological studies required to detect 
small increases in cancer risk at low dose and dose-rates, the need to capture all major sources of 
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radiation exposure, and the potential for bias and confounding present practical challenges, 
particularly at the lowest doses. The priorities in this area include the maintenance and 
improvement of key cohorts by continued follow-up, pooling of different studies, collection of 
information on confounders and reduction of misclassification of dose and health data. Key cohorts 
are characterized by large populations with exposure conditions and dose distributions that are 
relevant for radiation protection, good individual dosimetry, long and complete follow-up with 
good quality of health outcome data, particularly in relation to cancer occurrence; and the 
possibility of collecting information on relevant potential confounders either on the whole cohort 
or through targeted nested case-control studies.  
These studies should include, where possible and likely to be informative, the collection and 
appropriate storage of a large number of relevant biological samples, including tissue samples from 
cancer cases and somatic tissue from affected individuals; while this is generally difficult in large 
scale cohorts, it can be integrated in nested case-control studies. Through identification, validation 
and integration of relevant biological endpoints and markers into epidemiological studies, further 
insights will be gained into the risks associated at the population and individual level with such 
exposures. The integration of both epidemiological and mechanistic studies will improve cancer 
risk evaluation through molecular epidemiological studies or by mechanistic modelling.    
Priority research areas are:  
• To determine the shape of the dose and dose-rate response relationships in humans for total 
cancer, and where possible specific cancer sites, based on key informative epidemiological 
studies, including medical and occupational cohorts as well as those accidentally exposed.  
• To determine the risk for different cancer sites based on key cohorts (see above) in order to 
investigate differences in tissue sensitivity.  
• To evaluate the dose-response for tumour types, ideally defined by molecular 
characterisation  
 
• To investigate pre-stages of cancer in any available biological samples, e.g. tissue or 
saliva/blood and by imaging methods in study populations with well-characterised exposure 
to allow modelling of carcinogenesis, including adverse outcome pathway approaches.  
• To identify and validate biomarkers of exposure and health effects related to cancer, both 
working from early exposure biomarkers through intermediate steps to disease, and from 
epidemiological studies to disease markers and back to exposure – the ‘meet in the middle’ 
approach (Vineis and Perera, 2007, Cancer Epidemiol Biomarkers Prev. 16(10):1954-65).  
• To determine the value of evaluating cancer risks through systems biological analyses and 
models of carcinogenesis based on mechanistic studies and epidemiological data, and 
integration of the two.  
 
Research line: Basic mechanisms  
An LNT extrapolation model is currently used to estimate risk at low doses from higher dose 
epidemiological data. An important aspect of the justification of using this model is that radiation 
carcinogenesis is assumed to be primarily driven by damage to DNA and subsequent mutation of 
growth-regulating genes in target cells. Yet, a number of other potential mechanisms contributing 
to and modulating radiation carcinogenesis have been proposed, including epigenetic mechanisms 
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of gene regulation such as DNA methylation and miRNA expression, transmissible genomic 
instability, bystander effects and adaptive response, and it is important to determine their roles. 
The extent to which these modulating effects and non-mutational mechanisms challenge the 
validity of the LNT risk extrapolation model needs to be determined. For this purpose, the use of 
well validated animal and human cellular / tissue models of radiation carcinogenesis (both solid 
cancers and leukaemias) is required.  
Priority research areas are:  
• To determine the nature,roles and radiosensitivity of the various target cells for radiation 
carcinogenesis. The most important of these are generally taken to be stem and progenitor 
cell populations, which may have specific responses to radiation.  
 
• To determine the contribution of DNA damage / mutational processes at low doses and 
dose-rates and with differing radiation qualities.. Further information on the specific genes 
affected at low doses in the development of specific cancers and quantitative aspects can 
contribute to refining risk extrapolation models and the identification of radiation exposure 
and cancer biomarkers.  
• To determine the contribution of epigenetic modifications. Gene function and cellular 
processes can be regulated at the epigenetic level, the extent to which radiation affects 
epigenetic states that relate to carcinogenesis needs to be elucidated, and also how 
epigenetic factors affect response to radiation.   
• To determine the influence of cell micro-environmental, non-targeted and systemic 
processes that may promote or restrict the growth of pre-malignant cells in tissue, and how 
radiation exposure affects the tissue environment to facilitate or retard the growth of (pre)-
malignant cells. For example, the influences of low dose radiation exposure on inflammatory 
reactions and effects of radiation on of immune surveillance against cancer cells.  
• To examine the extent to which any of the above are different at high dose / dose-rate by 
comparison with low dose / dose-rate.  
 
5.2 Non-cancer effects   
It has been traditionally assumed that health effects other than cancer and hereditary diseases 
show a threshold (defined as the dose required to lead to 1% excess incidence) at doses that are 
well above the levels of exposure typically encountered in the public environment, at work or in 
diagnostic medical uses of ionizing radiation. Recent results from epidemiological and 
experimental studies indicate possible increased risks of circulatory diseases, cataracts, 
cognitive/neurological effects and others not only at high doses but also at down to 500mGy and, 
possibly even lower. Based on these findings the ICRP issued in 2011 a statement on tissue 
reactions (formerly termed non-stochastic or deterministic effects) that noted evidence that the 
threshold in absorbed dose for effects on the lens of the eyes is of the order of 500mGy (acute and 
protracted exposure). Consequently, a recommendation was made for a reduction in the annual 
equivalent dose limit for the eye lens to 20 mSv per year averaged over 5 years, with no one year 
exceeding 50 mSv. In addition, ICRP suggested that the dose threshold for circulatory diseases may 
be as low as 500mGy.  
 
Evidence for radiation-related hereditary effects is based on experimental animal studies. There 
is no direct evidence for hereditary/transgenerational effects from human studies, though 2nd 
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and 3rd generation studies are likely to be feasible in specific cohorts, e.g. in the Urals. The as yet 
uncertain contribution of hereditary risk to overall risk is expected to be small in comparison with 
that of cancers.  While the system of radiation protection includes hereditary effects in the 
calculation of low dose detriment along with cancers for risk management purposes, the range of 
diseases occurring among the offspring of irradiated parents includes both cancer and non-
cancer diseases  
  
For all outcomes, there are uncertainties and concerns about possible effects at low doses, which 
may have important implications for radiation protection. Results of available epidemiological 
studies are not always consistent, as in the case if cancers the risk estimates are prone to bias and 
confounding, and the biological mechanisms of relevance for health risks at these low doses are 
not known. The possibility of a stochastic nature of non-cancer effects without dose thresholds 
raises a wide range of questions and needs further investigation. In contrast to cancer, knowledge 
on the underlying biological mechanisms for radiation-related non-cancer effects in the moderate 
and low dose range is very sparse. Therefore, research to understand the mechanisms is necessary. 
In addition, epidemiological research of key cohorts with good information on potential 
confounding factors is needed to provide information on radiation-related risk of non-cancer 
diseases following low dose, protracted or fractionated exposure, relevant for radiation protection. 
Individual variation in risk, mixed exposures and impact of characteristics of radiation exposure will 
also need to be explored.   
 
.    
Research line: Health risk evaluation  
Quantification of non-cancer disease risk in humans at moderate or low doses or dose-rates is a 
key and difficult challenge for radiation protection, because the magnitude of risk due to radiation 
is expected to be low and the potential for bias and confounding is high. Informative 
epidemiological studies in this field will be characterized by cohorts of large size with exposure 
scenarios and dose values relevant for radiation protection, good dosimetry, high quality of health 
data, long follow-up and the possibility of collecting information on relevant potential confounders 
either on the whole cohort or through nested case-control studies. In addition, these studies 
should include – where possible and informative – collection of biological samples, relevant tissue 
samples from the relevant organ to allow mechanistic investigations, and extensive data on the 
health status during follow-up.   
Through improvement of key epidemiological studies (e.g., increasing the statistical power by 
pooling studies using standardized study protocols; improvement of appropriate organ and tissue 
dose assessment, e.g. different parts of the heart, main arteries and veins, as well as blood, brain, 
eye lens, etc) and, where possible and informative, the identification and integration of relevant 
biological endpoints and markers into epidemiological investigations further mechanistically-
informed insights will be gained into the risks associated with such exposures.   
  
Priority research areas are:  
  
• To determine the shape of the dose-rate and dose-response relationship, notably the 
presence or absence of threshold doses, in humans for non-cancer outcomes at low or 
moderate doses based on key informative epidemiological studies (molecular or otherwise, 
as appropriate).  While increasing numbers of studies concern circulatory diseases, little 
work is available on cognitive impairment and neuropathies, and there is little current work 
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on hereditary and transgenerational effects.  Any such studies require careful and explicit 
definition of the disease outcomes being assessed. 
• To identify, develop and validate biomarkers for exposure (especially for low doses and 
protracted/inhomogeneous exposures), early and late non-cancer effects.  Relevant tissue 
banks are currently available.  The development of such biomarkers should allow better 
estimation of the actual doses received and inform the evaluation of the dose-response 
relationship of non-cancer effects.   
• To investigate early stages in the progression of non-cancer effects in tissue or disease-
related endpoints in biological samples from members of appropriate epidemiological 
studies or individuals with similar living conditions and known exposure in order to 
understand spontaneous pathogenesis. This is a pre-requisite to understand radiation 
effects on pathogenesis.  
• To evaluate non-cancer risk through systems biological analyses and mathematical models 
combining and integrating mechanistic studies and the epidemiological data.  
 
Research line:  Basic mechanisms  
Deterministic effects or tissue reactions are classically thought to arise as a consequence of cell 
killing or functional inactivation by high radiation doses. They are characterised by steeply 
increasing dose-response relationships at doses exceeding a defined threshold. It is unlikely that 
cell killing/inactivation will explain fully the effects of lower radiation doses on circulatory diseases, 
cataract and cognitive dysfunction. Epidemiological investigations of populations with well-
characterised exposures require support from studies to identify the underlying mechanisms that 
lead to each of the non-cancer diseases. Each disease may have a different mechanistic basis, and 
it is not clear, if there will be any similarity with the mechanisms that lead to radiation related 
cancers.   
Low dose radiation may induce cellular senescence. The occurrence of this phenomenon in tissue 
stem cell compartments is an event that could have profound pathophysiological consequences. 
Alteration of stem cell functions may impair tissue renewal and homeostasis or on the contrary 
may promote non-cancer diseases or cancers. 
Priority research areas are:  
  
• To develop animal and in vitro models of radiation-related non-cancer diseases (circulatory 
diseases, cataract, cognitive/neurological dysfunctions, hereditary/transgenerational effects 
and other non-cancer effects), including organoids (e.g. cerebral, retinal, and others) derived 
from human pluripotent stem cells in order to clarify the pathways involved and conduct 
appropriately powered induction studies. In particular early stages of disease should be 
explored to define adverse outcome pathways for radiation-induced non-cancer effects.  
 
• To apply a full range of analytical methods including ‘omics’ technologies and consideration of 
the target cells and surrounding microenvironment. In this context emerging technological 
innovations including single cell ‘omics’ may help to identify differences in radiation sensitivity 
between relevant cells and tissues. The mechanistic knowledge gained is likely to be useful for 
the identification of relevant biomarkers, e.g. specific metabolic and pathological changes that 
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are clearly radiation-induced, and the development of mechanistic models of disease 
development.  
• To determine the contribution of radiation-related changes in the immune function and 
inflammatory processes in the pathogenesis of non-cancer effects at low doses and dose-rates.   
 
• To determine if other pre-existing conditions, such as neuropathies, inflammatory conditions 
or metabolic and mitochondrial  diseases for example, affect the incidence of radiation-
induced non-cancer outcomes 
•  
 
5.3 Individual variation in risk 
Individual variation in radiation-related cancer risk is a key area to address for radiation protection. 
Differences in the magnitude of radiation-induced risks between individuals, or groups, may relate 
to sex, age at exposure, state of health, genetic and epigenetic make-up, lifestyle, and attained 
age. Such differences, if significant, raise the very important ethical and policy questions as to 
whether some individuals or groups are inadequately- or over-protected by the present system 
and regulations. Similar concerns on variation in risk between individuals apply to non-cancer 
outcomes.  
  
At present, there is insufficient information about the size of the differences in response between 
individuals or groups of individuals and their consequent influence on risk estimates at low doses 
and dose-rates. In order to address policy questions, it is necessary to obtain better scientific 
information on the extent of the variations in sensitivity in the population, in the sizes of the 
variations, characteristics affecting the variation and in the proportions of the population that are 
affected.  Importantly, reliable and robust biomarkers predictive of individual risk need to be 
identified and characterised through basic mechanistic research before application in 
epidemiological studies. 
Healthy aging is an increasing concern in western countries, since there is a progressive aging of 
extant populations. Research in this field aims to improve quality of life for elder people. In this 
situation, any unnecessary or overlooked stresses have to be avoided. 
  Treatments with low dose radiation for medical purposes is increasing worldwide. These 
procedures are beneficial to the patient. Nevertheless, there is scant awareness of health risk 
associated with their uncontrolled use.  In particular, health risk may be higher in elderly patients 
due to increased vulnerability and poor recovery of homeostasis following a stress such as low dose 
radiation exposure. 
 
Consideration of how individual differences affect the relationship between absorbed dose (and 
dose distribution) and risk is required. For internal intakes of radionuclides, the dose and dose 
distributions can be very different in individuals for the same exposure because of anatomical and 
physiological differences (e.g. in airway morphology or breathing mode). These variabilities should 
be taken into account by accurate dosimetric and physiologically relevant biokinetic models. In 
addition, the nature of the interaction of ionizing radiation with co-exposures to other agents (e.g. 
tobacco smoke, heavy metals) and existing risk-modifying conditions (e.g. iodine deficiency for 
thyroid cancer) for the onset of various cancers and diseases are important in considering risk 
transfer between different populations.  
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Research line:  Health risk evaluation  
The quantification of the contribution that individual variation in response to radiation makes to 
radiation health risk on both an individual and population level is a key question. Realistic estimates 
of the magnitude of differences in response between individuals and groups are needed.   
Priority research areas are:   
• To identify and validate candidate biomarkers of individual sensitivity identified from 
mechanistic or clinical studies in cohorts of exposed and non-exposed subjects who have 
developed cancers or non-cancer diseases. As few suitable large cohorts with biological 
samples are currently available, proof-of principle studies with higher dose exposed cohorts 
should be conducted to refine methodologies and to extrapolate to low doses. 
• To improve or set-up molecular epidemiological cohorts or case-control studies to 
determine factors (host and environmental) that modify individual risk of radiation-induced 
cancer and non-cancer effects and quantify their effects.   
• To quantify the variation in risk between different population groups and the impact of 
different factors, for example, age at exposure, and attained age, as well as co-exposures 
and host factors, including anatomical and physiological differences. Knowledge of the 
nature of possible interactions between ionizing radiation and these factors on health risk 
(e.g. multiplicative, additive) is important in considering risk transfer between different 
populations.  
• To develop mechanistic or other mathematical models of radiation-induced disease 
pathogenesis that can account for individual risk factors.  
 
Research line:  Basic mechanisms  
Basic research is needed to establish which factors and processes (including genetic, epigenetic 
and environmental factors/processes, co-morbidities, co-exposures and lifestyle factors) lead to 
greater individual risk of late effects in terms of cancer or non-cancer diseases. This includes the 
discovery of genetic, phenotypic and molecular markers of these pathways, and the integration of 
mechanistic studies in the quantitative evaluation of health risks. A major focus should be the 
understanding of how these different factors may modify risk, keeping in mind that the 
radiosensitive phenotype is likely to be multifactorial. Another important question is whether 
biomarkers of radiation normal tissue reactions are related to risk of developing late effects 
following exposure to low and protracted doses of different LETs including internal exposures.   
Priority research areas are:  
• To develop an understanding of the cellular, organ and systemic responses determining 
individual susceptibility to radiation-induced health effects including, for example, 
inflammatory processes and immunological states) so that differences between individuals 
in the response pathways can be predicted, and biomarkers be identified.  
• To investigate mechanisms by which age at exposure, attained age, sex, lifestyle and other 
factors, including co-exposures to other agents and diseases affecting dose from a given 
exposure may modulate radiation risk.   
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• To investigate the impact of anatomical and physiological differences between individuals 
on radiation dose and dose distributions.  
 
• To start to explore modelling methods to predict differences in outcome at both individual 
(qualitative changes affecting health-relevant pathways) and population (quantitative 
changes in health outcomes) levels.  
5.4 Effects of spatial and temporal variation in dose delivery 
In the system of radiological protection, risk mainly depends on absorbed dose averaged over a 
given target mass. The biological outcome of the exposure is determined not only by the dose but 
also by the time frame of the dose delivery, and by the specific kind of radiation responsible for 
the energy deposition (radiation quality).  In order to account for the effects of temporal variation 
in dose delivery, a single dose- and dose-rate effectiveness factor (DDREF) is currently applied for 
low LET radiation in radiation protection; however, the evidence base for this judgement continues 
to be debated.  Concerning spatial variation, radiation weighting factors are currently applied for 
radiation protection purposes to account for the difference in the spatial pattern of energy 
deposition at the subcellular scale, due to different radiation qualities. At a larger scale, the effects 
of intra-organ (but supra-cellular) variation in dose delivery are not considered: the same health 
risk is assumed for all exposure types if they result in a given amount of absorbed energy, 
independently of whether the energy is absorbed by a single target cell or homogeneously 
distributed among all target cells of the same organ.  However, the biological effects and so the 
health consequences are unlikely to be the same. 
 
Inhomogeneity in dose delivery, both at the temporal and spatial level, is a real feature of many 
environmental, medical and occupational exposure scenarios. Mechanisms responsible for 
biological effects of different dose-rates or of inhomogeneous dose deposition are not fully 
characterized: at the cellular level they can be investigated with in vitro studies, but when it comes 
to how they finally affect health risk (both for cancer and non-cancer diseases) few relevant 
experimental models or valid datasets exist. In many situations, mixed field exposures are also 
relevant, but again there are few studies that consider risk in such exposed populations.  
 
The effects of spatial and temporal variation in dose delivery are also gaining importance because 
of the more wide-spread availability of external beam hadrontherapy, where out-of-field doses by 
scattered neutrons are of concern, the increasing clinical use of radionuclides, and the perspective 
of longer duration space travel (as well as space tourism) in the future. There is also a need to 
characterize how internal exposure, dose inhomogeneity and radiation quality influence the 
formation of candidate biomarkers so-far identified in response to low LET external exposure.  
 
Research line:  Health risk evaluation  
Quantification of health risk at low/moderate dose or dose-rates from internal exposures and from 
inhomogeneous dose distribution from external exposures is a key challenge for improved 
radiation risk assessment. As exposures frequently involve all three features noted above (effects 
of dose rate, radiation quality, and intra-organ dose distribution), relevant cohorts have to be 
identified or consolidated, where the separate effects of these three variations can be studied. In 
addition, collection and maintenance of relevant biological sample collections, including tissue 
samples from cancer cases and somatic tissue from affected individuals may also help to estimate 
the contribution of the effects of these three exposure characteristics. Sound individual dosimetry 
is particularly important in case of internal exposures.   
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Priority research areas are:  
 
• To determine cancer and non-cancer risk related acute and chronic  internal emitter-
exposures in epidemiological studies, incorporating detailed dosimetric assessment and 
evaluation of dosimetric uncertainties and, where appropriate, microdosimetric 
considerations. Where feasible and informative, these studies should include collection of 
appropriate biological samples and analysis of biomarkers of dose.  
• To determine the Relative Biological Effectiveness (RBE) for selected endpoints in 
epidemiological studies for specific cancer sites through comparison of risk related to low- 
and high-LET radiation exposure.  
• To better determine the risk (as well as possible countermeasures) associated with 
protracted exposure to the space radiation environment, in view of future interplanetary 
missions, both for cancer and non-cancer diseases (e.g. targeting possible impairments of 
cognitive and cardiovascular functions).  
• To develop and apply more detailed biokinetic and dosimetry models in order to better 
characterize dose distributions. 
 
 
Research line:  Basic mechanisms 
Effects of radiation quality and dose-rate on individual cells and at the cell population level are well 
documented. Many biological endpoints show a dose-rate dependence (notably DNA damage 
response) and data supporting an inverse dose-rate effect also exist. This raises the question of the 
effects of protracted exposures, particularly at low dose and low dose-rate. It is recommended to 
consider fluence (in addition to dosimetric information) when dealing with exposures to charged 
particles (particularly for high LET). Concerning spatial variation at the sub-cellular level, the 
biological outcome is clearly modulated by radiation quality indicators such as LET. Using e.g. 
microbeam irradiations, mechanisms determining the response to a highly inhomogeneous energy 
deposition can be addressed under controlled conditions.  
 
To provide further insights in the effects of intra-organ dose distribution, experiments with 
organotypic tissue models and animal models are required. The effects of locally high doses, when 
small parts of the tissue/organ are irradiated with high doses while the average dose remains low 
have to be quantified and compared to homogeneous exposures. Whether and how effects of the 
locally high dose propagate in the less exposed tissue also deserves investigation. Organotypic 
tissue models and animal models also allow to study the changes in tissue architecture in order to 
analyse the effects of intra-organ dose distribution. 
 
Priority research areas are: 
 
• To conduct experimental studies in vitro and in vivo to test exposure scenarios where 
dose/fluence modulation plays a role, e.g. localized versus uniform exposures, acute versus 
protracted exposures, to inform specific biomarker development and risk quantification. 
• To further develop suitable tissue and in vivo models for the quantification of the impact 
of dose inhomogeneity and radiation quality. 
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• When addressing the effects of internal contamination, specifically consider the role of 
chemical speciation in determining spatial distribution (at all scales) and biokinetics of 
radionuclides.    
• For all adopted experimental models, to develop in parallel modelling approaches able to 
tackle and quantify inhomogeneity at all scales: nano- (radiation track structure) and 
microdosimetric, dosimetric and biokinetic models at different levels of biological 
organisation.  
• To study mechanisms elicited by inhomogeneous dose deposition, integrating “dynamic” 
dose assessment and identification of relevant pathways (both for cancer and non-cancer 
diseases) in a systems biology approach, in order to characterize the response of the 
complex system as a whole.  
• To develop innovative ways in experimental studies to determine the Relative Biological 
Effectiveness (RBE) at low doses to determine/compare the effects of to low- versus high-
LET exposure. To characterize how internal exposure, dose inhomogeneity and radiation 
quality will affect the nature of candidate biomarkers so-far identified in response to low 
LET external exposure.  
• To develop experimental and modelling strategies to characterize the effects of exposures 
to mixed fields. 
• Build on knowledge acquired from basic mechanisms to identify relevant pathways for the 
quantification of the risk for cancer and non-cancer diseases, also using an adverse outcome 
pathway approach, determining those operating in case of inhomogeneous exposures   
 
6. Education and Training  
6.1 The role of education and training in low-dose radiation research 
The HLEG Report of 2009 (http://www.hleg.de/fr.pdf) identified a problem with the maintenance 
in Europe of the range of expertise essential to an effective programme of research into the risks 
to humans from low-dose radiation. The report advises that specific programmes aiming at 
knowledge management across generations have to be designed in order to achieve sustainable 
continuity and development.  
A large proportion of the groundwork of research is carried out as student projects and thesis work.  
For this reason, the research effort relies on a continuing relationship with universities, and on a 
healthy stream of high-level students. It is essential that this symbiosis is recognised and taken into 
account in research funding structures. 
A further intrinsic role of E&T within any specialized research area is in dissemination of new 
technologies, skills, and knowledge. To obtain maximum impact and benefit from research there 
should be an actively managed programme of workshops, seminars, summer schools, etc. which is 
integrated into the design and funding structure of all research. The programme should be aimed 
both at the sharing knowledge within the European low-dose research community and also at the 
wider radiation protection field including radioecology, emergency response, and the medical use 
of radiation. 
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6.2 Priorities for strategic support of E&T 
Following the comments in the previous section, support for E&T has two priority areas: support 
for students and young scientists, and promotion of E&T for dissemination. 
 
Support for students and young scientists 
• Students need to be able to find places at universities and placement with research groups 
for project/dissertation work.  This requires that the places must be available, but also that 
there are sufficient incentives to attract top students.  Universities are autonomous and 
develop new courses in response to a perceived need, taking account of staff expertise and 
specialization. Financial support from outside is not needed to achieve this end, although 
there is a role for influencing the perceived need.  On the other hand, increasing the access 
to students Europe-wide to university courses through industry-funded scholarships could 
significantly help to attract students. Setting up such a post-graduate scholarship scheme for 
attendance at approved universities should be seen as a priority. 
• In order to complement support at the post-graduate level and to help provide a career path 
for the most promising graduates, a scheme for provision of one or more post-doctoral 
fellowships should also be offered, to be taken up at approved research institutions.  
 
Promotion of E&T for dissemination 
• It should be explicitly in the wording for RTD calls that proposals will be judged favourably if 
a plan is included that explains how E&T will be integrated into the overall research 
programme, providing workshops or training courses dedicated to the presentation of new 
science/technology which is being used or developed in the project. 
• Parallel to the E&T supported by the RTD calls, it is seen as essential that a separately funded 
body (or part of a body with a ring-fenced budget) is responsible for the organization and 
sponsorship of targeted initiatives in order to promote the specialized skills and knowledge 
needed to maintain the full competence of the low-dose research community. These will be 
made readily available to postgraduate students and scientists.  The benefit to the former 
will be the provision of supplements to their university courses and to give them experience 
of the different areas of science on offer to them in their future careers.  For the latter, this 
will be a very effective way of providing continuing professional education, and for sharing 
knowledge with other research and educational institutions. 
 
Coordination and collaboration of E&T providers 
In order to get maximum benefit from E&T in the low-dose research area (both that which is 
already provided and the new initiatives proposed here) there should be an overall coordination 
of resources within the European community. Recommended priority actions are as follows: 
• Continuation and extension of the MELODI Education and Training Forum in order to bring 
together all platforms and other interested parties regularly to discuss needs and broaden 
the awareness of what is happening in EU member states. This should be seen as both a 
problem-solving and an advertising forum. There should be active participation by all other 
platforms involved in radiation protection (ALLIANCE, NERIS, EURADOS, EUTERP, EURAMED 
etc.) in order to share mutual experience and resources. 
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• There should be an active cooperation among groups promoting and supporting E&T in the 
radiation protection and research area (EURAYS, ENEN, etc.) and possibly use of mailing lists 
or social media to advertise programmes, courses, scholarships, fellowships, etc.  
 
7. Infrastructures   
One of the roles of MELODI is to ensure the availability of and facilitate ready access to the state 
of-the-art research infrastructures required to support the research efforts of radioprotection 
researchers. The priority is to promote the use of mature and up-to-date infrastructures and avoid 
unnecessary duplication. Furthermore, an effort should be made to harmonize practices amongst 
multiple facilities. Finally, the sustainability of rare but necessary facilities (such as those for 
internal contamination) needs to be guaranteed. This should include recommendations on the 
provision of the financial means to harmonize, sustain and access these facilities.  
Infrastructures include so-called large infrastructures such as exposure facilities such as  those for 
animal experimentation, as well as the collection and storage of cohort data, data bases, biobanks 
and analytical platforms.  
Within the project DoReMi, an extensive list of relevant infrastructures was generated for low dose 
research in particular irradiation facilities for internal and external exposure. In order to assess 
which infrastructures meet the needs of radioprotection scientists, it is necessary to develop and 
apply quality criteria determined by experts, specific to each type of infrastructure, for the listed 
large infrastructures. Financing for access to these facilities to support specific topics can then be 
included in future calls in which the selected facilities are partners in the future projects.  
Within the project DoReMi, a list of relevant cohorts was established and is currently being 
updated. Priority should be given to cohorts and biobanks that permit studies to improve the 
quantification of the risk associated with low dose and low dose-rate radiation exposure, for cancer 
and/or non-cancer diseases and/or to identify groups of individuals with specific sensitivity. In the 
relative short-term, some of the existing epidemiological cohorts can be used to support modelling 
and/or, in general through nested case-control studies, molecular epidemiological studies. In the 
long-term, new prospective cohorts can also be envisaged, as well as the development of new 
collections of biological material that will be necessary to support radiation research in the next 
decades.  
Within CONCERT infrastructures are highlighted via AIR2 bulletin and AIR2D2 Database. A 
webhandbook is ongoing, describing exposure facilities, cohorts, data bases, biobanks and 
analytical platforms. 
Within the EU-funded project STORE, an internet-based platform for sharing data from 
epidemiological studies, as well as data and biological samples from radiation experiments (new 
and past), has been developed and has been further carried forward and supported first by DoReMi 
then by CONCERT. Going forward, it will be necessary to promote activities to maintain the STORE 
data base by supporting the service of a curator, to further update and continuously expand the 
content of the data base, and to elucidate to what extent data from other radioprotection 
platforms (ALLIANCE, NERIS and EURADOS, EURAMED, SHARE can be incorporated into STORE or 
whether a separate but comparable data base would be more appropriate.    
The use of STORE as a repository for data linked to all publications arising from EU-funded projects 
in radioprotection research should be required, where appropriate and possible (ethics 
requirements and informed consent in epidemiological studies may prevent the data to be 
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uploaded into STORE, though collaborations with these studies can be envisaged) in line with the 
recent guidelines for H2020 supported projects.  
Furthermore, pointers to existing data sets from cohort studies or from radiological experiments 
(with animals or from the radioecology field) will need to be maintained and strengthened, and it 
will need to be indicated to what extent biological material is available. This should include the 
support of activities to identify valuable materials and archives that could be included in the 
database and the tissue bank, as well as to maintain relevant biobanks and rescue material from 
endangered biobanks. Furthermore, the use of biobanked material, where applicable, should be 
encouraged by including its use in future calls either indirectly for all relevant proposals or by 
specific topics dedicated to its use. In addition, funding should be included to support the 
biobanking of samples arising from Euratom/H2020 funded projects where appropriate.  In 
addition to studies of specific irradiated populations, there exist several major epidemiological  
cohorts established and followed primarily for reasons other than the assessment of radiation risk, 
some consideration of the benefits of utilising such cohorts and adding radiation exposure 
information could be assessed in the future. 
  
The maturation of the so-called ‘omics technologies, imaging and systems biology may offer novel 
opportunities for European radiation protection research.  As the quality of the technologies and 
supporting managerial and technical support varies widely, quality criteria will need to be 
established and applied in order to determine a limited number of facilities in each area which best 
meet the needs of radioprotection research. The use of these facilities should be linked to receiving 
funds in future calls, or at the very least a procedure will need to be put into place to assure the 
quality of those facilities outside of those on the list of recommended sites, such as for example, 
testing an agreed upon standard sample set, already tested by the listed facilities, within the scope 
of the funded projects.    
It is obvious that in the case of a major nuclear accident or attack, analytical platforms such as 
RENEB are accessible for the assessment of radiation exposure in order to differentiate “exposed” 
and “worried well” as support for medical triage, but later potentially for long-term risk assessment 
and subsequent screening of individuals. In addition to the use of such platforms in the cases of 
emergency, they can also contribute to research, e.g. for molecular-epidemiological studies or 
long-term follow up, when large numbers of bio probes need to be analysed. Therefore, the use of 
RENEB for research purposes needs to be actively pursued and supported in future calls where 
appropriate.  
Next steps will rely on further harmonisation of quality standards, practices and protocols, and co-
operation between the European radiation protection research platforms in relation to the 
provision and use of infrastructure. Huge efforts will be dedicated to sample/data acquisition and 
sample/data storage with the aims to re-use of archived materials. There is a need need of trans-
national agreement on a strategic work plan for maintenance, updating, mutual use of suitable 
infrastructures. Meanwhile, education and training actions will promote the use of European 
research infrastructures the advantage of using newer, larger, faster, more powerful 
infrastructures although not at the bench of each user. 
 
Priority areas are:  
• Improvement of the access to infrastructures  
• Favour open access to radiation research data within STORE  
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• Re-use of archived materials and existing epidemiological studies using specific 
retrospective approaches  
• Enlargement and sustainability of RENEB including inter-comparison exercises  
• Improvement of the awareness of existing infrastructure via E&T courses  
  
8. Research priorities (MELODI Statement)  
 
The purpose of the MELODI Association is to define priority scientific goals and to encourage the 
implementation research in the field of low dose rate radiation research. The Strategic Research 
Agenda of MELODI identifies these priority goals and the specific resources, infrastructures and 
training capabilities needed to further develop low-dose risk research within a time frame of 20 
years.  
Planning for the next EU research framework, Horizon Europe, is underway and this Statement 
strongly recommends the continuation of EU-funded radiation protection research to ensure that 
citizens are adequately and appropriately protected from radiation health risks.  This is at a time 
when exposures are increasing in the medical area, will continue to be a concern for members of 
the public in areas surrounding nuclear installations, and when terrorist threats remain a concern 
for many. 
The key priority for radiation protection research is to improve health risk estimates for low dose 
and dose-rates exposures encountered in occupational, medical and public/emergency situations. 
The approaches will need to be multidisciplinary and innovative. The integration of expertise 
outside of the conventional fields of radiation research will widen the possibilities to integrate 
modern technologies in health research in the assessment of health risk relevant to radiation 
protection.  
The ongoing MEDIRAD EU project has a specific focus on cardiovascular effects and diseases from 
radiotherapy in breast cancer patients and cancer following CT-scan among children, which 
constitute very specific exposure situations in specific populations. The HARMONIC project focuses 
on paediatric patients, undergoing interventional cardiology or proton therapy. As proton therapy 
applications in the clinic are relatively recent, this 5-year project will focus on short to medium 
term non-cancer outcomes (endocrine dysfunctions, cardiovascular toxicities and neurovascular 
damages) and will not assess cancer or cardiovascular risk directly. The objective of the WP on 
interventional cardiology, however, will be to assess risk of cancer.  
 
The ongoing LDLensRad, LEU-TRACK and SEPARATE projects, respectively focusing on dose and 
dose-rate effects on lens opacity, role of exosomes in radiation-induced leukaemogenesis and out-
of-field effects in normal tissues, are the only CONCERT-funded projects covering topics relevant 
to MELODI related to basic mechanistic investigations. 
 
While no specific EU- or EU-funded project calls for proposals are currently anticipated, the 
priorities may be used by national funding agencies, and are suitable for longer-term planning 
 
Priorities for 2020 – 2025 period:  
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• To explore and define the shape of the dose-response relationships for radiation-induced 
health effects (cancer and non-cancer outcomes, in particular cognitive and 
neurodevelopmental effects and immunological effects) (Overall priority) 
• To identify, explore and define adverse outcome pathways AOPs) for radiation-induced health 
effects, and determine if those operating at low doses and dose-rates are the same as those 
operating at higher levels of exposure, and when the triggering of an AOP is sufficient to disrupt 
normal homeostasis 
• To explore and define the role of epigenetic modifications in radiation-induced health effects 
• To identify, develop, validate and implement the use of biomarkers for exposure, and for early 
and late effects for cancer or/and non-cancer diseases.   
• To understand the potential impact of individual susceptibility on radiation-induced health 
effects. 
• To understand the health effects of inhomogeneous dose distributions, radiation quality and 
internal emitters.   
• To identify and enumerate the specific target cells for radiation-induced late developing health 
effects   
  
The current and previous MELODI statements can be found on the MELODI website. They generally 
provide information about short-term research priorities for specific calls. The definition of 
research priorities for the medium and long-term (“roadmap”) is currently under development.  
MELODI encourages, where appropriate, (1) the use of archived biological materials from prior EU 
funded research, (2) the integration of experienced laboratory networks (such as e.g. RENEB), (3) 
the consolidation and use of important epidemiological studies (both radiological and non-
radiological) where feasible, (4) the integration of expertise from outside the conventional fields 
of radiation research.  
  
  
9. Abbreviations, Websites  
  
ALLIANCE (European Radioecology Alliance) http://www.er-alliance.org/  
DoReMi Network of Excellence (Low Dose Research towards Multidisciplinary Integration) 
www.doremi-noe.net  
CONCERT https://concert-h2020.eu   
EURADOS (The European Radiation Dosimetry Group) www.eurados.org/  
EURAMED (European Alliance for Medical Radiation Protection Research) 
http://www.eibir.org/scientific-activities/joint-initiatives/european-alliance-for-
medicalradiation-protection-research-euramed/   
HLEG (High Level expert group) http://www.hleg.de/  
MEDIRAD (Implications of Medical Low Dose Radiation Exposure)  http://www.medirad-project.eu/ 
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MELODI (Multidisciplinary European Low Dose Initiative)  http://www.melodi-online.eu/  
NERIS (European Platform on preparedness for nuclear and radiological emergency response and 
recovery)  
http://www.eu-neris.net/  
OPERRA (Open project for European Radiation Research Area) http://www.melodi-
online.eu/operra.html    
SHARE (platform on social science and humanities) 
http://sites.exeter.ac.uk/nuclearsocieties/shine/  
STORE (platform for the archiving and sharing of the primary data outputs from 
research on low dose radiation)  https://www.storedb.org  
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1 Foreword 
 
The European Radiation Dosimetry Group (EURADOS) comprises a self-sustainable network of 
more than 60 European institutions and 300 scientists active in the field of radiation dosimetry. The 
aim of the network is to promote research and development and European cooperation in the field 
of dosimetry of ionizing radiation. For this, EURADOS has established Working Groups (WGs) in 
various dosimetric disciplines such as harmonization of individual monitoring, environmental 
dosimetry, computational dosimetry, internal dosimetry, dosimetry for medical applications, 
retrospective dosimetry, and dosimetry in high energy radiation fields.  
In autumn 2012 EURADOS decided to develop a Strategic Research Agenda (SRA) which will 
contribute to the identification of future research needs in radiation dosimetry. The SRA of 
EURADOS will be used as a guideline for the activities of the Working Groups. Moreover, the 
EURADOS SRA is an input to the recently launched OPERRA (Open Project for European Radiation 
Research Area) project funded by the European Commission (EC) that aims to build up a 
coordination structure that has the legal and logistical capacity to administer future calls for 
research proposals in radiation protection on behalf of the EC. Other projects such as the recent 
European Joint Programme Co-fund Action (EJP) intended to implement activities to attain 
objectives common to Horizon 2020 are also expected to benefit from this SRA.  
Since autumn 2012, each EURADOS WG has collected proposals for topics related to dosimetry 
which are believed to be important to the future of radiation research. During the EURADOS 
Annual Meeting that was held in February 20013 in Barcelona, Spain, the EURADOS Council 
established an SRA Working Group (members: W. Rühm (chair), E. Fantuzzi, R. Harrison, H. 
Schuhmacher, F. Vanhavere) who put together all collected information and – after the July 2013 
Council meeting in Berlin, Germany – began to draft the SRA. 
The present document formulates – based on input from EURADOS Working Group members – five 
visions in dosimetry and defines key issues in dosimetry research that are considered important for 
the next decades, for radiation research in Europe. This document was prepared for the EURADOS 
Annual Meeting to be held in Budapest, Hungary, in February 2014, where it was further discussed 
both at the EURADOS General Assembly and at Working Group meetings. A round of input from 
the EURADOS voting members was also organised. Thereafter the document was finalized and 
published as the EURADOS Strategic Research Agenda (first version). This version will then be the 
basis for a second round of improvement including stakeholder input.  
The present SRA was put together by the EURADOS Editorial Group on “Developing a Strategic 
Research Agenda“. The authors of this SRA (members of this group, members of the EURADOS 
Council, and the Working Group chairs) appreciate the input from the various EURADOS Working 
Groups. 
W. Rühm, et al. 
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2 Executive Summary 
 
The European Radiation Dosimetry Group (EURADOS) comprises a self-sustainable network of 
more than 60 European institutions such as reference and research laboratories, dosimetry services 
and companies, as well as more than 300 scientists active in the field of radiation dosimetry. The 
aim of the network is to promote research and development and European cooperation in the field 
of dosimetry of ionizing radiation and its implementation in routine practice, in order to contribute 
to compatibility within Europe and conformance with international practices. For this, EURADOS 
has established Working Groups (WG) on various dosimetric disciplines such as harmonization of 
individual monitoring, environmental dosimetry, computational dosimetry, internal dosimetry, 
dosimetry for medical applications, retrospective dosimetry, and dosimetry in high energy 
radiation fields. These groups demonstrate EURADOS’ capacity to develop, test and compare novel 
dosimetric techniques and, consequently, reduce uncertainty in dosimetry. This expertise is also 
considered important for tackling problems arising from new fields of applications of ionizing 
radiation needed to contribute to science-based policy recommendations in this area. The aspect 
of harmonization and education and training are also very important activities for EURADOS, by the 
organization of intercomparisons and training courses. 
At the end of 2012, EURADOS initiated a process for the development of a Strategic Research 
Agenda (SRA) which is designed to define which topics, if critically addressed over the next 
decades, are needed to significantly advance dosimetry in various applications. In the future, the 
EURADOS SRA will be an input for the recently launched OPERRA (Open Project for European 
Radiation Research Area) project funded by the European Commission (EC) that aims to build up a 
coordination structure that has the legal and logistical capacity to administer future calls for 
research proposals in radiation protection on behalf of the EC. Other projects such as the recent 
European Joint Programme Co-fund Action (EJP) intended to implement activities to attain 
objectives common to Horizon 2020 are also expected to benefit from this SRA. The efforts of 
EURADOS to develop an SRA for dosimetry, complement efforts of other platforms such as MELODI, 
ALLIANCE and NERIS which are developing their own SRA in the fields of low-dose research, 
radioecology, and emergency preparedness, respectively. Taken together, these SRAs will allow 
identification of research needs in Europe, in the general scientific field of radiation research with 
the final goal of improving radiation protection of workers and the public. 
Although the present document was based mainly on contributions from EURADOS members, it 
does include some indirect input from other institutions such as the International Commission on 
Radiological Protection (ICRP), the International Commission on Radiation Units and Measurements 
(ICRU), associations from the medical field and the International Organization for Standardization 
(ISO), because a number of EURADOS members are also members in these institutions. A more 
formal process of stakeholder involvement will be initiated at a later stage of SRA development. 
The present document formulates – based on input from EURADOS Working Group members – five 
visions in dosimetry and defines – for each vision – two to five challenges that are worked out in 
more detail by means of specific research lines.  
  
W. Rühm, et al. 
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Vision 1: Towards updated fundamental dose concepts and quantities  
 To improve understanding of spatial correlations of radiation interaction events 
 To establish correlations between track structure and radiation damage 
 To improve understanding of radiation-induced effects from internal emitters  
 To update operational quantities for external exposure 
Vision 2: Towards improved radiation risk estimates deduced from epidemiological cohorts  
 To improve exposure pathways not yet considered or validated 
 To improve retrospective dosimetry for exposure pathways already considered  
Vision 3: Towards an efficient dose assessment for radiological emergencies 
 To identify and characterize new markers of exposure  
 To develop strategies and methods to increase measurement capacity 
 To quantify doses after accidental internal contamination 
Vision 4: Towards integrated personalized dosimetry in medical applications  
 To improve out-of-field dosimetry for photon and particle therapy  
 To develop microdosimetric models for imaging and radiotherapy 
 To improve dosimetry in modern external beam radiotherapy 
 To optimize dose and risk estimations in interventional radiology  
 To establish reliable patient dosimetry in CT examinations 
Vision 5: Towards improved radiation protection of workers and the public 
 To implement new biokinetic models for intake of radionuclides  
 To develop calibration procedures for partial body counters 
 To develop accurate and on-line personal dosimetry for workers 
 To improve neutron dosimetry techniques 
 To include nuclide-specific information in dose rate measurements in the environment 
Because an important aim of EURADOS is to keep, circulate and improve knowledge in the field of 
dosimetry, EURADOS organizes training and education actions such as Winter Schools, Scientific 
Symposia and Training Courses. These actions are also described and future needs are discussed. 
Harmonisation of dosimetric practices in Europe is an additional field that is an important part of 
the EURADOS mission. Scientific work must generate reliable and reproducible results. 
Harmonization as applied to the deliverables of research work will enhance the consistency and 
coherence of scientific results, increasing reliability and improving accuracy. For this reason, actions 
such as intercomparisons and surveys of practices are described here in a separate chapter and 
their importance in future activities is highlighted.  
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3 Strategic Research Agenda 
3.1 Towards updated fundamental dose concepts and quantities 
To protect humans and the environment from excessive exposure to ionizing radiation, it has been 
necessary to develop systems for quantifying the radiation and its likely effects. The absorbed dose, 
the mean value of the energy imparted by ionizing radiation to a volume of interest divided by the 
mass of that volume, is defined on pure physical grounds, and generally provides a “quantitative 
description” of the interaction between ionizing radiation and exposed materials. However, for the 
purpose of radiation protection, the absorbed dose is not based on an adequately detailed 
description of the energy deposition for correlation with biological consequences. This inadequacy 
is due to the interplay of several factors: First, the dose-response relation for a particular biological 
system depends on the radiation quality, i.e. the spectrum of particles and their energies, and the 
stochastic pattern of energy deposition. Second, different biological systems, such as e.g. different 
tissue types in the human body, have different susceptibilities for producing radiation-induced 
effects. Third, as many biological processes are non-linear, the overall response of a biological 
system may be significantly different for inhomogeneous exposure. For the same reason, the 
biological consequences of an exposure may also differ depending on the temporal pattern of the 
irradiation (effects of dose rate and fractionation). 
In current radiation protection practice, the issue of radiation quality is taken into account for 
external exposures through the pragmatic approach of the operational quantities, developed by 
the International Commission on Radiation Units and Measurements (ICRU), which are based on 
the dose equivalent, H, obtained from the absorbed dose by introducing quality factors that are 
defined as functions of the linear energy transfer (LET) of the radiation involved.  
On the other hand, ICRP has defined a set of protection quantities that could be applied to all 
relevant exposure situations (internal and external, exposures with various radiation qualities, etc.). 
For these, the contributions to absorbed dose from different radiation qualities are multiplied by 
appropriate radiation weighting factors and added to obtain the equivalent dose, HT, in an organ or 
tissue, which in turn is multiplied by tissue weighting factors and summed over all organs and 
tissues, to obtain the effective dose, E. Additionally, for radiation protection purposes, the linear-
no-threshold (LNT) hypothesis is assumed to be valid. 
A major challenge to this current-practice dosimetric system arises from radioactive material 
incorporated in biological systems. The incorporation may result from unintentional uptake of 
natural or anthropogenic radionuclides from the environment or from the administration of 
radionuclides to an individual for diagnostic or therapeutic purposes. In all cases, the internally 
deposited energy is highly heterogeneous due to the uptake, biokinetics, retention and physical 
characteristics of the incorporated radionuclide and the transport within the body of the radiation 
emitted due to its decay. Therefore, averaging over certain tissues and organs as done for the 
calculation of E might be too simple. 
The goal should therefore be to provide physically and conceptually sound quantities to be used in 
radiation protection. The current system of dose quantities has unnecessary complexity and 
incoherence and a system of radiation protection quantities that avoids the unnecessary duality of 
dose equivalents vs. equivalent dose is desirable.  
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For the vision of updated fundamental dose concepts and quantities the following challenges were 
identified: 
 To improve the understanding of spatial correlations of radiation interaction events 
 To quantify correlations between track structure and radiation damage 
 To improve the understanding of the biokinetics of internal emitters 
 To update operational quantities for external exposure 
These challenges are described in detail in the following. 
 
3.1.1 To improve understanding of spatial correlations of radiation interaction events 
Introduction 
The dependence of biological effectiveness on radiation quality is commonly believed to be 
related to the differences in the energy deposition pattern on a microscopic scale. For charged 
particles, this pattern is called the track structure, where the loci of interaction events are 
concentrated around the primary particle trajectory. For photon irradiation, the pattern is given by 
the tracks produced by the electrons (and positrons) liberated in inelastic photon interactions, and 
for neutrons by the tracks of the recoil protons. At higher primary particle energies, further 
secondary particles produced such as alpha particles might also be of relevance. Information on 
spatial distribution and correlation of secondary particles from models (validated by 
measurements) should be important, for a fundamental understanding of microscopic dose and 
dose concepts and the associated uncertainties. 
Microdosimetry has provided experimental techniques for characterizing particle track structure in 
terms of the probability distribution of the stochastic quantity lineal energy, which is based on the 
energy transferred by a passing particle to a simulated microscopic target volume of typically few 
µm in size, i.e. in the order of the magnitude of cell nuclei. On the other hand, studies based on 
detailed numerical simulations of track structures provided evidence that the biologically relevant 
target size might be in the range of few nanometers where experimental microdosimetric 
techniques fail to be applicable. This led to the development of nanodosimetry where track 
structure is characterized in terms of the probability distribution of the number of ionizations 
produced by a particle track in a target volume of few nm in size. Similar to microdosimetry, the 
microscopic target is experimentally simulated by an equivalent gas target of macroscopic 
dimensions and use of theoretical density scaling relations.  
Micro- and nanodosimetry provide a pure physical characterization of microscopic track structure 
based on time and space correlations of the radiation interaction events. This could pave the way 
for new concepts for quantifying radiation effects in terms of radiation field properties, separating 
the physical and biological aspects involved in the biological effects of different radiation qualities. 
The goal would be a novel unified concept of radiation quality based on measurable properties of 
the particle track structure; its experimental realization and implementation with ‘dosimeter 
standards’ and traceable easy-to-use end-user measurement devices.  
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Research lines 
In principle, nanodosimetry enables a three-dimensional characterization of the particle track 
structure including the statistical correlations between different target volumes which may be 
decisive for biological effects of different radiation qualities. Such a comprehensive 
characterization of track structure is the prerequisite for an unbiased identification of the 
biologically relevant target size, which may depend on which biological endpoint is considered. In 
practice, however, the few existing nanodosimeters developed so far simulate only a single target 
volume and, as such, of different sizes. Only recently first attempts were made to develop track 
structure imaging techniques, on the one hand, and to investigate the relation between track-
structure characteristics measured with different instruments, on the other. In this context, the 
establishment of uncertainty budgets for measured nanodosimetric quantities is an important task 
for the future, where the budget needs to take into account all sources of uncertainty including 
bias introduced through incomplete collection of the ions produced in the target. Apart from 
laying the basis for the development of detection systems for practical use, the research on 
experimental track structure characterization also provides a benchmark for the validation of track 
structure simulation codes. In the long run, these activities need to be expanded to experimental 
investigation of radiation interaction with real nanometric objects in the condensed phase, such as, 
for instance, nano-droplets of DNA or proteins clustered with water molecules or nano-structured 
solid-state devices. 
Deriving estimates of the uncertainty of nanodosimetric characteristics of track structure is also a 
major need for the computational methods used for numerical simulation of particle tracks. These 
numerical methods are, in principle, well suited for studying particle track formation and for 
obtaining the probability distributions for micro- or nanodosimetric quantities. Some codes have 
been developed for this purpose by different groups. Using track structure simulation, first 
attempts to investigate correlations between nanodosimetric characteristics for different target 
volumes along the track and between target volumes of different size have been made. Further 
steps along this line towards a ‘multi-scale’ characterization of particle track structure need also to 
include studying the link between nanodosimetry and microdosimetry. In this context also the 
relevance of using interaction coefficients with biological molecules (DNA, proteins, etc.) as 
opposed to water, on whose radiation transport properties most track structure codes are based, 
needs to be investigated. 
Numerical simulation techniques for track structure are mostly based on Monte-Carlo techniques 
that take into account each individual interaction (step-by-step simulations as opposed to the 
common condensed-history approaches). Two major concerns have recently been raised against 
this approach. One is that in this Monte Carlo approach the ionizing particles are basically treated 
as classical particles for which location and momentum can be defined at the same time. 
Particularly for electrons with energy below 1 keV, i.e. for the vast majority of electrons produced in 
ionizing interactions, this is in contradiction to the Heisenberg uncertainty principle. The second 
challenge is related to the use of the cross section concept in a context where subsequent 
interactions occur at average distances in the nm range, so that they cannot be considered as 
independent. Some alternative methods for simulating track structure characteristics without 
using Monte Carlo techniques have been developed which, however, also rely on albeit effective 
cross sections.  
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With respect to the aim of developing measurement devices for track structure properties with the 
potential for practical applicability, the most advanced developments are miniaturized tissue-
equivalent proportional counters and solid-state microdosimeters based on silicon. In addition, 
also calorimetric microdosimeters are under development whose major potential lies in their 
capability to measure energy deposition directly in tissue-equivalent material, such as to obtain a 
means of ‘calibration’ for the other types of miniaturized microdosimeters. For nanodosimetry, first 
attempts are in progress to develop measurement devices for track structure that are based on the 
radiation-induced change in resistance of electrical circuits built from DNA molecules. 
 
3.1.2 To quantify correlations between track structure and radiation damage 
Introduction 
The comprehensive multi-scale characterization of the physical aspects of particle track structure 
will enable a quantitative investigation of the impact of particle track structure in terms of 
biological effects at the subcellular and cellular level. To this end, radiobiological experiments and 
radiobiological modelling need to be included. In order to obtain a quantitative and 
comprehensive characterization of the correlation between microscopic particle track structure 
and radiation damage to biological cells, biological cells need to be exposed to single particle 
tracks. In these radiobiological experiments, information on the geometrical relation between the 
particle track and the exposed cells is required such as to be able to relate the features of the track 
to the biological outcome.  
Track structure will most likely show a strong correlation with the induction of early biological 
effects such as the occurrence of single and double strand breaks of the DNA. As later biological 
endpoints also show a dependence on radiation quality, there should also be a correlation of track 
structure characteristics and the probability of inducing these later effects, such as chromosomal 
aberrations or cell death. It is not obvious a priori whether the same characteristics (e.g. probability 
distribution of the number of ionizations for a particular size of the target volume) will be of 
relevance for different biological endpoints.  
Many radiobiological assays available to date are often dependent on the availability of a large 
number of exposed cells, as intermediate steps in the applied protocols may have a limited 
selectivity for the cells of interest. This often leads to outcomes of limited statistical power. 
Furthermore, for many assays functioning protocols can only be established for a limited choice of 
cell types, and there is often a strong dependence on the human factor and a number of unknown 
factors which can jeopardize the success of the assay and appear to be beyond the control of the 
experimenter. For a high significance of the sought correlation between track structure 
characteristics and biological effects, an improvement of the dependability of radiobiological 
assays would be desirable. This would also be beneficial for biodosimetry as a tool for radiological 
emergencies.  
Research lines 
The method of choice for the purpose of overlaying particle track with biological cells under 
defined geometrical conditions are microbeams offering targeting capabilities for individual cells 
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and compartments of cells. Ion microbeams that provide primary particles with pronounced track 
structure can allow exposure to a controlled number of tracks per cell. Alternatives to ion 
microbeams are methods based on nuclear track detectors and biological assays that maintain the 
geometrical relation between cells and tracks.  
In these experiments, radiobiological assays are carried out on the irradiated cells to obtain the 
yield of a particular biological endpoint for a particular radiation quality and a particular 
geometrical arrangement of the particle track and the irradiated cell. A multi-scale characterization 
of the physical characteristics of the track structure would also be carried out by using 
nanodosimeters with multi-scale measurement capabilities or by employing track structure 
simulation codes that have been benchmarked with nanodosimetric measurements. Statistical 
cross-analysis would then be carried out to identify, for instance, correlations between the yield of 
a particular biological endpoint for different radiation qualities and nanodosimetric probability 
distributions for particular target sizes, such as to identify the most relevant target size for this 
endpoint.  
Depending on the biological endpoint, radiobiological modelling will be involved to a different 
extent in establishing these correlations. Benchmarking will therefore be essential. This could for 
instance be achieved by exposing cells to ‘equivalent’ combinations of particle tracks of different 
radiation quality. These ‘equivalent’ combinations could be found using simulations of track 
structure and would be defined by producing the same combined probability distributions used as 
track structure characteristics (for the identified ‘relevant’ target size). The benchmarking would 
require cells exposed to particle tracks of mixed radiation quality, which would need appropriate 
irradiation setups to be developed.  
The correlation between yields of certain biological endpoints and track structure characteristics 
would have to be systematically studied for a variety of human cell types of different differentiation 
and coming from donors of different age and gender such as to obtain information on the 
presence or absence of age and sex dependent differences as well as on interpersonal variability. 
The goal would be to find potential weighting functions for track structure characteristics that 
allow predictions of biological effects based on track structure measurements. This would be a 
prerequisite for new dosimetric concepts quantifying radiation effects at the level of individual 
cells or small compartments of tissue. If the sought correlations should predominantly occur for a 
specific value of target size, nanodosimeters simulating this target size could be used for the 
realization of these new dosimetric quantities. Otherwise, measurement techniques for their 
realization would need to be developed from scratch.  
 
3.1.3 To improve understanding of biokinetics and dosimetry of internal emitters  
Introduction 
One of the key issues in internal dosimetry is how information on dosimetry and biokinetics of 
internal emitters can be used to improve our understanding of radiation-induced effects and 
mechanisms of effect occurrence. 
Low concentrations of incorporated radionuclides are characterized by spatially and temporally 
inhomogeneous dose distributions within a tissue or organ. The spatial inhomogeneity of target 
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cells as well as the sensitivities of various cells in a given tissue or organ may result in different 
health effects. Additionally, the temporal exposure inhomogeneity, that is acute, chronic or 
fractionated irradiation, and the dynamic behaviour of radionuclide distribution within tissues and 
organs may affect the biological outcome. Thus, average quantities like average absorbed organ 
doses may not be appropriate for the estimation of biological effects of low doses. This is partly 
taken into account by the latest ICRP models which for example consider the inhomogeneous 
distribution of target tissues in the skeleton and (on a larger scale) of deposited activity in the 
respiratory tract. 
Radiologically important radionuclides in internal dosimetry which may require a microdosimetric 
approach are alpha and beta emitters, such as isotopes of plutonium and strontium in the skeleton 
or short-lived radon progenies in the lungs, and Auger emitters, such as iodine isotopes, in the 
thyroid. For example, in case of inhalation of short-lived radon progeny in the lung, highly localized 
deposition of alpha-emitting radon and thoron progeny may induce very high doses on a very local 
(a few hundred micrometer) scale that may even lead to cell killing, although the mean organ 
absorbed dose to the lung might be quite low. 
One of the most important issues in low-dose research is the analysis and characterization of 
possible thresholds in observed health effects. By decreasing the dose, its role may become 
negligible compared to the role of confounding factors or compared to the repair mechanisms of 
cells and tissues. Another consequence of inhomogeneous cellular dose distributions is that 
modelling of tissue response instead of single cell responses becomes even more important 
because of interaction among adjacent cells. 
Low-dose effects of high and low LET radiation are quite different. High LET radiation reaches only 
a small number of cells depositing a high amount of energy whilst low LET radiation affects more 
cells with a smaller amount of energy imparted. Thus, alternative ways of assessing high and low 
LET exposures should be investigated such as fluence, hit probability and microdosimetric energy 
distributions. Improving dosimetric quantification can decrease the uncertainty of the dose effect 
relationships. 
Research lines 
Characterisation of the spatial inhomogeneity of dose and its effects on different scales from 
individual molecules to the whole body is needed, with a particular focus on  the development of 
calculation tools for alpha microdosimetry. Other scenarios of interest are the deposition of 90Sr 
within femur bone, radon and thoron in the lung, deposition and clearance models for inhaled 
radon progeny, cellular effects of low doses and low dose rates with the focus on DNA damage and 
stress response, simulation of microdosimetry in a virtual cell and track-structure-based 
calculations of initial radiation damage and its effects on the DNA, tissues and organs. This will 
require the study of deposition of radioactive material on different scales from organelles to the 
whole body including benchmarking of Monte Carlo codes – from micro to macro dosimetry. At 
the very end of this line, alternative quantities based on nano- and microdosimetry instead of 
absorbed dose may be developed to predict health effects. 
These efforts must be accompanied by the development of more realistic models of radionuclide 
deposition in the various regions of the lung than are currently available, describing the energy 
deposition of incorporated alpha emitters on a micrometer and nanometer scale and estimating 
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the corresponding local biological effects. The results should be combined with epidemiological 
observations, for example after residential radon exposure or inhalation of plutonium 
(occupationally or accidentally). The same approach can be applied to the development of more 
realistic thyroid models that permit studying deposition of electron and photon emitters in the 
thyroid after accidental intakes of radioiodine isotopes; this study will focus on public exposures, 
taking into account a wide range of ages from foetus to adolescents and also adults. This research 
may even include development of new dose concepts that are described in Chapter 3.1 of this 
report. 
There is increasing evidence that the tissue response after irradiation with high LET radiations may 
be different from that observed in individual cells, e.g. through the interaction of cells via 
bystander mechanisms. To extrapolate from effects in single cells, where experimental information 
is currently available, to biological effects in tissue, which may be related to epidemiological 
findings, requires research on radiation effects in 3D tissue models, both experimentally and 
theoretically. In terms of dosimetry, this raises the question, whether currently identified 
progenitor cells are indeed the primary target cells or whether all surrounding cells may contribute 
through bystander mechanisms.   
For radiation protection purposes, carcinogenesis is the most important radiologically induced 
health effect at low doses. It is common practice in cancer research to assume a multi-step model, 
including initiation and promotion mechanisms. Initiation is currently assumed be related to 
cellular transformation in single cells and thus depends on the local dose. An important 
promotional factor is inflammation of the irradiated tissue, which is again related to local dose. 
Hence from a dosimetric point of view this raises the question of which cells in a tissue are the 
primary targets for initiation and promotion, and, consequently, which are the relevant cellular 
doses. In the case of lung tumors, cigarette smoke is the most important promoting agent, as 
evidenced by epidemiological studies, whose deposition pattern follows very similar biokinetics as 
that of inhaled radionuclides.  
 
3.1.4 To Update Operational Quantities for External Exposure  
Introduction 
The protection quantities cannot be physically determined by measurement. In order to answer 
both social needs and metrology, a quantity, or set of quantities, is required that can be related to 
the protection quantities for the purpose of the safe control of ionizing radiation and legislative 
requirements, and can be determined by measurement. The quantities must be: self-evident 
(obvious); comprehensible to the users (simple); as easy as possible to determine; stable; without 
ambiguity for defining all the components of the radiation field at a point or at a position on the 
body; having mathematical properties (additivity, linearity). The role of the operational quantities is 
to provide a reasonable estimate of the protection quantities for optimization and in assessing 
compliance with the limits. The operational quantities must be defined, without restriction, for all 
particles and energies for which the protection quantities are provided. 
Research lines 
W. Rühm, et al. 
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The current operational quantities were defined by ICRU. Conversion coefficients for the 
operational quantities and the protection quantities were published by ICRU and ICRP for photons, 
neutrons, and electrons. 
ICRP has recently published revised formulations of the protection quantities (Publication 103), a 
standard set of male and female anthropomorphic phantoms (Publication 110), and a set of 
conversion coefficients for the updated protection quantities (Publication 116). In the new 
compilation, particle type and energy range of the conversion coefficients are extended compared 
to earlier publications. The conversion coefficients calculated using full transport of particles, are 
presented for photons (up to 10 GeV), neutrons (10 GeV), electron/positrons (10 GeV) plus protons 
(10 GeV), muons (10 GeV), pions (200 GeV) and He ions (100 GeV/nucleon). The extension of 
particle type and energy range is intended to meet a need for exposures in high-energy particle 
accelerators, aircraft and space. The operational quantities will be needed for these particles over 
the whole energy range in order to adapt the new protection quantities to the system of radiation 
protection. In this context, further consideration is being given to the definitions of the operational 
quantities: any changes made to the definitions can have an impact on the design of area monitors, 
personal monitors, and calibration procedures.  
As far as operational quantities are concerned, neither Hp(0.07) nor H‘(0.07) may provide the best 
assessment of the stochastic or deterministic effects in skin. Thus, a modified system of operational 
quantities (addressing for example the control of exposure due to hot particles and other external 
sources of skin irradiation) is needed.The operational quantities used in radiation protection 
practice including those mentioned above for skin dose assessment must be capable of being 
measured with simple monitoring instruments, and they should provide a sufficiently conservative 
estimate of organ and tissue equivalent doses and effective dose limits. Therefore, it is very 
important to consider the availability of device and calibration facilities as well as the 
establishment of calibration procedures to define the operational quantities for new particles and 
extended energy ranges. 
3.2 Towards improved radiation risk estimates deduced from epidemiological 
cohorts 
Radiation dosimetry for irradiated humans is important (i) for the treatment, diagnosis and 
protection of the individual and (ii) for the understanding of the effects of ionising radiation on 
humans. Current knowledge of relationships between dose and radiocarcinogenic risk, non-cancer 
diseases and other radio-induced pathologies (e.g. eye lens opacity, fibrosis) depends largely on 
the analysis of situations where large populations have been exposed to ionizing radiation, e.g. 
acutely at the Japanese bombings and some medical exposures, or chronically by radionuclide 
releases from the Mayak nuclear facilities in the Southern Urals). The basis for all risk estimates is 
absorbed dose. In order to give maximum support for future epidemiological studies, and to 
underpin theoretical radiobiological developments, dose distributions in the body following 
exposures from all known sources of radiation should be quantified and evaluated, in particular for 
mixed radiation fields which were present for example at work places of nuclear workers, or if there 
were multiple exposures to ionizing radiation in medical applications (diagnostics and therapy). 
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Radiation research is performed to quantify the radiation risk involved in a certain exposure 
situation, in order to judge whether this exposure can be justified or not. In this context the 
concept of risk coefficients, i.e. the risk of a certain outcome per unit dose, is a central element. In a 
dose-response curve, the risk coefficient can be interpreted as the slope of the curve which 
corresponds to the ratio of the risk and the dose, at a given dose. From this it is evident that 
uncertainties in quantification of the outcome (risk) or uncertainties in quantification of the dose 
would both contribute to the uncertainty of risk coefficients. In this sense, radiation dosimetry 
must be considered as an essential foundation of radiation risk estimates. Dosimetry therefore 
represents an essential input to radio-epidemiological studies, whether in radiotherapy and 
diagnostic imaging follow-ups, studies on occupational exposure and exposure of the general 
population, or accidental exposures. 
Presently the most important radio-epidemiological cohort is the cohort of atomic bomb survivors 
from Hiroshima and Nagasaki which has been followed-up by the Radiation Research Effects 
Foundation (RERF; former ABCC) since 1950. Although considerable efforts have been made since 
the 1950s to quantify the doses of the survivors included in the so-called Life Span Study (LSS) on 
an individual level – with the DS02 Dosimetry System being the most advanced of a number of 
consecutive dosimetry systems – still a number of fundamental open issues have been defined 
recently. 
Other cohorts include populations exposed at the Techa River area from releases of the Mayak 
nuclear facility, after the Chernobyl accident (thyroid cancer) and more recently after the 
Fukushima accident. Among occupationally exposed groups, uranium miners, radiation 
technologists, Chernobyl liquidators, Mayak workers, other nuclear workers, air crew etc. are of 
concern, while other studies include individuals exposed due to radiotherapy (tinea capitis, 
hemangioma, breast cancer, thyroid cancer, etc.).  
In a few years, follow-up of a number of studies will finish, due to the aging of the involved cohort 
(e.g., LSS) and consequently other cohorts of irradiated humans may become more and more 
important in the future, including offspring cohorts of exposed parents. Cohorts such as 
radiotherapy and diagnostic imaging patient populations, for example, are useful candidates 
because of the large number of individuals involved, the medium-high doses, and especially 
because patient doses are well controlled and documented. For this reason, development and 
harmonization of medical dosimetry is important. Other efforts include the establishment of 
national cohorts of individuals of the general populations.  
In the past, in most cases incidence and/or mortality of various cancer types were of major concern 
(all solid tumours combined, tumours at certain organs, leukaemia, thyroid cancer, etc.) while more 
recently, cancer diseases following in-utero exposure, and non-cancer diseases such as 
cardiovascular diseases, neurological impairments, or eye lens opacities have become of increasing 
concern. 
In order to improve risk estimates deduced from such cohorts, a number of dosimetric 
improvements are required: 
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 Quantification and validation of exposure pathways that have not yet been considered so 
far for certain cohorts. This includes doses to certain organs and tissues that need specific 
attention (e.g. eye lens, brain, foetus), doses to substructures of certain organs (e.g. heart 
arteries and walls), and determination of the micro-distribution of doses in certain tissues 
(e.g. in the lung after inhalation of alpha emitters) 
 Improvements in techniques of retrospective dosimetry for historical cohorts and 
validation of the doses estimated (e.g. for Chernobyl liquidators, Techa River populations, 
LSS, Mayak and Sellafield nuclear workers, uranium miners) 
 Improvement of uncertainty evaluation of doses estimated by retrospective dosimetry 
techniques 
For the vision of improved radiation risk estimates deduced from epidemiological cohorts the 
following challenges were identified: 
 To explore exposure pathways not yet considered or validated 
 To improve retrospective dosimetry for exposure pathways already considered 
These challenges are described in detail in the following. 
 
3.2.1 To explore exposure pathways not yet considered or validated 
Introduction 
While considerable efforts have been made in the past to quantify exposure of individuals in 
cohorts used to deduce various radiation-induced risks for various endpoints (e.g. solid cancer, 
non-cancer diseases, chromosome aberrations, cataracts, etc.), we have identified a number of 
exposure pathways that have not yet been included or validated in dose estimates of relevant 
radio-epidemiological cohorts. These cohorts include, for example, atomic bomb survivors, aircrew, 
medical radiotherapy cohorts, Techa River population, and national cohorts of populations 
currently being established in a number of countries. For the pathways identified the 
corresponding doses must be quantified in an effort to establish an integrated individual 
dosimetry to be used for deduction of reliable dose-response curves from epidemiological cohorts. 
We also note that for a number of tissues and organs that are important for radio-epidemiological 
cohorts, exposures cannot adequately be calculated yet. For example, cancer following prenatal 
exposures, and non-cancer effects induced by ionizing radiation such as cardiovascular diseases, 
neurological (cognitive) impairments or lens opacities (cataracts) are of increasing concern, and a 
number of epidemiological studies have already provided some evidence for statistically 
significant radiation-induced non-cancer effects and cancer risk due to in-utero exposure (e.g., 
atomic bomb survivors, Mayak workers, Techa River population). For the establishment of reliable 
dose-response relationships for these endpoints, realistic dose estimates to the organ of concern 
must be available. Such doses are, however, not yet fully considered in dosimetry and have to be 
developed. 
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Research lines 
Recently, open issues in a-bomb survivor dosimetry of the Life Span Study were discussed and it 
was felt that exposure from residual radioactivity induced by neutrons in the environment and 
some internal exposure pathways need still to be addressed. Biodosimetric methods such as EPR 
on tooth enamel or measurement of stable chromosome aberrations (translocations) in peripheral 
blood samples of survivors may help to quantify individual exposures. Neutrons are still of some 
concern and although neutron activation products have recently been successfully measured in 
tissue samples (enamel) from survivors, calculated fast neutron doses for the Nagasaki cohort still 
require experimental validation of environmental samples.   
In the case of air crew exposed to secondary cosmic radiation during flight, considerable efforts 
have been made in the past to quantify – mainly by simulations that were validated by 
measurements – annual effective doses. These efforts showed that in many countries pilots and 
cabin crew is the cohort with the highest occupational exposure (both in terms of mean annual 
effective dose and mean annual collective dose). Dose contributions from Solar Particle Events, that 
may increase the dose rate from secondary radiation in the atmosphere by 1-2 orders of magnitude 
for several hours, however, have not yet been addressed. Some efforts must be made, in particular 
with respect to quantification of the energy distributions of primary protons emitted by the Sun 
during such events and with respect to measurement campaigns onboard aircraft, before reliable 
dose estimates can be made. This also holds for astronauts in space, and may also be important, for 
example, for studies on electronic effects (Single Event Upsets) to electronic components used in 
aviation and space, keeping in mind that highly-engineered modern societies are particularly 
vulnerable if SPEs affect electronic communication and GPS navigation.  
Epidemiological studies of second cancers following radiotherapy must have a specification of 
dose to the patient. In some studies, however, it has not yet been possible accurately to determine 
dose to the tissue at the site of the second cancer. By harmonizing out-of-field dosimetry 
techniques for radiotherapy patients, and dosimetry for various diagnostic procedures, EURADOS 
can contribute significantly to future epidemiological studies by developing “the complete dose 
specification” from all sources of radiation (see also section 3.4). This may even include dose 
contributions calculated on a sub-organ level as described below.  
Currently, in a number of countries such as Germany there are efforts to establish national cohorts. 
These efforts aim to investigate causes of common diseases among the general population such as, 
among many others, cardiovascular diseases and cancer, quantification of risk factors, and 
identification of prevention strategies (see e.g. http://www.nationale-kohorte.de/index_en.html for 
Germany). Due to the large number of individuals included (about 200,000) and the planned 
length follow-up (10-20 years) such cohorts may also be suitable for the investigation of the role of 
ionizing radiation in the induction of the various investigated endpoints. A prerequisite is of course 
reliable dosimetry for the participants. While this will not be possible for all participants, we expect 
that in these cohorts, sub-groups will be defined for which sophisticated determination of all 
relevant exposure pathways from natural sources of ionizing radiation (cosmic radiation, terrestrial 
radiation, radon, internal) will be performed. Methods need to be developed to measure these 
exposure pathways on an individual level without compromising the daily life of the participants.  
Exposure scenarios typical for the population at the Techa River are particularly complicated 
because they include a combination of external and internal exposures. For an integrated 
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individual dosimetry of the members of this group, a combination of dosimetric techniques must 
therefore be applied. Physical dosimetry on environmental samples using TL, and analysis of 
radionuclide composition in historical water samples as well as historical dose rate measurements 
in the environment have already been used to validate assumptions on the source terms of the 
Mayak releases. Biological dosimetry such as fluorescence in situ hybridization (FISH) techniques to 
identify stable chromosome aberrations and EPR on tooth enamel should be complemented by 
internal dosimetry techniques (in-vivo and in-vitro bioassay methods) quantifying the dose from 
incorporated long-lived radionuclides such as 90Sr or plutonium isotopes. The radiation-induced 
EPR signals result from combined contributions of external exposure and radionuclides 
incorporated in tooth tissues. Techniques for assessment of the internal dose to tooth tissues and 
data analysis must be improved to enhance discrimination of external and internal dose 
components and to separate contributions of natural background radiation and atmospheric 
radionuclide releases. The effects of radiation may be altered by the presence of confounding 
factors or of other contaminants or stressors which may be the case when cytogenetic methods of 
dose reconstruction are used; this will require further analysis. 
After the Fukushima accident in Japan, a considerable number of members of the public were 
exposed to released radioiodine isotopes. EURADOS has been collaborating with the National 
Institute of Radiological Sciences in Japan (NIRS) since 2012 in a project for the reconstruction of 
early internal doses in the TEPCO Fukushima Daiichi Nuclear Power Station Accident. For this 
project, computational dosimetry is used as an alternative tool in internal dosimetry when physical 
phantoms are not available for in-vivo calibration of whole body counters. Monte Carlo simulations 
using voxel phantoms permit calculation of counting efficiency of the detectors used for 
measurements, for different ranges of age of the exposed population, resulting in more accurate 
calculation of activity of radioiodine deposited in the thyroid. This approach should be 
implemented to improve the on-going process of reconstruction of doses to workers and the 
population affected by the Fukushima accident, but can be also applied in other scenarios. 
Furthermore it is our vision that during the next decades, models of critical organs such as the 
heart, the brain or the eye lens with high spatial resolution will become available that allow 
quantification of absorbed doses in substructures of the organs of interest. This will require 
development of voxel phantoms of these organs with voxels on a sub-mm size that will allow – in 
combination with radiation transport calculations in the human body – calculation of absorbed 
doses from primary and secondary particles in organ sub-structures such as, for example, the 
arteries of the heart. The final goal of this research will be to establish fluence-to-dose conversion 
coefficients for organ sub-structures of interest, for relevant radiation types. This research should 
include organs of various sizes, and in particular organ sizes that are typical for children and young 
adults (adolescents). The radiation to be studied depends on the exposure scenario of the 
investigated cohort and may include photons (medical cohorts, e.g. CT exposures), a mixed photon 
and neutron field (a-bomb survivors), combined photon, proton, neutron, and ion exposure 
(particle therapy), photons and alpha particles from incorporated alpha-emitters (Mayak workers), 
beta particles (90Sr in Techa River, radioiodine intakes due to Chernobyl and Fukushima accidents 
or in radiotherapy patients), or even mixtures of external exposures and internal exposures due to a 
variety of incorporated radionuclides (Techa River populations, Chernobyl population, uranium 
miners, nuclear workers).  
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For any organ of interest, the computational efforts described above should be complemented by 
development of miniaturized detectors that will allow measurement of doses from various 
radiation types within small substructures of a suitable phantom, or even within a patient during 
irradiation (e.g., brachytherapy).  
 
3.2.2 To advance retrospective dosimetry for exposure pathways already considered 
Introduction 
Retrospective dosimetry consists of methods that measure persistent chemical, biological or 
physical changes, in biological tissues or inert materials, which can be directly related to the 
absorbed dose of ionizing radiation. In other words, retrospective dosimetry measures markers of 
exposure which persist long enough to measure doses received weeks or years before sampling. In 
epidemiological studies, these methods are appealing because they complement conventional 
dosimetry, such as film badges, when this is not available or reliable, and allow for a dose estimate 
which is independent of the analytical models. Retrospective dosimetry has indeed helped 
significantly to validate analytical model-based doses either of environmental samples, or of 
individuals such as inhabitants of contaminated territories and Mayak and other nuclear workers, in 
the largest epidemiological studies. In particular, long-lived (i.e. for years) markers of exposure have 
been valuable tools for dose assessment of historical and chronic cohorts (e.g., survivors in 
Hiroshima and Nagasaki, inhabitants of the Southern Urals). 
The ideal objective is to use retrospective dosimetry for molecular epidemiology, i.e. to provide 
individual doses having little bias and small random errors, and to permit discrimination between 
different pathways of exposure (i.e. internal vs. external) and radiation qualities. In our vision, this 
long term objective can be approached through the following research lines. 
Research lines 
In all the epidemiological studies of historical cohorts, the dose estimates fell mainly in the low-
intermediate dose range. Currently, the most consolidated long-lived markers (EPR with teeth, FISH 
of stable translocations in lymphocytes, TL/OSL in ceramics) have a detection limit in the 25-300 
mGy dose range. These levels should be reduced in an effort to reduce the uncertainties at low 
doses. Markers of exposure with higher sensitivity and lower detection limit than those currently 
used should also be investigated. 
Approaches to both reliably assessing and reducing the uncertainties associated with estimated 
dose should be explored. Possible ways to do this are: inter-laboratory comparisons and error 
propagation from the single sources of uncertainty, e.g. by Monte Carlo calculation. 
Epidemiological studies of long-term effects are usually carried out between six months and some 
decades after exposure, so the marker must be stable enough to provide significant dose estimates 
after this time. EPR of tooth enamel, TL/OSL of ceramics and FISH of stable translocations in 
lymphocytes are nowadays considered the most reliable markers for dosimetry in cases of radiation 
exposure that occurred many years ago. Other stable markers should be identified, including those 
that are suitable for molecular epidemiological studies. 
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To reduce the bias in retrospective dosimetry, confounding factors should be identified and 
reduced. Especially, how the effects of radiation are changed when other contaminants or stressors 
(chemical, biological or others) are present should be studied. Other sources of bias might be age- 
or gender-dependent. It will be necessary to characterize further the dynamics of lymphocyte 
homeostasis and circulation within the body and the effect of radiation on these processes. 
As a general rule, in epidemiological studies, sampling should be as minimally invasive as possible. 
In historical cohorts, in some cases, tissues can be collected as they become available over the 
years, as, for instance, tooth enamel for which large sample banks exist. However, for other tissues, 
such as blood, storing can affect the quality of samples or the information contained therein. 
Appropriate sampling and storing methods have therefore to be identified and harmonized. 
The number of subjects studied using retrospective dosimetry in epidemiological studies has been 
relatively small because of the relatively low capacity of measurement and because of the invasive 
sampling. For instance, one single EPR laboratory can measure, full time, about 150 tooth samples 
in one month. Possible ways to enlarge the measurable cohort  are, in our vision: a) developing 
faster and minimally invasive techniques, such as in vivo EPR on teeth or mini-biopsies techniques 
in combination with high frequency EPR, b) surveying high throughput biological techniques, c) 
making techniques easier to perform, field deployable and cheaper (for instance using cheaper 
reagents), d) considering web scoring of cells, and e) making use of an analysis network consisting 
of several laboratories working with standardized and harmonized protocols for both, biological 
sample handling and analysis of biomarkers. The last approach (e) could clearly improve 
retrospective dosimetry results in molecular epidemiological studies, e.g. long-term follow up of 
exposed person groups. Such an infrastructure, which could act as a research service network and 
offer a high cell scoring capacity, is currently being established within the RENEB collaboration. 
The improvement of the dosimetry of internal exposure in epidemiological studies is expected to 
come from the improved realism of updated reference biokinetic and dosimetric models as well as 
from the collection of information on measurement techniques and on individual exposure. The 
characteristics of measurement techniques and exposure depend on countries, sites, and time 
periods in history. The collection of individual specific information on measurement techniques is 
important in interpreting the available data correctly, especially where they are reported as less 
than a detection limit. The understanding of exposure is important in the correct application of the 
dosimetric models by specifying a realistic time course of intake, deposition and absorption rates 
of radionuclides, depending on the working or living habits and the physicochemical form of the 
radionuclides. 
The measured dose should be easily related to a single organ. This is not always achieved for the 
currently available methods, especially for internal contamination. Exposures to penetrating 
external radiation result in fairly uniform irradiation of body tissues, hence similar doses to all 
tissues, for which FISH and EPR dosimetry can provide a reliable measure of this whole body dose. 
However, intake of radionuclides by inhalation or ingestion may result in retention in specific 
organs and tissues, so that the distribution of dose is highly heterogenous. For radionuclides 
emitting short-range radiations (e.g. alpha particles), this heterogeneity can apply to dose delivery 
within tissues and between cells within tissues. Work is ongoing in an attempt to address the 
question of whether FISH provides valid estimates of cumulative red bone marrow radiation doses 
in cases of incorporation of radionuclides or combined external and internal exposures. To date, 
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research in this area has been chiefly focused on data from the Mayak and Techa cohorts and by 
considering evidence regarding the origin and lifetime dynamics of lymphocyte subsets in the 
human body in relation to the localized delivery of dose from the internal emitters strontium-90 
and plutonium-239. Although it is currently accepted that the FISH translocation assay can be 
usefully applied for detecting internal and combined external gamma and internal doses from 
internally deposited strontium-90, with fairly large uncertainties, much work remains to be done in 
terms of establishing and validating dose-response relationships for plutonium-239, as well as 
other radionuclides. A key component of this work will be establishing the relative biological 
effectiveness of the different types of radiation, as there is currently a distinct lack of conclusive 
evidence with regard to formation of stable chromosome aberrations, in the published literature. 
A reliable assessment of uncertainty of individual internal doses in epidemiological studies such as 
that on the Techa River population, or that of the Mayak workers, Russian and UK plutonium 
workers, European uranium miners and workers, is expected to improve evaluation of any dose 
response function and of its statistical significance. The assessment of dose from internal exposure 
to radionuclides is subject to uncertainty due to activity measurement errors, individual variability, 
imperfection of biokinetic and dosimetric models, and unknown parameters of exposure. The 
uncertainty on the estimated dose is acknowledged to be generally higher than for external 
exposure, but is usually not evaluated in practice. 
Discrimination of acute/chronic exposures, or different radiation quality might be achieved by a 
multiparametric approach, i.e. merging the results from several retrospective dosimetry 
techniques. This should be feasible especially for neutrons. 
In the short term, retrospective dosimetry will continue to be used for validation of analytical 
model-based doses in representative groups. However, there is a difficulty in obtaining biosamples 
from a representative group of persons and there can be a factor of 100 between the number of 
collected samples and the number of samples to represent a group adequately. Sharing of data 
and biosample banks within the international scientific community should therefore be 
encouraged. 
Development of new methods and improvement of the existing ones should be tested on a 
significant number of samples. This is hampered by the difficulty of assessing biosamples for single 
laboratories. Development and validation of the existing exposure markers have been mainly 
achieved in the course of large epidemiological studies. Biosample banks should be made available 
for the purpose of research. 
Multiparametric approaches should be also developed to distinguish partial/total body exposure. 
As far as Chernobyl dosimetry is concerned, a couple of years ago the FP7 ARCH (Agenda for 
Research on Chernobyl Health) project was carried out which produced a scientifically sound 
prioritized list of studies of post-Chernobyl effects in the most relevant cohorts. The studies 
suggested also the inclusion of some work on dosimetry, although the major foci were medical and 
biological follow-up studies (http://arch.iarc.fr/). Further validation and retrospective recalibration 
of historical official dose records could be considered as well as improvement of eye lens beta 
dosimetry, as a further development of the UACOS (Ukrainian-American Chernobyl Ocular Study) 
dosimetry. Possibly, some critical review and summary of dosimetric monitoring practices, 
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retrospective dosimetry efforts and evaluation of radiation protection approaches might be of 
value as a lesson and recommendation for the future.  
Further development of the time-and-motion approach to reconstruct radiation exposures might 
be of use. This should include elaboration of methods for assessment of uncertainties in the 
information obtained by interviews of individuals who were exposed some time ago. Development 
of computer-assisted interview techniques, that include a virtual 3-D representation of the local 
exposure situation, is also considered helpful, in an effort to facilitate recall of those exposed.  
3.3 Towards efficient dose assessment in case of radiological emergencies 
Radiological emergencies are considered a major challenge of modern societies. These 
emergencies may include 
 incidents that have an impact on large geographical areas (such as the Chernobyl or the 
Fukushima accident) and lead to exposure of large groups of the general populations,  
 terroristic attacks using for example dirty bombs that involve conventional explosives and 
(allegedly) radioactive material, and  
 accidents that involve radiation sources used for example in industry or medicine. 
Each of these exposure scenarios is associated with specific problems in determining the radiation 
doses and the radionuclides involved, identifying individuals who are at highest risk (triage), and 
deciding the best method to be applied for evacuation, medical treatment and remediation. All 
this must be considered keeping in mind some loss in infrastructure (disturbed electricity, 
destroyed roads, problems in transportation and electronic communication, traffic jams, etc.).  
In handling such events, many aspects need to be considered  which are beyond the scope of the 
present SRA. These aspects include information strategies, risk communications, evacuation 
concepts, treatment of radiation injuries, etc. and should be dealt with by networks such as NERIS 
or – if distribution of radionuclides in urban and other environments are concerned – STAR. A 
quick, efficient and reliable estimate of doses to affected individuals or groups of individuals 
involved in such an incident is, however, a prerequisite which must be known before any further 
decisions can be made by the responsible authorities and decision makers. Dose assessment is 
complicated because a number of different exposure scenarios might be of concern including 
internal exposures from incorporated radionuclides or external exposures from various possible 
sources. Moreover, real-time monitoring data might be scarce and those which are available may 
rapidly change with time.  In order to provide an efficient assessment of potential exposures and 
doses in a radiological emergency, a number of dosimetric improvements are required, to allow 
decision makers to initiate the most urgent actions, including those allowing for a) rapid 
identification of individuals with high risk of developing radiation-induced injuries (external 
exposure), b)  handling of a large number of dosimetric samples in a short time (external exposure), 
and c) improvement of methods to assess and reduce doses after internal contamination. 
For the vision of an efficient dose assessment in case of radiological emergencies the following 
challenges were identified: 
 To identify and characterize new markers of exposure  
 To develop strategies and methods to increase measurement capacity 
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 To quantify doses after accidental internal contamination 
These challenges are described in detail in the following section. To meet those challenges, a 
multidisciplinary approach involving scientists operating in biological, physical and clinical 
dosimetry is required. 
 
3.3.1 To identify and characterize new markers of exposure 
Introduction 
If a large number of individuals is potentially exposed in a large-scale accident, then it will be of 
utmost importance to separate the truly exposed from the vast majority of the “worried-well” and 
to identify those whose exposure is so severe that immediate medical car is needed.  This has to be 
accomplished while taking into account additional, independent information on doses, exposure 
scenarios (external, internal), time constraints and number of affected individuals involved. An 
effective triage is important because the available infrastructure or stocked medicine to treat 
radiation injuries will be limited, and medical care should be first focused on highly-exposed 
individuals. Realistically, very few or even none of the affected individuals will have worn a 
radiation dosimeter. Thus, initial dose estimates must be made based on expert judgement and 
rough calculations, and any means that would provide additional dose information will be helpful.  
Research lines 
Currently efforts are being made towards identification of materials of daily life that could be used 
as fortuitous dosimeters. These objects could be personal items worn on or close to the human 
body such as portable electronic devices, chip cards, glass, clothing, shoes, plastics, and precious 
and semi-precious stones, measureable by EPR, OSL and TL. The same measurement techniques 
can also be applied to biological materials tooth enamel, bones, finger nails and hairs. Other 
objects that are not worn by individuals but were exposed at a certain place could also be used to 
estimate the radiation field during an emergency. These objects may include household salt or 
sugars, bricks or other domestic or industrial materials. In all these cases, the response of the 
chosen material to different radiation qualities (alpha, beta, gamma, neutrons) must be 
investigated, the stability of the radiation-induced signal be quantified, and measurement 
protocols identified to allow a quick and efficient first determination of the radiation dose involved. 
For biological samples, there is a large interest and potential for mobile systems for application in 
the field. In order to avoid invasive sampling, research on in vivo EPR of tooth enamel is focused on 
development of spectrometers with portable magnets. Different approaches for the in vivo EPR 
measurements are under investigation: continuous wave with low microwave frequency or pulsed 
with X band microwave. The development of a suitable in vivo method using a portable OSL reader 
supplied with optical fibers for tooth enamel measurements is also of interest. Alternatively, further 
research on tooth enamel mini-biopsies (2-5 mg) measured by high frequency EPR to minimize the 
invasive sampling and EPR/TL/OSL analysis of fingernail clippings is also desirable. 
While the above includes well established techniques such as TL, OSL, or EPR, investigation of other 
physically based analysis techniques (pulsed EPR, radioluminescence, cathodoluminescence, 
ionoluminescence, Raman, Infrared, UV spectroscopy) could widen the range of materials that can 
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be used as a dosimeter, and offer further options in an efficient dose assessment. On the other 
hand, OSL offers the unique possibility to expand the range of stimulation and emission 
wavelengths to possibly identify signals with greater stability and/or sensitivity. 
As for genetic techniques, research is currently focused on further development of the use of 
microarray and quantitative polymerase chain reaction (PCR) technologies, which should enable 
gene expression assays to produce and validate a reliable signature of human exposure to ionizing 
radiation in the near future. This signature will probably not allow prediction of a given dose but 
will rather allow a distinction between exposed and non-exposed individuals, and as such could be 
helpful in identifying an exposure above a dose threshold, provided that the post-exposure time is 
within a defined time period. 
Immunocytochemical techniques are relatively new, and thus a large amount of work will be 
required before they can be used as reliable dosimeters. Nevertheless, protein biomarkers such as 
γ-H2AX, CRP or serum amylases have some advantages over cytogenetics assays. For example, 
results can be obtained within hours rather than several days after sampling; sample processing 
and analysis can be optimized and automated for high throughput; non-invasive sampling may be 
possible (saliva, buccal cells, hair), depending on the marker, and deployable assay formats already 
exist or are in development. However, a number of issues have to be considered before these 
techniques can really be used as robust biodosimetric tools: a) as they are not as specific for 
ionizing radiation as for example the dicentrics assay, confounding factors need to be fully 
characterized, b) several calibration curves for different post-exposure times and exact timing 
between exposure and sampling are required, c) in contrast to cytogenetic and DNA damage foci 
assays, dose response curves for CRP and amylase cannot be performed ex vivo; in vivo 
experiments with suitable animal models and validation studies with radiotherapy patients are 
therefore required but the translation of animal or cancer patient data to the response of ‘normal’ 
humans needs to be considered carefully, d) available data suggest a larger variation than seen for 
the dicentrics assay and finally, e) there is very little known about their response to different 
radiation qualities. 
Computational techniques are quite straightforward in their concept, but their implementation 
often requires sophisticated solutions, in particular in urban environments. For this reason the 
automatic direct input of dose rate measurement data into the databases, powerful interpolation 
and extrapolation algorithms and tools for prediction of doses are the main routes of further 
development of time-and-motion techniques. In addition, unlike other retrospective dosimetry 
techniques, computational methods have the potential for conversion into prognosis and 
optimization tools for planning of post-accident response, finding the safest 
evacuation/transportation routes, optimization of the activities of responders and public in 
different ways – i.e. by collective or individual doses, time before withdrawal from radiation hazard 
zone, etc. Once implemented, this approach would allow provision of retrospective assessment of 
individual and collective doses and estimation (prediction) of doses at subsequent time intervals 
Whatever technique and dosimetric material is used, the following properties are usually indicated 
as ideally necessary in retrospective dosimetry in an emergency situation: a) specificity to ionizing 
radiation, b) reproducibility of the measurements, c) a discernible dose range from 0.5 Gy to tens of 
Gy, d) good signal stability to allow analysis of recent and distant exposures, e) ability to estimate 
the extent of partial body exposure, f) ability to discriminate between internal and external 
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exposure, g) well defined dose response relationships for different radiation qualities and dose 
rates, h) possibility of generating an in vitro calibration curve, i) possibility of assessing the 
uncertainty of the dose estimate, j) low inter-individual variation, k) controllable impact of 
confounding factors, l) non- or minimally invasive sampling, and m) standardized, rapid 
(automated if possible) and cheap sample processing and analysis. These characteristics need to be 
investigated in detail before a material can be considered as suitable to be used as a dosimeter in 
an emergency situation.  
Despite the importance of research, some of these and other radiation markers may not be suitable 
as stand-alone biodosimeters or physical dosimeters but would work as part of a multi-parametric 
dosimetry system which produces a dose-dependent signature. This situation will most probably 
never change despite ongoing research to improve each method because each tool is inherently 
limited with respect to the above mentioned requirement. 
More and more dosimetric applications on smartphones, using the CMOS camera of the 
smartphone itself or an external detector, are available and can be used very easily by the public. 
The main advantage of such public applications is that a huge amount of geo-localized data could 
be potentially available in “real time” and could be very useful, especially in case of large-scale 
accidents (like Fukushima). Nevertheless, the major disadvantage is that the quality of the data is 
strongly dependent on the application and the methodology used to do the measurements. So, it 
is of great importance to establish protocols for validation of doses measured by the public using 
smartphone applications.   
 
3.3.2 To develop strategies and methods to increase measurement capacity  
Introduction 
In an emergency situation involving many potentially exposed individuals, measurement of a large 
number of samples may be required that could far exceed the capacity of nearby dosimetric 
laboratories. This may be due to the fact that the required dosimetric method is not practiced 
there, the laboratory equipment is limited, the number of available skilled staff members is too low, 
or problems in infrastructure after the emergency may prevent optimal use of the existing facilities. 
In general, a solution to this problem is automation of sample preparation and measurement, 
development of rapid screening methods for radiation exposure, and improved world-wide 
networking. 
Research lines 
Analysis of dicentric chromosomes and micronuclei is performed in a computer assisted mode. The 
metaphases are identified, recorded and captured fully automatically while the final step of the 
analysis (evaluation of metaphase) is performed by eye. This last step could also be fully automated 
and there is already some experience in some laboratories that should further be broadened. Even 
then, however, the comparatively slow autocapture of metaphase images limits the throughput to 
~75 tests per day per system. More focus should be given to the development of methods for high 
throughput and cheap measurements – such as gene expression or protein biomarkers. Despite 
their potentially larger variability, these assays could at least serve as initial triage tools to enable 
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rapid identification of any critically exposed individuals among hundreds or even thousands of 
‘worried-well’. 
Web-based scoring of captured images is emerging as a fast and easy method of performing 
chromosome analysis whilst involving laboratories spread all over the world. Meanwhile the 
meaning and usage of such an approach is generally accepted and platforms are being developed 
to disseminate huge numbers of images easily.  
Moreover, networking of laboratories has been identified as a very useful approach to get fast and 
reliable results of dose estimation. Such networks need to be established and their functionality 
has to be trained and practiced. Major attention has to be given to quality assurance (QA) and 
quality management (QM), to guarantee operational readiness of the network and its members 
and reliability of the results produced. In other words, a great potential for workload sharing 
through national and international networks, such as the RENEB or the WHO BIODOSENET 
networks, is expected. 
The current situation is characterized by a lack of linkage among retrospective (bio and others), 
clinical/medical, and physical dosimetry. Therefore, closer collaborations between the laboratories 
involved in these disciplines should be set up. Development of the complementarity of all the 
different techniques will be required, as worldwide networking efforts lead to a greater need for 
comparisons between techniques as well as laboratories. Efforts are required to standardize the 
new methods and develop rigorous statistical analysis methods to enable formal comparisons of 
techniques. This particular task was, and is currently being addressed through the EU FP7 
MULTIBIODOSE collaboration as well as the RENEB collaboration. Availability of techniques in 
Europe and around the world is also of interest, and current efforts are additionally focused on 
training and dissemination of information about the different techniques, which is also expected to 
reduce measurement uncertainties through inter-laboratory comparisons (see also Chapter 4 on 
Education and Training, and Chapter 5 on Harmonization and Practice). 
 
3.3.3 To quantify doses after accidental internal contamination 
Introduction 
So far, not much work has been done to link internal dosimetry from incorporated radionuclides 
with biological dosimetry methods. Biological dosimetry is well established and validated for 
providing dose estimations following external radiation exposures. In contrast, internal exposures 
are generally regarded as ‘difficult’ – experienced bio-dosimetrists try to avoid these because 
interpreting biodosimetry data in such cases is very challenging, and the standard calibration 
curves generated in vitro are often not valid. Less experienced colleagues who are unaware of all 
the complicating factors frequently provide dose estimates for internal exposure cases, naively 
assuming that comparison with their standard calibration curves is all that is needed. Additionally, 
in vivo data derived from animals can be misleading because of differences between species in the 
spatio-temporal dynamics of radionuclide and lymphocyte distributions in tissues. The current 
method of choice for estimating internal doses is based on biokinetic modelling of radionuclide 
measurements in urine and faeces. 
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On other hand, in cases of high level of internal exposure, bioligands or chelators are commonly 
administered as a treatment after incorporation of radionuclides of high radiotoxicity such as 
actinides. Decorporation therapy with DTPA (Diethylentriamene pentaacetate) is a treatment 
applied after incorporation of significant amounts of plutonium or other transuranium elements. 
Generally, chelating agents disturb the regular human biokinetics by enhancing their excretion. 
However, the resulting decrease in radiation dose is currently not well understood and difficult to 
predict. As a consequence of this the assessment of the final dose does not guarantee a reliable 
result of the actual internal exposure, or an accurate result of the averted dose.  
Moreover, in case of an emergency with suspected incorporation of radioactive materials of a large 
number of individuals, specific emergency bioassay methods may be needed that have not yet 
been developed. Dose estimation in cases of mixed external and internal exposure presents a 
particularly complex challenge. 
A specific issue of concern is accidental intake of radioiodine. In such cases, different types of 
detectors may be used for thyroid counting, and exposed individuals of different ages (foetus, 
infants, children, teenagers, adult males and females) and sizes may need to be measured for dose 
evaluation. Intakes of, and doses from, radioiodine accumulated in the thyroid can be also assessed 
using Monte Carlo (MC) simulations combined with patient-based computational phantoms (voxel 
phantoms, NURBS phantoms). 
Research lines 
In general, areas to be investigated are (i) the definition of reliable biological end-points which are 
radiation-specific, stable with time and particularly suitable for the case of a chronic exposure with 
variable dose-rate; (ii) the definition of the proper dosimetric quantity to be compared to the 
biological end-point (a major deficit of most of the current studies is use of wrong dose indicators, 
e.g. administered activity). Cases of accidental and occupational internal exposures from literature 
should be identified for which biological dosimetry has been performed and for which bioassay 
data (e.g. in-vitro measurement of activity in urine samples) are available and sufficient for reliable 
physical internal dosimetry. Special models have to be developed for reliable blood dosimetry, to 
determine the blood dose and to assess how and to what extent this dose is correlated with the 
information provided by biological assays. At the moment it is difficult to evaluate this correlation 
correctly because a) calibration curves for biological dosimetry are usually generated using 
external radiation; and b) it is not clear against which dose (blood dose, marrow dose, or total body 
dose) the results of the biological assays should be tested. The situation could be clarified by 
performing investigations with nuclear medicine patients including evaluation of time-activity 
curves in blood by means of dynamic acquisitions, and simultaneous collection of blood samples at 
consecutive times for performing the biological assay. From the time-activity curve in blood, the 
blood dose at different time post-administration can be assessed, and compared to the results of 
the biological assay. These kinds of experiments should be conducted in cooperation with nuclear 
medicine departments. They will have the advantage that in this way it will be possible to assess for 
each patient an individual rather than an average blood dose.  
If investigations are performed using different radiopharmaceuticals, it will be possible to 
investigate if and to what extent radiation type and quality (energy) influence the response of the 
biological assay. These experiments, combined with the aforementioned literature survey should 
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enable the assembly of a comprehensive set of in vivo human reference data for biodosimetry 
following radionuclide intake which, in turn, could significantly improve the quality of biological 
dose estimates for intake and mixed exposure cases. This activity could also be seen as an 
important contribution to setup and validate dosimetry techniques that are needed for the 
implementation of point 2.3.3 of the MELODI SRA (individual radiation sensitivity). 
For accidental intakes of high radiotoxic radionuclides (alpha emitters like actinides, the beta 
emitter 90Sr and others), rapid methods for in-vitro monitoring of these radionuclides must be 
developed and validated. For other radionuclides this approach may be complemented by in-vivo 
monitoring. For example, protocols for the determination and/or screening of radioiodine (131I, 133I) 
in the thyroid in case of a nuclear emergency should be developed and complex intake scenarios 
(interference of other radionuclides) should also be considered. Additionally, application of 
available computational phantoms of the thyroid and development of new thyroid voxel 
phantoms for children of different ages and for adults of different sex, age and size may be useful, 
based on CT scans provided from hospitals. Validation of MC results will be obtained by proper in-
vivo measurements, while development of reference data on thyroid doses to individuals of 
different ages from measurements using various types of detectors (e.g. Geiger counters) will help 
responders in public health management. These efforts are expected to help in the reconstruction 
of thyroid doses of the population exposed after the Fukushima accident in Japan. 
In order to understand the reduction of radiation dose from incorporation of plutonium or other 
actinides after administration of DTPA, a reference biokinetic model for plutonium under DTPA 
therapy should be developed to improve the reliability of dose assessments for individuals 
internally exposed (e.g. in Mayak facility and U.S. Uranium and Transuranium Registries (USTUR)). 
In-vitro studies and targeted animal investigations will be performed to further investigate the 
mechanisms involving the chelation route due to DTPA administration. The “physiological realism” 
approach will be considered, integrating more knowledge of the basic physiological processes into 
the models for radionuclides. The aim here is to provide a more realistic description of the 
processes behind the metabolic behaviour of the considered radionuclides, and to understand the 
factors that change their biokinetics. The latter could be used to adapt the model to the individual, 
therefore sensitivity analysis for identification of the relevant parameters is required, and to find 
physiological indicators that can be measured in the individual; the results of this study will help 
the development of more advanced chelating agents. To achieve all these goals, both in vitro 
cell/tissue experiments and animal experiments will be required. In particular, in-vitro studies (e.g. 
speciation studies with bioligands and chelators) will provide a fundamental understanding of the 
complex physiological mechanisms behind the biokinetics of decorporation, which can then be 
implemented in the models to improve them further. This study will contribute to the definition of 
an operational tool that will be useful and easy to apply in the case of emergency situations. 
3.4 Towards an integrated personalized dosimetry in medical applications 
Modern medicine offers a variety of diagnostic methods and tools that include imaging techniques 
where the diagnosed individual is not exposed to ionizing radiation, such as ultrasound and 
magnetic resonance imaging. In contrast, other methods do involve ionizing radiation such as X-
ray imaging, CT scans, PET and others. In many European countries, for example, the use of CT 
scans has continuously increased over the last decade and this trend is expected to continue. As a 
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result, even if averaged over the whole population of a certain country, medical exposures are 
largely responsible for exposure from man-made sources of ionizing radiation, and optimization of 
the received doses is very important. 
Additionally, in European countries a considerable fraction of the population will face a cancer 
diagnosis at a certain time in life, and radiotherapy (using ionizing radiation) represents one of the 
major methods of treatment. Approximately half of all cancer patients will receive radiotherapy at 
some point in their illness. A large world-wide population of patients is therefore exposed to high 
target doses (mainly using photon beams) in a controlled and well-documented way. The 
distribution of dose within the body following radiotherapy varies considerably with many factors: 
the size and shape of the patient, the anatomical location of the target volume, the prescribed dose 
and the type and energy of radiation (photons, electrons, hadrons) and its application (external, 
internal). In all cases, doses can vary spatially from tens of gray to milligray. All parts of the dose-risk 
curve for subsequent cancer induction are therefore involved, from low dose effects including 
regions where non-linear mechanisms have been postulated (e.g. bystander effects), through the 
region defined largely by the Japanese lifespan study, to the further non-linear region at high 
doses where cell kill and re-population effects are known to occur. 
The development of dosimetry techniques and the measurement of doses is an important pre-
requisite for advancing this field of study which will need major efforts in the future. As described 
in chapter 3.2, epidemiological studies of second cancers following radiotherapy require a 
specification of dose to the patient at the site of the subsequent malignancy, making out-of-field 
dosimetry an important field of dosimetric development. Moreover, because additional dose 
contributions may come from diagnostic procedures, epidemiological studies will require 
quantification of all sources (therapy and/or imaging), for an estimation of combined risk. Finally, 
some of the sections in this chapter (e.g. sections 3.4.4 and 3.4.5) may have direct links to chapter 
3.5 (e.g. section 3.5.3).  
For the vision of integrated personalized dosimetry the following challenges were identified: 
 To improve out-of-field dosimetry for photon and particle therapy, including the 
development of analytical models for out-of-field dosimetry calculations 
 To improve dosimetry (including the development of 2D and 3D dosimetry techniques) in 
modern external beam radiotherapy and brachytherapy. This should also include photon 
and charged particle radiotherapy, including perhaps boron neutron capture therapy 
(BNCT) and the development of microdosimetric models for incorporated particles 
 To optimize dose estimations in interventional radiology 
 To establish reliable patient dosimetry in CT examinations 
These challenges are described in detail in the following. 
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3.4.1 To establish out-of-field dosimetry for photon and particle therapy 
Introduction 
In order to estimate and quantify the risk of second cancers that may occur even decades after 
treatment of the primary tumour, an overall assessment of patient dose is required. However, to 
gain a complete picture of the out-of-field (i.e. outside the target volume) dose distribution 
following radiotherapy is not trivial, because it is necessary to estimate and combine the dose 
contributions from a)  the primary beam to regions outside the target volume in the therapeutic 
beam path, for photons, electrons and hadrons; b) scattered photons from the patient and linear 
accelerator leakage; c) neutron production at higher photon energies, and for hadron (protons, 
carbon ions) therapy; and d) imaging exposures used as part of the radiotherapy process (e.g. 
treatment planning and verification imaging, at diagnostic and therapeutic x-ray energies).  
In addition to second cancer risk estimation, out-of-field dosimetry data will be also important for 
estimating (i) risks of deterministic effects, (ii) foetal doses and risks for radiotherapy patients 
treated whilst pregnant, (iii) risks of non-cancer stochastic effects (e.g. heart & respiratory disease), 
(iv) risks of cardiac pacemaker malfunction, and (v) genetic risks.  
These data will also be important in the development, testing and validation of analytical models 
for calculating out-of-field doses. Such models are useful since it is impracticable to measure out-
of-field doses under all possible combinations of treatment parameters. 
In this context, specific emphasis should be placed on paediatric radiotherapy because (i) risk 
factors for children and young adults are higher than in later life and (ii) many paediatric 
treatments have a good prognosis and patients may be expected to live for periods greater than 
the latent period for expression of a second cancer. 
Research lines 
The strategic goals to be achieved in the next 20 years are a) to develop and harmonize dosimetry 
techniques for the measurement and estimation of the complete dose specification from all 
sources (therapeutic and diagnostic) to patients receiving radiotherapy, (b) to develop analytical 
models for the calculation of doses at any point in the body from all sources of radiation c) to use 
the complete dose specification as input to risk models for deleterious effects of ionizing radiation, 
and d) to support future epidemiological studies of second cancer incidence following human 
exposure to ionizing radiation (see section 3.2) by developing and harmonizing techniques for 
comprehensive dose measurements over the whole body. 
A prerequisite of this challenge is the development and harmonisation of methods for the 
synthesis of the total out-of-field doses to patients from all sources (therapy & imaging) during 
radiotherapy, and the estimation of combined risk. This requires strategies to quantify and store 
patient-relevant doses and to communicate radiation risks to the public and the medical 
profession. The challenge of integrated patient dosimetry also requires the consideration of 
potential doses to the patient from radiotherapy imaging procedures. These may include CT 
scanning, the combination of PET and CT imaging, MV and kV cone beam CT for treatment 
planning, localisation, verification and image-guided radiotherapy (IGRT). Studies of the 
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relationship between image information and patient dose in supporting imaging examinations are 
important, with the final goal of optimising patient doses from imaging procedures.  
Modern radiotherapy includes irradiation modalities featuring – among others – photons with 
energies above 10 MeV, high-energy protons of about 200 MeV and more, and carbon ions with 
typical energies of several hundred MeV per nucleon. In all these cases, secondary neutrons may be 
produced in surrounding materials (linear accelerator components and treatment room structures) 
and within the patient. These neutrons are of particular concern because they are not confined to 
the target volume (tumour) but are distributed throughout the patient and contribute to the 
overall patient dose. Precise dose quantification is desired in particular for tumours with good 
prognosis, as a successful treatment resulting in a long life expectancy will – through aging of the 
patients – be associated with an increased risk of neutron-induced secondary cancers. It is our 
vision that novel small-scale detectors for neutrons and photons be developed that could be used 
to measure the dose distribution – preferably with a spatial resolution that allows deduction of 
organ doses or sub-organ doses, thus accounting for potential dose variations within an organ – 
within suitable phantoms irradiated according to typical radiotherapy modalities. Ideally, these 
dosimeters can be arranged in a phantom as row, matrix or cubic combination for volumetric dose 
mapping, without significantly disturbing the dose fluence. Given the fact that some of the 
radiation sources used in radiotherapy are operated in a pulsed mode, and new such sources are 
currently being developed such as laser-induced proton sources, special attention should be given 
to the behaviour of these neutron and photon detectors at high dose rates. These dosimeters must 
be compared and evaluated, and the associated measurement uncertainties quantified. Special 
attention must be given to the detection of high-energy neutrons (above 20 MeV) which are a 
typical component of the energy distribution of secondary neutrons produced in proton 
radiotherapy (see chapter 3.5.3).  
These developments must be accompanied by development of a variety of anatomical or semi-
anatomical phantoms including water tanks, BOMAB-like phantoms, anthropomorphic phantoms 
for dosimeter comparisons and clinical simulations, with special emphasis on paediatric phantoms.  
Once suitable detectors and phantoms have been developed, measurements of out-of-field doses 
in photon and particle radiotherapy based on the simulation of clinical treatments need to be 
performed. It is anticipated that these measurements would form part of a pan- European project 
in which many radiotherapy centres would participate, sharing expertise and equipment, and 
progressing towards harmonisation of out-of-field dosimetry techniques. 
It is apparent that detector and phantom developments need to be complemented by simulation 
of the complex mixed fields of photons, protons and neutrons that is used in these treatment 
modalities. This includes simulation of the primary particle field produced by various medical 
accelerators, and interaction of this field with the patient and the materials present in the therapy 
room. The final goal should be calculations of energy distributions of all particles that contribute 
significantly to patient dose. This is particularly important for proton and heavy ion radiotherapy 
where again particular emphasis must be placed on particles with energies above 20 MeV, and 
currently open questions at those high energies such as missing cross sections, production of 
secondary particles, validation of Monte Carlo transport codes, nuclear reaction models, etc. need 
to be investigated in detail. 
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The results of extensive measurement campaigns, performed using optimized dosimeters and 
phantoms for currently used radiotherapy beams, verified and extended by Monte Carlo radiation 
transport calculation, should become available in a dedicated database. An ultimate goal of this 
research is to develop a set of analytical algorithms for calculation of photon and neutron doses, 
which can easily be incorporated into modern Treatment Planning Systems (TPS) used in radiation 
oncology. These analytical functions implemented into TPS would enable the calculation of a 
complete map of doses for each patient which could be used to assess doses in future 
epidemiological studies or even, in some special cases, for optimization of radiation therapy of 
young patients.   
Both development of devices for detection of neutrons above 20 MeV and simulation of detector 
responses and patient doses require reference fields for quasi-monoenergetic high-energy 
neutrons where these devices and simulations can be benchmarked. We note that in the very near 
future, it is most likely that in Europe such a facility will no longer be available. 
 
3.4.2 To improve dosimetry in modern external beam radiotherapy 
Introduction 
Radiation therapy plays a major role in treating about half the number of cancer patients. It is very 
important to be able to measure the dose distribution given to the tumor, in an effort to check if 
this agrees with the treatment plan. However, in vivo dosimetry during external beam therapy 
could benefit from the development of improved dosimetry techniques. Next to this, the rapid 
development in new radiotherapy techniques (flattening filter free (FFF) fields, volumetric arc 
therapy, small fields, proton and heavy ion therapy, microdosimeric characterization for hadrons, 
etc.) requires a continuous effort in dosimetry research, not only to develop on-line dosimetry 
techniques, but also to improve calibration techniques.  
Research lines 
Novel dosimeters (boron doped diamond detectors, liquid-IC, scintillator, luminescent techniques, 
etc.) should be developed, which can be arranged within a phantom as row, matrix or cubic 
combination for volumetric dose mapping, without disturbing the dose fluence, and which can be 
used for in-vivo dosimetry. In this context, development of smaller and more accurate 
electrometers, capable of working without cables would also be useful. Further, rapidly developing 
techniques of 2D and 3D dosimetry which use extended dosimeters such as polymer gels, capable 
of millimeter resolution, should also be developed and applied to volumetric dose mapping. 
Improving the dosimetric performance for special radiotherapy techniques such as flattening filter 
free (FFF) fields, volumetric arc therapy, small fields, proton and heavy ion therapy, microdosimeric 
characterization for hadrons is also required 
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3.4.3 To include internal microdosimetry in radiotherapy and medical imaging 
Introduction  
X-rays and radiopharmaceuticals have been used in medical imaging and radiotherapy, 
respectively, to diagnose and to treat cancer and disease for human health care. The unique 
features of cellular and molecular radiobiological effects depend strongly on the spatial and 
temporal distributions of initial physical tracks, on induced chemical radicals and later on 
dynamical molecular biological progresses. Risk assessment after application of alpha- and Auger-
emitters and beta radiations in radiotherapy requires knowledge of the fundamental pattern of the 
inhomogeneous absorption of radiation energy in organs and tissues at the molecular and cellular 
levels. In additional to the conventional average organ dose approach, modern approaches of 
microdosimetry and nanodosimetry represent powerful tools to describe the stochastic nature of 
the energy depositions and the induction of radicals, and to characterize the health and biological 
effects of internal emitters. 
The analysis of radiation covers – as a first approach – alpha- and Auger-emitters and beta 
radiation. The analyses will include levels of molecule, cell, tissue, organ and organism. Several 
types of methods will be applied: in-vivo experiments, animal experiments, application of 
epidemiological data, computational modelling and integrated approaches. Furthermore, the 
potential application of gold nanoparticles in medical diagnostic imaging and radiotherapy will be 
investigated. Molecular biological experimental and theoretical Monte Carlo simulation studies are 
considered important to reveal the correlation between the experimental biological findings at the 
cellular level in specific organs, like the lungs and kidneys, and the microdosimetric and nanometer 
scale doses of these emitters. 
Research lines 
The local radiation dose at the molecular level of the Auger-emitter 125I needs to be simulated. The 
experimental investigations described in the literature on DNA damage and cell survival and cell 
killing of cancer cells incorporated with 125I should be used to indicate the possibility of applying 125I 
in genetic radiotherapy. 
To investigate the potential application of nanoparticles in radiotherapy, Monte Carlo programs 
may be used to simulate the interactions between the gold nanoparticles and x-rays. In these 
simulations, the geometry of the cells can be assumed spherical and/or ellipsoidal, and different 
concentration distributions and sizes of the gold nanoparticles in and around the cells must be 
tested. The simulations can be complemented by experiments where cancer cells coupled with 
and without nanoparticles are exposed to x-rays of various energies. The physical interactions 
between x-rays and secondary electrons with soft tissues and gold nanoparticles should be 
followed. 
We expect spectral CT medical imaging with gold nanoparticles as a contrast agent to be 
investigated with Monte Carlo methods in an effort to identify the smallest percentage of gold 
nanoparticles needed to be used as a CT contrast agent in humans. The quantity of gold 
nanoparticles which is specifically targeted to malignant tissues can be investigated with cell 
culture experiments as well. The tumor specific monoclonal antibody cmHsp70.1 could be 
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conjugated to gold nanoparticles with a diameter of 50 nm, and the actual location of the gold 
nanoparticles in and around the cells be visualized by transmission electron microscopy (TEM). 
The medical internal radiation dose (MIRD) committee provides some of the necessary tools that 
will allow estimation of the absorbed dose at the cellular level. These tools take the form of cellular 
S-values (absorbed dose per unit cumulated activity). S-values can be used to calculate the 
radiation dose received by a target region when the radioactivity is distributed in a source region. 
S-values can be calculated by using Monte Carlo codes. 
Knowledge of the spatial distribution of energy deposition in cellular and subcellular structures is 
important for understanding the biological effects of radiation. Such information is crucial with 
regard to developing new pharmaceuticals for cancer therapy and to choosing the suitable 
labelling radionuclide. For modelling the distribution of a local energy deposit as well as radiation 
effects, Monte Carlo track-structure codes can be used for simulating event by event the slowing-
down process of all generations of particles. 
 
3.4.4 To optimize dose estimations in interventional radiology  
Introduction 
The dose to patients in interventional procedures can be high, leading even to deterministic 
effects. Thus, an improved system of dose calculation and dose monitoring in interventional 
radiology (IR) for adult and paediatric patients needs to be developed. This would enable 
assessment and improved use of diagnostic reference levels (DRLs), achievable dose levels (ADLs) 
and skin dose alert (trigger) levels for optimization of patient doses, improved accuracy of skin and 
other organ doses, and improved accuracy of population dose estimation. 
If this vision is realized, patient-specific real time dose mapping of skin dose, other organ doses, 
effective doses and practical dose quantities (Dose Area Product (DAP), Cumulative Air Kerma (CK)) 
will be possible, with known uncertainty and with efficient use of DICOM information. Thus, based 
on DRL and ADL values, practical systems of patient dose monitoring for local as well as wide-scale 
evaluation and comparison of patient doses will be available. These systems can be used to 
estimate patient doses and radiation-induced risks, and to prevent accidents. 
Research lines 
Practical methods of skin dose measurement need to be developed and tested (using large area 
detectors, TLD methods and advanced detectors) and the related uncertainties in skin dose 
measurements and dose mapping need to be evaluated. New systems of automatic dose mapping 
tools, based on DICOM information, are becoming available in modern equipment. These should 
be applied, tested and calibrated.  
Determination of, and recommendations on, skin dose alert (trigger) levels are still needed, 
including the investigation of the correlation between skin dose and dosimetric indicators for 
several IR procedures, including paediatric IR. This will require collaboration with industry and 
standardization bodies, in order to implement the concept of dose alert for daily use. 
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DRLs and ADLs for different levels of complexity of IR procedures need to be defined and 
measured, as well as an improved methodology on their determination and requirements on 
statistics. Studying the feasibility of using continuous DRL-curves with the possibility of introducing 
different levels of complexity in accordance with achievable values can be done.  
A similar concept to DRLs for patients should be developed for equipment used in IR procedures. 
For this purpose it is necessary to collect and to compare equipment dose rates for different IR 
procedures, establish calibration procedures for dose measuring devices, and to organise 
intercomparisons between clinics involved in such procedures.  
Ideally, online patient dosimetry in different imaging modalities should become available. This will 
require adequate dosimetric quantities for fluoroscopy, computed tomography, cone beam CT and 
hybrid imaging. In collaboration with industry, improved dosimetric information must be identified 
that should be provided by future x-ray units for different imaging modalities. Also the possibilities 
of keeping dose records of patients should be improved through collaboration with the industry. 
Following online patient dosimetry all the relevant dosimetric quantities and risk evaluators (like 
effective dose and organ doses) should become available automatically; this will need calibration 
and testing. 
 
3.4.5 To establish reliable patient dosimetry in CT examinations 
Introduction 
For CT examinations it is important to develop systems of dose monitoring and scanner calibration 
(with known uncertainties) in order to provide easy use of DRLs, improved optimization of patient 
doses, improved accuracy of organ dose determination for risk estimations and improved accuracy 
of population dose estimation. The focus should always be put on paediatric patients.  
Research lines 
Automatic dose mapping systems should be developed. The research line to be followed will 
include definition of the parameters of interest for dose mapping, analysis of commercially 
available and individually developed systems, and evaluation of the feasibility of using automatic 
systems that allow collection of patient dose data on a regional or national scale, in particular for 
the establishment of DRLs and the estimation of population dose. Harmonisation is a key feature 
that should allow – in collaboration with industry and standardization organizations – promotion 
of the practical implementation of these automatic systems. 
Harmonisation is also important because there are currently different approaches for patient dose 
determination and scanner calibration (International Electrotechnical Commission (IEC), American 
Association of Physicists in Medicine (AAPM), ICRU). These approaches must be tested (e.g. the IEC 
pragmatic approach with different size of detectors) and compared, and their feasibility for clinical 
implementation must be investigated. In particular, the impact of applying these approaches for 
the determination and use of DRLs must be studied and the added value of using dose estimates 
that depend on patient size (Size-Specific Dose Estimates – SSDE) must be quantified.  
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Another field of improvement concerns the use of phantoms for scanner calibration and QA 
measurements in clinical practice, in particular for modern cone beam CT where the use of flat 
panel detectors poses some dosimetric problems. There are various phantoms proposed and used, 
and these need to be tested and compared in clinical practice (e.g., ICRU phantom). In particular, 
with respect to feasibility and practicability, the use of only single-size phantoms requires 
investigation, and the aspect of using phantoms to evaluate image quality vs. dose should be 
addressed. Finally – again in collaboration with industry and standardization organizations – the 
most promising phantoms must be identified, produced, and widely distributed.  
In an effort towards personalized dosimetry, methods of patient dose determination should cope 
with varying patient sizes (e.g. the approach proposed by the AAPM). This needs investigation of 
the optimum parameters for size specification of patients, tests of the use of SSDE as a DRL 
quantity in various CT examinations and the possible added value to the Computed Tomography 
Dose Index (CTDI), studies of the use of the product of SSDE and scanning length as a DRL quantity 
in various CT examinations and the possible added value to Dose Length Product (DLP). Again, 
particular emphasis should be placed here on the determination of DRLs for paediatric 
examinations. Appropriate and practical quantities that can be used for patient dosimetry in CT, 
and that can take into account the fast evolution in CT modalities, should be developed. 
It is our vision that in the end, patient-specific conversion factors from SSDE to organ doses should 
be available for risk estimations and population dose estimation. This may be achieved by means of 
Monte Carlo calculations for SSDE and organ doses in various CT examinations for a range of 
patient sizes, complemented by an experimental determination of SSDE and organ doses for a few 
cases, to verify the MC calculations. This can include the development of individualized voxel 
phantoms of patients from CT images in real-time. Such organ doses can help in epidemiological 
studies of radiosensitive organs, such as eye lens and cataract development, or for the heart to 
investigate cardiovascular effects.  
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3.5 Towards improved radiation protection of workers and the public 
Much research and technical development in radiation protection dosimetry for workers and the 
public has been carried out, to a large extent within projects funded by the EC. The results of these 
developments have been transferred to operational radiation protection, including guidelines and 
technical recommendations. Despite of these efforts, a couple of areas exist in which the status is 
unsatisfactory, necessitating further research. For the vision of an improved radiation protection of 
workers and the public the following challenges were identified: 
 To improve, validate and implement new biokinetic models  
 To develop accurate and on-line personal dosimetry for workers 
 To improve neutron dosimetry techniques 
 To include nuclide-specific information in environmental monitoring 
These challenges are described in detail in the following. 
 
3.5.1 To refine, validate and implement new biokinetic models 
Introduction 
The assessment of dose from internal exposure to radionuclides is subject to uncertainty due to 
activity measurement errors, individual variability, imperfection of biokinetic and dosimetric 
models, and unknown parameters of exposure. The resulting overall uncertainty in the estimated 
internal dose is acknowledged to be generally higher than that for external irradiation, but is 
usually not evaluated in practice. Thus, in a very general sense, improvements in internal dosimetry 
are needed, with potential benefits in radio-epidemiology (see also chapter 3.2), diagnostic and 
therapeutic nuclear medicine, and radiation protection of workers and the public. In this context, 
the availability of databases including autopsy cases should be acknowledged and used to validate 
any developed new biokinetic model. 
Research line 
It is intended to implement the latest biokinetic models which will be published in the new ICRP 
documents on Occupational Intake of Radionuclides (OIR). These new models are very complex 
and difficult to apply in individual dose assessment. A EURADOS report should be written with 
recommendations and guidance on how to use these complex ICRP models for individual dose 
assessment. The reason for this task is to be able to obtain the most realistic individual dose 
assessment not only for monitoring purposes but also as a fundamental basis for research on dose 
response relationships. 
The assessment of the effects on internal dose of using sex-dependent biokinetic parameters must 
be considered as well as the implementation of the new OIR systemic models, including quality 
assurance of the model results and model formulation. In this context, the National Council on 
Radiation Protection and Measurements (NCRP) Wound model requires validation with human 
data, using real cases from databases of the EU-funded project IDEAS and from USTUR (United 
States Transuranium and Uranium Registries).  
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While biokinetic models for workers and members of the public used for radiation protection 
purposes consider the biokinetic behaviour of radionuclides in healthy reference persons, 
radiopharmaceuticals are administered to patients who may suffer from diseases which might 
change the biokinetic behaviour of the radiopharmaceutical. Currently, dose assessment is done 
based on state-of-the-art biokinetic models used in radiation protection. It is obvious, however, 
that in nuclear medicine therapy, individual dose assessment is essential rather than doses to 
reference persons and consequently, biokinetic models that take into account the influence of 
certain diseases need to be developed.  
An additional aspect also deserves attention when biokinetic models are used for dose assessment 
of patients after application of radiopharmaceuticals: because of the short half-lives of 
radioisotopes used in nuclear medicine, a more realistic modelling of blood retention and urinary 
bladder voiding is needed. For radiopharmaceuticals which are secreted into the gastro-intestinal 
tract, consideration of the secretion pathway via the gall bladder may also be relevant, together 
with a gall bladder voiding model.  
The reliable assessment of uncertainties in individual doses would enable epidemiological studies 
of internal exposure to radionuclides to improve the evaluation of the dose response function and 
its statistical significance. 
 
3.5.2 To develop calibration procedures for partial body counters 
Introduction 
Dose assessment of individuals with internal contamination is subject to uncertainty due to many 
factors. Retrospective dose assessment is based on in-vitro and in-vivo measurements. In vivo 
measurements represent a highly valuable method since they provide actual information on 
radionuclide activity within the body of an individual. It has many beneficial aspects, but requires a 
detection system to be properly calibrated in order to obtain quantitative and accurate results. 
Calibration is usually performed by an object (physical phantom) which resembles as closely as 
possible the anatomy of the human body or one of its parts. There is no standard procedure to 
calibrate a partial body counter, and anthropomorphic phantom(s) such as those used in order to 
assess the skeletal activity of bone seeking radionuclides (e.g., plutonium and americium isotopes) 
are scarce. Skeletal activities are usually assessed from measurement positions at the knee, elbow 
or skull. It important to note that calibration based on available skull phantoms, for example, may 
differ by a factor of two. This is partially caused by individual body parameters such as head size, 
and by properties of different phantoms (e.g., differences in the construction or activity 
distribution).  
Research line  
It is intend to develop and implement standard physical and mathematical phantoms and 
procedures for calibration of partial body counters. Newly developed physical phantoms should 
improve currently available phantoms and provide a reliable base for general calibration. These 
phantoms should be complemented by their mathematical representation (voxel, mesh, non-
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uniform rational basis spline (NURBS) phantoms), in order to account for individual variability of the 
persons to be measured. 
Improved and standardized calibration procedures will be beneficial for two reasons. Firstly they 
will directly reduce the uncertainty of the measurement and thus affect final dose assessment. 
Secondly, more accurate and unified data will provide a better basis for design and improvement 
of anthropomorphic models. 
 
3.5.3 To develop accurate and on-line personal dosimetry for workers 
Introduction 
The challenge is to provide reliable, accurate and on-line personal dosimetry for occupationally 
exposed workers. This requires monitoring the workers in real time for all limiting quantities (whole 
body, eye lens, extremities, brain, heart), regardless of the protection methods used, and to provide 
input for the optimal application of the ALARA principle. Dosimetric research for personal 
dosimetry should deliver good characterized active and passive dosimeters for all relevant 
dosimetric quantities, and good computational tools using advanced tracking technology. 
Research lines 
Active dosimeters need to be developed for all radiation fields relevant for occupational exposure. 
Many devices exist already, but they are not suited for all of these fields. These active dosimeters 
should be developed in a way that they can also be used for official dose records. For fields that are 
used in medical applications and in particular for pulsed fields, improvements are still needed, and 
for example the dependence of active dosimeter response on dose rate must be investigated. 
Besides that, all existing devices must be tested for all relevant fields in which they are used. Active 
dosimeters should also be developed for eye lenses and extremities. Improvement of active 
dosimeters is also needed so that the measured dose is visible to the operator on-line and that the 
results can be easily implemented in advanced staff databases. 
There is still quite some work on eye lens dosimetry to be done. For example formalisms to 
measure eye lens doses, to develop practical eye lens dosimeters, and to test and compare 
different eye lens dosimeters are needed. There is also a lack of data for eye lens doses of workers 
in different fields such as those present in medical applications, where correlations of eye lens 
doses with other dose quantities, determination of reference eye lens doses for different 
procedures, and testing and improvement of the efficiency of different protection measures like 
lead glasses need to be explored. Particularly, the development of a dosimetry protocol to assess 
eye lens doses when protective eye glasses are used is urgent. However, the reduction in the dose 
limit for the lens of the eye to make it equal to the whole body dose limit makes it potentially the 
limiting quantity in any field where the dominant direction of radiation is from the front, even for 
fields for which neutrons contribute a significant component of absorbed dose. There is hence an 
urgent need to assess where eye lens doses are limiting across the breadth of industries where 
radiation protection is required.   
There is also still a lack of practical and reliable extremity dosimetry. Therefore, development of 
practical extremity dosimeters are called for, to test and compare different extremity dosimeters, to 
W. Rühm, et al. 
 
 
 38 EURADOS Report 2014-01 
 
explore correlations with other dosimetric quantities, and to improve dosimetry in mixed 
beta/gamma fields, especially low-energy beta fields. 
In the medical field, there is the special problem of whole body dosimetry in case of lead shielding 
(lead apron, thyroid shield). This requires determination of the best algorithm for double dosimetry 
and development of the best method to monitor effective doses in case of inhomogeneous 
irradiation (which is typically the case when a lead apron is used). 
In the future, the inclusion of dosimetry of other potentially radiosensitive organs (brain, heart) 
might also be needed. Dependent on the outcome of biological research on brain and 
cardiovascular risk, for example, doses to these organs might need to be determined. 
 
3.5.4 To develop neutron dosimetry techniques further 
Introduction 
Neutron sources are intentionally used and/or incidentally created in various scientific areas and 
technical applications (e.g. electricity generation, radiography and tomography, materials research, 
activation analysis, fundamental research, military activities, production of 
radioisotopes/radiopharmaceuticals). Some of the fields represent new challenges due to strongly 
pulsed radiation or very high energy ranges, i.e. radiation fields around high-energy particle 
accelerators and at flights at high altitudes or space missions.  
On the other hand, external dosimetry for neutron radiation, which is inevitably accompanied by a 
photon component, still presents challenges despite many years of development of neutron 
personal dosimeters. Neutron dosimetry is still a very challenging task as neutrons are present in 
mixed-fields, they are indirectly ionizing particles and pose more problems for their detection than 
other types of radiation. Their energy may cover extremely large energy ranges from 9 (nuclear 
industry) to 12 (particle accelerators, flight altitudes) orders of magnitude, and their “quality” and 
subsequently their conversion coefficients from fluence to dose varies by a factor of 50 over the 
entire energy range. At certain work areas neutrons can dominate the total dose received. 
However, the higher detection threshold of neutron personal dosimeters can lead to 
underestimation of the collective dose received from neutrons: this detection threshold remains 
one of the main deficiencies of neutron personal dosimetry relative to that for photons.  
The accuracy required for routine neutron dosimetry is not at the same level as for photon 
radiation in most workplaces, though this is not always true. Previous studies carried out have 
clearly shown that responses of personal neutron dosimeters in various workplace fields in the 
nuclear industry can show over- and under- responses of up to an order of magnitude. Therefore 
workplace monitoring is a prerequisite to achieve sufficient accuracy, i.e. by evaluating a spectrum 
correction factor to be applied.  
Whilst neutron dosimetry concerns a relatively small fraction of all exposed workers and the usual 
neutron Hp(10) contribution is often small compared with the dose limit; for some workers, such as 
air crew, it can be a significant component of total dose equivalent; it cannot be disregarded and 
reliable dosimetry with higher accuracy should be pursued. 
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Research lines 
Improvements of the existing dosimeters are required not only through improvements of existing 
techniques and/or development of new ones but also through the development of reference 
radiation fields to determine their response. Unfortunately, the actual reference radiation fields do 
not cover the required overall ranges in energy and angles encountered in the workplace. Because 
a facility that provides suitable neutron reference fields is extremely expensive and challenging, a 
European effort to develop and realize improved neutron testing and calibration facilities is the 
best way to achieve overall better results. 
Furthermore there is a need to characterize simulated workplace fields at a reference laboratory 
and radiation fields at the working area in terms of personal dose equivalent Hp(d). Workplace 
monitoring is well-established, and is performed mainly with multi-sphere spectrometers or simply 
by area monitors, both of which do not provide information on the directional distribution of 
neutrons. Therefore the results obtained are not sufficient to determine personal dose equivalent. 
The simultaneous measurement of energy and directional distributions is still a matter for research. 
Calibration of neutron personal dosimeters requires specific attention. In standard laboratories it is 
not possible to reproduce the variety of conditions (mixed-fields and wide energy and angle of 
incidence ranges) in which dosimeters are then used in workplace fields. Essential tools to guide a 
development in neutron dosimetry are regular intercomparisons either in standard laboratories or 
“in-field” conditions. Such intercomparisons are usually not achievable in only one country and 
therefore European efforts in designing and planning such testing sessions are needed (see 
chapter 5). 
There are specific needs for calibration of detectors and instruments in high-energy and pulsed 
neutron fields. Currently, reference high-energy fields are strongly dependent on simulation tools, 
with the measurements themselves being dependent on those same simulation tools for 
calibration. There is the additional problem of under-reading by active detectors in pulsed fields. 
Research is required into the appropriate dose rates for high energy and pulsed neutron fields. 
 
3.5.5 To include nuclide-specific information in environmental monitoring 
Introduction 
In March 2011, the nuclear power plant accident in Fukushima Daiichi demonstrated the 
indispensable need for permanent and reliable environmental radiation monitoring. At present, in 
Europe more than 5,000 stations allow radiological monitoring data to become available in nearly 
real-time. In case of a nuclear emergency, national dose rate data have to be provided to the 
European Commission (EC) on an hourly basis, via the European Radiological Data Exchange 
Platform (EURDEP). Based on these and other radiologically relevant data, the EC, which is in charge 
of the European Community Urgent Radiological Information Exchange System (ECURIE) may issue 
recommendations to the EU member states which could affect millions of people and may have 
severe economic and sociological consequences.  
Currently most dosimetry network stations in Europe are equipped with conventional dosimetry 
detector systems, which do not provide any nuclide-specific information. However, in case of a 
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major radiological emergency, in addition to reliable data of dose rates values, nuclide-specific 
information and data on ground and air contamination levels are of key importance for adequate 
governmental decisions, and first efforts are currently being made (e.g. in Finland and Germany) to 
improve the situation.  
Research lines 
In order to improve environmental radiation monitoring in Europe, we expect novel and improved 
instrumentation for field-station use to be developed, to allow for measurement of dose rates and 
collection of nuclide-specific information. New and improved measurement systems based on 
“high-resolution” spectrometric detectors such as NaI(Tl), LaBr3, or Cd-Zn-Te, which are in principle 
all well suited for this purpose, require comprehensive scientific investigations of detector features, 
spectra evaluation, and deconvolution methods, in order to fulfil today’s QA standards. These 
spectrometry systems could become the core instrumentation of the next generation of 
environmental radiation monitoring networks in Europe. They could also be used – through 
measured in-situ gamma spectra – to validate Monte Carlo simulations of dose rate and 
contamination levels. 
In a complementary effort, the use of passive dosimetry systems should also be explored for 
environmental radiation monitoring, and their advantages and disadvantages systematically 
discussed and compared with existing and other newly developed systems. 
3.6 Concluding remarks – the role of computational methods in dosimetry 
In many of the areas of research described above, computational methods play an important role. 
The domain of computational physics is not solely reliant on the Monte Carlo method, but also 
incorporates deterministic methods that attempt to solve the Boltzmann transport equation, and 
unfolding methods used to derive neutron energy distributions from experimental data. These 
other methods are important and should not be overlooked, but the availability of modern codes 
and powerful computers has made the Monte Carlo method dominant in radiation protection and 
dosimetry. Important areas of research where computational methods are needed also include 
representations of the human body at the macroscopic, microscopic and nanometric level. To give 
another example, the operational quantities used in radiation protection are defined in a manner 
that only permits their values to be calculated via Monte Carlo calculations. This is equally true for 
the protection quantities, which are defined in voxelized phantoms that cannot be constructed 
physically but must be simulated. The availability of Monte Carlo methods has allowed this system 
of radiation protection to be developed, which makes it an integral part of the field. Consequently, 
computational methods play a crucial role in most of the radiation protection fields where further 
research is needed. 
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4 Training and Education 
 
Education and training (E&T) has always been a key issue in EURADOS activities. For example, 
EURADOS Working Groups often allow attendance of corresponding members or observers in 
order to offer the chance to scientists, especially young scientists, who can listen to scientific 
discussions and be updated on the actual scientific programmes, thus allowing their participation 
in the future. In addition, EURADOS regularly organises specific training events like training 
courses, winter schools and scientific symposia.  
As for training courses, they usually last 3 to 5 days, with limited participation to about 40 
attendees and they are related to specific topics in the field of the EURADOS Working Groups. In 
the past, some of the training courses had two or more editions and were slightly updated if 
necessary, according to the demand. EURADOS Winter Schools have taken place at EURADOS 
Annual meetings since 2007. They usually last one or half a day and they provide “refresher 
courses” on topics relevant to radiation dosimetry. In contrast, scientific symposia also organized at 
EURADOS Annual Meetings, are usually related to research topics or results from EURADOS 
Working Groups or related research projects. Proceedings of the symposia have been published in 
peer-reviewed journals.  
EURADOS E&T actions are generally organised in an effort to maintain the competence in the field 
of dosimetry, in Europe. These actions are considered important and will be continued in the future 
including training on upcoming new dosimetric techniques. Coordination with E&T efforts of other 
platforms is recommended, in order to guarantee efficient use of techniques in dosimetry in all 
relevant research disciplines where exposure quantification is needed.  
As an additional aspect, experience after the Chernobyl and Fukushima accidents demonstrated 
that much fear among the population arose from lack of information about what radiation is and 
what "dose" means. It is thus believed that a constantly improved education of the general public 
and especially of key figures (physicians, physics teachers, journalists) is needed, aiming at a better 
understanding of ionizing radiation and radiation dose, as well as development of emergency 
programs to educate and train a large number of people (especially journalists, representatives of 
local authorities, etc) about technical terms involving radiation and dose. 
4.1 Implementation of EC directives and technical recommendations into practice 
Recently EURADOS has prepared training courses on ”Implementation of RP 160 and on lessons 
learned from intercomparison exercises”. This course was held for the first time in 2012 in Krakow, 
Poland, with 41 attendees from Europe and Japan. Among others, the course was very 
instrumental in defining the future strategy needed for a better harmonisation of dosimetric 
practice: Participants in the WG02 training course have identified the need for more practical 
information on a) the work necessary to apply for accreditation, b) information on how to use the 
results of type testing and/or intercomparisons in the uncertainty budgets, and c) guidance on a 
practical assessment of uncertainties. 
Future training actions in this field will be based on this experience and on the input by the 
individual monitoring service (IMS) community. It is desirable that IMSs will regularly attend the 
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EURADOS Annual Meetings and discuss issues of common interest. On the other hand, the analysis 
of QA/QC surveys organized on a regular basis is a means of identifying topics where training 
actions might be needed and welcomed by IMSs. To meet the request of attendants to the 2012 
training course the 2013 version had more emphasis on the practical implementation of 
EN/ISO/IEC 17025 as requested. Further planning of training courses should be linked to the needs 
of the IMS community. 
4.2 Training courses on novel or improved dosimetric methods 
EURADOS continues to organize a number of training activities, in order to maintain competence in 
the field of dosimetry. Past training courses included were “Methods in Radiation Measurement”, 
“Internal Dosimetry”, “Use of MCNP in Radiation Protection and Dosimetry”, “Voxel Phantom 
Development and Implementation for Radiation Physics Calculations”, etc. (see Appendix for more 
details). 
In case of internal exposures, training for fundamentals of internal dosimetry will be required in 
many scenarios, covering knowledge about quantities, monitoring techniques, biokinetics of 
incorporated radionuclides, interpretation of monitoring data, dose assessment, uncertainties and 
quality management. Reference publications, software and other tools required are, among others, 
ICRP OIR reports, ISO Standards, IDEAS Guidelines and NCRP Models and Reports.  
Other activities that were carried out and which need to be continued in the future include training 
on upcoming new dosimetric techniques such as, for example, EPR/OSL and TL dosimetry. 
4.3 Winter schools, workshops and scientific symposia 
In the past, Winter Schools were held on the general topics of "Relative Biological Effectiveness, 
radiation weighting factor and quality factor: their role in quantifying effectiveness of ionizing 
radiation" (AM2014), “Status and Future Perspectives of Computational Micro- and Nanodosimetry” 
(AM2012), “Radiation Protection for Medical Staff” (AM2011), “Radiological Emergencies – Internal 
exposures” (AM2010), “Low-Dose Radiation Effects” (AM2009), “Retrospective Dosimetry” 
(AM2008), and “Uncertainties in Radiation Dosimetry” (AM2007). These efforts will continue in the 
future, on general topics which are thought to be important for the EURADOS community.  
Scientific workshops and symposia have been organized in the past on actual research topics 
where EURADOS Working Groups are involved. Typically, proceedings of these workshops are 
published in peer-reviewed journals. The following topics were addressed in the past: “Dosimetry 
for second cancer risk estimation in radiotherapy” (AM2012), “Accelerator radiation protection and 
shielding” (AM2010), “Cosmic Radiation and Aircrew Exposure” (AM2009), “Dosimetric Issues in the 
Medical Use of Ionizing Radiation” (AM2008), “Characterization of Workplaces for the Assessment 
of the Doses to Individuals” (AM2007), “Uncertainties in Dosimetry – Principles Through to Practice” 
(AM2006), “Radiation Protection Dosimetry and Dosimetry for Medical Applications” (AM2005), and 
“Biological and Physical Dosimetry for Radiation Protection” (AM2004) (see Appendix for more 
details). These actions will also continue in an effort to present new research findings that were 
gained from various EURADOS WG actions. 
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5 Harmonisation and Practice 
 
The goal of harmonisation of dosimetric procedures in Europe is central to the overall EURADOS 
vision. It is obvious that every strategic objective discussed in the above Strategic Research Agenda 
has an element of harmonisation. That is, for all areas of research where dosimetry is required 
(epidemiology, occupational exposures, environmental monitoring, emergency preparedness, 
medical applications, etc.) a consistent approach in determining individual doses of exposed 
subjects and/or ambient dose rates is indispensable.  
As far as individual monitoring is concerned, the European Commission acknowledged the need 
for harmonisation in dosimetric practices in Europe, and publication of the Council Directive 96/29 
EURATOM (13 May 1996) had major implications for individual monitoring. This document 
requested individual monitoring to be performed by approved dosimetry services, generalized the 
use of the operational dosimetric quantities, and placed an increased importance on quality 
assurance (QA) and quality control (QC) measures and their application to the routine work of 
individual monitoring services (IMSs). In reaction to the initiative of the European Commission, in 
December 1996 EURADOS set up an action entitled “Harmonization of dosimetric quality assurance 
in individual monitoring of external radiation” with the main aims of assisting the consolidation 
within the EU of the quality of individual monitoring using personal dosimeters and to facilitate 
harmonized procedures. Meanwhile requirements on individual monitoring services (IMS) were 
defined and quality management standards were set that highlight the technical competence of 
staff, and requests technical procedures to be used, in order to guarantee that any IMS is capable of 
generating technically valid results. These standards also require IMSs to regularly take part in 
inter-laboratory comparisons.  
In some countries, national performance tests are offered, and successful participation is necessary 
for an IMS to be officially approved and allowed to maintain the activity as a service provider. In 
other countries, however, such organized exercises do not exist and it seems likely that the 
International Atomic Energy Agency (IAEA) will favour regions of the world other than the 
European region. EURADOS experience in this field may prove useful in the future. 
As far as environmental monitoring is concerned, in Europe, at present, more than 4,500 stations 
provide almost real-time radiological monitoring data. In case of a radiological emergency with 
trans-boundary implications in Europe, national dose rate data must be reported to the European 
Commission (EC) on an hourly basis, via the European Radiological Data Exchange Platform 
(EURDEP). Based on these and other radiologically relevant data, the EC – being in charge of the 
European Community Urgent Radiological Information Exchange System (ECURIE) – may issue 
recommendations to the EU member states which could affect millions of people and may have 
severe economic and sociological consequences. Thus, reliable monitoring data of ambient dose 
rates, coordinated with data from other international radiological networks, are indispensable for 
adequate environmental radiation monitoring in Europe. The harmonisation of ambient dose rate 
measurements in Europe is a prerequisite for the reliability of the ECURIE system and an important 
contribution to its quality assurance.  
In view of the need to harmonize dosimetric practices (both for individuals and the environment), 
and based on the interest of the European Commission and the earlier EURADOS activities 
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described above, EURADOS will continue with such activities in the future. These are described in 
the following sections. 
5.1 Intercomparison for dosimeters used in individual monitoring 
For individual monitoring it is our vision to create a long-lasting self-sustained system of actions 
that ensures harmonised dosimetric practises in Europe and that will contribute through 
participants from overseas (US, Japan) to a world-wide system of harmonised individual 
monitoring services.  
First, this requires a network of contacts that in the ideal case should include one person per 
interested country, who would participate in and contribute to the relevant EURADOS activities. 
Depending on the type of information necessary, this individual would contact the IMSs and/or 
national radiation protection authorities in his/her own country and/or neighbouring countries. At 
present such a network has already been established including contacts with persons of all EU 
member states as well as Switzerland, Norway, Ukraine and Turkey. Keeping our vision in mind to 
extend this concept to regions outside Europe, this network needs to be expanded in the future 
and strategic contacts need to be established with regions outside Europe. 
Second, this requires organisation of intercomparison exercises at accredited (EN ISO/IEC 17025) 
metrology laboratories for the required irradiations, collection and analysis of results declared by 
participants, preparation of certificates to participants, and eventually organization of a 
participants’ meeting to report and discuss the overall results. In general, such a meeting is held at 
EURADOS Annual Meetings. Dissemination of the results will be done through EURADOS reports, 
presentations at conferences attended by the community and publications in peer-reviewed 
scientific journals.  
So far, three whole-body photon intercomparison exercises were organized with a two-year 
interval (see Appendix). This meets the IMS needs to comply with EN/ISO/IEC 17025 requirements 
for accreditation. This concept proved very successful and it is our vision that it will be continued in 
the future on a regular basis. More specifically, our future plans include organisation of 
intercomparisons for whole-body dosimeters for photon fields, every 2 to 3 years, and with a 
smaller frequency for extremity dosimeters and neutron dosimeters (3 to 5 years interval).  
The experience gained by EURADOS in the realization of such actions in the past may prove useful 
to other organizations such as IAEA and collaboration may be useful in organising similar actions in 
other parts of the world. 
5.2 Intercomparison for early-warning systems used in environmental monitoring 
For environmental monitoring it is our vision that contamination levels down to a few kBq/m2, 
which correspond to an increase of the ambient dose equivalent rate (H*(10)) of about 5 nSv/h 
(about 5 % of the natural background) from, for example, 137Cs, can be determined in the fastest 
possible way. We note that in case of a major radiological emergency, an early and reliable 
assessment of contamination levels of farmland and of dose rate levels in urban areas are of key 
importance for the protection of the health of the public against dangers arising both from direct 
external radiation and from intake of radioactivity from foodstuffs.  
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Validation of procedures and the traceable calibration of any detector systems used to supply data 
to monitoring networks, e.g. EURDEP, will be required. For this purpose, existing reference field 
stations, such as Intercal of BfS in Freiburg, Germany, and those presently under construction, e.g. 
the future underground calibration facility of IFIN-HH at Slanic-Prahova in Romania, should be 
metrologically linked with the primary standard facilities available for dosimetry at low dose rates. 
Currently, there is only one traceable calibration service for low dose rates (100 nSv/h and below) 
available worldwide, i.e., the underground facility UDO II, operated by PTB in Braunschweig, 
Germany. The Romanian installation may help to improve the calibration capabilities, especially for 
East-European countries which have not yet participated in intercomparison exercises such as 
those organised by EURADOS. 
EURADOS intends to support operators of national early warning dosimetry networks and consult 
regulatory bodies and the Joint Research Centre (JRC) Ispra concerning legal aspects of 
environmental radiation monitoring, especially those related to Article 35 and 36 of the Euratom 
Treaty. The stimulation of cooperation, especially between the Institute for Environment and 
Sustainability (IES) with regard to EURDEP (European Radiological Data Exchange Platform) and 
EURADOS is considered to be a key element in developing further the idea of harmonisation in 
environmental monitoring. This will also include definition of standards and publication of 
technical recommendations.  
5.3 Surveys on practical dosimetry 
Accreditation is gradually becoming more and more important for European IMS, and quality 
assurance and quality control is a central element. Here EURADOS can play a leading part in the 
future, if the actions mentioned above (intercomparison exercises, training courses) can be 
organised in a self-sustained manner. Monitoring the success of these actions is of course 
important, and regular surveys should be instigated by EURADOS, to document the quality of 
dosimetric practises in Europe and to compare it to that in other regions of the world. A survey 
organised by EURADOS in 2012-2013, for example, indicated that the profile of QA is high amongst 
the responding IMS and that most are following good practice. The majority of services are certified 
(around 70%) or declared themselves compliant to quality standards, mostly in accordance with 
EN/ISO/IEC 17025 (or with ISO 9001). These results, while in general very promising, suggest that 
further and continuous efforts must be made to guarantee a sustained, long-lasting, and consistent 
quantification of exposures to ionizing radiation.  
In general, dissemination of the results should be done through EURADOS reports, presentations at 
conferences attended by the community and publications in peer-reviewed scientific journals. To 
support dissemination, the EURADOS network is involved in the organization of the conferences on 
individual monitoring as members of the scientific committees, invited lecturers, session chairs, co-
chair and rapporteurs, referees for the preparation of proceedings, etc. So far Individual Monitoring 
conferences were organized in 2000 (Helsinki, Finland), 2005 (Vienna, Austria), and 2010 (Athens, 
Greece), and another is planned to take place in 2015 in Bruges (Belgium). 
To ensure optimum use of the lessons learned from surveys and intercomparison exercises, a 
regular analysis of results must be ensured, reasons for observed deviations be identified, and 
suggestions for an improvement of dosimetric quality be made. This will require maintaining, 
updating and extending the contact details of interested IMS, regularly assessing the performance 
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of the participating IMS, in compliance with reference documents that are based on the analysis of 
EURADOS surveys and intercomparison results, and preparing training courses adapted to the 
identified lessons learned. 
In order to keep dosimetric practises up-to-date, current and future ICRP and ICRU concepts and 
recommendations as well as corresponding EU Directives must be continuously scrutinized and 
their potential implications on measurement quantities, phantoms, etc. evaluated. Additionally, 
any new technical developments with respect to passive dosimeters (traditional film, TLD, OSL, 
track-etch, etc.) and in particular to active personal dosimeters must be also included in this 
evaluation. 
Following the publication of ICRP60 in 1991 and ICRP103 in 2007 and although the radiation and 
tissue weighting factors were revised, the system of quantities suggested by ICRP and ICRU seems 
to be stable, namely, Hp(d) for the next period. However, recent work on radiation effects 
suggested that the Hp(3) quantity might deserve further attention, particularly with the decrease of 
the corresponding annual dose limit for the lens of the eye. As a consequence, the measurement of 
this quantity received increased importance as the output of recent projects show: (i) dedicated 
dosimeters have been proposed for the measurement of Hp(3) closer to the eye lens; (ii) a 
cylindrical phantom as surrogate of the head instead of the slab phantom to be used for calibration 
of eye-lens dosimeters has been proposed; (iii) conversion coefficients for Hp(3)/Ka, Hp(3)/ for 
photons, electrons and neutrons (for both cylindrical and slab phantom) have been published by 
various authors in the open literature to complement the values published by ICRU/ICRP as 
international agreed values for Hp(10), Hp(3) and Hp(0,07); (iv) international standards on procedures 
for the calibration of dosimeters in terms of Hp(3) have not been updated yet. In the near future, the 
use of Hp(3) in routine and related measurement procedures may be expected. Important QA and 
QC issues for Hp(d) might also include the quantity Hp(3) and related measurement issues and/or 
problems. 
5.4 Intercomparison of dose assessment in cases of internal exposures 
Doses from intakes of radionuclides cannot be measured directly but are estimated from 
monitoring data of activity in total/partial body and in excreta samples (urine and faeces). Such 
assessments require application of biokinetic and dosimetric models, and assumptions about the 
pattern of intake and the properties of the radioactive material inside the body. Past 
intercomparison exercises (Doerfel 2000, Hurtgen 2005) have shown a wide range in doses that can 
be obtained from the same data set from different assessors demonstrating the need for guidance 
on harmonising internal dose evaluations.  
Intercomparison exercises of dose assessment in cases of internal exposures are required to 
validate the capability of the dosimetrists in the correct interpretation of monitoring data to 
provide the best estimate of the intake and Committed Effective Dose E(50).  
The last international intercomparison exercise on internal dose assessment was organized by the 
IDEAS Group (IDEAS Project,EU Contract No. FIKR-CT2001-00160) in 2005. A new action is required 
taking into account the state-of-the-art tools currently available and forthcoming publications as 
follows: 
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 ICRP/OIR Reports: Occupational Intakes of Radionuclides (in progress). A series of 
documents that will replace the ICRP Publications 30, 54, 68 and 78, to provide revised dose 
coefficients and bioassay data for occupational intakes of radionuclides by inhalation and 
ingestion. The revised dose coefficients have been calculated using the ICRP100 Human 
Alimentary Tract Model (HATM) and a revision of the Publication 66 Human Respiratory 
Tract Model (HRTM). In addition, information will be provided on absorption in blood 
following inhalation and ingestion of different chemical forms of elements and their 
radioisotopes. Revisions have been made of many systemic models with more 
physiologically realistic representations of uptake and retention in organs and tissues and 
of excretion. The reports will also include some guidance on monitoring programmes and 
interpretation of bioassay monitoring data.  
 Revised IDEAS Guidelines for the Estimation of Committed Doses from Incorporation 
Monitoring Data (EURADOS Report 01-2013, Casstellani et al). The IDEAS Guidelines are 
based on a general philosophy of a) harmonisation – by following the Guidelines any two 
assessors should obtain the same estimate of dose from a given data set, b) accuracy – the 
"best" estimate of dose should be obtained from the available data, and c) proportionality – 
the effort applied to the evaluation should be proportionate to the dose – the lower the 
dose, the simpler the process should be. 
 ISO Standards in internal dosimetry, generated by ISO TC85/SC2/WG13  
EURADOS has been involved in the organization of intercomparison exercises on dose assessments 
at an international level for many years and will take the initiative in organizing the next exercise 
after the publication of the new ICRP/OIR Reports. A plan of intercomparisons and training actions 
will be established for the next decades to help the internal dosimetry community to deal with 
intakes of radionuclides. 
5.5 Intercomparisons of computational methods in dosimetry 
Computational methods form a part of the work programme of all EURADOS Working Groups and 
a high fraction of papers published in radiation protection and dosimetry. These methods have 
moved from the domain of experts to become routine tools, which are commonly given to the 
most junior scientists in research teams, partly because of their IT skills. Those scientists may have 
the poorest understanding of the physics issues which are, however, crucial to the correct 
application of the code. Many of the codes that are now available can be obtained and installed 
with relative ease, and the manual may be used instead of any formal training, or the training may 
be provided informally in-house by those who are not expert and but who may already employ 
some practice.  
Intercomparisons have been performed on modelling tasks ranging from simulations of 
accelerators to unfolding of neutron energy distributions, all of which have shown the potential for 
good agreement between solutions and also the potential for large systematic errors in results. 
Consequently, where misapplied, these methods can cause the cost and time savings available to 
be lost. Worse, they can lead to underestimates of risk or overprotection where, for example, vastly 
more expensive shielding is installed than is necessary. 
Recent and ongoing intercomparisons have included: 
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 Design and calibration of a linac: a complex modelling problem involving the full design 
process and the characterization of the radiotherapy radiation field. 
 Neutron energy distribution unfolding: computer models have been developed in which 
the neutron field is simulated. Bonner sphere detectors have been placed within these 
models to simulate the response and provide data for the unfolding process. 
 Implementation of the ICRP reference phantoms: these are supplied in voxel form for the 
used to convert to the appropriate input for their computer code. This intercomparison will 
test both the ability of the user to construct the voxel phantom from the data provided, but 
also their ability to use the model to calculate the appropriate dose quantities. 
 Micro and nano scale track structure: these studies are fundamental to the radiation 
damage to human tissue that leads to detriment. These calculations are at the cutting edge 
of Monte Carlo methods, since they are pushing at the boundaries of the data that are 
available and even the uncertainty principle. 
 To summarize, computational methods are important for help with planning and design, 
interpretation of results/experiments and for more fundamental studies, there is scope for 
poor application. Questionnaires performed by EURADOS in the past showed the poor 
level of quality assurance performed by those using these methods, a situation that is likely 
to have got worse as their use has become more and more widespread.  
Although computational methods are important for help with planning and design, interpretation 
of results/experiments and for more fundamental studies, there is scope for poor application. 
Questionnaires performed by EURADOS in the past showed the poor level of quality assurance 
performed by those using these methods. This situation is likely to become even more critical in 
the future because it is likely that these codes will become more and more widespread. EURADOS 
continues to perform modelling intercomparisons, commonly as collaborations between Working 
Groups. These efforts need to be intensified. 
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Appendix 
A.1. History of EURADOS 
During a meeting of scientists involved in contracts with the European Commission held in 
September 1981 at Homburg/Saar, Germany, EURADOS was conceived. It was decided that the 
activities of EURADOS would be focussed on the collection, processing and dissemination of 
information on research in dosimetry of all types of ionising radiation, and on the practical co-
ordination of ongoing research projects and joint planning of future programmes. 
The required financial support was received within the various Framework Programmes of the EC. 
Over the years this changed from general support for the network to dedicated support for 
projects. In this period EURADOS was fully dependent on EC funding. 
EURADOS has mainly been operated by setting up Working Groups on particular topics. Such 
groups were installed for performing specific tasks and are usually dissolved after these tasks have 
been fulfilled. Examples were Working Groups on skin dosimetry, assessment of internal dose, 
criticality accident dosimetry, development of individual dosimeters for external penetrating 
radiation, basic physical data for gas ionising devices, and radiation exposure of air crews. Often a 
Working Group organised a workshop or seminar at the end of its work programme, presenting 
and discussing its results and/or published a detailed report. 
EURADOS was registered in 2001 as a "society with restricted authority" at the chamber of 
commerce in the Netherlands. In particular the fact that the personal liability of the Council 
members was not restricted no longer allowed EURADOS to be a direct contractor in EC-funded 
projects. In addition, EURADOS was unable to organize self-supporting actions, such as 
intercomparison exercises, which may include a financial risk. 
In 2007 the General Assembly initiated the change of EURADOS into a self-sustained network and a 
new legal entity. This was accomplished in 2008. 
In the past, the European Commission has continuously shown interest in dosimetry issues. For 
example, end of 2006 the Commission issued a call for tender for the preparation of new European 
technical recommendations for monitoring individuals occupationally exposed to external 
radiation that would replace EUR 14852. In the resulting EU-Trimer project, EURADOS was 
instrumental in establishing a consortium and writing a document that was the result of a wide 
consensus of national radiation protection bodies, national metrology laboratories, authorities, 
standardization bodies (ISO, IEC), European IMS, etc. The final document was approved by the 
Group of Experts established under Article 31st of the EURATOM Treaty, and published by EC DGE 
as Radiation Protection n. 160 in November 2009. 
A.2. Current Status of EURADOS 
The European Radiation Dosimetry Group (EURADOS) comprises a network of more than 60 
European institutions (Voting Members) and 300 scientists (Associate Members). The aim of the 
network is to promote research and development and European cooperation in the field of 
dosimetry of ionizing radiation. It includes experts, reference and research laboratories, and 
dosimetry services. This enables appropriate specialist groups to be formed in a timely manner to 
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solve scientific problems or promote research identified within EURADOS or upon request from 
external bodies. 
EURADOS e. V. was registered 2008 in the German Register of Societies as non-profit association, 
exempted from income tax. The rules of the association are governed by a constitution, 
complemented by "Rules of Procedure" to define further details. EURADOS Voting Members are 
institutions performing or promoting research in dosimetry. Each Voting Member nominates a 
permanent representative (delegate) who attends the General Assembly. The General Assembly is 
responsible for the governance of EURADOS and for the approval of objectives and strategy. The 
General Assembly elects the Chairperson and Vice-Chairperson of EURADOS. EURADOS is 
administered by this Council consisting of at least eight but no more than twelve associate 
members. The elected Chairperson and Vice-Chairperson are automatically members of the 
Council. Four Council members, so-called officers (Chairperson, Vice-Chairperson, treasurer, 
secretary) comprise the Executive Board which runs the daily work of EURADOS. The Council itself 
can install or close Working Groups, which in turn are comprised of individuals – so-called 
Associate Members – whose application must be approved by the Council. EURADOS may be 
supported by “Supporting Institutions” such as dosimetry services, manufacturers, and other 
institutions such as ICRU, ISO, IAEA etc. The main bodies of the association and their relationship 
are shown in Fig. A.1. 
 
 
Fig. A.1: EURADOS as an organisation 
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The network’s financial resources originate from sponsoring institutions, from voting members, 
from levies raised for activities organized by EURADOS (annual meetings, training courses and 
intercomparison exercises), and from projects funded by the European Commission. Due to this 
structure, EURADOS is a self-sustainable network.  
Areas of activities – science 
EURADOS activities encompass a) coordination of Working Groups that promote technical 
developments in radiation dosimetry and their implementation in routine work which contribute 
to compatibility and harmonisation within Europe and conformance with international practices, b) 
organization of scientific meetings and training activities and c) organization of dosimetry 
intercomparisons and bench mark studies.  
The core of EURADOS activities is aimed at promoting scientific and technical research and 
development in the field of ionizing radiation. The work is performed in Working Groups (WG) 
which are composed of Associate Members. Scientific actions include individual monitoring for 
external exposure, individual monitoring for internal exposure, retrospective dosimetry, 
environmental radiation monitoring, diagnostic and interventional radiology, nuclear medicine, 
radiation therapy, and computational dosimetry. These scientific areas are reflected in the various 
Working Groups established by EURADOS. Currently (May 2014) EURADOS includes eight Working 
Groups that deal with certain aspects of research and harmonization in dosimetry: 
 WG2: Harmonization of individual monitoring in Europe: Chair - João Alves, IST, PT 
 WG3: Environmental dosimetry - Chair: Stefan Neumaier, PTB, DE 
 WG6: Computational dosimetry - Chair: Rick Tanner, PHE, UK 
 WG7: Internal Dosimetry - Chair: Maria Antonia Lopez, CIEMAT, ES 
 WG9: Radiation protection dosimetry in medicine - Chair: Roger Harrison, Newcastle, UK 
 WG10: Retrospective dosimetry - Chair: Clemens Woda, HMGU, Germany 
 WG11: High energy radiation fields - Chair: Werner Rühm, HMGU, Germany 
 WG12: European Medical ALARA Network - Chair: Zeljka Knezevic, Croatia 
Members of Working Groups, Voting Members, and Council members meet regularly once a year 
during the Annual Meeting typically held end of January or early February. Annual Meetings are an 
opportunity for Working Group members to meet for 1 to 2 days and at the same time participate 
in Winter Schools and Workshops, and the representatives of voting members may take part in the 
General Assembly. A reasonable attendance fee is generally necessary to cover the organizing 
expenses and generate a small, positive balance. 
Additionally, the Working Groups meet in summer or autumn for plenary Working Group meetings, 
complemented if necessary by meetings of task groups as defined within the Working Groups.   
Areas of activities – training and education 
EURADOS training actions include winter schools, workshops and training courses. In order to 
respond to the need for training in the field of radiation dosimetry, EURADOS Winter Schools were 
included in the Annual Meetings for the first time in 2007. Topics are selected based on 
suggestions from Voting Members or the Council. In addition various training courses have been 
organised. A list of past Winter Schools, Workshops, and training courses is given below. 
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The following Winter Schools were held during Annual Meetings: 
 Relative Biological Effectiveness, Radiation Weighting Factor and Quality Factor: Their Role 
in Quantifying Effectiveness of Ionizing Radiation (AM2014) 
 Status and Future Perspectives of Computational Micro- and Nanodosimetry (AM2013): 
 Radiation Protection for Medical Staff (AM2011) 
 Radiological Emergencies – Internal exposures (AM2010) 
 Low-Dose Radiation Effects (AM2009) 
 Retrospective Dosimetry (AM2008) 
 Uncertainties in Radiation Dosimetry (AM2007) 
The following Workshops were held during Annual Meetings: 
 Dosimetry for second cancer risk estimation in radiotherapy (AM2012) 
 Accelerator radiation protection and shielding (AM2010) 
 Cosmic Radiation and Aircrew Exposure (AM2009) 
 Dosimetric Issues in the Medical Use of Ionizing Radiation (AM2008) 
 Characterization of Workplaces for the Assessment of the Doses to Individuals (AM2007) 
 Uncertainties in Dosimetry – Principles Through to Practice (AM2006) 
 Radiation Protection Dosimetry and Dosimetry for Medical Applications (AM2005) 
 Biological and Physical Dosimetry for Radiation Protection (AM2004) 
The following education and training actions were held as self-supporting actions: 
 2nd EURADOS Voxel Phantom School (HMGU, Neuherberg, 2014) 
 2nd EURADOS Training Course: European Technical Recommendations for Monitoring 
Individuals Occupationally Exposed to External Radiation (RBI, Zagreb, 2013). 
 EURADOS WG7 - KIT Training Course on Monte Carlo Methods for calibration of body 
counters (KIT, Karlsruhe  2013) 
 EURADOS Training Course: European Technical Recommendations for Monitoring 
Individuals Occupationally Exposed to External Radiation (CTU, Prague, 2012) 
 EURADOS School on Retrospective Dosimetry – Practical exercise in Solid State & 
Cytogenetic dose reconstruction (HMGU, Neuherberg, 2012) 
 EURADOS Voxel Phantom School (IRSN, Forntenay-aux-Roses, 2011) 
 EURADOS/IAEA Regional Training Course on Advanced Methods for Internal Dose 
Assessment (CTU, Prague, 2009) 
Areas of activities – intercomparisons 
Intercomparisons and benchmark exercises are important tools for quality assurance. EURADOS 
carried out such activities on the areas of Individual Monitoring of External Radiation, Early Warning 
Radiation Monitoring Systems, Computational Codes in Radiation Dosimetry, Neutron 
Spectrometry, and Internal Dosimetry 
The more recent actions (in brackets the Working Groups which carried them out) were: 
 EURADOS Intercomparison 2014 for whole body photon dosimeters (IC2014) (WG2) 
 EURADOS Intercomparison 2014 for passive environmental dosimeters (WG3) 
 EURADOS Intercomparison 2012 for whole body neutron dosimeters (IC2012n) (WG2) 
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 EURADOS Intercomparison 2012 for whole body photon dosimeters (IC2012ph) (WG2) 
 6th EURADOS Intercomparison 2012 of Early Warning Dosimetry Network Systems (WG3) 
 Measurements at high-energy neutron fields 2011 (WG11) 
 EURADOS Intercomparison 2010 for whole body dosimeters (IC2010) (WG2) 
 Intercomparison 2010 on Monte Carlo modelling of in vivo measurements of lung 
contamination with a Livermore phantom (WG6 and WG7) 
 5th EURADOS Intercomparison 2009 of Early Warning Network Systems (WG3) 
 EURADOS Intercomparison 2009 for extremity dosimeters (IC2009) (WG2) 
 EURADOS Intercomparison 2008 for whole body dosimeters (IC2008) (WG2). 
 3rd EURADOS Intercomparison 2006 to harmonise European early warning dosimetry 
systems (WG03): 
Participation in such intercomparison exercises has always been successful and is even increasing; 
it now also includes IMSs from outside Europe, as data reported in the following table show: 
 
IC exercise Number of 
participants 
Number of 
dosimetry 
systems 
European 
countries 
non 
European 
countries 
IC2008 
IC2009 
IC2010 
IC2012ph 
IC2012n 
IC2014 
52 
44 
70 
76 
27 
97 
62 
59 
85*  
88 
34 
112 
19 
18 
27 
25 
15 
27 
2(i) 
 
3(ii) 
5(iii)  
3(iv) 
8(v) 
(*) IC2010, the participation of 9 systems was sponsored by the IAEA 
(i) Turkey and Ukraine 
(ii) Argentina, Turkey and Ukraine 
(iii) Argentina, Israel, Turkey, Ukraine and USA 
(iv) Israel, Japan and USA 
(v) Argentina, India, Israel, Japan, Lebanon, Turkey, Ukraine, USA 
 
Sources of income and self-sustainability 
In all undertaken actions (intercomparison exercises, training courses, training schools, annual 
meetings) the revenue from the participants’ fees is used to cover all expenses and preferably 
generate a positive balance.  
In general, actions are carried out by an organizing group suggested by the Working Group and 
appointed by the Council following the analysis of a calendar and the approval of a preliminary 
budget. The budget includes manpower costs for the co-ordinator and collaborators respective 
institutes, consumables, travel and subsistence and other costs depending on the action, e.g. 
irradiation costs in the case of intercomparison exercises. Although travel and subsistence are 
covered at real costs, EURADOS counts on the collaboration of the home institutes particularly for 
manpower charges, that is, manpower is not charged at the real cost of dedicated amount of time 
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and/or work. On the other hand, the institutes also recognise the importance of the activity and 
increased visibility for their institution within the dosimetric community by taking part in the 
action. 
At present 32 institutions and companies annually support EURADOS with a sponsorship fee.  
Other Conferences with support from the Eurados network 
EURADOS actively initiates and supports the continuation of a series of conferences on Individual 
Monitoring (IM) and Neutron- and Ion Dosimetry (NEUDOS). Past examples were IM2005 (Vienna), 
IM2010 (Athens), NEUDOS9 (Delft, Netherlands, 2003), NEUDOS10 (Uppsala, Sweden, 2006), 
NEUDOS11 (Cape Town, South Africa, 2009) and NEUDOS12 (Aix-en-Provence, France, 2013). In 
these cases, the EURADOS council took the initiative by calling for proposals to host the respective 
conference. The selection of the organizer and venue was then done by the EURADOS Council and 
the members of the scientific committee of the previous conference. 
In addition, EURADOS provides financial support for other conferences where dosimetry is an 
important topic. Examples are EPR-BioDose 2010 (Mandelieu-La-Napoule), France, and 2013 
(Leiden, The Netherlands) and the 5th MELODI workshop (Brussels, Belgium, 2013). 
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Abstract
Reflecting the change in funding strategies for European re-
search projects, and the goal to jointly improve medical radi-
ation protection through sustainable research efforts, five
medical societies involved in the application of ionising radi-
ation (European Association of Nuclear Medicine, EANM;
European Federation of Organizations for Medical Physics.
EFOMP; European Federation of Radiographer Societies,
EFRS; European Society of Radiology, ESR; European
Society for Radiotherapy and Oncology, ESTRO) have iden-
tified research areas of common interest and developed this
first edition of the Common Strategic Research Agenda
(SRA) for medical radiation protection.
The research topics considered necessary and most urgent
for effective medical care and efficient in terms of radiation
protection are summarised in five main themes:
1. Measurement and quantification in the field of medical
applications of ionising radiation
2. Normal tissue reactions, radiation-induced morbidity and
long-term health problems
3. Optimisation of radiation exposure and harmonisation of
practices
4. Justification of the use of ionising radiation in medical
practice
5. Infrastructures for quality assurance
The SRA is a living document; thus comments and
suggestions by all stakeholders in medical radiation protec-
tion are welcome and will be dealt with by the European
Alliance for Medical Radiation Protection Research
(EURAMED) established by the above-mentioned
societies.
Main messages
•Overcome the fragmentation of medical radiation protection
research in Europe
• Identify research areas of joint interest in the field of medical
radiation protection
• Improve the use of ionising radiation in medicine
• Collect stakeholder feedback and seek consensus
• Emphasise importance of clinical translation and evaluation
of research results
Keywords Radiation protection . Research . Optimisation .
Justification .Medicine . Dosimetry
Preamble
Reflecting the changing funding strategies of research
projects within Europe and the goal of jointly improving
medical care by sustainable research efforts, the following
medical societies involved in the application of ionising
radiation, namely,
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5 ESTRO, Rue Martin V 40, 200 Brussels, Belgium
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European Association of Nuclear Medicine (EANM)
The EANM is the umbrella organisation representing
nuclear medicine in Europe and represents 40 National
Member Societies, approximately 3200 individual
members and around 30,000 professionals working in
Nuclear Medicine in Europe. EANM aims to advance
science and education in nuclear medicine for the bene-
fit of public health, relating to the diagnosis, treatment,
research and prevention of diseases through the use of
unsealed radioactive substances and the properties of
stable nuclides in medicine, throughout Europe.
European Federation of Organisations for Medical
Physics (EFOMP)
The EFOMP serves as an umbrella organisation
representing 35 national member and affiliated organi-
sations of more than 7000 physicists and engineers
working in the field of medical physics in Europe.
EFOMP aims to harmonise and advance medical physic
in both its professional clinical and scientific expression
throughout Europe by bringing about and maintaining
systematic exchange of professional and scientific infor-
mation, through the formulation of common policies,
and by promoting education and training programmes.
European Federation of Radiographer Societies
(EFRS)
The EFRS is the non-profit umbrella organisation
representing 39 professional societies and 51 education-
al institutions representing over 100,000 radiographers
across Europe. The aims of the EFRS are to represent,
promote and develop the profession of radiography in
Europe, across medical imaging, nuclear medicine and
radiotherapy areas of radiography practice.
European Society of Radiology (ESR)
The ESR is a non-profit organisation representing the
general interests of radiology in Europe. The aims of
ESR are to serve the healthcare needs of the general pub-
lic through the support of science, teaching and research
and the quality of service in the field of radiology as well
as the promotion and coordination of the scientific, phil-
anthropic, intellectual and professional activities of radi-
ology in all European countries. The ESR has over
69,300 individual members as well as 59 institutional
member societies of which 44 are national radiology so-
cieties and 15 are European Radiological Subspecialty
Societies and European Allied Sciences Societies.
European Society for Radiotherapy and Oncology
(ESTRO)
The ESTRO is a non-profit scientific organisation
representing radiation oncologists, medical physicists,
radiobiologists and radiation therapists with over 5000
members both within and outside Europe. ESTRO aims
to foster the role of radiation oncology in order to im-
prove patient care in the multimodality treatment of
cancer by promoting innovation, research and dissemi-
nation of science through its congresses, special meet-
ings, educational courses and publications.
decided that it was necessary and would be helpful to
develop a corresponding common Medical Strategic
Research Agenda (Medical SRA) to overcome current
and future deficits and to be a constructive partner in
European radiation protection research. To this end, re-
search areas of interest have been jointly identified and
agreed upon in this common SRA endorsed by the med-
ical societies.
The effort of the medical societies in developing an SRA
for the medical application of ionising radiation complements
the efforts of other European platforms such as MELODI,
EURADOS, ALLIANCE and NERIS, which have developed
or are developing their own SRAs in the fields of general low-
dose research, dosimetry, radioecology and emergency pre-
paredness, respectively.
In a memorandum of understanding (MoU) signed by the
medical societies, MELODI and EURADOS in 2014, it was
decided to cooperate in order to promote the integration and
the efficiency of European radiation protection research, to
maintain and use a common European infrastructure for this
research as well as to bring forward scientific education and
training in the field of radiation protection for medical appli-
cations of ionising radiations.
The mission is to achieve the following objectives:
& Ensure an adequate level of information exchange be-
tween the signatories in the fields of joint interest within
the scope of the MoU;
& Identify gaps of joint interest in existing SRAs with re-
spect to RTD needs for improving radiation protection in
the medical field, or for improving the effectiveness/
exposure ratio of medical protocols based on the use of
ionising radiations, so as to optimise the SRA contents and
avoid duplication of efforts;
& Identify research areas of joint interest where progress
may benefit from contributions from signatory organisa-
tions, or the members thereof, e.g. some low-dose effects
or dosimetry research projects may benefit from contribu-
tions in a clinical environment, conversely, some medical
protocol researchmay benefit from advanced dosimetry or
radiobiology developments;
& Develop joint documents to support the elaboration of
research and technological development (RTD) calls
in the framework of the Horizon 2020 programme,
both in the EURATOM/Fission and in the Health
programmes;
& Optimise and coordinate the dissemination of scientific
knowledge resulting from research, particularly through
education and training actions.
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The stakeholders are involved through a formal consulta-
tion process that has been initiated, is ongoing and will be
reflected in future updates of the SRA presented here.
Summary
Reflecting the change of funding strategies for research pro-
jects within Europe, and the goal of jointly improving medical
care by sustainable research efforts, the medical societies in-
volved in the application of ionising radiation have identified
research areas of interest and agreed upon these in this com-
mon SRA endorsed by the medical societies.
The research that is seen to be necessary and most urgent
for effective medical care, under the best harmonised practice,
and efficient in terms of radiation protection can be
summarised to the following five main topics:
1. Measurement and quantification in the field of medical
applications of ionising radiation
2. Normal tissue reactions, radiation-induced morbidity and
long-term health problems
3. Optimisation of radiation exposure and harmonisation of
practices
4. Justification of the use of ionising radiation in medical
practice
5. Infrastructures for quality assurance
The subtopics defined for each topic describe the specific
research aspects that are identified as areas of great importance
regarding research for establishing optimal radiation protec-
tion in the field of medical applications. These descriptions
can be found in Chap. 3.
It is important to highlight that the approach to improve the
use of ionising radiation in medicine by pure fundamental
research would lack impact and influence unless having im-
mediate consequences for and being translatable to everyday
clinical practice. It is also important that the results of the
research are not only translatable but really translated into
daily routines. Therefore it is essential that the research is
undertaken in a concise manner by persons educated and
trained for good medical practice. The results have to be eval-
uated in clinical practice and have to be made public in a way
that it is easy to access (results and implementation guidelines
available on the internet) and to implement the methodologies
developed. It is also essential that the same level of importance
is placed on educating the staff working in the field to guar-
antee a direct clinical impact and to ensure high-level,
standardised medical care and related radiation protection ful-
ly exploiting and profiting from all research conducted with
regard to radiation protection in the medical field throughout
Europe. This aspect of the SRA is reflected in Chap. 4.
Background
Over the last 5 to 10 years the structure of research funding by
the European Commission (EC) has gradually changed. The
intention is to bring together all interested parties to facilitate
European research projects in the field of radiation protection
research and “to set up a European umbrella structure for the
administration of radiation protection research calls”. To this
end, SRAs have been developed or are currently under
development.
Therefore, a medical SRA is especially important in view
of the applications of ionising radiation in the medical field,
since the medical use of ionising radiation is the largest man-
made source of exposure to the human population. The ad-
vantages of such SRAs include:
& Providing guidance on/help to identify the most relevant
and urgent research topics in the fields they cover
& Demonstrating the importance of research areas to the
stakeholders
& Justifying research expenditure in defined areas
& Facilitating discussions with other members of the scien-
tific community in the field of radiation protection
& Determining important topics and influencing research
calls of the EC, OPERRA and CONCERT.
Since medical applications are among the most important
contributors to exposure of the population in Europe to ionis-
ing radiation, for medical radiation protection research to be
effective, it is critical that the results of the research projects
are directly transferred into clinical practice, i.e. translational
research.
This SRA has been the cornerstone for a common platform
of the European medical societies dealing with topics related
to the use of ionising radiation. In September 2016 the
European Alliance for Medical Radiation Protection
Research (EURAMED) was launched by EANM, EFOMP,
EFRS, ESR and ESTRO and is currently run as a joint initia-
tive under the umbrella of the European Institute for
Biomedical Imaging Research (EIBIR). The medium-term
goal is to establish EURAMED as a separate legal entity with
a sustainable governacne and membership structure to allow
other stakeholders to participate actively in the platform.
Updates are available at www.euramed.eu.
Research topics
Measurement and quantification in the field of medical
applications of ionising radiation
A key priority for radiation protection research in radiation
oncology, nuclear medicine and also interventional and
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diagnostic applications of ionising radiation is to improve
techniques and methods for measurement and quantification.
The research approaches will need to be multidisciplinary and
innovative. The key research questions in measurement and
quantification research are:
Characterisation of exposure
The basic quantity for the characterisation of exposure is the
absorbed dose, so whereever possible dose measurements or
calculations/calibrations should be stated in terms of absorbed
dose (1–3). One of the main challenges for future research is
the pronounced anatomical heterogeneity of (absorbed) doses
within and between critical organs in all areas of medical uses
of radiation. This needs to be supplemented by optimisation of
models and model parameters to translate absorbed doses into
equivalent, organ, biologically effective doses or any other
indirect dose entities. Accurate and precise measurements
with known uncertainty (4, ) are a prerequisite for the adequate
implementation of dosimetric techniques into medical practice
and medical routines, specifically for different types
(qualities) of radiation and levels of spatial resolution.
Therefore, the following issues need to be addressed in
research:
& Calibration of dosimeters for medical applications is cur-
rently performed using secondary standards non-specific
to the radiation fields used in medical application of ion-
ising radiation leading to undefined measurement uncer-
tainties. Therefore, exact measurements require calibra-
tion against radiation fields specific to medical
applications.
& There is a limited availability of dosimeters for use inside
the human body; this implies that currently simulations of
radiation transport and deposition are necessary, e.g. using
Monte-Carlo (MC) methods (6, 7), as is normalising them
to measured quantities.
& Real-time measurement of doses is relevant to reduce
doses to staff. Therefore, the development of specific do-
simeters is required, allowing real-time monitoring, e.g. of
eye structures and extremity/finger doses, from interven-
tional radiology/cardiology and nuclear medicine. The
existing dosimeters are either not for online measurements
or they suffer from technological limitations in terms of
highest dose rates as in pulsed radiation fields or size or
practicability.
& Non-uniform spatial (3D) and temporarily varying (4D)
dose distributions can lead to differences of up to several
orders of magnitude in local dose distributions (8).
Therefore, micro-dosimetric measurement devices and
techniques for use within and between cells, the anatom-
ical structures of organs and the human body are neces-
sary, e.g. for dosimetric use with regard to individual
structures in the eye, the brain and the heart, and also other
organs depending on the basis of future research results.
& Different types of radiation (photons, electrons, protons,
heavy ions, secondary neutrons) are used for and/or asso-
ciated with medical purposes. Correct determination of
doses to and dose-distributions within patients at different
levels of spatial resolution is necessary depending on the
required purpose in terms of radiobiological questions or
optimisation of procedures. Also mixed fields and energy
spectra need to be taken into account for reliable measure-
ments and calculations of dose-distributions.
& Knowledge on track structure and/or microdosimetry
of internal emitters (alpha, beta, Auger) is a prerequi-
site to predict the associated biological effects (9).
Therefore, computational methods need to be further
developed and connected to the results of correspond-
ing research on measurements and calibration proce-
dures (see above).
& Development of updated or alternative quantities and con-
cepts for describing the anatomical dose distributions
within organs, tissues and the body as the basis for
predicting health effects rather than mean absorbed doses
(e.g. dose averaged over an organ) or dose volume
histograms.
& Methodologies have to be developed for determination,
description measurement and calculation of doses outside
the planning target volume (PTV) for radiation therapy,
i.e. the peripheral dose. This is urgently required to build
and optimise prediction models for secondary tumours,
but also tissue effects, and to enable comparison of differ-
ent techniques and/or technologies.
This research would be a prerequisite for the accurate and
precise evaluation of the dose as the basis for better radiation
protection of the patient and medical personnel as explained
below.
Individual dosimetry
Individualised patient dose assessment methods, e.g. by ad-
justed phantoms for measurements (10), size-specific conver-
sion factors, dose measurements taking into account imaging
parameters shielding, etc., are needed to allow for accurate
patient dose estimation (2) and risk assessment (11). Many
dose distributions would depend on individual patient consti-
tution (e.g. size, weight, shape, age and biological factors such
as the distribution and kinetics of radioactive markers () or
susceptibility to different therapeutic procedures). Therefore,
the following dosimetric procedures need to be addressed in
research:
& Development of computational methods for dose distribu-
tion calculations based on patient-specific and equipment-
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specific characteristics for all medical procedures using
ionising radiation, including for example CT, interven-
tional and nuclear medicine procedures as well as
radiotherapeutic procedures avoiding different dose indi-
cators for different types of procedures in order to get
comparable meaningful information about organ doses
of individuals.
& Development of optimal measurement protocols in nucle-
ar medicine for accurate estimation of absorbed doses
using patient-specific and equipment-specific characteris-
tics. Refinement, validation and implementation of new
biokinetic models for dosimetry in molecular radiotherapy
using for example physiologically based pharmacokinetic
(PBPK) models for the individual assessment of
biokinetics (13), including uncertainty budgets (14).
& Development of methods to estimate or measure the actual
delivered radiation dose in radiotherapy.
& Development of a unique dose indicator that describes the
absorbed dose to organs in order to perform risk
assessment.
This research would be essential for accurate and precise
determination and evaluation of indication-, therapy- and/or
subgroup-specific doses and therefore risks of radiation-
induced morbidities of individual patients and thus on a per-
patient basis for better radiation protection of patients and
medical personnel.
Quality metrics for diagnostic imaging and therapy
For the use of quantitative imaging approaches, standardised
protocols for each clinical indication and/or specific disease
common clinical indication need to be developed (15).
Therefore, the following issues need to be addressed in
research:
& Development of dosimetric and image quality metrics to
fully assess the impact of novel detector technologies (e.g.
low or lowest noise as well as energy-resolving detectors)
and image reconstruction methods available for reducing
radiation exposure to the patients. To this end, research is
needed on which requirements (system stability, noise re-
duction, influence of individual patient characteristics, it-
erative reconstruction parameters) have to be met for
quantitative imaging to yield reliable and reproducible
results.
& Measuring methods (e.g. phantoms, reading protocols,
etc.) need to be improved or developed and standardised
to address the improvements in medical technology as
well as new methods, e.g. particle therapy or new molec-
ular imaging technologies.
& There is an increasing need also for quality metrics of
treatment plans to allow easier quality assurance to
facilitate comparability of methods used in radiation ther-
apy and to allow more standardised research regarding
clinical treatment outcomes.
& The concepts and the use of diagnostic reference levels
(DRLs) and achievable dose levels (ADLs) have to be
redefined to meet the requirements of organ-specific dose
distributions or critical organ structures doses.
This research enables the translation of quantitative tech-
niques to widespread clinical use for the benefit of the patient.
In addition, this research is also a prerequisite for the
harmonisation of practices and quality assurance.
Sources and influences of uncertainty
Uncertainties need to be determined for all techniques
described above, be it measurements or computations.
Many components independently contribute to the uncer-
tainty in the determination, reporting and performance of
medical applications and in its characterisation (4, 16). It
is of utmost importance to develop methods to assess the
contributions of different stages in the chain of medical
interventions to be able to define the relevant points of
optimisation, which means putting effort into those parts
of a medical application scheme where there is the highest
benefit. Therefore, the following issues need to be ad-
dressed in research:
& Quantification of the influence and sensitivity of different
parameters (technique dependent, system dependent, pa-
tient dependent, medical staff dependent).
& Development of methodologies for classifying different
influencing parameters and to build a system that allows
the optimisation of medical applications of ionising radi-
ation for individual patients or methods.
Knowledge of the integral uncertainty and its components
is key to identifying the most relevant steps, to allow for
prioritisation and targeted optimisation, thus making more ef-
fective use of clinical and research resources.
Normal tissue reactions, radiation-induced morbidity
and long-term health problems
A key priority for radiation protection research in radia-
tion oncology, nuclear medicine and also interventional
and diagnostic applications of ionising radiation is to im-
prove health risk estimates. The corresponding research
approaches will need to be multidisciplinary and innova-
tive. The key research questions in tissue reactions and
biological risk research are:
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Exposure-associated cancer risk: dose, dose distribution
and dose-rate dependence
Knowledge of the dose dependence of the radiation induction
of primary or secondary cancers, in particular in relation to
dose inhomogeneities and dose rate, is of major importance to
optimise therapeutic efficiency and reduce unwanted side ef-
fects. In radiation oncology, this refers to high doses within the
planning target volume (PTV) as well as to out-of-PTV doses,
e.g. low to moderate doses, in particular in intensity-
modulated and image-guided radiotherapy, but also in brachy-
therapy and molecular (radionuclide) radiotherapy (17). It also
needs to include other, additional treatment modalities, partic-
ularly chemo- and biologically targeted therapy. Diagnostic
procedures must also be considered, especially in view of
interventional or fluoroscopic procedures or nuclear medical
imaging techniques and those applied in preparation for
treatment.
Non-cancer effects in various tissues and radiobiology-based
effect models for individual morbidity endpoints
Radiation-induced morbidity (cancer and non-cancer diseases
and disorders) may be observed early or late (occurring after 3
months to 5 years after radiation exposure), not only in the
tissues and organs exposed to high doses. Also, very late
health effects (occurring after more than 5 years to many de-
cades after exposure) may not only be observed in high-dose
radiotherapy (>5 up to 50 Gy) but also in the intermediate (0.5
to 5 Gy) or low-dose (<0.5 Gy) ranges. Examples of these
very late occurring normal tissue morbidities, which may be
induced by localised radiation exposure outside the planning
target volume of radiotherapy or by repeated interventional
procedures, are: cardiovascular or cerebrovascular diseases,
functional or structural damage to eye structures, various de-
layed, persistent immunological changes, progressive micro-
vascular injuries, but also late and very late developmental and
functional detriments after radiation exposures in diagnostic
procedures and paediatric radiotherapy and many more
radiation-associated health disorders. The contribution of oth-
er treatment modalities, particularly chemo- and biologically
targeted therapy, to the development of very late side effects is
currently poorly understood and needs also to be considered
along with any diagnostic procedures, especially for interven-
tional or fluoroscopic and nuclear medicine procedures and
those applied in preparation for treatment.
Current morbidity risk models and normal tissue compli-
cation probability (NTCP) models are largely empirical or
based on hypothetical data-fitting models of assumed process-
es of damage development and lack the evidence of a mech-
anistic basis. Moreover, they do not consider the influence of
the position of the doses within one organ or the interaction of
dose distributions in “corresponding” organs, such as lung and
heart, or the effect of additional treatments, such as chemo-
therapy (18, 19). These factors, however, must be included to
get appropriate estimates for the patterns of risk of any indi-
vidual patient with regard to modern techniques in radiother-
apy, nuclear medicine and radiological diagnosis.
Individual patient-related radiation sensitivity and early
biomarkers of response and morbidity
The individual sensitivity of patients may be considered in the
choice of specific diagnostic procedures and/or therapeutic
strategies. This can be based on intrinsic factors (age, gender,
genomics, proteomics) of their tumours or different normal
tissues, but also on concomitant diseases impacting on general
or specific normal tissue tolerance, lifestyle (e.g. reduced
lung/liver tolerance due to smoking and alcohol consumption)
or previous/parallel treatments.
In a number of tumours, biological factors affecting radio-
sensitivity, i.e. predictive factors, such as local hypoxia, tu-
mour heterogeneity, or viral infections, were identified. Such
investigations need to be extended and may also consider the
early response of the tumour to a specific treatment. Imaging
biomarkers of tumour radiosensitivity are needed in this con-
text, as well as biomarkers of morbidity, which can be identi-
fied before or early in the treatment phase and may help in the
selection of the adequate treatment of the individual patient.
These have so far been rarely studied. However, patients with
a high risk for a certain, severe, morbidity symptom may re-
quire a change in dose distribution or in treatment strategy, or
follow-up protocols may need to be adjusted to the individual
morbidity risk pattern based on early biomarker expression ().
Radiobiological mechanism of radiation-induced side effects
and protective strategies
The radiobiological molecular mechanisms of radiation-
induced morbidities in normal tissues and organs are very
complex and vary between different signs and symptoms of
morbidity in the same organ and between different organs.
Also the tumour responses to therapeutic exposure to ionising
radiation, including radiotherapy using hadrons, are currently
largely unknown. The radiobiological molecular mechanisms
are even more complex for combined radiotherapy and
chemo- or biologically targeted treatment strategies. These
mechanisms need to be clarified for specific clinical morbidity
endpoints in order to develop specific strategies for protection,
mitigation or management of the clinical consequences of
exposure. They are even more important for medical radiation
procedures in paediatric patients given the evidence showing
that the complexity and severity of morbidities and develop-
mental injury and the risks of therapy-induced malignant dis-
eases are particularly high after radiotherapy (in almost all
instances in combination with chemotherapy).
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Similarly, novel strategies for improving the diagnostic
and/or therapeutic efficacy for the application of ionising ra-
diation may be based on the synergistic combination with
upcoming technologies such as combinations with high-
intensity focussed ultrasound and biology-based approaches
relying on tumour genomics, proteomics or metabolomics in-
cluding local enhancement of drug delivery.
Both the protective and sensitising strategies need to be
established and validated in preclinical as well as in subse-
quent clinical studies. These investigations need to focus on
the efficacy of the novel approaches and also on their selec-
tivity for the respective target tissue to guarantee a therapeutic
gain.
Optimisation of radiation exposure and harmonisation
of practices
According to the European Basic Safety Standard (BSS)
(2013/59/EURATOM) (21), the radiation protection of indi-
viduals subject to public or occupational exposure must be
optimised with the aim of keeping the magnitude of individual
doses, the likelihood of exposure and the number of individ-
uals exposed as low as reasonably achievable (ALARA) tak-
ing into account the current state of technical knowledge, eco-
nomic and societal factors. The optimisation of the protection
of individuals subject to medical exposure should be consis-
tent with the medical purpose of the exposure.
The EU Directive on patients’ rights in cross-border
healthcare (2011/24/EU) (22) calls for a concerted strategy
in terms of harmonisation of clinical practices, meeting pa-
tients’ expectations of the highest quality healthcare, including
when they seek treatment away from home.
According to the literature, high variability of mean effec-
tive doses or organ doses of patients across Europe persists
across all medical ionising radiation procedures and is seen
across single countries, hospitals or even at the departmental
level (23), despite technological developments facilitating re-
ductions in patient dose, thus highlighting the importance of
harmonisation of ionising radiation procedures and the devel-
opment of new and more efficient optimisation methods in-
cluding evaluation criteria. For this optimisation, there needs
to be a general definition as to what is an acceptable level of
quality, what kind of optimisation should be performed and
what is the optimal level. With the main goal of maximising
the clinical outputs of the procedures while minimising the
exposure of patients and staff, the key research questions are:
Patient-tailored diagnosis and treatment
The comprehensive tailoring of imaging and therapeutic pro-
cedures in terms of the clinical question, anthropometric and
physiological parameters of each patient, especially children,
and lesion-specific characteristics is a key challenge that is
largely yet to be fully addressed. Furthermore, imaging is
essential to patient-tailored therapy planning, therapy moni-
toring and follow-up of disease, as well as targeting non-
invasive or minimally invasive treatments, especially with
the rise of theranostics (combination of diagnostic and thera-
peutic procedures to optimise treatment).
For the reasons given above, and in view of reducing radi-
ation exposure to the patients by individually tailoring their
diagnosis and treatment, research needs to be conducted with
regard to the following currently unresolved issues:
& Development of quantitative imaging biomarkers for each
common clinical indication and/or specific disease/organ
and their standardisation with regard to required image
quality in conjunction with related radiation exposure.
& Recent advances in imaging using specific radiotracers
will provide additional tools for better characterisation of
a lesion at the molecular level. This will provide an insight
into lesion heterogeneity and targeting, with perspectives
in guiding biopsy of lesions, prediction of treatment re-
sponse and image-guided therapy.
& For optimal treatment prescription in targeted radiothera-
py the knowledge of the dose-response relationship is es-
sential. In targeted radiotherapy, patient-specific dosime-
try is essential for both the prediction of the adverse events
of a treatment and of the tumour response (24).
& Research on the requirements that have to be met for
quantitative imaging to yield reliable and reproducible re-
sults, e.g. in view of system stability, image reconstruction
techniques, influence of individual patient characteristics
and applied radiation exposure.
& Development of approaches for low-dose time-resolved
volumetric imaging (4D), e.g. of blood flow or volume
distribution (perfusion) as well as organ-motion depen-
dent imaging, especially in view of therapy planning and
treatment response imaging.
& Development of body-mass index (BMI)-specific image
acquisition protocols and specific dose-reduction algo-
rithms for obese patients, since obese patients require
higher than average radiation doses, and exploitation of
techniques normally used for radiation exposure reduction
to achieve diagnostic image quality.
& Development of approaches for low-dose treatment re-
sponse and follow-up imaging solely focussing on the
detection of “change” (relative to a standardised baseline
acquired at higher radiation exposure) providing reliable
diagnostic assessment, e.g. through development of
standardised disease- or treatment-specific imaging proto-
cols especially for those patients frequently imaged.
& Research for identifying underlying relationships among
demographic, disease-related and ‘omics’ biodata and im-
age and treatment data for fully developing personalised
medicine in order to offer the best medical diagnostics and
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treatment associated with the lowest possible dose to each
individual patient.
The benefit of this research could be to develop systems for
diagnosis and treatment allowing for more efficient treatment
techniques, which may also offer economic benefits. This re-
search could also provide further insights into disease process-
es of individual patients and therefore foster precision
medicine.
Full exploitation and improvement of technology
and techniques
Despite the potential for the exponential growth in the tech-
nological features of medical imaging equipment to decrease
patient doses, such benefits are not always realised in daily
clinical practice (25).
Therefore research on development, improvement, clinical
applicability and full clinical exploitation of (new) technology
and techniques for offering diagnosis and treatment delivery
associated with the lowest technically possible radiation ex-
posure to the patients is required. In this context, currently the
following topics need to be addressed by research:
& Low-dose CT imaging enabled by low tube potentials and
current-time products in view of its clinical applicability,
indication, standardisation as well as its potential diagnos-
tic and technical limitations.
& Novel image reconstruction techniques enabling low- or
lowest-dose image acquisitions, with regard to their rou-
tine clinical applicability and their limitations in view of
ensuring diagnostic accuracy and reliability.
& Novel detector technology in medical imaging in view of
its clinical applicability and potentially associated techni-
cal limitations.
& Diffraction enhanced imaging and other newly developed
approaches.
& Further development, implementation and application of
patient- and disease-adapted techniques and protocols of
combined modalities as for example SPECT/CT (26),
PET/CT, PET/MRI and LINAC-MRI.
& Optimisation of image guidance procedures in
radiotherapy.
& Strategies for a reduction in peripheral doses in radiother-
apy, e.g. by defining indications for ion therapy.
& Research for, and production of, novel radionuclides and
radiopharmaceuticals for either improving diagnostic and
therapeutic outcome or reducing associated exposure.
& Data-crawling and -mining approaches based on large-
scale data contained in imaging and treatment biobanks,
e.g. for extracting indication-specific acquisition or treat-
ment protocol parameters along with associated patient
exposure data for the purposes of diagnosis and treatment
optimisation, standardisation and harmonisation (through
the definition of European DRLs) as well as for extraction
of higher-order patterns of disease, its diagnostics and
treatment along with associated doses, and the possible
interrelation of this data, e.g. to genomic data
(radiogenomics).
While research with regard to technology development may
remain basic research that is institution- or manufacturer-
driven and controlled, though requiring and relying on input
and feedback from medical research and routine clinical appli-
cations, research on clinical applicability, improvement and
full exploitation of technology and techniques enabling radia-
tion exposure reduction is driven by, and requires, active med-
ical research in the fields of radiological diagnosis and radio-
pharmaceutical and therapeutic treatment. There needs to be an
emphasis on the close link between technology developments
at research institutions, especially at manufacturers’ sides, and
the clinical research facilities with feedback options and espe-
cially to define a process to consolidate the achievements in
terms of harmonisation.
Any optimisation inmedical imaging techniques, including
dose reduction strategies, must be evaluated thoroughly in
terms of the resulting image quality. In determining whether
an image is diagnostic or fit for purpose, it is important to take
into account not only the physical measurements of image
quality [e.g. signal-to-noise ratio (SNR), modulation transfer
function (MTF) and detector quantum efficiency (DQE)] but
also to include psychophysical methods (e.g. contrast detail
assessment and spatial resolution assessment) and clinical,
diagnostic performance approaches such as visual grading
analysis (VGA), receiver-operating characteristic (ROC) and
psychometric scales. The current variability and absence of
validated approaches and guidelines represent a significant
barrier to effective optimisation research. The 1996
European Guidelines on Quality Criteria for Diagnostic
Radiographic Images (27) aimed to provide some assistance
with image quality assessment but these were very limited,
have deficiencies, were never validated and are now dated.
There is thus an urgent need for establishment of robust, val-
idated approaches to facilitate this critical aspect of optimisa-
tion research.
Technologically meaningful developments, with re-
spect to the possible output for patient, staff and public,
are at varying levels of maturity in terms of a technologies
status as a product line and their applications in the med-
ical environment.
In this context, multi-professional engagement together
with educational institutions and equipment manufacturers
will facilitate the required development of strategies for the
harmonisation of ionising radiation procedures and standards
of practice, since several studies have highlighted the hetero-
geneous use of technology and the unanticipated patient and
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staff dose increases. This is of particular importance in paedi-
atric populations as well as for patient cohorts requiring mul-
tiple consecutive diagnostic, radiopharmaceutical or therapeu-
tic procedures.
Clinical and dose structured reporting
Clinical reporting: Medical imaging procedure workflow in-
volves several steps, ending with a clinical report. Currently,
medical imaging reports are often presented with little or no
structure to the text. This can present difficulties in under-
standing the content of the report for both referring physicians
and patients. The development of a structured reporting sys-
tem will improve the clinical outcome of a medical imaging
procedure, by focussing on the essential message, in a
harmonised way, thus facilitating the communication process
along the clinical pathway of the patient.
There are many advantages of such reports, including im-
proved follow-up for returning or chronic patients, easy re-
trieval of pertinent information enabling clinical and transla-
tional research, integration of the information in imaging
biobanks and automated translation.
Another related issue is the lack of a centralised med-
ical databank on imaging procedures for each individual
patient on a national and European level, often leading to
unnecessary repeated diagnostic procedures and hence un-
necessary radiation exposure. Harmonisation of clinical
reports could facilitate the development of such a
centralised medical registry at a European level. Also, a
centralised dose data collection algorithm for therapeutic
procedures would allow for improved analyses of dose-
effect relationships for adverse events, including stochas-
tic radiation sequelae.
Dose reporting: Structured dose reporting in radiation di-
agnostics and therapy (or documentation of administered
activities in nuclear medicine) is a growing area of focus
and will benefit all professions directly involved in the
ionising radiation procedures and patients undergoing
such procedures in the years to come. However, the ade-
quate specification of dose distributions has not been ad-
dressed yet in research and clinical practice sufficiently
(1). In radiation oncology structured dose reporting needs
to address absorbed doses in organs at risk and/or at their
subvolumes, relevant for adverse event endpoints. The
latter needs to be specified and their scaling to be defined.
Moreover, anatomy-related dose distributions in the irra-
diated volume and in the periphery, at least down to the
1% isodose, need to be reported or re-constructible from
the documented treatment information and then specifical-
ly related to potential radiation sequelae.
The main benefits would be:
& To establish a model for providing information, in radia-
tion diagnostics and nuclear medicine, about patient dose
exposure in an easily accessible way (e.g. by integrating
visual scales for the referring physicians to understand the
level of exposure).
& To facilitate the rapid determination of local, national and
European DRLs.
& To facilitate establishment, in radiation oncology, of dose
response relationships for adverse events in organs at risk
as well as for stochastic radiation effects both close to the
PTVand in the periphery of the patient.
Structured dose reporting in radiation diagnostics (or doc-
umentation of administered activities in nuclear medicine) is
an essential tool for the harmonisation of the dose manage-
ment systems and the comparison of doses, creating a com-
prehensive, common language for health professionals.
Structured dose reporting in radiotherapy is essential to estab-
lish firm dose-effect relationships for adverse deterministic
and stochastic events.
Protection of staff, patients, carers and the general public
Aside from the optimisation of protocols and procedures, their
standardisation and their personalisation, it is most important
to optimise radiation protection using existing radiation pro-
tection measures (28). To optimise radiation protection in
terms of applicability and best benefit for staff and patients,
the establishment of key indicators of safety and quality in
radiation protection is essential according to the general
ALARA principle discussed before. The primary goal of the
development of safety programmes is to reduce morbidity
risks from excessive exposure to ionising radiation for specific
procedures and populations, e.g. interventional radiology and
the paediatric population. Another focus is on cost-benefit
analysis of the implementation of radiation protection devices
and safety programmes. Neither proven criteria of cost nor
proven criteria of benefit have been established so far.
Research must explore both external and internal radiation
exposure and their associated protection measures.
Justification of the use of ionising radiation in medical
practice
The principle of justification is one of the key pillars of radi-
ation protection underlined in the recently revised European
BSS Directive (21). This principle focusses on weighing the
benefits versus the risks. Further important elements are pa-
tient communication, as the basis for shared decision-making
including the patient rights for influencing the decision, as
well as the appropriateness of the radiological procedure with
respect to the clinical setting. The key research questions in
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research into the justification of the use of ionising radiation in
medical practice are:
Benefit/risk assessment and communication
While the clinical benefit of a diagnostic or interventional
imaging procedure is assumed to be established, an estimation
of the risk related to effective dose exposure for a given patient
is a difficult step because the current estimations are for a
general population. The current uncertainties in this area make
the establishment of a reliable benefit/risk assessment virtually
impossible.
Therefore there is the urgent need for research aimed at risk
estimation for an individual patient. However, it is unclear
how this can be implemented for the stochastic mechanisms
based on epidemiologic data. Increased risk factors for organ-
specific patient groups or patient-parameter-based changes on
optimal imaging procedure setups may however be investigat-
ed. For the development of such a research programme for
diagnostic imaging and interventional procedures, reference
to a centralised repository of imaging data would be an im-
portant resource for data mining and the following risk assess-
ment (see Sects. 3.5.1 and 3.5.2).
The proposed research will have a direct benefit for the
patient in general and especially in the context of screening
methods based on the use of ionising radiation.
Most new therapeutic radiation technologies are clinically
introduced to reduce exposure to healthy tissue. In the near
future, an increasing number of cancer patients will be treated
with particles (e.g. protons and carbon ions). Although parti-
cle therapy will result in lower dose levels to many critical
structures as compared to the currently used photon-based
technologies, the consequences in terms of reduction of late
and very late side effects remain to be determined and have to
be weighed against the higher costs.
In the context of the current drive for patient empowerment
and involvement in the decision-making process, the develop-
ment and subsequent evaluation of novel tools for patient
communication have become necessary. Some professional
organisations such as the ACR, ESR, RSNA and national
clinical societies have developed communication guidelines
and platforms for diagnostic imaging; however, a unified ap-
proach regarding methodology and content is currently
missing.
The proposed research work will aim to develop a
European evidence-based electronic communication platform
focussing on all types of diagnostic imaging using current
information technology that is endorsed by the relevant pro-
fessional organisations, patient organisations and other rele-
vant stakeholders. The European platform will be designed in
a way to allow for localisation and adaptation to the national/
regional settings. The establishment of such a system has to be
based on the successful completion of the cost-benefit re-
search activities outlined above.
Improvement of use of evidence-based guidelines
Clinical imaging guidelines are intended to help physicians
decide when an imaging study would be useful and identify
the most appropriate examination for a particular patient. In
recent years, imaging guidelines, in view of the referral pro-
cess, have received much attention from the radiation protec-
tion community and international organisations given the in-
creasing number of medical imaging procedures and studies
that have shown that about 30% of the imaging procedures
performed in Europe were found to be inappropriate (29). The
recently revised European BSS Directive (27) requires that
clinical imaging guidelines are available in all EU Member
States.
In 2011, the European Commission awarded a European
tender project to assess the availability and implementation of
clinical imaging guidelines in EU member states. One of the
key conclusions, also highlighted in subsequent studies, was
the recommendation that the awareness and use of clinical
imaging guidelines in Europe need to be improved and novel
approaches are needed for that purpose (30).
The proposed research work should identify and develop
methods to improve the use of clinical imaging guidelines in
Europe especially in view of the referral process at large, e.g.
through incentives, regulatory requirements, IT tools, etc. The
research work is related to a key priority in medical radiation
protection as outlined among others in the Bonn Call for
Action (31) and must be relevant for all diagnostic applica-
tions of ionising radiation. To define the proposedmethods, an
evaluation and impact assessment of the use of currently
existing European and national guidelines must be performed
with an emphasis on evaluating the usability of the guidelines
and their impact on daily clinical practice (29, 32).
The outcome of the proposed research work should be a
European recommendation paper on how to improve the dis-
semination, integration into the clinical workflow and use at
large of clinical imaging guidelines in view of the referral
process. In addition methodologies and guidelines for adop-
tion/localisation/adaptation of the guidelines need to be
proposed.
The recommendation paper shall serve as guidance for pro-
fessional societies and policy-makers in Europe.
Infrastructure for quality assurance
To perform investigations on tissue reactions, optimisation
procedures as well as risk and benefit evaluations, it is
important to rely on optimal, quality assured data, which are
gathered under defined conditions and which are necessary for
various reasons including legal questions pertaining or
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specific to the research to be performed. In addition, the
clinical system of medical applications of ionising radiation
has to be standardised (33) and evaluated concerning its effec-
tiveness in radiation protection.
Data coding, collection and management
It is crucial for the future of medical imaging in Europe to
develop a European medical imaging coding system
(EMICS) including radiology and nuclear medicine imaging
procedures. EMICS should apply to all medical procedures
based on ionising radiation, giving policy makers and
healthcare providers an objective and clear view, on a
procedure-level basis, at the national and EU levels. This
would be a fundamental tool for future studies such as popu-
lation dose studies and/or parameter-dependent image quality
studies. According to the recently published Dose DataMed 2
report “in order to compare x-ray examination frequency data
between countries, and to assign typical effective dose values
to examinations, it is crucial that an ‘X-ray examination’ is
defined and counted in a consistent way” (34). Therefore, the
development of EMICS, based on an alphanumerical code
structure, must be facilitated and must be integrated into all
HIS/RIS systems.
EMICS would also support the harmonisation of the “lan-
guage” for medical imaging and therapy across Europe giving
healthcare providers a powerful tool for the future planning of
health systems at local, regional, national and European
levels. This should be extended to the acquisition of data on
the long-term consequences of radiation exposure, diagnostic
or therapeutic, potentially in combination with other therapeu-
tic procedures, to allow structured long-term follow-up, as-
sessment and documentation of treatment-related morbidity
and the possibility to relate morbidity to anatomical dose dis-
tribution. Requirements and structures, along with administra-
tive characteristics, including data protection issues, need to
be defined. Such data management structures will provide a
basis for epidemiological investigations into relevant medical
questions. Data should be collected throughout Europe ac-
cording to this standard using defined mandatory and where
possible additional data regarding exposure and if possible
image quality as well as certain patient-specific data.
Comprehensive medical database/imaging biobank
Biobanks are repositories for the storage and retrieval of bio-
logical samples of a large number of subjects. A major goal of
biobanks is the organised collection of biological material and
associated information to spread access among scientists re-
quiring this information. Extending this concept to medical
imaging and especially to radiation protection is needed to
collect radiation protection metrics and to allow for long-
term follow-up for specific cohorts, which will be called a
comprehensive medical database or imaging biobank. It might
be important for various reasons:
Importance for dose collection: The concepts and the use of
DRLs and achievable dose levels (ADLs) have to be redefined
to meet the requirements of organ-specific dose distributions
or critical organ structure doses as mentioned in Sect. 3.1.
Large-scale (national, regional) patient inter- and intra-organ
dose distribution monitoring is necessary for the purpose of
definition, optimisation and periodic assessment of DRLs and
ADLs. This aim can be achieved by developing large-scale
archives and automatic data analysis using the recently devel-
oped standards allowing sending and archiving of dose
information.
The development of automatic methods for phantom image
quality assessment (and patient image quality assessment) to-
gether with the use of advanced IT technologies (e.g. large-
scale archives, data-mining methods, expert system tech-
nique) is required for supporting users in the optimisation
process.
Importance for long-term follow-up of cohorts: There is clear
evidence that radiotherapy may cause, in organs and tis-
sues close to the PTV but also in organs in the periphery,
an increased risk for late and very late side effects that are
clinically relevant and have a major impact on quality of
life. Although there is an increasing awareness of
radiation-induced very late side effects, the infrastructure
to systematically collect relevant data to get more insight
in the factors that contribute to these risks is largely
lacking.
The proposed research work should involve the develop-
ment of a structure for a European imaging biobank infrastruc-
ture integrated with a European radiation oncology biobank
infrastructure.
Developing key performance indicators for quality and safety
Key performance indicators (KPIs) have been successfully
introduced as a performance measurement in many areas of
healthcare in line with the EU Agenda on Quality of Health
Care and Patient Safety put forward by the EC DG SANTE.
Currently there is no recognised gold standard in the fields of
medical imaging or radiation therapy. A general concept of
performance indicators for imaging and radiation therapy is
thus needed and should also include indicators for the safety
of patients and of procedures and how to maintain safety stan-
dards, according to the optimisation and justification
processes.
The proposed research work will consist in the establish-
ment of KPIs for the quality achieved regarding specific med-
ical procedures and in general terms of radiation protection
and harmonisation at the European level. For integration into
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the workflow, pilot studies in dedicated centres and impact
assessment before dissemination are envisaged.
Audit systems
Clinical audit is a tool designed to improve the quality of
patient care, experience and outcome through formal re-
view of systems, pathways and outcome of care against
defined standards, and the implementation of change
based on the results. Audit cannot be carried out without
a preset standard against which performance can be
assessed.
As laid down in the revised European BSS Directive (21),
Member States shall ensure that clinical audits are carried out
in accordance with national procedures. Clinical audit is a
relatively new concept in radiation protection. It seeks to im-
prove the quality and outcome of patient care through struc-
tured review of medical radiological practices, procedures and
results, whereby these are examined against agreed standards
for good medical radiological procedures, with modification
of practices, where appropriate, and the application of new
standards if necessary.
In October 2009, the EC published guidelines relating
to clinical audits for radiological practice, including all
investigations and therapies involving ionising radiation
(35). In spite of this document, clinical audit is still clear-
ly underdeveloped in Europe. To address this shortcom-
ing, the proposed research must aim to develop an easy-
to-use, cost- and time-effective European clinical audit
tool taking into account existing initiatives from profes-
sional organisations. The tool will facilitate implementa-
tion of the relevant requirements in the European BSS
Directive and could potentially provide the basis for fu-
ture European accreditation processes based on quality
and safety.
Education and training metrics
There is a strong demand for new education and training
models in medical radiation protection because of the rapid
development of medical techniques based on ionising radia-
tion, growth of hospitals and the continuous need to produce
competent health professionals. The major challenge is ad-
dressing the variety of professions and professionals, with
different knowledge background and different needs, but all
working towards the same objective: patient and staff safety
(36, 37).
To achieve that objective it is necessary to establish a
harmonised and sustainable safety culture in radiation
protection amongst health professionals through
specifically oriented education and training courses.
External assessment of the quality of education or
training provision is needed (37) and should be provided
by a European accreditation body.
It is important to develop through research:
& A metric system to measure the knowledge, skills and
competence outcomes from education and training in ra-
diation protection for the different health professions in-
volved in ionising radiation procedures.
& An assessment system to measure:
– the impact of the implementation of a continuous profes-
sional development model for education and training in
radiation protection;
– the type of needs for education and training, considering
the installation of new equipment and/or new procedures.
There is a need to create a European certification system for
education and training in radiation protection, based on the
development of standards of proficiency for health profes-
sionals, as an instrument to guarantee safety procedures to
European citizens, through harmonisation of practice through
education and training.
Education and training
As highlighted in the recent EC Radiation Protection No. 175
‘Guidelines on radiation protection education and training of
medical professionals in the European Union’ there is a con-
tinuing and growing need for high-quality education and train-
ing in the field to ensure the radiation protection of patients,
staff and the public. This education and training must be ac-
cessible and delivered at an appropriate level for all profes-
sionals working in the field of medical ionising radiation as
well as those utilising the services provided by medical ionis-
ing radiation professionals. EC Radiation Protection No. 175
came about as an outcome of the MEDRAPET project and
describes education and training in radiation protection using
the European qualifications framework (EQF), knowledge,
skills and competence (KSC) structure and European credit
transfer system (ECTS) (38).
It is essential that any research in the area of medical ion-
ising radiation is translated into clinical practice to ensure that
patients and staff see the direct benefits of this research. As
highlighted in Sects. 3.3 and 3.4 of this SRA, there is evidence
that this translational research often fails because of the ab-
sence of parallel education and training programmes. High-
quality education and training programmes will raise aware-
ness of ongoing EU research projects and initiatives and en-
sure their uptake into clinical practice at local, national and
European levels. Separately, there has been an identified need
to also develop high-quality education and training
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specifically for researchers to help strengthen the medical ion-
ising radiation research community.
Education and training may consist of traditional, face-to-
face lectures and practical sessions but should also focus on
becoming more clinically focussed and case based. Online, or
e-learning, approaches to the delivery of content at all levels
utilising mobile devices is a key consideration, which includes
the development of dedicated appropriate e-learning tools, e.g.
facilitated by a multidisciplinary European e-learning
platform.
Education of staff
In the former chapters necessary and relevant topics for re-
search related to the optimal use of ionising radiation and
radiation protection in medical applications have been ex-
plained. Also, measures have been mentioned concerning
how these optimisation have to be implemented throughout
European by means of standardisation and harmonisation.
However, it is obviously not sufficient just to define methods
for harmonisation but this has to be reflected within the edu-
cation of the staff (28, 39).
This education needs to reflect the basic aspects of:
& radiation physics,
& radiation biology,
& radiation protection,
& radiation communication and
& specific parts for the procedures/areas that are supposed to
be covered by the staff.
Therefore, within this SRA it is proposed to develop a
standardised education rule describing topics that have to be
covered. In addition there is a need for securing the highest
level of knowledge transported reflecting state-of-the art tech-
nology as well as standardisation and harmonisation efforts.
Finally, establishment of a European certification approved by
the medical societies issuing this SRA should also be covered,
not only after the completion of initial training, but also
throughout the whole professional life of each professional.
Education of researchers
To provide valuable research dealing with these identified
relevant topics with potential impact, it is important to
perform well-founded and structured research along cer-
tain lines. To do so, it is also necessary to train re-
searchers in performing research according to the best
practice. This especially holds true for research working
with humans or biological material, but also with any data
related to humans. There has to be a standardised training
structure also reflecting the actual state of the art for re-
search procedures with the goal of fostering the efficiency
of projects reflecting the research topics identified above
especially in terms of optimal patient care and radiation
protection.
In this respect it is important to deal with best practice
regarding:
& literature and citation practices;
& statistical power of investigations;
& uncertainty budget calculation of measurements and cal-
culations/simulations;
& clear hypothesis-driven project definition;
& pre-research feasibility estimates of proposed outcomes.
ACR, American College of Radiology; ADLs, Achievable
Dose Levels; ALARA, As Low As Reasonably Achievable;
ALLIANCE, European Radioecology Alliance; BMI, Body-
Mass Index; BSS, Basic Safety Standard; CT, Computed
Tomography; CONCERT, European Joint Programme for
the Integration of Radiation Protection Research; DE, Dual-
Energy; DRLs, Diagnostic Reference Levels; EANM,
European Association of Nuclear Medicine; EC, European
Commission; ECTS, European Credit Transfer System;
EFOMP, European Federation of Organisations in Medical
Physics; EFRS, European Federation of Radiographer
Societies; EMICS, European Medical Imaging Coding
System; EQF, European Qualifications Framework; ESR,
European Society of Radiology; ESTRO, European Society
for Radiotherapy and Oncology; EU, European Union;
EURADOS, European Radiation Dosimetry Group;
EURAMED, European Alliance for Medical Radiation
Protection Research; HIS, Hospital Information System; IR,
Interventional Radiology; IT, Information Technology; KPIs,
Key Performance Indicators; KSC, Knowledge, Skills and
Competence; LINAC, Linear Accelerator; MC, Monte
Carlo; MEDRAPET; Medical Exposures Directive’s
Requirements on Radiation Protection Training of Medical
Professionals in the EU; MELODI, Multidisciplinary
European Low Dose Initiative; MRI, Magnetic Resonance
Imaging; NERIS, European Platform on Preparedness for
Nuclear and Radiological Emergency Response and
Recovery; NTCP, Normal Tissue Complication Probability;
OPERRA, Open Project for European Radiation Research
Area; PBPK, Physiologically-based Pharmacokinetic; PET,
Positron Emission Tomography; PTV, Planning Target
Volume; RIS, Radiology Information System; RSNA,
Radiological Society of North America; RTD, Research and
Technological Development; SPECT, Single Photon
Emission Computed Tomography; SRA, Strategic Research
Agenda; TCP, Tumour Control Probability
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1. FOREWORD 
The NERIS Platform (The European Platform on Preparedness for Nuclear and Radiological Emergency 
Response and Recovery) was established in June 2010 in Helsinki. The vision of the Platform was published 
in 2011 (http://www.eu-neris.net/). The Platform was established to be a forum where joint European 
arrangements for nuclear and radiological emergencies can be developed and improved in the future. The 
Platform addresses all notable trends, arrangements and capabilities in the area of response to and recovery 
from nuclear and radiological emergencies. 
Since August 2012, the NERIS Platform is registered as a legal association under the French Law of the 1st of 
July 1901. Today, the NERIS association comprises 49 organisations, with 21 supporting organisations and is 
driven by a management board of 10 organisations. The participating organisations represent stakeholders 
with a wide range of backgrounds, e.g. authorities, emergency centres, research organisations and the 
academic community.   
The main objectives of the NERIS Platform are to improve the effectiveness of current European, national 
and local approaches for preparedness concerning nuclear or radiological emergency response and recovery, 
promote more coherent approaches in Europe through the establishment of networking activities, maintain 
and improve know-how and technical expertise among all interested stakeholders in Europe by developing a 
supranational training programme, and to identify needs for further research and development and address 
new and emerging challenges. 
The Platform intends to enhance confidence in the solutions, reduce overlapping work, produce savings in 
total costs of research and implementation, and make better use of existing competences and research 
infrastructures in Europe. 
The NERIS Strategic Research Agenda (SRA) provides the basis for priorities regarding R&D (research & 
development), in particular the Key Topics to be dealt with in order to achieve the Vision. This document 
therefore communicates the future research & development needs, but will also be an instrument for 
creating synergies, co-operation and coordination internally between the NERIS participants and externally 
with activities taking place within the European Joint Programming for Radiation Protection Research and 
within other international forums. 
2. INTRODUCTION 
A total of 183 nuclear power reactors are operational in Western, Central and Eastern Europe today [1], as 
well as many other nuclear facilities, such as research reactors. In addition to this, transports of radioactive 
materials are organized on a regular basis throughout European countries. Being aware that every man-made 
facility, equipment or activity is always at risk for malfunction or an accident, it is more than likely that bigger 
or smaller nuclear or radiological incidents and accidents may happen in the future. Significant efforts for the 
safety of nuclear installations in Europe have been achieved, but when the risk comes true it will have 
multidimensional consequences in the society. The accident at the Fukushima Daïchi nuclear power plant has 
reinforced the concern of all stakeholders on this issue and called for an improvement of the safety as well 
as the preparedness for managing short and long term consequences of nuclear events. Furthermore, it 
demonstrated that accidents at large distances from Europe, 448 nuclear power reactors are operational 
worldwide [1], call for response within Europe to protect European Citizens in the affected regions, to provide 
assistance to the affected countries and to monitor economic activities such as the import of foods or 
contaminated goods. 
Apart from nuclear facilities, there are thousands of smaller installations using radioactive sources and 
materials. Of course, incidents and accidents in connection with these facilities would have more limited 
radiological consequences compared with big nuclear facilities. However, sources could possibly be stolen or 
bought by persons with malicious intent and purposely applied in devices designed to harm people and 
create anxiety and disruption. These possibilities stress the links between safety and security issues.  
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Nuclear and radiological safety and security have common goals. In the past 25 years, major progress has 
been made at the International, European, national and regional levels in the management of response to 
and recovery from nuclear and radiological emergencies. Notwithstanding the provisions now in place in 
most European countries and internationally, complacency would be misplaced and continuing vigilance 
remains important.  Improvements, of a technical, organisational or political nature supported by important 
R&D efforts are still needed in emergency management. In addition, general technological evolutions such 
as the increasing computer power, the growth of social networks, big data and the availability of low cost 
radiation monitoring capabilities bring challenges for emergency management, not existing a decade ago.   
The accident at the Fukushima Daïchi nuclear power plant in Japan in March 2011 proved that an event 
regarded as almost impossible was possible and a very small risk became reality. The Fukushima accident 
also demonstrated that consequence assessments and actions were needed also in Europe although the 
accident itself happened far away. In connection of remote accidents, European authorities and decision 
makers have to react to protect their own citizens staying close to the accident site. The more coherent the 
decisions are in different European countries the more confidence they arouse among the public.  
Europe is a heterogeneous array of independent and sovereign countries having different cultural and 
political background and polity. The countries also have different threats as far as nuclear or radiological 
emergencies are concerned depending on their geographical location and distance from major nuclear 
installations. Therefore attempts to implement Europe-wide arrangements, in operational way, in the use of 
compatible systems and tools in radiation monitoring, decision making, and in communication between 
different actors is very complex. Interactions with scientific, technologic, economic and social areas and 
involvement of competent authorities at national and European levels are necessary. Thus, a full set of 
competencies is needed to address the challenges of conducting necessary actions in a nuclear or radiological 
emergency and recovery at local, national, regional and European levels.  
R&D in the field of nuclear emergency preparedness, response and recovery including different disciplines is 
in the above mentioned context of utmost importance to further improve the operational management of 
nuclear and radiological threats. 
3. FRAMEWORK OF THE STRATEGIC RESEARCH AGENDA (SRA) 
An integral part of the mission of NERIS is to identify gaps and needs for further research and developments 
and addressing new and emerging challenges in the field of preparedness for nuclear or radiological 
emergency response and recovery. The Strategic Research Agenda (SRA) of NERIS, coordinated by the NERIS 
R&D Committee, identifies the research areas and topics important for improving the nuclear and 
radiological emergency management in the preparedness, response and recovery phase of an accident. An 
overview of the different phases considered and related terminology used within the SRA is given in Figure 1. 
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Figure 1. The different phases and terminology used in emergency management and recovery. It has to be noted that different phases can take place in different locations at the same time, and 
some phases can be missing depending on the nuclear or radiological event. (Terminology adopted in General Safety Guide GSG-11, IAEA in blue/ Terminology adopted by ICRP in green
Declaration of Emergency End of Emergency Response phase Termination of Emergency 
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The NERIS SRA has a clear focus on off-site emergency preparedness, response and recovery. However, it 
does not exclude links with on-site emergency preparedness and response. Emergency management has 
many different perspectives. As NERIS is a radiation protection platform, this SRA focuses on the radiation 
related aspects of nuclear and radiological emergency management, but also includes non-radiological 
aspects such as socio-economical and ethical factors, not excluding links with other perspectives. 
The following threats were identified. These are in general considered as potential nuclear and radiological 
events for which emergency preparedness, response and recovery is required: 
} Incidents and accidents (including criticality accidents) in Nuclear Installations (Power generation, 
research reactors, etc.)  
} radioactive waste repositories; 
} Transport accidents of radioactive material; 
} Lost/orphan sources; 
} Terroristic threats involving radioactive material/ionizing radiation; 
} Military installations and operations (including submarines); 
} Satellite re-entry with radioactive sources; 
} Other events involving the non-controlled exposure or spread of radioactivity (Hospitals, Medical & 
Industrial Isotope Production Facilities, Space Weather, etc.). 
Decision support systems, such as ARGOS and JRODOS have been developed over the past decades and are 
regularly updated with new tools, developments and demands from end-users. They focus on simulation 
models for all phases of an emergency, impact assessment, countermeasure strategies, consequence 
assessment and application at various levels of decision making (local to national). Stakeholder engagement 
related to the evaluation of countermeasure strategies is an important aspect for the realisation of 
management options in the simulation models.  
3.1. Process of development of the Strategic Research Agenda (SRA) 
A short history of the NERIS SRA development is given in Annex 1. The current version of the NERIS SRA is 
based on: 
} Discussions within the NERIS R&D Committee meetings. The current composition of the NERIS R&D 
Committee can be found on the NERIS website (http://www.eu-neris.net/ ); 
} Results and insights gained by past and running European projects: NERIS-TP [4], PREPARE [5], 
SHAMISEN, ENGAGE, CONFIDENCE, TERRITORIES; 
} Identified operational challenges: e.g. linked to the European Basic Safety Standards and 
international recommendations such as the ICRP. Operational and general challenges are also 
addressed in the NERIS working groups; 
} Discussions and outcomes of the NERIS working groups, currently defined as: 
• Working Group N°1 on the practical implementation of the ICRP recommendations on 
emergency and rehabilitation; 
• Working Group N°2 on processes and tools for emergency and rehabilitation preparedness 
at community level; 
• Working Group N°3 on contaminated goods; 
• Working Group N°4 on Information, Participation and Communication.  
} Findings from work presented at the NERIS Workshops 2016 [6], 2017 [7], and 2018 [8]; 
} Findings from work presented and meetings during the 2016, 2017 and 2018 European Radiation 
Protection Week. 
} Consultation with NERIS Supporting Organisations, the members of the CONCERT stakeholder 
group, the associated CONCERT Projects leaders, and Research Platforms correspondents. 
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The current update of the NERIS SRA is largely done in context of the ‘CONCERT-European Joint Programme 
for the Integration of Radiation Protection Research’ under Horizon 2020 (http://www.concert-
h2020.eu/) 
3.2. Identifying, characterizing and prioritizing of topics of SRA 
The structure and the topics included in this version of the SRA are largely based on the previous version 
(NERIS SRA version 4 of 22 December 2017). Three key areas are defined with a total of 10 key topics. An 
overview is given below and a detailed discussion of the key topics is found in the next section. 
Research area 1. Challenges in radiological impact assessment during all phases of nuclear and 
radiological events  
Within this area all research challenges are aimed to improve the radiological impact assessment in all phases 
of a nuclear or radiological event. It includes improvements in modelling, monitoring and the combination of 
both (data assimilation for e.g. source term estimation) for human dose and environmental impact 
assessment. This includes research related to impact assessments for planning, real-time impact assessments 
during the response phase, dose reconstruction in a later phase, uncertainty quantification of the impact 
assessment and visualization. 
Research area 2. Challenges in countermeasures and countermeasure strategies in emergency & 
recovery, decision support & disaster informatics 
This research area covers all challenges related to decisions on and implementation of protective actions 
during an emergency, including justification and optimization. It comprises: countermeasures and 
countermeasure strategies including lifting of countermeasures and transition from emergency to existing 
exposure situation; formal decision support, including multi criteria analysis and disaster informatics; the 
study of the use of information technology in the preparation, mitigation, response and recovery phase of a 
nuclear or radiological disaster. 
Research area 3. Challenges in setting-up a trans-disciplinary and inclusive framework for 
preparedness for emergency response and recovery 
The third research area focuses on the overall emergency response and recovery framework, including 
reference levels, stakeholder engagement, the involvement of the public, communication research and non-
radiological perspectives such as health, ethical and societal aspects. This area also integrates multi-
disciplinary research to cope with incomplete information, typical for of emergency situations, and improved 
decision making under high uncertainty.  
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4. KEY TOPICS OF THE STRATEGIC RESEARCH AGENDA (SRA) 
Research area 1. Challenges in radiological impact assessment during all phases of nuclear and 
radiological events  
The following key topics and subtopics are defined: 
Area 1. Key topics Sub-topics 
Key topic 1. Improved modelling Atmospheric transport and dispersion modelling 
(ATM/ADM) 
Hydrological transport modelling 
Dose modelling 
Environmental modelling 
Key topic 2. Improved monitoring Monitoring techniques and strategy 
Data collection & sharing 
Optimisation 
Key topic 3. Data assimilation Improved source term estimation 
Improved impact assessment 
Big Data, Data fusion 
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Key topic 1. Improved modelling  
Objective: To make more reliable and accurate forecasts on dispersion of radioactive materials in different media, human radiation doses and 
effects on the environment, taking into account uncertainties 
Expected results: Models and Decision Support Systems (DSSs) with extended capabilities.  
Sub-topic Description and current research challenges within this (sub)topic Relation with recent & running 
projects and other SRA’s 
Atmospheric 
transport and 
dispersion modelling 
(ATM/ADM) 
ATM/ADM at different scales and complexity is the basis for the impact assessment of releases to 
the atmosphere as well in the planning phase (preparedness), the response phase and for dose 
reconstruction. It includes forward (prognostic) modelling as well as inverse modelling (e.g.; source 
term reconstruction). Currently following challenges are identified: 
• Modelling approaches for complex settings (urban or confined spaces): development of 
models for the intentional or accidental releases of radiological or nuclear material in complex 
environments (e.g.; urban, near range). Combination of complex (e.g.; CFD- Computational 
Fluid Dynamics) modelling with more simple approaches;  
• Non-conventional emissions: extension of capability of dispersion models in existing DSSs to 
treat detailed information for particular types of sources (e.g.; explosions, two-phase, aerosol 
sprays, fires, general short-term releases), and to simulate dispersion of particular substances 
(aerosol, phase-changing, particles with spectrum of different size, chemical transformations); 
And specific scenarios such as transport of sources, releases from waste repositories, etc. 
• Fine-tuning modelling parameters and algorithms: Extension of capability of dispersion 
models in DSSs to treat phenomena that currently are not fully considered, in particular for 
low wind speed, very stable conditions, high precipitation and different forms of precipitation. 
• Uncertainty quantification: ensemble calculations, Quantification/assessment of ATM/ADM 
uncertainties: uncertainties due to input meteorological data, through the use of e.g., 
meteorological ensemble forecasts; uncertainties due to other input data (source term, 
physical properties of dispersed material, etc.); uncertainties due to modelling assumptions / 
approximations / parameterizations; uncertainties due to natural variability of the atmosphere 
/ assessment of probability density functions / highest or most probable expected values for 
concentration, exposure, etc.; ensemble dispersion modelling 
Projects: 
PREPARE, 
HARMONE, 
CONFIDENCE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent & running 
projects and other SRA’s 
Hydrological 
transport modelling 
Dispersion modelling in different hydrological systems is the basis for impact assessments of liquid 
releases and atmospheric releases with deposition resulting in aquatic contaminations in the 
planning phase (preparedness), response phase, for reconstruction and for guiding recovery. 
Currently following challenges are identified: 
• Urban hydrology 
o Contamination of urban fresh water supply: Development and implementation in 
existing DSSs of models to predict the activity concentrations in the urban fresh water 
supply system due to contamination of freshwater basins from radioactive cloud; 
o Waste water from urban decontamination: Development and implementation in 
existing DSSs of models to estimate the activity concentration in the waste water due 
to washout of deposited radionuclides in urban areas; 
o Better representation of wash-off processes linked to actual or prognostic information 
on precipitation events (plus essentially the same for food producing areas). 
• Models for coastal areas: Development and implementation of relocatable hydrodynamic 3D 
models of coastal circulation for real time predictions of transport of radioactivity in the coastal 
zone; 
• Coupling with weather forecast models: Coupling with weather forecast models to provide 
forcing for wave models; 
• Runoff to sea: Coupling with runoff (land to river to sea) models for the emergency phase and 
long term phase calculations in the case when the power installation is located near the coast 
– combination with deposition maps of fall-out on the land near the coast; 
• Uncertainty quantification: As for atmospheric dispersion, uncertainties have to quantified for 
the hydrological models. This includes approaches for transport and dispersion models as well 
as approaches for the integrated food chain as is typically the case for box models. Here the 
movement of the marine species between boxes has to be considered 
Projects: 
PREPARE 
Platforms: 
ALLIANCE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent & running 
projects and other SRA’s 
Dose modelling Dose models aim at estimating the dose to humans (retrospective and/or predictive: e.g.; first year 
dose) in different environments (urban, agricultural, forest, …) and conditions (normal living, 
applying certain countermeasures, …) 
• Intercomparison between different models; 
• Evaluation of dose models along available data from past accidents; 
• Extending dose modelling to a wider range of radiological events (criticality) and exposures 
(direct exposure, cloud shine); 
• Development of dose models for population movement; 
• Impacts of population changes over time. 
Projects: 
HARMONE,  
TERRITORIES, 
CONFIDENCE 
Platforms: 
EURADOS 
Environmental 
modelling 
Modelling the behaviour and the effect of radioactive substances in the biosphere. It comprises 
source term and release, transport through the abiotic part of the biosphere, food chains, intake 
and distribution in humans and the effect of radiation on living organisms. Here are excluded the 
atmospheric and hydrological dispersion. 
Currently following challenges are identified: 
• Marine food chain  
• Customising of the existing environmental models into the regional circumstances in Europe 
(close co-operation with the Radioecology Alliance): revision of model parameters as FDMT1  
• Local radio-ecological models: Development of local radio-ecological models interlinked with 
monitoring information and the more global and food chain dose models, integrated in general 
DSS; 
• Multiple stressors: Models able to tackle multiple stressors in the assessment of 
countermeasure strategies and in relation to malicious dispersion (CBRNE); 
• Process based models (extension to non-common radionuclides) 
Projects: 
PREPARE 
HARMONE 
TERRITORIES 
CONFIDENCE 
Platforms: 
ALLIANCE 
  
                                                             
1 FDMT software : Food Chain and Dose Module for Terrestrial Pathways  
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Key topic 2. Improved monitoring 
Objective: Improve monitoring capabilities and efficiency in emergency and post-emergency/existing situations 
Expected results:  
} Optimized monitoring and monitoring strategies; 
} Improved link between modelling efforts and monitoring efforts. 
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and current 
running projects and other SRA’s 
Monitoring 
techniques & 
strategies 
• The further development and integration of novel techniques and methods for the measurement of 
radiation and radioactivity, such as drones, small detector devices and smartphone apps, retrospective 
dosimetry, etc. will become very important in the next decades in nuclear and radiological emergencies;  
• The further development and integration of existing techniques of key importance for the monitoring 
of persons, such as whole body, thyroid, lung counting; 
• Improved assessment of measurement uncertainties in the field during emergency monitoring; 
• Development of improved measurements strategies supporting and tailored to decisions; 
• Optimised use of monitoring resources, including mobile units and trans-border issues. Use of new 
monitoring technologies;  
• Development of processes and tools for integrating the monitoring results from experts and lay people 
into a common operational picture (monitoring crowdsourcing) Information fusion (radiological and 
non-radiological); 
Platforms: 
EURADOS 
Data collection  • Data collection for model validation: Availability of data are crucial for validating models, such as for 
example a program for resuming measurements of Chernobyl contaminants on different surfaces (and 
if possible Fukushima-measurements). Other data from routine releases, small incidents or obtained by 
controlled experiments (e.g.; RDD’s) for model validations. Implementation of new experimental 
campaigns; 
• Establish an overview of / guidance on which data should be collected for recovery operations to be 
considered; 
• New meteorological data: optimised use of new meteorological instruments (E.g.; Lidar, ..) with 
evaluation of application to improve modelling. 
Projects: 
HARMONE, 
SHAMISEN-SINGS 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and current 
running projects and other SRA’s 
Optimisation • Optimized use of specific monitoring resources for nuclear and radiological emergencies (early warning 
networks, mobile teams, laboratories, …), in function of protective actions and decision support; 
• Optimization of early warning networks and other monitoring resources, including aerial surveys taking 
into account new technologies, such as the potential use of drones.  
 
Projects: 
DETECT 
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Key topic 3. Data assimilation 
Objective: Source term estimation based on monitoring and inverse modelling, combining monitoring and modelling effort to decrease 
uncertainty on impact assessments. 
Expected results: better source term reconstruction and operational data assimilation techniques, reduced uncertainty allowing improved 
protective actions and countermeasure strategies. 
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Improved 
source term 
estimation 
• Rapid analytical tools: Development of rapid analytical tools in combination with mobile and automated 
equipment to assess source terms and contamination levels in a short time frame; 
• Advanced source term estimation methods: Further development of advanced operational source term 
estimation computational methods – including unknown source location - combining inverse modelling 
with data assimilation of observations. Of special interest are operational data assimilation methods for 
estimation of unknown source location and strength in urban (i.e., complex) environments. Research is 
needed on the effects of modelling and measurement uncertainties that enter in the data assimilation 
methods; 
• Combined ensemble dispersion modelling with data assimilation. 
Projects: 
PREPARE 
Improved 
impact 
assessment  
• Combining different types of measurements in the data assimilation for improved assessment of impact 
or estimation of source term – ranking types of measurements, including the uncertainty of measurement 
results and phase of accident; 
• Data assimilation models: Development of operational data assimilation methods and models for doses 
and concentrations (aiming at “correcting” parameters other than source term). In particular for areas 
without dense monitoring and in the time when monitoring is still limited: quantification of uncertainties 
in the assessed concentrations and doses depending on the amount and quality of available observations; 
integration of such methods in DSS. 
Projects: 
CONFIDENCE 
Big data, 
data fusion 
• Employment of advanced Information Technology instruments to develop computational structures (e.g., 
platforms, aggregators) that would allow storing, processing and combining large volumes of 
heterogeneous and of different origins data (modelling, observational) for purposes like unknown source 
term estimation, radiological impacts assessment, etc. 
• Further development of platforms and protocols for sharing and exchange of data, taking into account 
different existing data formats such as EURDEP/IRIX 
Projects: 
SHAMISEN-SINGS 
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Research Area 2. Challenges in countermeasures and countermeasure strategies in emergency & 
recovery, decision support & disaster informatics 
The following key topics and subtopics are defined: 
 
Area 2. Key topics Sub-topics 
Key topic 4. Countermeasures and 
countermeasure strategies 
Countermeasures/management options 
Implementation and monitoring of countermeasures, 
including lifting of countermeasures 
Consequence assessment, justification and optimisation of 
countermeasure strategies 
Key topic 5. Formal decision support Decision making, methods and tools 
Decisions under high uncertainty 
Key topic 6. Disaster informatics Analytical platform 
Knowledge database 
DSS interface, output  and coupling 
Serious gaming 
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Key topic 4. Countermeasures and countermeasure strategies 
Objective: Development of flexible and user friendly simulation models that allow the definition of sensible countermeasure strategies by 
combining individual management options. In addition improvement of understanding of processes related to countermeasures (e.g. movement 
of contamination, parameter selection for different environment). Models have to be improved to allow also for estimation of termination of 
countermeasures based on criteria that have to be defined. Identification, characterisation and assessment of the response of the actions 
(management options) and strategies to mitigate the consequences of a radiological or nuclear event. Analyses of behavioural aspects, such as 
self-evacuation, self-initiated protective actions on countermeasure effectiveness 
Expected results: Improved countermeasure models fit for purpose. 
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Countermeasures 
& countermeasure 
strategies 
• Revision of the European handbooks: Generic revision and revision of European handbook 
sections (creation of addendum) for consideration of malicious dispersion scenario’s; 
• Countermeasure strategy preparedness: Development of sustainable preparedness strategy 
at local, national and European level, based on the analyses of countermeasures for relevant 
accident scenarios, ensuring that parameters governing the radiological consequences can 
be identified in time to enable optimized remediation; 
• More detailed studies and evaluations of countermeasure effectiveness, especially if 
several countermeasures are combined, or impact from other environmental and external 
conditions 
Projects: 
PREPARE,  
CONFIDENCE 
Platforms: 
ALLIANCE 
Implementation 
and monitoring of 
countermeasures, 
including lifting of 
countermeasures 
• Development of tools for the usage at the local level: Analyse the need of the local actors 
in respect to local-national interaction, for implementation of mitigating actions in response 
and recovery phases. Compatibility of local and national tools.  
• Timeline of implementation; 
• Termination and withdrawal of protective measures: Development of framework and 
guidance for setting up criteria to lift in particular early phase countermeasures. This includes 
guidelines for returning people but also compensations schemes. 
• Feedback on decision / action effectiveness: Feedback on the use of methods and tools to 
monitoring of situation and evaluate the effectiveness of protective actions. Simple 
measurement strategies are needed to secure that CM’s implementation is optimised in 
practice.  If this is not done, a ‘paper-optimised’ strategy may well fail completely in practice; 
Projects: 
NERIS-TP, 
PREPARE, 
CONFIDENCE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Consequence 
assessment and 
optimisation of 
countermeasure 
strategies 
• Consequence assessment: Establishment of evaluation criteria and their metrics to 
estimate the consequences of the action alternatives; qualitative and quantitative 
methods; consideration of the uncertainty; 
• Optimisation: Development and application of criteria, indicators and methods to 
optimise the management options and/or the protective strategies. 
Projects: 
NERIS-TP, 
PREPARE, 
CONFIDENCE, 
TERRITORIES 
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Key topic 5. Formal decision support 
Objective: Improvement of the decision making process by using tools to structure the process and support the selection of appropriate options.  
Expected results: new methods and tools that can be used by decision makers at all levels of the decision making process. 
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and 
running projects and other 
SRA’s 
Decision-making, methods 
and tools 
• Structuring the decision processes at national, regional and local levels with the help of 
formal decision aid tools, such as multi-criteria analysis; 
• Development of guidance on the use of DSS based on feedback from stakeholder processes 
and from Fukushima experience in emergency response and recovery; 
• Development of Machine Learning techniques for decision making. 
Projects: 
PREPARE, 
CONFIDENCE, 
TERRITORIES 
Decision under high 
uncertainty  
• Assessment and communication of uncertainties: Investigation of data uncertainties (model 
or monitoring results), how they are transferred in chains of successive models and how they 
can be communicated or presented, e.g. in model results and in DSS to help decision-makers 
to understand the radiological situation; 
• This also includes work on model sensitivity, validity of model results and inter-comparisons 
of models and measurements 
• How uncertainties influence optimization process 
Projects: 
CONFIDENCE 
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Key topic 6. Disaster informatics 
Description: Study of the use of information and technology, including artificial intelligence, in the preparation, mitigation, response and recovery 
phases of disasters and other emergencies. 
Objective: Development of databases and methods to support decision making when little information is given and assessments with simulation 
models are very uncertain. This should be based on historic experience and/or scenarios that can be processed by DSS. Further to this, a coupling 
of the strategic tools (e.g. DSS) with tools from first responders (e.g. Command and Control) that have to carry out recommendations is of interest. 
Use of Artificial Intelligence methods. 
Expected results: Knowledge databases and tools that use existing knowledge to support decision making when little information is available 
and also supports the first responder in considering resources when recommending countermeasures.   
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Analytical platform • Access/exchange platform collecting and distributing results from governmental and 
non-governmental organisations; 
Projects:  
PREPARE 
Knowledge database • Development of a knowledge database with scenarios and response, including lessons 
learned from historic events and decision support tools developed in international 
handbooks such as the European handbooks; 
• Development of information material of general nature on radiation emergencies, 
countermeasures and recovery based on lessons learnt from past events. 
Projects: 
PREPARE 
DSS interface, output  
and coupling 
• Tailor the output of DSS’s to the user’s needs: Modification of existing interface of DSS’s 
to allow easy selection of specific output in particular calculation points and export of 
results to other formats; 
• Coupling of the existing strategic DSS such as ARGOS and RODOS to Command and 
Control (C2) systems. 
• Study on optimising exchange of information: covering all aspects of data exchange 
throughout emergency response and recovery. 
Projects:  
BOOSTER 
Serious gaming  • Development of virtual and augmented reality  to train the emergency response actors 
(first responders, competent authorities, decision makers…); 
• Other types of serious gaming for exercise/training support. 
Projects: 
TERRITORIES 
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Research area 3. Challenges in setting-up a trans-disciplinary and inclusive framework for 
preparedness for emergency response and recovery 
The following key topics and subtopics are defined: 
 
Area 3. Key topics Sub-topics 
Key topic 7.  Emergency response and 
recovery framework, including reference 
levels 
Implementation of BSS including reference levels and 
relation with operational levels 
Governance of preparedness 
Long term management 
Contaminated goods 
Integration in all-hazard approach 
Exercises and drills 
Key topic 8.  Stakeholder engagement, 
involvement of the public & communication  
Stakeholder engagement processes including the public 
Communication 
Citizen Science 
Key topic 9.  Integrated emergency 
management – non-radiological aspects 
(health surveillance, ethical aspects, 
economic issues, etc.)  
Health Surveillance 
Ethical aspects 
Socio-economic aspects 
Integrated surveillance and monitoring 
Accident waste management 
Radiological protection culture 
Key topic 10.  Uncertainty and incomplete 
information handling  
Deal with, manage and address uncertainties in the 
decision making process 
Communication of decisions under uncertainty 
Train decision makers to better deal with uncertainties 
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Key topic 7. Emergency response and recovery framework, including reference levels 
Objective: Development of radiological decision criteria and implementation frameworks to improve and ensure the sustainability of emergency 
response and recovery management, addressing societal and ethical issues.  
Expected results: Operational radiological decision criteria and guidance for implementation taking into account societal and ethical issues, and 
management framework for improve sustainable emergency response and recovery. 
 
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running  
projects and other SRA’s 
Implementation of 
BSS including 
reference levels 
and relation with 
operational levels 
• Development of socially and scientifically robust Operational Intervention Levels (OILs) and 
radiological decision criteria for the transition and longer-term management; 
• Investigate the potential of simulation models to set up possible radiological decision criteria 
and reference levels early in the emergency to support decisions such as temporary or 
permanent relocation; 
• Development of methodology and tools to better address actual and future risks and 
vulnerabilities and their management in the implementation of countermeasures; 
• Adapt decision support systems to implement results from the screening of reference levels;  
• Development of governance approaches at local, national and international levels to better 
integrate radiation protection into a broader environmental protection framework; 
• Development of stakeholder engagement approaches in context of BSS implementation; 
• Study on which factors can influence and enhance the coordination and harmonization in 
emergency preparedness, response and recovery in neighbouring countries and at the 
European and international level in general; 
• Study on good indicators for nuclear preparedness in different countries including cross-
border aspects. 
Organizations: 
HERCA 
Projects: 
ENGAGE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running  
projects and other SRA’s 
Governance of 
preparedness 
• Development of processes, methodologies and tools to support sustainable strategies of 
preparedness of European member states to the occurrence of nuclear events including relevant 
stakeholders:  
o Identifying the specificities of respectively preparedness to emergency response and 
preparedness to recovery process and corresponding knowledge, skills and culture; 
o Roadmaps for the development of RP culture during the preparedness phase; 
o Clarifying the respective role of the different concerned categories of stakeholders in 
the preparedness process (considering the option of incremental in time engagement 
of stakeholder categories), notably local communities; 
o Articulating with existing CBRN capacities and drawing lessons from preparedness 
processes in other fields such as Chemicals, Biological, Natural events; 
• Investigating the conditions for Human resilience at individual and community levels and 
possible preparedness strategies for increasing resilience;  
• Defining strategies for reviewing preparatory processes over time, overcoming the turnover of 
qualified actors while articulating with rolling stewardship of society; 
• Experimenting and testing the developed preparedness methodologies at national level while 
supporting diffusion and coordination of preparedness processes at EU level.   
Platform:  
Jointly with SHARE 
Long term 
management 
• Develop long term, sustainable communication models and stakeholder engagement 
frameworks to improve public health and well-being ; 
• Development of decision criteria for lifting of countermeasures and transition from emergency 
to existing exposure situations; 
• Test the guidance on communication and participatory processes in stakeholder groups and 
improve the framework. 
Projects: 
CONFIDENCE 
TERRITORIES 
ENGAGE 
SHAMISEN-SINGS 
Platforms: 
SHARE 
ALLIANCE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running  
projects and other SRA’s 
Contaminated goods • Further analysis on the implications of trade and use of goods from contaminated territories 
in the perspective of a sustainable recovery, including the management of business activities; 
• Development of simulation models that allows the quantification of potential doses from 
usage of contaminated goods; 
• Development of guidance on management strategies for goods, addressing health, societal, 
economic and ethical issues. 
Projects: 
PREPARE 
CONFIDENCE 
Integration in all-
hazard approach 
• Nuclear and/or radiological emergencies can be part of a larger natural or man-made hazard, 
development of approaches to optimize emergency preparedness response and recovery in 
such scenarios, including the stress test of the nuclear emergency plan. 
 
Exercises, drills • Emergency exercises and drills are the key moments to practise nuclear and radiological 
emergency preparedness and response: research related to the methodological and 
practical/technical development of emergency exercises and on the return-of-experience from 
exercises. 
Projects: 
ENGAGE 
CONFIDENCE 
 
  
 NERIS SRA, version November 2019                                                                                                              24 
Key topic 8. Stakeholder engagement, involvement of the public & communication 
Objective: Improve the efficiency and social robustness of emergency response. Ensure that stakeholders are involved in decisions that impact 
their lives. 
Expected results: 
} Maintain the inclusion of social aspects of emergency response and stakeholder engagement; 
} Greater recognition of the importance of stakeholder and public engagement; 
} Improve understanding of the factors and criteria for successful stakeholder engagement; 
} Improved preparedness for media and social media communication. 
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and 
running projects and other 
SRA’s 
Stakeholder 
engagement 
processes 
including the 
public 
• Defining stakeholders and framing problems: Identifying roles, constraints, responsibilities and 
cooperation among European/national/regional/local levels in order to improve the Preparedness Plans 
for each phase of the emergency and post-accident 
• Stakeholder engagement database: Database on experiences of stakeholder engagement in 
preparedness and response highlighting lessons learned and guidance for best practice, taking into 
account the national context; 
• Public participation and dialogue: Develop guidance on information and participation of population, 
increasing effectiveness if multiple sources of information may compete or conflict; 
• Analysis of societal needs for an evaluation of legal instruments and governance frameworks supporting 
access to information, public participation and access to justice in relation with RP issues; 
• Examination, assessment and design of stakeholder and public participation tools and methodologies 
for emergency and post-accident emergency situations. Roles and rules of stakeholders in the 
engagement process. Motivational factors (including motivations for dis-engagement), ethics and link 
between theory and practice. Impact of engagement processes and update of their outcome; 
• Preservation of knowledge and experience of local stakeholders’ (e.g.; local community, schools, citizens) 
involvement and participation. Community research and tracing for development of participation culture 
in relation to different exposure situations. 
Projects: 
ENGAGE 
NERIS-TP 
PREPARE 
CONFIDENCE 
TERRITORIES 
SHAMISEN-SINGS 
Platforms: 
SHARE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and 
running projects and other 
SRA’s 
Communication • Assessment of the mechanisms by which the public gains information: Investigate the conditions and 
means for pertinent, reliable and trustworthy information to be made available to the public in due 
time according to its needs in the course of nuclear emergency and post-emergency contexts; 
• Trustworthiness of information: Development and usage of social media and other information 
sources in emergency response: how social media can be used to improve emergency response and 
better communicate and cooperate with the public;  
• Role of social media link: Links between perception of radiological risk and radiation protection 
behaviour, or individual strategies to cope with perceived risk in relation to radiation exposure, using 
both cross-sectional and longitudinal studies focusing on one or more of these aspects: 
o different exposure context (workers, population living in areas affected by radiological 
contamination); 
o different time scales (e.g.; different generations); 
o cultural context; 
o socio-economic issues of behaviour change;. 
o Social and traditional media impact on perception of radiological risk and general well-being 
linked to radiation exposures. This includes the influence of citizen journalism on radiation 
protection behaviour in different exposure situations and developing models for integrating 
scientific journalism in radiation protection? 
• Developing long term communication models to improve radiation protection culture and public well-
being in long term exposure situations;  
• Use and perception of technical information and risk estimates in communication with various publics 
(lay people, experts, informed civil society): 
o Media communication about ionizing radiation, in particular low radiation doses and related 
uncertainties in the field of radiological protection including inter-media agenda setting in 
different exposure situations; 
Projects: 
PREPARE, 
CONFIDENCE, 
ENGAGE, 
SHAMISEN, 
SHAMISEN SINGS 
Platforms: 
SHARE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Citizen Science • Potential and pitfalls of citizens involvement in knowledge production for radiological risk 
governance; 
• Authorities versus citizen measurements/science: integration, interpretation, stakeholder 
involvement, interaction between different partners, assessment of technical aspects on 
reliability, … 
• Mutual influence of citizen science and radiation protection culture. 
Projects: 
ENGAGE, 
TERRITORIES, 
SHAMISEN-SINGS, 
CONFIDENCE 
Platforms: 
SHARE, 
EURADOS 
 
  
 NERIS SRA, version November 2019                                                                                                              27 
Key topic 9. Integrated emergency management, including non-radiological aspects (health surveillance, ethical aspects, economic issues,…) 
Objective: Better addressing non-radiological aspects for developing guidance and framework in an integrated way to improve emergency 
response and recovery management, covering many disciplines including the non-radiological aspects. 
Expected results: Improved knowledge on the role of non-radiological aspects in emergency response and recovery, and procedures and 
guidance for the development of an integrated approach. 
Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Health Surveillance • Development of procedures for health surveillance including monitoring of population and dose 
reconstruction and involvement of stakeholders; 
• Socio-psychological and economic aspects of medical follow-up after accidental or other 
exposures. 
Projects: 
SHAMISEN, 
SHAMISEN SINGS, 
ENGAGE 
Platforms: 
MELODI, 
SHARE 
Ethical aspects • Ethical aspects of crisis situations, particularly ethical questions of evacuation, and post-accident 
management (“emergency ethics” vs. “normal ethics”), the transition from emergency to 
existing radiation exposure situations; 
• Practical implications for emergency and recovery preparedness; 
• Compensation: Ethical perspective of compensation for damage incurred due to various 
situations of radiation exposure and differences among countries; 
• Ethical basis and values underpinning risk communication about ionizing radiation exposures. 
Projects: 
ENGAGE, 
SHAMISEN 
Platforms: 
SHARE 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Socio-economic 
aspects 
• Public behaviour response analyses: Understand how the population reacts and which information 
related to the behaviour of the population can be used by local-national tools to improve the 
response – research on gap knowledge and behaviour (knowledge – action gap);  
• Assessment of factors important for social trust in emergency situations and recovery: 
Development of methods and procedures for analysing the information flow related to social trust 
including traditional information sources as well as social media and modern IT-based structures; 
• Comprehensive approaches studying the perception of radiological risk and environmental 
remediation actions in post-accident and existing exposure situations; 
• The interplay of psychological aspects associated with radioactivity, social environment and 
radiation protection behaviours; 
• Perception of radiological risks from low doses of radiation, accounting for cultural differences in 
routine, emergency and other exposure situations; 
• Development of socio-economic valuation and multi-criteria decision aid methods to formally 
structure the evaluation and integration of radiological and non-radiological factors for different 
ionising radiation exposure situations; 
• Studying compensation schemes. 
Projects: 
CONFIDENCE, 
TERRITORIES, 
SHAMISEN, 
ENGAGE 
Platforms: 
SHARE 
Integrated 
surveillance 
and monitoring 
• Investigate connections between issues of health surveillance, human dose assessment, 
environmental monitoring and food monitoring from the point of view of institutions and local 
populations in the emergency response and transition phases; 
• Investigate connections between these different dimensions of surveillance, healthcare and the 
development of radiation protection culture; 
• Develop guidance on the way to set up comprehensive surveillance and monitoring systems 
articulating health, body, environment and food surveillance and healthcare, taking into account 
the potential of citizen-based monitoring; 
• Test the guidance with local and national stakeholders on the way to set up comprehensive 
surveillance and monitoring systems articulating health, body, environment and food surveillance 
and healthcare, taking into account the potential of citizen-based monitoring. 
Projects: 
ENGAGE, 
SHAMISEN,  
SHAMISEN SINGS, 
TERRITORIES,  
CONFIDENCE 
Platforms: 
SHARE, EURADOS 
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Sub-topic Description and current research challenges within this (sub)topic Relation with recent and running 
projects and other SRA’s 
Accident waste 
management 
• Analyses of environmental and socio-economic aspects of waste management after an 
accident  
Projects: 
CONFIDENCE 
Radiological 
protection culture 
• Awareness on radiation; 
• The role of RP culture, in particular: 
o The contribution of RP culture in the implementation and improvement of the protection 
“system”; 
o How RP culture can improve health and well-being of populations? 
Practical achievements from developing / building a RP culture (impact on level of exposure, 
protective actions, decision making processes,…). 
• Development of tools, methods, processes to build, maintain and transmit RP culture: 
o Needs and concerns of stakeholders regarding RP culture, with attention to the 
development of participatory tools and low dose exposure situations; 
o Development of tools / methods / processes to enhance RP culture in specific 
fields:  emergency and late phase nuclear accident preparedness, NORM activities, Radon 
exposure, paediatric imaging; 
o Processes to maintain/ transfer RP culture through generations; 
o Guidance for enhancing RP culture for specific publics (communities around nuclear 
installations, schools, patients, pregnant women, medical doctors). 
Projects: 
ENGAGE, 
SHAMISEN, 
SHAMISEN-SINGS 
Platforms: 
SHARE 
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Key topic 10. Uncertainty in the decision making processes 
Objective: Improve the capabilities to perform sensible and robust decisions at all levels under high uncertainty. (This includes communication 
and visualisation of uncertainties in model results but also the consideration of how uncertainties are used when making decisions). 
Expected results: Improved (communication) tools to present uncertainties in model results and tools and methods to include this information 
in the decision making process. 
Sub-topic Description and current research challenges within this (sub)topic Relation with current projects 
and other SRA’s 
Deal with, manage 
and address 
uncertainties in the 
decision making 
process 
• Identify key information that should be considered for decision-making in the various phases 
of an emergency and develop indicators that indicate the usefulness of model results for 
decisions in the different phases, e.g. robustness or quality indicators; 
• Based on the needs for decision making initiate studies on model sensitivity, validity of model 
results and inter-comparisons of models with measurements to better judge the quality of 
model results for decision-making; 
• Investigating overall uncertainties and how uncertain model results can be better integrated 
into decision support systems to help decision makers to fully assess the radiological situation; 
• Investigate how uncertainties influence optimization process of management strategies, 
• Further develop formal decision aiding tools such as Multi Criteria Decision Analysis to 
integrate uncertain information from model result and uncertain preferences of decision 
makers; 
• Explore agent based simulation systems to systematically study the decision making process 
under different aspects such as composition of team, preference settings, constraints, and 
blockage of consensus seeking. 
• Investigate how local actors and non-institutional stakeholders make sense of uncertainty in 
their own decision-making processes and what governance mechanisms can facilitate these 
processes. 
Projects: 
CONFIDENCE, 
TERRITORIES 
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Sub-topic Description and current research challenges within this (sub)topic Relation with current projects 
and other SRA’s 
Communication of 
decisions under 
uncertainty 
• Investigate how decisions taken under high uncertainty can be communicated to media and 
general public; 
• Investigate media communication about ionizing radiation, in particular low radiation doses and 
related uncertainties in the field of radiological protection including inter-media agenda setting 
in different exposure situations; 
• Develop tools and methods for a two-way communication of uncertain information between 
experts and non-experts;  
• Review the developments from the first decade and develop further needs for improved 
communication of uncertainties; 
• Investigate to which extent serious gaming can be used in communication of uncertainties. 
Projects: 
CONFIDENCE, 
TERRITORIES 
Train decision 
makers to better 
deal with 
uncertainties 
• Develop education and training material for decision makers on uncertainty management; 
• Investigate to which extent serious gaming or other modern IT-tools can be used for training of 
first responders and decision makers. 
Projects: 
CONFIDENCE 
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5. CROSS-CUTTING TOPICS 
5.1. Education and training 
Education and training is an essential part of any Strategic Research Agenda both for guaranteeing high level 
research in the field as well as for transfer of knowledge gained through research and development towards 
the operational field of nuclear and radiological emergency preparedness and other stakeholders. 
Maintenance of the range of expertise vital to keep up competence and run an effective Programme of 
research into radiation protection in general and specifically in nuclear and radiological emergency 
preparedness, response and recovery has been identified to be critical.  Specific Programmes aiming at 
knowledge management across generations are designed in order to achieve sustainable continuity and 
development. The NERIS supported early and late phase emergency courses (organized respectively by the 
SCK•CEN Academy and CEPN) described in Annex 3 and organized since many years  in different frameworks 
are essential parts of such a Programme. In addition to this basic courses in nuclear emergency, preparedness 
and recovery specific courses, organized within the E&T activities under the CONCERT umbrella, are 
important. Especially the “Assessment of long-term radiological risks from environmental releases” 
organised  by the Technical University of Denmark and the travel grants for participation of young scientists 
in workshops and conferences in the field, such as the yearly NERIS workshop and the European radiation 
Protection Week. 
The initiative was taken to organize during the yearly NERIS workshop a young scientist award with the goal 
to promote presentations by and participation of young scientist in the Workshop.  
The ARGOS and RODOS user groups, described in Annex 4, offer also good training opportunities in the 
technical aspects of both decision support system, crucial to get started with the use of these systems. 
5.2. Safety and security related activities 
Radiation and nuclear safety and (radiation and nuclear) security have a common goal — the protection of 
people, society and the environment. In both cases (safety and security), such protection is achieved by 
preventing a large release of radioactive material. Many of the principles to ensure protection are common, 
although their implementation may differ. Moreover, many elements or actions serve to enhance both safety 
and security simultaneously. For example, the containment structure at a nuclear power plant serves to 
prevent a significant release of radioactive material to the environment in the event of an accident, while 
simultaneously providing a robust structure that protects the reactor from a terrorist attack. Similarly, 
controls to limit access to vital areas not only serve a safety function by preventing or limiting exposures of 
workers and controlling access for maintenance to qualified personnel, but also serve a security purpose by 
inhibiting unauthorized access by intruders.  
The IAEA defines safety and security in the following way (IAEA 2007): 
} (Nuclear) safety: “The achievement of proper operating conditions, prevention of accidents or 
mitigation of accident consequences, resulting in protection of workers, the public and the 
environment from undue radiation hazards.”; 
} (Nuclear) security: “The prevention and detection of, and response to, theft, sabotage, 
unauthorized access, illegal transfer or other malicious acts involving nuclear material, other 
radioactive substances or their associated facilities.” 
Stemming from their different historical roots, the areas of safety and security have long been treated within 
separate research communities with their own terminologies and methods. But since almost all systems 
today are connected to global networks, safety and security have become very much interdependent, 
meaning that safe systems also need to be secure and vice versa. Recent terrorist events have served as a 
catalyst for the development of an array of new nuclear security arrangements. Although concern about 
malicious acts involving nuclear installations is not new, recent terrorist events have demonstrated that an 
attack on a nuclear facility might be attempted and that terrorists have formidable capabilities and 
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dedication. This has led to an increased focus on defences against terrorists at nuclear facilities, as well as at 
other critical infrastructures. The development of revised security arrangements arises at a time when the 
public expects high standards of nuclear safety and security to be met. The challenge in meeting these 
expectations is predicted to grow in light of the interest in the new construction of nuclear power plants. In 
the Seventh Framework Programme (FP7) of the European Commission, security related research is centred 
in the Security Programme and radiation and nuclear safety research in the Euratom Programme 
(http://cordis.europa.eu/fp7/home_en.html ).  
As noted above, the fundamental goal of safety and security actions is the same — the protection of people, 
society and the environment. The acceptable risk is presumptively the same whether the initiating cause is a 
safety or a security event. Moreover, the philosophy that is applied to achieve this fundamental objective is 
similar. Both safety and security typically follow the strategy of defence in depth — that is, the employment 
of layers of protection. The fundamental nature of the layers is similar. Priority is given to prevention. Second, 
abnormal situations need to be detected early and acted on promptly to avoid consequent damage. 
Mitigation is the third part of an effective strategy. Finally, extensive emergency planning should be in place 
in the event of the failure of prevention, protection and mitigation systems. The steps taken to provide 
protection against malicious acts incorporate specific features to ensure physical protection, but also rely on 
provisions that may have been installed for safety reasons.  
NERIS Platform follows and recommends the R&D activities both in the safety and security areas and 
encourages scientists in these areas to collaborate with each other to achieve the best possible impact of 
research in nuclear and radiological emergency management. 
5.3. Collaboration with other platforms 
The NERIS Platform creates close co-operation relationships with other research platforms in the areas of 
radiological protection and nuclear safety in Europe. It is of special importance to follow R&D and collaborate 
in the areas of radioecology, biological effects of exposure to ionizing radiation and epidemiology, and 
dosimetry and medical issues. This is guaranteed by the integration and active involvement of NERIS in the 
‘CONCERT-European Joint Programme for the Integration of Radiation Protection Research’ under Horizon 
2020. NERIS also signed in 2013, a Memorandum of Understanding with the European research platforms in 
the domain of radiation protection (MELODI, ALLIANCE and EURADOS). In addition, for developing and 
implementing its SRA, NERIS has established interactions with different European and International 
organisations involved in radiation protection. The main research platforms and organisations interacting 
with NERIS are the following: 
European Radioecology Alliance, (http://er-alliance.eu/ ) was founded in 2009 to strengthen European 
R&D in the area of radioecology. Radioecological studies are of special importance to assessment and 
management of nuclear or radiological emergency response and recovery, notably for developing Decision 
Support Systems (DSS) and addressing scientific issues associated with environmental contamination and 
countermeasure strategies. Reliability of environmental models used in emergency and recovery depends on 
radioecological parameters incorporated in the models. The Radioecology Alliance focuses not only on 
radiological protection of humans, but also on protection on wildlife. This aspect has to be taken into account 
in nuclear and radiological emergencies. 
MELODI (Multidisciplinary European Low Dose Initiative, http://www.melodi-online.eu/) is an European 
Platform dedicated to low dose radiation risk research, founded in 2010 as a registered association with 
currently 30 members. MELODI aims at identifying R&D priorities for Europe in its field of competence and 
seeking the views of stakeholders on the priorities for research, keeping them informed on progress made, 
and contributing to the dissemination of knowledge. Since MELODI focuses on better understanding the 
health effects of exposure to low dose ionising radiation, its work is directly linked with the work of NERIS 
when protective measures in response to and recovery from nuclear and radiological emergencies are 
discussed. NERIS closely follows the work of MELODI and investigates how new findings of MELODI could be 
implemented in the European emergency management procedures. 
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EURADOS (European Radiation Dosimetry Group, http://www.eurados.org) is a network of more than 60 
institutions and more than 500 scientists from the European Union, Switzerland, Eastern and Central Europe. 
It serves the promotion of research and development and European cooperation in the field of the dosimetry 
of ionizing radiation. The scope of EURADOS includes the fields of radiation protection, retrospective 
dosimetry, environmental radiation monitoring, radiobiology, radiation therapy, diagnostic and 
interventional radiology. Its activities promote technical development and its implementation into routine 
and contribute to compatibility within Europe and conformance with international practices. Dosimetry and 
monitoring issues are part of the management of emergency and recovery. NERIS follows the current 
developments in this field to improve preparedness. 
EURAMED (European Alliance for Medical Radiation Protection Research), created in 2015, represents a 
consortium of associations involved in the application of ionising radiation in medicine, with the goal of jointly 
improving medical care and its radiation protection issues through sustainable research efforts. The main 
objective of this collaboration is improve the application of ionising radiation in medical care by developing 
and exploring common research strategies and by actively promoting the translation of results into clinical 
practice. Several topics have to be considered with EURAMED for better addressing medical issues in the case 
of a nuclear accident. NERIS is currently engaging a discussion with EURAMED in this perspective. 
SHARE (Social Sciences and Humanities in Ionising Radiation Research) Building a more robust role for SSH in 
Ionising Radiation (IR) is imperative. This would open vital opportunities for multiple research communities 
to integrate social and ethical considerations into IR research, thereby expanding research options, clarifying 
values, and fostering collaborative approaches to research and innovation. The Platform will ensure that: 
i/existing and future research, policy and practice, in all areas relating to IR, can better take into account the 
concerns, values and needs of a wider range of stakeholders, including citizens and communities; ii/ the 
findings of social sciences and humanities (SSH) research can be better co-ordinated and also be better 
integrated in European research and development on IR; iii/research relating to IR will be conceived as 
transdisciplinary and inclusive, integrating technical and non-technical inputs from the start. 
5.4. Collaboration with European and International Organizations 
HERCA (association of the Heads of European Radiological protection Competent Authorities, 
http://www.herca.org/) is a collaboration forum of the European radiation protection authorities, founded 
in 2007. HERCA has recognized the need for a more harmonised approach with regard to the management 
of nuclear and radiological emergency situations as a top priority. HERCA has also recognised that the events 
at the Fukushima Daiichi NPP in March 2011 dramatically illustrate that similar needs for a common 
understanding and, whenever possible, a common approach in the field of nuclear emergency response also 
exist for accidents happening even at great distance from Europe. National radiation protection authorities 
are the key players in nuclear and radiological emergencies and therefore the objectives of HERCA and NERIS 
are common. NERIS is the forum where new methods and tools are developed and the radiation protection 
authorities, among the others, take care of implementing them. Therefore it is of primary importance that 
these two forums work closely together. 
ICRP (International Commission on Radiological Protection, http://www.icrp.org), created in 1928, helps to 
prevent cancer and other diseases and effects associated with exposure to ionising radiation, and to protect 
the environment. ICRP is an independent, international organisation with more than two hundred volunteer 
members from approximately thirty countries across six continents. These members represent the leading 
scientists and policy makers in the field of radiological protection. ICRP has developed, maintained, and 
elaborated the International System of Radiological Protection used world-wide as the common basis for 
radiological protection standards, legislation, guidelines, programmes, and practice. NERIS is recognised as 
liaison organisation by ICRP and participates each year to the exchange meetings to identify the main 
challenges for the application of the radiological protection system in emergency and recovery situations.  
IAEA (International Atomic Energy Agency, https://www.iaea.org) was created in 1957 in response to the 
deep fears and expectations generated by the discoveries and diverse uses of nuclear technology. Widely 
known as the world’s “Atoms for Peace” organization within the United Nations family, the IAEA is the 
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international centre for cooperation in the nuclear field. The Agency works with its Member States and 
multiple partners worldwide to promote the safe, secure and peaceful use of nuclear technologies. Specific 
developments have been made following the Chernobyl and Fukushima accidents and regular meetings are 
organised, leading to publications and recommendations for the management of emergency and recovery. 
NERIS interacts regularly with IAEA to exchange information and identify areas where NERIS researches can 
be disseminated. 
IRPA (International Radiation Protection Association, http://www.irpa.net) is the international association of 
the national societies of radiation protection. It aims to provide a medium whereby those engaged in 
radiation protection activities in all countries may communicate more readily with each other and through 
this process advance radiation protection in many parts of the world. NERIS interacts more specifically at the 
occasion of the international and regional congresses, providing an opportunity to present and discuss the 
results of research developments among the community of radiation protection experts. 
NEA (The Nuclear Energy Agency) is an intergovernmental agency that facilitates co-operation among 
countries with advanced nuclear technology infrastructures to seek excellence in nuclear safety, technology, 
science, environment and law. The NEA, which is under the framework of the Organisation for Economic Co-
operation and Development, is headquartered in Paris, France. 
WHO (World health Organization) The WHO is building a better, healthier future for people all over the world. 
Working with 194 Member States, across six regions, and from more than 150 offices, WHO staff are united 
in a shared commitment to achieve better health for everyone, everywhere. Together we strive to combat 
diseases – communicable diseases like influenza and HIV, and noncommunicable diseases like cancer and 
heart disease. We help mothers and children survive and thrive so they can look forward to a healthy old 
age. We ensure the safety of the air people breathe, the food they eat, the water they drink – and the 
medicines and vaccines they need. 
NUGENIA (NUclear GENeration II & III Association). Established in 2011, NUGENIA is an international non-
profit-making association according to the Belgian law of 1921, headquartered in Brussels. Today, we gather 
more than 100 members worldwide to advance the research and development of nuclear fission 
technologies, in particular for Generation II and III nuclear plants. The association aims to be an integrated 
framework for R&D to ensure safe, reliable and competitive Gen II & III fission technologies by: i/ Fostering 
collaboration between industry, SMEs, research organisations, academia and technical safety organisations; 
ii/ Building knowledge and expertise and iii/ Generating R&D results with added value for the nuclear 
community 
EC-DG-JRC (European Commission  - Directorate General - Joint Research Centre). The Joint Research Centre 
is the Commission's science and knowledge service. The JRC employs scientists to carry out research in order 
to provide independent scientific advice and support to EU policy. 
EC-DG-ENER (European Commission - Directorate General – Energy) This Commission department is 
responsible for the EU's energy policy: secure, sustainable, and competitively priced energy for Europe. 
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6. WAY FORWARD 
The vision of the NERIS Platform is that all European organizations being involved in nuclear emergency 
management and recovery are sharing common views and common approaches as well as, developing and 
using state-of-the-art compatible technology and methods for consequence management of the 
emergencies. This vision presumes commitment of all key players in a joint European approach and existence 
of necessary technology and methods to be applied in response to and recovery from an emergency 
situation. Mission of the NERIS Platform is to encourage European, national, regional and local authorities, 
technical support organisations (TSOs) and other players to co-operate to achieve this vision. The aim is to 
get national players in different European countries to act in a coherent way in order to avoid confusion and 
to enhance confidence among the population. Role of the European Commission and other bodies having a 
mandate to establish binding arrangements in management of nuclear and radiological emergencies and 
recovery have a central role in achieving more coherent European approach. 
The NERIS Platform itself shall have a clear vision of what development is needed to achieve a functioning 
European emergency response and recovery arrangements. The Strategic Research Agenda should include 
these needs. The SRA is a living document. This is the third update and the platform shall always update it at 
more or less regular intervals. The Key Topics in the future research and development are identified in this 
SRA and the Platform will go all out for getting these topics in the appropriate European research 
programmes in the coming years. Of course, engagement of the European Commission in the process is 
extremely important.  
7. CONCLUSION 
A NERIS SRA defines ten key topics in three research areas. The three areas are seen as equally important to 
achieve the overall goals in nuclear emergency preparedness, response and recovery. All defined key topics 
require further R&D. Specific challenges are largely based on the previous versions of the NERIS SRA, but 
substantial changes were made to take into account the progress made in the different R&D projects 
currently running and that have recently been concluded. Priorities are not defined in this document and all 
challenges are identified as important. Further prioritization has been done in NERIS statements, in the 
context of CONCERT or in the NERIS roadmap. The relation with other European radiation protection 
platforms (MELODI, ALLIANCE, EURADOS, EURAMED and SHARE) and EU projects addressing part of the 
topics have also been indicated. 
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9. ANNEX 1. Previous SRA versions  
Three previous versions of the NERIS SRA has been published on the NERIS website: 
 
• Strategic Research Agenda of the NERIS Platform, SRA-Report-v2.pdf, published on 30 March 2012 
 
• Strategic Research Agenda of the NERIS Platform - v2, NERIS_SRA_version4_22122017.pdf, 
Published on 22 April 2014  
 
• Updated version of the NERIS SRA - December 2017, NERIS Roadmap_20_november_2017.pdf, 
Published on 09 January 2018  
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10. ANNEX 2. NERIS RELATED RESEARCH PROJECTS 
NERIS-TP 
The NERIS- TP Project (2011-2014) aimed on the one hand to keep the momentum gained through the 
European Project EURANOS in establishing a platform where the operational and research community can 
meet and discuss with all the relevant stakeholders the topics related to emergency response and recovery 
preparedness and on the other hand to tackle urgent research topics in the area of nuclear emergency 
response and recovery preparedness. Through a collaboration of industry, research and governmental 
organisations in Europe, methodological aspects and computational models have been developed to be 
consistent with recommendations from international bodies such as the ICRP (International Commission for 
Radiological Protection) and improve Europe’s response by coupling decision support systems with an 
emergency information system such as the European wide information system ECURIE. Within this project, 
the NERIS platform was established as a unique place for combined meeting of the research and the 
operational community. 
FP7-project PREPARE (Innovative integrative tools and platforms to be prepared for radiological 
emergencies and post-accident response in Europe) - Finished 
The European research project PREPARE ended in January 2016 and brought together 46 partners from 
Europe and Japan. The objective was to close gaps identified after the Fukushima accident. The following 
results have been obtained: 
} Atmospheric modelling:  
• First prototype of inverse source term estimation modules (released activities, isotopic 
composition, height) through data assimilation of near or far field measurements; 
• Improvements in the speed of calculation allowing to use them for long lasting releases; 
• Improved deposition modelling of particles with spectrum of different sizes and densities. 
} Aquatic modelling: 
• Improved models for coastal areas; 
• Improved run-off modelling, however still very limited; 
} Data mining, information gathering and providing information to stakeholders and mass media: 
• Analytical Platform for data exchange; 
• Knowledge data base – so far limited to the early phase, but work in HARMONE will deal with 
the later phase; 
• Trustworthiness of information. 
} Stakeholder engagement and dialogue: 
• Contaminated goods. 
} Social media/networking technology: 
• Public behaviour; 
• How the public obtains information; 
• Factors important for trust. 
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OPERRA-project CATHyMara (Child and Adult Thyroid Monitoring after Reactor Accident) - Finished 
The Cathymara project aims at setting-up guidance for monitoring the internal contamination in the case of 
a large scale nuclear accident, with a focus on the measurement of I-131 content in the thyroid, especially 
for children and included: 
} Evaluation of existing response capabilities for thyroid monitoring in Europe in case of a large scale 
accident; 
} Harmonization of measurement practices and establishment of a robust protocol in case of the need 
to monitor children; 
} Setting-up the basis for a sustainable network of responders, including trained but non-specialized 
operators; 
} Studying to what extent the total committed effective dose (internal dose) can be evaluated from I-
131 measurements and the development of emergency oriented dose assessments methods; 
} Developing the optimal monitoring strategy, including guidelines and recommendations. 
OPERRA-project HARMONE (Harmonising Modelling Strategies of European Decision Support Systems for 
Nuclear Emergencies) - Finished 
The HARMONE project started December 1, 2015 and aimed to reduce scientific, methodological and 
operational gaps identified in the strategic research agendas of the four European Platforms in the area of 
radiation protection and issued as TOPIC 2 of the OPERRA-2014 Call: “Spatial and temporal environmental 
modelling and human dose assessment after a nuclear accident”. This included the following work activities: 
} Development of a knowledge data base and guidance that allows, according to the first event 
description, to propose a first management strategy to reduce doses and highlights potential issues 
for the dose assessment; 
} Refinement of simulation models for all exposure pathways to obtain a better assessment of the 
total dose. This would include also a methodology for the regionalisation of the model to have 
assessments on all relevant scales; 
} Development of guidelines for dose monitoring to back-up the first two steps and facilitate the 
refinement of the simulations. 
OPERRA-project SHAMISEN (Nuclear energy situations – Improvement of medical health surveillance) - 
Finished 
The aim of the project is to build upon the experience and feedback from Chernobyl, Fukushima and other 
emergency situations to develop recommendations for health surveillance and medical follow-up of affected 
populations for: 
1. Dose assessment in support of emergency response, clinical decision-making in the aftermath of a 
radiation accident, and long-term follow-up of exposed populations;  
2. Improvement of living conditions of affected populations, responding to their needs, and engaging 
them in surveillance programmes without generating unnecessary anxiety; and 
3. Improvement of population estimates of radiation-induced risk both for radiation protection and for 
communication with affected populations, if and where feasible. 
Five complementary subtasks (ST) have been executed: ST1 focuses on learning from radiation accidents; ST2 
looks at the needs of populations by way of case-studies; ST3 will develop recommendations for health 
surveillance aimed at improving living conditions of affected populations and knowledge on health effects; 
ST4 focuses on cross-cutting issues (stakeholder engagement, ethics, and economics of health surveillance); 
and ST5 is dedicated to efficient project management.  
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BOOSTER (BiO-dOSimetric Tools for triagE to Responders) 
The BOOSTER project, gathering seven partners from five different countries, addressed the effective 
management of an event involving the exposure of numerous people to radioactive material, whether 
accidental of following malevolent act, requiring a mechanism for rapid triage of exposed individuals. A 
unique toolbox was developed that allowed to quickly assess the radiological situation in the field and to 
provide fast and reliable biodosimetric tools to Triage Teams to evaluate the radiological dose received by 
each victim. This allows to speed up the categorisation of the triage and provided material for any potential 
further follow-up. 
The BOOSTER System architecture was designed to fit the current procedures for radiological crisis 
management, generally based on the definition of different areas around the scene. An exclusion area and a 
controlled area are defined based on radioactivity levels measured in these zones. The equipment used in 
the controlled area allows the cartography of the radiological situation and therefore the real-time 
assessment of the dose received. In the Decontamination area, victims are controlled for contamination and 
a decontamination process is applied if necessary. Several measurement devices are deployed to assess the 
level and position of external contamination on individuals 
When affected people arrive to the Support area, a deeper analysis is performed for radiological triage. A 
complete kit for a first determination of the dose received by internal contamination and irradiation is 
installed in the Support area: Low-Background Spectroscopy on biological samples and environment samples, 
portable LIBS analysis of biological samples, retrospective dosimetry using environment samples and SMD 
resistors from cell phones, biodosimetry using γH2AX quantification. All results, obtained in less than 20 min, 
are linked with the victim ID and stored in a database processed by Decision Support System for triage 
instructions and medical care. 
As supporting tools two easily deployable DSS systems consisting in rugged laptop with SIMACOP and RODOS 
applications are available for crisis managers and authorities, to show all information from the Controlled 
area as well as second level information from the Support area. 
The BOOSTER equipment was demonstrated at Budapest on May 16, 2013, to present all the techniques 
developed during BOOSTER project and their final integration. 
CONFIDENCE COping with uNcertainties For Improved modelling and DEcision making in Nuclear 
emergenCiEs 
The H2020 CONFIDENCE Project aims to address existing gaps in several areas of emergency management 
and long-term rehabilitation. It concentrates on the early and transition phases of an emergency, but 
considers also longer-term decisions made during these phases. The work-programme of CONFIDENCE aims 
to understand and, if possible with the given resources, to reduce and cope with the uncertainty of 
meteorological and radiological data and their further propagation in decision support systems, including 
atmospheric dispersion, dose estimation, foodchain modelling and countermeasure simulations models. 
Consideration of social, ethical and communication aspects related to uncertainties is also considered. First 
attempts will be made to combine simulation with monitoring to help gaining a more comprehensive picture 
of the radiological situation. Decision making principles and methods will be investigated to understand the 
need for uncertainty handling in the decision making process. A comprehensive education and training 
programme is linked with the research activities.  
TERRITORIES To Enhance unceRtainties Reduction and stakeholders Involvement TOwards integrated and 
graded Risk management of humans and wildlife In long-lasting radiological Exposure Situations 
The TERRITORIES project targets an integrated and graded management of contaminated territories 
characterised by long-lasting environmental radioactivity, filling in the needs emerged after the recent post-
Fukushima experience and the publication of International and European Basic Safety Standards. A graded 
approach, for assessing doses to humans and wildlife and managing long-lasting exposure situations (where 
radiation protection is mainly managed as existing situations), will be developed through reducing 
uncertainties to a level that can be considered fit-for-purpose. The overall outcome will be a first attempt to 
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provide an umbrella framework, that will constitute the basis to produce, and disseminate, novel guidance 
documents for dose assessment, risk management, and remediation of NORM and radioactively 
contaminated sites as the consequence of an accident, with due consideration of uncertainties and 
stakeholder involvement in the decision making process. 
 
ENGAGE: ENhancinG stAkeholder participation in the GovernancE of radiological risks for improved 
radiation protection and informed decision-making  
ENGAGE seeks to identify and address key difficulties and opportunities for stakeholder engagement in three 
fields of exposure to ionising radiation: i/  medical use of ionising radiation, ii/ post-accident exposures, and 
iii/ exposure to indoor radon. The ENGAGE project is part of CONCERT European Joint Programme for the 
Integration of Radiation Protection Research’ under Horizon 2020. 
 
SHAMISEN SINGS project -   Stakeholder INvolvement in Generating Science after Nuclear Emergencies 
SHAMISEN-SINGS, building on the recommendations of the EC-OPERRA funded SHAMISEN project, aims to 
enhance Citizen Participation in preparedness for and recovery from a possible radiation accident through 
the evaluation and development of novel tools and APPs to support data collection on radiation 
measurements, health and well-being indicators.  
The project’s goals: 
} Interaction with stakeholders to assess their needs and interest in contributing to dose and health 
assessment through the use of new technologies, for example, mobile applications (APPs); 
} Review of existing APPs for citizen-based dose measurements and for health monitoring, 
establishing minimum standards of quality. Develop a core protocol for a possible citizen-based 
study on health, social, and psychological consequences in the case of a radiation accident; 
} Develop the concept/guidelines for one or more APPs that could be used to monitor one’s radiation 
dose (possibly contributing to radiation exposure assessment after an accident including 
visualisation of real-time radiation conditions), and log behavioural and health information.  In 
addition to contributing to   citizen science studies, these Apps would be designed to provide a 
channel for practical information, professional support and dialogue, as needed by stakeholders.  
} Address ethical issues related to the use of these Apps through a consensus workshop. 
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11. ANNEX 3. NERIS supported training courses 
Preparedness and response for nuclear and radiological emergencies 
The course on "Preparedness and response for nuclear and radiological emergencies" addresses the state of 
the art in nuclear and radiological emergency management including the latest international 
recommendations, the lessons learned from the Fukushima accident and the challenges we still face. The 
main objective is to provide fundamental knowledge and practical advice to all actors involved in emergency 
planning and response. Main topics in the course are the principles of intervention; radiological evaluations; 
decision-support tools; different aspects of planning and organization in off-site emergency response; 
economic, social and psychological impact; European Community legislation; and international data and 
information exchange. The course is organized by the SCK•CEN Academy for Nuclear Science and Technology, 
in collaboration with the main European emergency management actors and the European platform NERIS 
(Preparedness for Nuclear and Radiological Emergency Response and Recovery). It is building on over 20 
years of organizing this international course in different frameworks and it is organised on a yearly basis: see 
https://academy.sckcen.be/en/Customised_trainings/Open_courses/Open_emergency  
Late Phase Nuclear Accident Preparedness and Management 
The Training Course on  “Late Phase Nuclear Accident Preparedness and Management” is organised by the 
Nuclear Protection Evaluation Center (CEPN - France) and the Institute of Radiology (RIR - Belarus) in 
cooperation with the European platform NERIS on emergency and post-accident preparedness and response. 
The training course is co-funded by the European Joint Program for the integration of radiation protection 
research CONCERT. The main objective of the course for late phase nuclear accident preparedness and 
management is to provide principles and practical guidance for the key players involved in the preparedness 
and recovery of living conditions in contaminated areas in the aftermath of a nuclear/radiological accident. 
The course offers a comprehensive overview of the various dimensions and challenges of the long-term 
rehabilitation. It includes also practical elements for the implementation of countermeasures for managing 
long-term contaminated rural and urban environments, notably through the planning of direct meetings and 
dialogue with local stakeholders (inhabitants, pupils, local authorities, etc.) living in the areas affected by the 
Chernobyl accident. 
The course is based on international recommendations and on the material produced and developed in 
several European and international projects: ETHOS, SAGE, FARMING, CORE, EURANOS, NERIS TP, etc. as well 
as the first results obtained under PREPARE and SHAMISEN programs. The course is made of lectures, 
practical working sessions, technical visits and discussions. It strongly relies on the practical experience of 
Belarussian organisations in the management of the Chernobyl consequences as well as on the first lessons 
from the management of the consequences of the Fukushima accident. 
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12. ANNEX 4. User groups  - Decision Support Systems 
The ARGOS Consortium 
PDC (Prolog Development Centre) and DEMA (Danish Emergency Management Agency) originally developed 
the ARGOS system to be used for CBRN(E) Emergency Preparedness and Response. In 2001 the ARGOS 
Consortium was founded to give other organizations the possibility to use ARGOS and participate in the 
further development. The purpose and mission of the ARGOS Consortium is to establish a forum for 
exchanging knowledge and ideas about the use of ARGOS, and to further develop the system to become the 
best possible tool for emergency preparedness and response. The Consortium arranges annual meetings 
where all members have the opportunity to influence the development of the system. New ideas and cases 
are discussed and the members decide on which new facilities to develop, which new models to include, etc. 
This way, the ARGOS Consortium ensures a user driven development of ARGOS. New members can enter the 
Consortium and get access to ARGOS license free - but there is an annual member fee that covers future 
developments and maintenance. ARGOS integrates and relies heavily on models from several Consortium 
Partners. ARGOS supports emergency management organizations in 13 countries covering more than 400 
million people worldwide. 
 
The RODOS user group 
The RODOS Users Group (RUG) has the following objectives  
• To provide a platform through which the members of the RUG can communicate their views, needs and 
comments and exchange their experience related with all elements of the RODOS system and its use, in 
particular provide response and guidance on refinements to make the system more user friendly and 
for any future developments of RODOS.  
• To share experience gained while integrating RODOS in the national emergency management 
arrangements, and to enable RUG members to enhance their own arrangements.  
• To identify best practices, to share technical know-how and organisational solutions, software 
developments and data bases and their implementation, and to provide mutual support, particularly on 
a regional basis.  
• To share practice and solutions related with use of RODOS for training and in exercises.  
• To provide a forum through which the members of the RUG can network with each other, independent 
of the RUG’s activities.  
• To establish contacts to the User Groups of other decision support systems within Europe (e.g. ARGOS) 
and overseas.  
• Strive at reaching compatibility of the RODOS system with other decision support systems.  
• To ensure sustainability of the RODOS decision support system through the establishment of 
maintenance procedures and sustainable arrangements between the users and the developers.  
• Promote the use of RODOS in Europe.  
RODOS user group meetings are organized on a yearly basis and last in general for 2 days. In general a 
European RODOS user hosts the meeting.  
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The European Radioecology Alliance 
The member organisations of the European Radioecology Alliance (ALLIANCE)1 bring together parts of 
their respective research and development programmes into an integrated programme that addresses 
scientific and educational challenges in assessing the impact of radioactive substances on humans and 
the environment and that maintains and enhances radioecological competences and experimental 
infrastructures. This integration is important and required to enable tackle complex radioecological 
challenges that could not be dealt with by one organisation alone. 
To address emerging issues in radioecology within Europe, eight founding organisations signed a 
Memorandum of Understanding (MoU) in 2009 that formed the ALLIANCE. The MoU states the 
intentions of ALLIANCE members to integrate a portion of their respective R&D efforts into a trans-
national programme that will enhance and sustain European radioecological competences and 
experimental infrastructures. The MoU asserts that ALLIANCE members will jointly address scientific 
and educational challenges related to assessing the impacts of radioactive substances on humans and 
the environment. 
The ALLIANCE members, at present incorporating an expanding number of organisations, recognise 
that their shared radioecological research can be enhanced by efficiently pooling resources among its 
partner organizations and prioritising group efforts along common themes of mutual interest. A major 
step in this prioritisation process was to develop a Strategic Research Agenda (SRA). This is one of the 
tasks of the SRA Working Group of the ALLIANCE. 
The ALLIANCE is an Association open to other organisations with similar interests in promoting 
radioecology, both within and outside of Europe. Thus, although the development of the SRA was 
largely a European effort, the hope is that it will stimulate an open dialogue within the international 
radioecology community. 
The list of the ALLIANCE members at the date of the 2019 General Assembly is given below.  
                                                          
1 European Radioecology Alliance http://www.er-ALLIANCE.org/, the association created by 8 founding organizations in 
Europe to integrate radioecological research in a sustainable way; also referred to the Radioecology Alliance. 
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Table 1 – List of the ALLIANCE member organisations and representative persons in Working Groups 
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SCK.CEN - Nuclear Research Center - Belgium (founding member - 2012) 
Hildegarde Vandenhove x   x     x       
Nele Horemans x   x           x lead 
Jordi Vives i Batlle x x         x lead     
Lieve Sweeck  x       x x       
Nathalie Vanhoudt          x x       
Talal Al Mahaini          x x       
DSA - Radiation and Nuclear Safety Authority - Norway (formerly NRPA - founding member, 2012) 
Jelena Mrdakovic Popic  x     x   x       
Anne Liv Rudjord      x             
Justin Brown          x         
Mikhail Iosjpe              x     
Bredo Moller                x   
Dag Brede                  x 
IRSN - Institute for Radiological Protection and Nuclear Safety - France (founding member, 2012) 
Rodolphe Gilbin x lead x             x 
Celine Duffa x           x lead     
Olivier Masson x             x lead   
Laureline Fevrier      x     x       
Marie Simon-Cornu          x         
Sylvain Bassot            x       
Chartlotte Cazala            x       
Rodolfo Gurriaran                x   
NERC-CEH - Centre for Ecology & Hydrology - UK (founding member, 2012) 
Nick Beresford  x x lead     x lead x x   x 
Catherine Barnett         x lead         
Dave Spurgeon                  x 
STUK - Radiation and Nuclear Safety Authority - Finland (founding member, 2012) 
Sisko Salomaa                
Maarit Muikku  x   x             
Pia Vesterbacka     x     x       
Tuomas Peltonen          x         
Juhani Lahtinen          x         
Antti Kallio            x       
SSM - Radiation Safety Authority - Sweden (founding member, 2012) 
Karolina Stark  x       x       x 
CIEMAT - Center for Energy, Environmental and Technological Research - Spain (founding member, 2012) 
Almudena Real  x x x lead     x   x   
Danyl Perez-Sanchez          x         
Juan Carlos Mora           x x     
Catalina Gascó               x   
MªAntonia Simón                x   
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Table 1 (cont’d.) 
ALLIANCE members EJP CONCERT Working Groups Topical Roadmaps Working Groups  
Table 1 (cont’d.) 
SRA E&T Infra Stkhlds 
Food 
Chain 
NORM Marine  Atmo TESS 
BfS - Federal Office For Radiation Protection - Germany (founding member, 2012) 
Martin Steiner x   x x lead x x x     
Bernd Hoffmann          x x       
Jacqueline Bieringer               x   
Christopher Strobl               x   
CEA - Alternative Energies and Atomic Energy Commission  - France (2014) 
Laure Sabatier          
Catherine  Berthomieu  
Virginie Chapon 
x       
 
X 
x 
      
Jacques Bourguignon          x x       
Olivier Evrard             x     
Dominique Calmet                x   
NNCRK - National Nuclear Centre of the Republic of Kazakhstan (2014) 
Sergey Lukashenko          
Zhanat Baigazinov          x         
HMGU - Helmholtz Zentrum München - Germany (2014) 
Jochen Tschiersch  x             x lead   
Jan Christian Kaiser          
HZDR - Helmholtz-Zentrum Dresden-Rossendorf - Germany (2014) 
Thuro Arnold x         x lead       
Susanne Sachs x         x lead       
Karim Fahmy                 x 
EPA - Environmental Protection Agency  - Ireland (2014) 
Simon O'Toole  x           x     
GIG - Central Mining Institute - Poland(2015) 
Boguslaw Michalik  x x x   x x     x 
Malgorzata Wysocka          
Krystian Skubacz                x   
Izabela Chmielewska                  x 
IST - Technical University of Lisbon - Portugal (2015) 
Maria José Madruga  x       x x       
Isabel Paiva    x       x       
José Corisco      x   x x       
Mário Reis        x x x       
NMBU-CERAD - Center for Environmental Radioactivity - Norway (2015) 
Brit Salbu x             x x 
Lindis Skipperud    x       x       
Ole Christian Lind     x         x   
Hans Christian Teien     x       x     
Deborah Oughton       x x         
Yevgenia Tomkiv        x           
IMROH - Institute for Medical Research and Occupational Health - Croatia (2015) 
Ivica Prlić            x       
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Table 1 (cont’d.) 
ALLIANCE members EJP CONCERT Working Groups Topical Roadmaps Working Groups  
Table 1 (cont’d.) 
SRA E&T Infra Stkhlds 
Food 
Chain 
NORM Marine  Atmo TESS 
Marin Mladinic           x       
NCSR Demokritos - Institute of Nuclear and Particle Physics - Greece (2016) 
Kostas Eleftheriadis                x   
Eleni Florou          x         
CLOR - Central Laboratory for Radiological Protection - Poland (2016) 
Paweł Krajewski  x   x     x       
Krzysztof Ciupek    x               
UB - University of Barcelona - Spain (2016) 
Miquel Vidal  x x x   x x       
Anna Rigol          x         
LARUEX - Environmental Radioactivity Laboratory of the University of Extremadura - Spain (2017) 
Francisco Jav. Guillén Gerada    x x   x x x x   
UPV-EHU - University of the Basque Country - Spain (2017) 
Fernando Legarda  x       x         
Margarita Herranz    x       x       
Raquel Idoeta      x     x       
Saroa Rozas          x         
UGR - University of Granada - Spain (2017) 
Mohamed L. Merroun  x x       x       
Thünen Institute (2017) 
Marc-Oliver Aust          
Pedro Nogueira  x       x   x   x 
University of Porto - Portugal (2018) 
Ruth Pereira            x     x 
University of Aveiro - Portuga (2018) 
Sonia Mendo            x     x 
Joana Lourenço            x     x 
Leibniz Universität Hannover - Germany (2019) 
Georg Steinhauser   x     x     x   
Clemens Walther   x     x         
NRG – Consultancy & Services  - Netherlands (2019) 
Govert de With  x       x x x     
CNRS-IN2P3 - National Institute of Nuclear Physics and Particle Physics - France (2019) 
Gilles Montavon            x       
IER - Institute of Environmental Radioactivity at Fukushima University - Japan (2019) 
Hirofumi Tsukada                   
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Preface and Executive Summary 
The ALLIANCE Strategic Research Agenda (SRA) devoted to radioecology is a living document that 
defines a long-term vision (20 years) of the needs for, and implementation of, research in radioecology 
in Europe. Initiated by the STAR2 Network of Excellence (Hinton et al., 2013), the current reference 
document is the third version of our SRA. It integrates the update of the research strategy 
implemented under the EU funded COMET3 project (Garnier-Laplace et al., 2018). The CONCERT 
European Joint Program (EJP) extended the opportunity for integration at the European level in a 
synchronised manner for all the platforms for research in radiation protection by coordinating the 
release of a joint research roadmap for all platforms, planned in December 2019. This reference 
document, shared by stakeholders and researchers, will serve as an input to those responsible for 
defining EU research call topics. 
This updated version of the SRA constitutes the ALLIANCE contribution to the CONCERT WP2 task 
for the development of SRA, roadmap and priorities for research on radioecology. A first activity was 
to make sure that recent scientific knowledge from radioecology (research outputs from the EC-funded 
projects (STAR, COMET and CONCERT funded projects: CONFIDENCE, TERRITORIES), main research 
advances from the ALLIANCE members and relevant international research outputs was integrated. 
Thus, it considers the state of radioecology and the stakeholders views, the interests of ALLIANCE 
member organisations, the research needs, data gaps and recommendations for the future of 
radioecology, and its sister science of ecotoxicology. 
Research in radioecology and related sciences is justified by drivers of various types, such as policy 
changes, scientific advances and knowledge gaps, radiological risk perception by the public, integration 
of research infrastructures, education and training to serve recruitment, lessons learned from the 
Fukushima disaster and a growing awareness of interconnections between human and ecosystem 
health. This version of the SRA is formulated by considering several aspects related to these drivers. 
Furthermore, it explores how social and human sciences, including ethical developments and 
communication issues, could contribute to the consolidation of European radiation protection culture, 
bringing together human perceptions and behaviour with science and technology. Research and 
innovation supporting the implementation of the revised European Basic Safety Standards is also 
considered.  
The strategy underlying the SRA development and its implementation within a roadmap is driven by 
the need for improvement of mechanistic understanding across radioecology, such that we can 
provide fit-for-purpose human and environmental impact/risk assessments in support of protection 
of man and the environment, in interaction with society and for the three exposure situations 
defined by the International Commission on Radiological Protection, ICRP (i.e., planned, existing and 
emergency).  
 
                                                          
2 https://radioecology-exchange.org/content/star 
3 https://radioecology-exchange.org/content/comet 
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Adequate research infrastructures and capabilities (facilities, equipment, methods, databases and 
models) are a necessary resource for state-of-the-art radioecological research. Ideas about how to 
study and evaluate the behaviour and impacts of radiation and radionuclides on the living world are 
changing. Consequently the required infrastructure and capabilities are also changing. Therefore, the 
updated version of the SRA specifically addresses the research infrastructures and capabilities needs 
in this SRA.  
Implementation of the SRA and the future of radioecology will depend on scientists and professionals 
being trained with skills relevant to industry and the needs of other stakeholders. It is critical for a 
vibrant science to continually attract and recruit bright, young talents into the discipline. Thus, the 
updated version of the SRA also includes a section on education and training challenges in 
radioecology, the associated vision and key action lines.  
The SRA prioritises three important scientific challenges that radioecology needs to address. Each of 
these scientific challenges includes a vision statement of what should be accomplished over the next 
20 years, followed by key research lines required to accomplish the vision. Addressing these challenges 
is important to the future of radioecology to enable the science to provide adequate scientific 
knowledge and tools to decision makers and the public. Other European platforms, among MELODI 
(Low-dose health effects), NERIS (Emergency preparedness and post-emergency management), 
EURADOS (Dosimetry of ionising radiation), have expressed common interests for some of the research 
lines. 
The three scientific challenges presented below, with their 14 associated research lines, are a strategic 
vision of what radioecology could achieve in the future through a directed effort and collaboration by 
many organisations. It is a vision in which the participants were asked to think creatively and without 
boundaries as they imagine the results that could most shape the future of radioecology and benefit 
stakeholders.  
 
Challenge one: To Predict Human and Wildlife Exposure in a Robust Way by Quantifying Key 
Processes that Influence Radionuclide Transfers and Exposure 
Our strategic vision is that over the next 20 years, radioecology will have achieved a thorough 
mechanistic conceptualisation of radionuclide transfer processes within major ecosystems (terrestrial, 
aquatic, urban), and be able to accurately predict exposure to humans and wildlife by incorporating a 
more profound understanding of environmental processes. 
Research Lines: 
1. Identify and mathematically represent key processes that make significant contributions to the 
environmental transfers of radionuclides and resultant exposures of humans and wildlife 
2. Acquire the data necessary for parameterisation of the key processes controlling the transfer 
of radionuclides 
3. Develop process-based transfer and exposure models that incorporate physical, chemical and 
biological interactions and associated kinetics, and enable predictions to be made spatially and 
temporally 
4. Represent radionuclide transfer and exposure at a landscape or large geographic scale with an 
indication of the associated uncertainty 
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Challenge two: To Determine Ecological Consequences under Realistic Exposure Conditions 
Our strategic vision is that over the next 20 years radioecology will have gained a thorough mechanistic 
understanding of the processes inducing radiation effects at different levels of biological organisation, 
including the consequences on ecosystem integrity, and be able to accurately predict effects under 
realistic exposure conditions. 
Research Lines: 
1. Mechanistically understand how processes link radiation induced effects in wildlife from 
molecular to individual levels of biological complexity 
2. Understand what causes intra-species and inter-species differences in radiosensitivity (i.e. 
among cell types, tissues, life stages, among contrasted life histories, influence of ecological 
characteristics including habitats, behaviour, feeding regime...) 
3. In a broader exposure context, understand the interactions between ionising radiation effects 
and other co-stressors 
4. In a broader ecological context, understand the mechanisms underlying multi-generational 
responses to long-term ecologically relevant exposures (e.g., maternal effects, hereditary 
effects, adaptive responses, genomic instability, and epigenetic processes). 
5. Understand how radiation effects combine in a broader ecological context at higher levels of 
biological organisation (population dynamics, trophic interactions, indirect effects at the 
community level, and consequences for ecosystem functioning) 
 
Challenge three: To Improve Human and Environmental Protection by Integrating Radioecology 
Our strategic vision is that over the next 20 years radioecology will develop the scientific foundation for 
the holistic integration of human and environmental protection, as well as their associated 
management systems. 
Research Lines: 
1. Integrate uncertainty and variability from transfer modelling, exposure assessment, and 
effects characterisation into risk characterisation 
2. Integrate human and environmental protection frameworks 
3. Integrate the risk assessment frameworks for ionising radiation and chemicals 
4. Provide a multi-criteria perspective including decision support systems for an optimised 
decision-making 
5. Towards better interaction and integration of radioecology with other disciplines, including 
social sciences and humanities (SSH) 
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The reality is that the SRA will require considerable resources and time to bring to fruition. The “how”, 
“means” and “practicality” of accomplishing the research items presented in the SRA are being 
developed in topical roadmaps that have been initiated by the COMET project, with the help and 
endorsement of the ALLIANCE Working Groups (WGs), on five priority subjects: 
1. Marine Radioecology. 
2. Human food chain. 
3. Naturally Occurring Radioactive Materials (NORM). 
4. Atmospheric Radionuclides in Transfer Processes. 
5. Transgenerational Effects and Species Radiosensitivity. 
The topical roadmap WGs regularly reviews the various roadmaps at a higher level to ensure that they 
are being consistent and complementary, without substantial overlaps, and without significant gaps. 
Their inputs were considered in this version of the SRA. Furthermore, a constant effort is to ensure 
that the roadmaps are translated effectively into adequately funded research programs, with funding 
at intra-national, national and international levels. 
 
 
 
_____________________________ 
 
The vision statements of our strategic agenda concentrate on the research aspects of radioecology. 
The Strategic Agenda also includes plans for other equally important aspects of our science (i.e. 
maintaining crucial radioecological infrastructures and knowledge management). 
Thanks to this work, the ALLIANCE has now the constituents to build a global roadmap with other 
research platforms in Radiation Protection. This will be the main output from the WP3 of the CONCERT 
EJP. This global roadmap will help in giving visibility to priority research to be implemented consistently 
with stakeholders’ needs and request for associated funds. Based on building blocks constituted by 
topical roadmaps, the ALLIANCE roadmap will be established and viewed as a global picture of the 
main achievements planned for the next 15 to 20 years. 
For society to obtain a significant contribution from the radioecology of the future, a long-term, 
multidisciplinary approach is needed that goes beyond national boundaries. It is our hope that a 
Strategic Research Agenda for radioecology will focus and priorities our collective efforts, resulting in 
increased value and more rapid advancement in our understanding of environmental radioactivity. 
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1. Introduction to the Strategic Research Agenda 
Radioecology is a branch of environmental science devoted to a specific category of stressor: 
radioactive substances. The science includes key issues common with other groups of pollutants, 
particularly metals (e.g., environmental transport, speciation, bioavailability, and effects at various 
levels of biological organisation), as well as aspects specific to radionuclides (e.g., specialised source 
terms including radioactive particles, external irradiation pathway, radiation dosimetry, radioactive 
decay, and unique aspects of very low level measurements). Radioecology emerged as a science in the 
late 1940s and 50s in response to concerns about releases from nuclear weapons production facilities 
and radioactive fallout from nuclear weapons tests. Scientific studies of several subsequent accidents 
at nuclear facilities enhanced knowledge about radioecology; however, much of the early data was 
classified and not publicly available until the cold war ended in the late 1980s (Iiyin and Gubanov, 
2004). 
Radioecological expertise is needed whenever ionizing radiation within the environment is of potential 
concern. The CONCERT First Joint Roadmap Draft (Impens et al., 2017) grouped four contexts, from 
which three of them result from environmental release (or remobilisation) of radionuclides: 
- Human activities related to the nuclear energy cycle and other industrial applications of 
ionising radiation not related to medical applications: Installations from the nuclear fuel cycle 
(from uranium mining through deposition of radioactive wastes); Industrial and scientific 
applications of ionising radiation; Military (former nuclear bomb testing sites, weapons fallout, 
nuclear-powered vessels. 
- Human activities related to the use of natural resources, containing naturally occurring 
radionuclides (NORM/ TENORM): Mining, processing, waste management of natural 
resources containing natural radionuclides  (e.g. oil and gas extraction, NOR-rich ore mining); 
use, processing, recycling and waste management of technologically enhanced naturally-
occurring radionuclides, including decommissioning of NORM affected industrial facilities; 
NORM contaminated legacy sites. 
- Natural radiation as source of ionising radiation: terrestrial and cosmogenic radiation, natural 
events leading to radionuclide releases: High natural radiation background areas, potentially 
resulting in radon and thoron in indoor and outdoor air/ or in natural nuclides present in 
water/food; exposure to cosmic radiation at high-altitude or in space.  
Seven exposure scenarios related those contexts have been identified and grouped according to the 
ICRP classification in planned, existing and emergency exposure situations. Five of these scenarios 
covers environmental exposure of the public and the ecosystems (two scenarios are not related to 
environmental exposures, i.e. patient exposure regarding medical applications and exposure of 
workers). 
- Exposure of the general public, workers and the environment as a consequence of industrial 
applications of ionising radiation and the use of NORM in normal operation conditions. 
- Exposure of the general public and the environment with regard to nuclear legacy. 
- Exposure of the public and the environment to the natural radiation environment. 
- Exposure of the general public, workers and the environment following a major nuclear or 
radiological accident or incident including long term consequences. 
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- Radiation protection of the public, workers and environment as a consequence of a 
malevolent nuclear or radiological act including long term consequences. 
Following the Chernobyl accident, European research in radioecology excelled such that Europe's 
foremost expertise was widely recognised. Radioecology was faced with a substantial decrease in 
funding in the beginning of the 21st century leading to a decline of expertise. One major reason for the 
decline is that research efforts that were intensive during the years following the Chernobyl accident 
have substantially decreased. FUTURAE (2008), a Euratom Coordinated Action within the European 
Commission’s 6th framework, surveyed the state of radioecology in Europe and found deficiencies in 
research, as well as in education, funding and infrastructure support. Following FUTURAE but also 
following the Fukushima disaster, where a call for radiological expertise from various embassies in 
Japan, alerted several government agencies to the scarcity of qualified personnel (e.g., U.S. case4). 
Since then there has been a small but steady European funding but also the responsible authorities in 
the different European member states invested again in radiation protection research. 
This Strategic Research Agenda is a suggested prioritisation of research topics in radioecology, with a 
goal of improving research efficiency and more rapidly advancing the science. It responds to the 
question: “What topics, if critically addressed over the next 20 years, would significantly advance 
radioecology?” 
The ALLIANCE is an Association open to other organisations with similar interests in promoting 
radioecology, both within and outside of Europe. Thus, although the development of the SRA has 
largely been a European effort, the hope is that it will stimulate an open dialogue within the 
international radioecology community: 
• other pan-European platforms with research topics that require radioecology 
[Multidisciplinary European Low Dose Initiative (MELODI); European Platform on 
Preparedness for Nuclear and Radiological Emergency Response and Recovery (NERIS); 
Implementing Geological Disposal of Radioactive Waste Technology Platform (IGD-TP)]; 
• other radioecology networks around the world [e.g., National Centre for Radioecology 
(NCoRE), within the United States]; 
• the International Union of Radioecology (IUR); 
• international organisations [e.g., World Health Organization (WHO); United Nations Scientific 
Committee on the Effects of Atomic Radiation (UNSCEAR); International Commission on 
Radiological Protection (ICRP), International Atomic Energy Agency (IAEA)]; 
• regulators;  
• industry; and 
• other interested stakeholders. 
The original SRA was distilled from several evaluations on the state of radioecology, including input 
from stakeholders (FUTURAE 2008), the interests of ALLIANCE member organisations, the IUR5, lists of 
research needs, identification of data gaps and recommendations for the future of radioecology, or its 
                                                          
4 Information from presentation made by representatives of the U.S. Centers for Disease Control and Prevention during the 
annual meeting of the National Council on Radiation Protection (Washington, D.C.; 13 March 2012; see pages 13-14 of 
the 48th Annual MeetingReport): 
http://www.ncrponline.org/Annual Mtgs/2012 Ann Mtg/Electronic NCRP 2012 Annual Mtg Program.pdf 
 
5 www.iur-uir.org/en/ 
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sister science of ecotoxicology (Whicker et al. 1999; Hinton 2000; Brechignac et al. 2003; Calow and 
Forbes 2003; Brown et al. 2004; Eggen et al. 2004; Garnier-Laplace et al. 2004; Shaw 2005; Alexakhin 
2006; OECD-NEA 2007; Brechignac et al. 2008; Larsson 2009; Pentreath 2009; Salbu 2009a; Repussard 
2011; Artigas et al. 2012; Garnier-Laplace et al. 2018). 
The updated SRA was formulated by considering a number of different drivers (Garnier-Laplace et al., 
2018): 
• Credibility concerns: Uncertainties and lack of predictive power in risk assessments are major 
contributors to the public’s reduced credibility of the radiological sciences, and thus a major 
driver for additional research to enhance knowledge. Credibility of assessment models is 
particularly important because their predictions are often key constituents in decisions made 
about emergency response, waste management, environmental remediation, and mitigation 
(Whicker et al. 1999). Some of these uncertainties originate from the exposure assessment, 
which is largely dependent on knowledge of the environmental behaviour of radionuclides.  
• Generating trust: The general public needs to have the necessary confidence in decision 
makers to be able to trust their judgements, advice and recommendations. The increasing 
environmental awareness of the public reinforces the need for clarity and transparency within 
the scientific community relative to the long-term ecological consequences of any nuclear 
accident or chronic exposure situation. For example, the divergent scientific opinions on the 
effects on human health and wildlife in the Chernobyl exclusion zone do little for public 
confidence. This means that multidisciplinary opinions, either consensual or divergent, have 
to be shared and used to revisit evidence and related actions. Even more, as it has been 
demonstrated in the event of a nuclear accident, scientific consensus does not always translate 
into consensus of action by authorities (e.g., Oughton 2011; Hasegawa 2012; Beresford et al 
2016). 
• New paradigms and scientific advancements: Recent changes relevant to radiation effects on 
humans are also relevant to radioecology, and go beyond the previous dogma of single target 
theory for cell survival as the only mode of action for cell death. New ideas are being 
incorporated into the science, such as epigenetics, bystander effects, genomic instability and 
population consequences from multigenerational exposures. Radioecology also must 
capitalize on the rapid advances in the “-omic” and AOP sciences to help develop mechanistic 
explanations and early warning biomarkers. 
• Changing policy: The present framework of radiological protection is moving towards the 
need to demonstrate the protection of the environment explicitly as opposed to an 
assumption of protection. For example, this is seen in the revised versions of the 
international Basic Safety Standards (BSS) (IAEA 2011) and to a lesser extent, in the Euratom 
BSS (European Commission 2013) in their interim or draft status at the time of the SRA 
inception. 
• Integration issues: Recognition that radioecology’s future success, such as for example, 
meeting stakeholder needs, will require integration into the whole system of radiological 
protection. The recent ICRP rearrangement of its Committees to address protection of people 
and the environment in an integrated manner is a further indication of the recognition of this 
need.  
• Potential risks: The lessons learned following the accidents at Three Mile Island (USA, 1979), 
Chernobyl (Ukraine, 1986) and Fukushima (Japan, 2011) demonstrate a number of knowledge 
gaps, with excessively large uncertainties associated with a number of environmental 
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processes governing the fate and effect of radionuclides within ecosystems. Future events (e.g. 
misuse of nuclear weapons, attack on nuclear installations, or use of dirty bombs containing 
many poorly researched radionuclides) may release radionuclides to the environment that are 
different from those for which we now have the most knowledge. This situation results in 
uncertainties in human and wildlife dose assessments, making it difficult to robustly support 
the decision-making process. 
• Impact of controversial findings: In the context of ecological consequences of nuclear 
accidents, the growing number of peer-reviewed publications alleging ecosystem damage 
from radiation doses at the level of natural background (and sometimes even below) 
undermine credibility in radioecology. If such findings evidencing the biological effects of 
ionising radiation at very low dose rates are correct, both the systems for environmental 
protection and protection of humans from ionising radiation will be questioned.  
• The growing awareness by the public of the importance of the global quality of environmental 
resources and biodiversity, with many examples of national regulations directed to the 
protection of the environment as a whole (e.g., nature conservation, uses of environmental 
resources, air, soil, water quality). Even more significantly, human and ecosystem health are 
now recognised as strongly interconnected as evidenced, for example, by several principles 
and goals for sustainable development recently agreed upon in the 2030 development agenda 
of the United Nations (2015). 
• The need for an integrated approach in order to improve the degree of realism in dose 
assessments (and therefore in evaluations of the associated impacts or risks) either for the 
public or wildlife for a wide range of exposure situations. Going towards more site specific, 
individual (for humans) dose assessments to enhance realism imply a need to improve risk 
communication among stakeholders as to the most significant uncertainties. 
• The need to develop applied research activities in order to solve several statements of the new 
Euratom BSS that are related to radioecology. These needs are urgent since the BSS are already 
being translated into corresponding national laws. 
Based on consideration of the items above, the SRA prioritises three major scientific challenges facing 
radioecology. Each of these scientific challenges is developed as a separate section of the SRA and 
includes a vision statement of what should be accomplished over the next 20 years in that area of 
radioecology. The Strategic Research Agenda includes key research lines deemed necessary to 
accomplish the vision. 
The three scientific challenges presented below, with their 14 associated research lines, are a strategic 
vision of what radioecology can achieve in the future through a directed effort and collaboration by 
many organisations. It is a vision in which the participants were asked to think creatively and without 
bounds as they imagine the results that could most shape the future of radioecology and benefit 
stakeholders. Implementation of the SRA and the future of radioecology will depend both on (1) 
adequate research infrastructures and capabilities (facilities, equipment, methods, databases and 
models) and (2) scientists and professionals being trained with relevant skills for industry and the needs 
of other stakeholders. It is critical for a vibrant science to continually attract and recruit bright, young 
talent into the discipline. Thus, the updated version of the SRA also includes a section on 
Infrastructures and Capabilities and on Education and Training challenges in radioecology, the 
associated vision and key action lines. Those sections includes inputs from the CONCERT WP6 (access 
to infrastructures) and WP7 (Education and Training).  
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2. Three Scientific Challenges in Radioecology 
2.1. Challenge One: To Predict Human and Wildlife Exposure in a Robust Way 
by Quantifying Key Processes that Influence Radionuclide Transfers and 
Exposure 
One of the fundamental goals of radioecology is to understand and predict the transfers of 
radionuclides and consequent exposure of humans and wildlife. This is needed for a wide range of 
sources and release scenarios, exposure situations and assessment contexts in atmospheric, terrestrial 
(agricultural, semi-natural, natural, urban) and aquatic (marine, freshwater, estuaries) environments. 
The problem is that the key processes that govern radionuclide behaviour, associated transfers among 
environmental compartments and resulting exposures are not always well understood, leading to 
models that have an incomplete (or even inaccurate) representation of the processes, i.e. model 
conceptual uncertainty. Scientific knowledge is gradually being accrued through on-going 
improvements in our understanding of these underlying processes. Hence in recent years, a number 
of research programmes have contributed to challenge 1 including EU-funded projects such as STAR, 
COMET with two associated COMET-FRAME and COMET-RATE projects, HARMONE associated to 
OPERRA, CONFIDENCE and TERRITORIES associated to CONCERT or national funded projects such as 
the French-funded projects (AMORAD) and the UK-funded RATE. The major achievements of these 
programmes can be summarised as follows: 
• Improvement of wildlife dose assessment by initiating alternative models to the concentration 
ratio (CR) approach (Beresford et al. 2013, 2016, STAR) and exploring the application of Bayesian 
approaches (Hosseini et al., 2013) and allometric models for wildlife (Beresford and Vives i Batlle, 
2013, STAR).  
• Assessments of animal-environment interactions were performed with the view of determining if 
current assessment models are fit for purpose (Aramrun et al., 2019; Hinton et al., 2015, 2019) and 
from these recommendations for improved field dose assessments (Beaugelin-Seiller et al. in-
press, on-line) (STAR/COMET). 
• Regionalisation of radioecological food chain models (Brown et al. 2018) and development of 
taxonomy based models for freshwater (Cs) and terrestrial wildlife species (Cs, Pb, Se, Sr and U) 
(Beresford et al. 2013; Beresford & Willey 2019; Søvik et al. 2017, COMET and OPERRA-HARMONE). 
Evaluation of these led to the recommendations that they need to bef urther parametrised for the 
edible portions of plants (currently the models are parameterised using green shoots only) 
(Beresford et al. 2019, CONCERT-CONFIDENCE). 
• Development of process-based soil-plant transfer models (Almahayni et al., 2019, CONCERT-
CONFIDENCE and Shaw et al. 2019, UK-funded RATE) and addition of a process-based sub-model 
in to an existing human food chain model (Almahayni et al., 2019, CONCERT-CONFIDENCE). 
• For NORM, identification of the key processes for safety assessment studies using an FEP approach 
(Features, Events and Processes) to highlight future research priorities (COMET), but no EC-funded 
project  
• For marine radioecology, a dynamic transfer model for biota was applied to the Fukushima 
environment (Vives i Batlle et al., 2016, COMET-FRAME), dynamic transfer modelling was further 
integrated with emergency methodologies (OPERRA-HARMONE) and different levels of complexity 
  
page 19 of 61 
 
of marine models were compared to simulate the West Cumbrian beaches, contaminated by 
releases from the Sellafield reprocessing facility (CONCERT-TERRITORIES). 
• For forest modelling a handbook giving practical guidance on the need and applicability of process-
based modelling in conjunction with other approaches from simple to complex, for modelling 
contamination in forests (Diener et al., 2017, COMET) and further in CONCERT-TERRITORIES  to 
produce guidance in forest modelling. ECOFOR SVAT (a soil vegetation atmosphere transfer 
model), was fully developed and parametrized under controlled conditions at the Belgian NORM-
contaminated forest Observatory (ECOFOR, Vives i Batlle et al., 2019), whereas another one was 
based on meta-analysis of Japanese data (Gonze & Calmon, 2017). A major achievement of these 
is including of incorporation as one of the key processes in cycling process-based models (Gonze 
& Calmon, 2017). 
• For radioactive particles, progress was made in quantifying the processes of their transformation 
in the environment and associated radionuclide leaching and to assess their ecosystem transfer 
(Salbu et al., 2018, COMET-RATE). The CONFIDENCE project has for the first time begun to assess 
the relevance of particles when modelling human food chain transfer (Lind et al., 2019). 
• Finally in the aftermath of the Fukushima accident a number of projects have studied the 
applicability of different models dynamic transfer models for marine biota to the Fukushima 
scenario. In this respect also the early stage dynamics of radiocesium in forest ecosystems, mainly 
driven by the rates of canopies depuration (returns to forest floor processes/fluxes) were 
investigated within several Japan-funded and a French-funded projects (AMORAD) for various 
species (Loffredo et al., 2015 ; Kato et al., 2019). Additionally translocation of forest contamination 
to other environmental compartments (rivers, watersheds), with potential entry into the food 
chain was investigated by Japanese colleagues ter (Laceby et al., 2016; Naulier et al., 2017). 
Within this context, some innovative methods for removing radionuclides from contaminated solid 
and liquid matrices were also developed and proposed as part of the « post-accidental » 
management of contaminated territories (eg. DEMETERRES project- Chagvardieff et al., 2017).  
 
The challenge faced by radioecologists to date is to further incorporate this knowledge into models 
capable of realistically representing the behaviour of the radionuclides, ideally considering the 
different levels of organisation present in the environment, from small to large scales (i.e., from 
molecules to environmental compartments and global ecosystems). By making the models more 
realistic and process-based, we expect: (i) a significant reduction in model uncertainty; (ii) a better 
quantification of environmental variability; (iii) identification of the most influential parameters; and 
of parameters/factors contributing the most to the overall uncertainties, (iv) improved modelling tools 
capable of predicting radionuclide migration overtime and subsequent exposure to humans and 
wildlife under a variety of conditions, thereby enhancing predictive power and the robustness of both 
human and wildlife assessments of exposure to ionising radiation, and; (v) to be able to provide 
scientifically justified safety assessments for hypothetical future situations that need to take into 
account biogeochemical cycling of radionuclides over large time scales, changing climate conditions, 
and changing landscapes (Figure 1). 
The input data and models needed for assessing the radiological environmental and human impacts 
differ depending on the source term, release conditions (aquatic versus atmospheric, routine versus 
accidental), assessment endpoints and the type of space- and time-dependency (dynamics and 
speciation) of the problem. The simplest is a static scenario in which the radionuclides are released in 
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a continuous and uniform way which is in balance with physical decay, chemical and microbiologically 
influenced reactions and dispersion into the wider environment. This assumes the radionuclides to be 
in a “constant” equilibrium and is a reasonable (i.e. fit-for-purpose) approximation for most routine 
release and existing exposure situations. However, the approach has limitations for releases occurring 
on short time scales such as a planned series of rapid pulsed releases, accidental situations or simply 
when processes are influenced by dial and seasonal variations. In such events, a simplistic, empirical 
ratio approach is no longer valid and a dynamic, process-oriented modelling approach is required. 
Fundamental research is hence needed to better understand and model the key dynamic processes, 
such that powerful dynamic process-based radioecological models can be parameterised and 
populated. However, from recent consultation with industrial and regulatory end-users (Almahayni et 
al., 2019) a need to more clearly communicate the need and benefits for process-based models was 
demonstrated. This will include a need for validation of the models and an opportunity for the 
ALLIANCE (and other relevant platforms) to collaborate with the International Atomic Energy Agency 
within their model orientated programmes (e.g. EMRAS, MODARIA6). 
 
 
Figure 1. Scheme of key aspects to challenge one: To Predict Human and Wildlife Exposure More 
Robustly by Quantifying Key Processes that Influence Radionuclide Transfers, and Incorporate the 
Knowledge into New Dynamic process-based Models. 
 
Sthe description and assessment of the source term and its evolution. For numerous elements soil-
to-plant transfer factors were available for only 10 % of the plant and soil group combinations or were 
derived from only a single generic value estimated by expert judgment, or derived by analogy to a 
chemically similar element (IAEA 2009). The scarcity of data also increases with trophic level and stages 
in the human food chain. For approximately 50 % of the listed radionuclide-animal product 
combinations, no transfer coefficient data were available. The wildlife empirical ratios compiled by 
IAEA (2014) also have substantial data gaps and many of the values are based on few data (345 of 946 
values for the generic wildlife groups are derived from less than 3 observations). The STAR-COMET-
                                                          
6https://www-ns.iaea.org/projects/modaria/modaria2.asp?s=8&l=129 
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CONCERT-CONFIDENCE EURATOM funded projects and the UK sponsored TREE project7 have advance 
extrapolation approaches (e.g. Beresford et al, 2016). However for a range of radionuclides 
assessments is still needed (Beresford et al. 2019x). These include radionuclides released by medical 
facilities (e.g. radioisotopes of Cr, F, Fe, Ga, Ho, In, La, P, Re, Sm, Tc, etc.); associated with the 
decommissioning of nuclear licenced sites (including, 108,108mAg, 243Am, 10Be, 41Ca, 152,154,155Eu, 55,59Fe, 
203Hg, 93Mo, 22Na, 93mNb, 147Nd, 93mNb, 193Pt, 46Sc, 151Sm and 182Ta); relevant to fusion reactors (including 
activation products such as Fe, Ni, Mn); long-lived radionuclides associated with geological disposal 
facility assessments. For some of these radionuclides there are no existing data for either human or 
wildlife assessment, and no guidance on how to conduct an assessment given this lack of data. 
Uncertainty also arrives from the use of simple empirical ratios in radiological assessment models (Ng, 
1982; IAEA, 2009) as to represent the transfer between environmental media means aggregating many 
physical, chemical and biological processes into one parameter, and this is an implicit weakness of the 
approach leading to the observed variability and uncertainty in model predictions. For example, 
'distribution coefficients' (Kd's) defined as a simple solid/water activity concentration ratio, assuming 
equilibrium conditions have been shown to vary by orders of magnitude under changing geochemical 
conditions. Therefore process-based dynamic models not relying on Kd’s are supposed to describe the 
situation more realistically (Børretzen and Salbu, 2002). A major improvement here is to further 
develop the “smart Kd” concept (Stockmann et al., 2017) that relies on data bases of surface 
complexation constants which are combined with information from the respective field sample. 
Additionally, the large variation in soil-to-plant transfer factors for e.g., Cs among agricultural crops 
(IAEA, 2009) is mainly because soil processes affecting radiocaesium fluxes are not adequately 
captured by empirical ratios, even when grouped by soil texture classes. Alternatively, the semi-
mechanistic model of Absalom et al. (1999) explained 60 to 90 % of the observed variability in Cs 
uptake by plants by including soil contamination level, clay content of the soil and the soil 
exchangeable K status. Further understanding of the chemical speciation of radionuclides in different 
soils, as well as the influence of microbiological processes, is crucial to understand and be able to 
describe the transport of radionuclides through the environment and the manner in which humans 
and other organisms are exposed to radiation. Improving our understanding and developing process-
based approach should result in models which are globally applicable and potentially able to model 
the impact of soil-based countermeasures (e.g. Cox et al., 2005).  
The environmental behaviour of radionuclides is controlled by complex biological, chemical and 
physical processes and may vary (1) spatially - due to differences in water chemistry, sedimentary 
dynamics, soil type, land use management, and diversity of biological assemblages and communities; 
(2) temporally - due to time after release, organism’s life stage, climatic stressors such as floods, 
storms, water cascading, biologically-driven processes, landscape evolution and scenarios of global 
change; and (3) with source term - due to history of the releases, physico-chemical forms (speciation), 
and presence of co-contaminants. Unfortunately, although these factors are acknowledged to be 
important and have been the focus of considerable research (e.g., Salbu, 2009b; Vandenhove et al., 
2007; Eyrolle et al., 2009), they are still poorly developed in radionuclide transfer and exposure 
models. Spatially implemented process-based soil-crop models have previously been developed and 
incorporated into decision support systems (Gillett et al., 2001; Cox et al., 2005). However, such models 
have not been widely adopted likely because of poor communication of their benefits and lack of 
                                                          
7https://tree.ceh.ac.uk/ 
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confidence by end-users as they are perceived to be too complicated (Almahayni et al., 2019). With 
respect to predicting the exposure of wildlife the potential importance of considering the extent to 
which spatial variability may need to be considered has been highlighted in studies which have 
attached dosimeters and GPS collars to animals in contaminated environments  (Aramrun et al., 2019; 
Hinton et al., 2019 Jones et al., 2019, CONCERT TERRITORIES). Work in CONCERT-CONFIDENCE has 
begun to address the lack of data for Mediterranean food production systems (Guillén et al. 2019); 
similarly data have recently been provided for Mediterranean wildlife in collaboration with the COMET 
project (Guillén et al. 2018).   
A gap generally exists between the measurement scale typically used in research studies and the 
scale needed in management decisions and regulatory measures. One of the reasons for this gap is 
that the understanding of radionuclide interactions in the environment is often based on small-scale 
observations or experiments, and it is not known how such processes or changes may affect key 
processes and functioning of environmental systems at larger scales. Therefore, understanding of 
spatial scales between and within environmental compartments and the impact from global circulation 
patterns needs to be expanded to provide improved assessment and management strategies for 
radionuclides released into the environment. This is particularly important in atmospheric and marine 
modelling as highlighted by the findings of COMET project FRAME regarding radionuclide transport 
processes in marine ecosystem near Fukushima (such as, for example, groundwater infiltration to sea) 
and of the IAEA MODARIA working group on marine dispersion modelling, also in Fukushima. 
Process based models have varying degrees of complexity that depend on the situation modelled. Yet 
a process based model is not necessarily always too complex and may be easier to explain to the public 
than a ‘black-box’ model based on ratios and rate constants. The observation that the model 
complexity may change depending upon need has led to the suggestion that it would be useful to have 
one modelling package where different components are modularly assembled. The implementation of 
the FDMT food chain model, the ‘Absalom’ model and a sub-model for particle source terms into the 
EGOLEGO package within CONCERT-CONFIDENCE (Brown et al., 2018; Lind et al., 2019) are a good 
demonstration of how we could develop models in the future. 
In summary, the priority given in this SRA to process-based modelling is based on sound science, the 
ability of such models to reduce modelling uncertainty, increased predictive power, their ability to 
treat dynamic situations, potential to model soil-based countermeasures and their higher 
transferability compared with empirical models. There is however, as already noted, a lack of uptake 
of the previously developed process-based models by end-users and we need good communication, 
training and the ability to demonstrate validation to improve this in the future.  
2.1.1. Strategic vision for research  
Our strategic vision is that over the next 20 years radioecology will have achieved a thorough 
mechanistic conceptualisation of radionuclide transfer processes within major ecosystems (terrestrial, 
aquatic, urban) for a wide range of source terms, release and migration scenarios and exposure 
situations, where relevant and needed, and be able to accurately predict exposure to humans and 
wildlife by incorporating a more profound understanding of environmental processes and assure that 
fit-for-purpose process-based models based on scientific modelling of the radioecological mechanisms 
will have found a way into future assessment tools.  
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2.1.2. Strategic agenda  
The major aim of challenge one is to develop process based models of environmental transfer and 
exposure to substantially improve human and environmental dose and impact assessment. Research 
should be focussed on those factors contributing the most to uncertainties in exposure assessments. 
The developed process-based models will begin to form part of the next generation of assessment 
tools. They should also contribute to addressing the need for an integrated approach to human and 
wildlife exposure assessment.  
The approach can be applied (with an appropriate level of complexity) to a wide range of sources 
encompassing existing (e.g. uranium mining and milling sites, NORM sites, post-accident situations), 
planned  (e.g., new build, (geological) waste disposal, NORM involving industries, medical radio-
isotope and radiopharmaceuticals production facilities) and emergency (accident, incident, malevolent 
acts) exposure situations. Emergency situations are the focus of the SRA of NERIS so the radioecological 
related aspects will be researched and developed in close collaboration with NERIS); aspects of source-
term characterisation, distribution and migration through food chains, development of 
countermeasures and remediation strategies are within the remit of Challenge 1 of the ALLIANCE’s 
SRA. Related to (high-level) waste disposal our SRA will concentrate on the biosphere and 
geosphere/biosphere interaction zone, linking to networks such as BIOPROTA8, IGD-TP9  and 
EURADScience10 as well as the IAEA MODARIA successor projects. Environments other than temperate 
ecosystems will be considered.  
The mechanistic, process-based, approach should  
• Enhance scientific knowledge about environmental processes and their mutual interactions. 
Radionuclides then become tracers to understand local and large scale processes, which in 
turn can help inform other disciplines (such as ecology, geochemistry and toxicology); 
• Enable long-term forecasts and the influence of climate and landscape changes on the 
environmental transfers of radionuclides;  
• Assist in the development of tools for response, remediation, and restoration; and  
• Support multi-criteria analysis and hence decision making.  
Validation of developed models will be important to ensure end-user uptake; there is potential for a 
strong collaboration with IAEA programmes in model validation. 
2.1.2.1. Identify and mathematically represent key processes that make significant 
contributions to the environmental transfers of radionuclides and resultant exposures 
of humans and wildlife 
A challenge for radioecologists over the next two decades is to develop a profound understanding of 
environmental transfers and exposure processes that permit observations to be explained and robust 
predictions to be made. The main aspects will be (i) identifying processes, parameters or factors that 
                                                          
8 http://www.bioprota.org/ 
9 http://www.igdtp.eu/ 
10 http://hal.in2p3.fr/in2p3-02169313 
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contributes the most to the overall uncertainties, (ii) determine the level of model complexity needed 
for specific exposure scenarios and (iii) justifying the additional research required for data generation 
and to parameterise dynamic-mechanistic models.  
Criteria will be developed to identify key processes that have a significant impact on radionuclide 
transfers in atmospheric, terrestrial, aquatic and built-up (e.g. urban) environments. For example 
through process sensitivity analysis developed in geological disposal safety assessment (Features, 
Events and Processes - FEP) where processes rather than parameters are varied/added/removed to 
test the optimum process representation in a radioecological model; this approach was applied by the 
COMET project and further refined by CONCERT-TERRITORIES. Amongst the model features considered 
will be source-term-specific release scenarios (including physico-chemical forms), spatial and temporal 
dynamics in source term–environment interfaces (dispersion and dilution, changes in radionuclide 
speciation due to physical, chemical and biological interactions), migration and cycling pathways in 
specific ecosystems, and radionuclide uptake, accumulation, redistribution and depuration by 
organisms. Once the key processes have been identified, equations will be derived that capture their 
temporal and spatial kinetics. Criteria to identify the relevant factors and processes could be inferred 
from the variability observed in aggregated parameters and the associated uncertainties in transfers, 
as shown by scatter plots of empirical transfer factor values and associated cumulative distribution 
functions. A classification based on key environmental characteristics, taxonomy, source term, etc. 
along with a scientific understanding of radioecological mechanisms, should help unravel and classify 
the processes underlying the aggregated parameters.  
One of the goals of this research line is to identify the key processes, based on fundamental physical, 
biogeochemical and ecological principles that govern the transfer of radionuclides within major 
ecosystems types (e.g., agricultural, grasslands, coniferous forests, freshwater lakes and rivers, marine 
systems, urban environments) or contexts (e.g. nuclear or NORM related industrial environments, 
waste disposal environments). Some elements of this knowledge may exist in other fields (e.g. soil 
scientists). This goal can be realised by the development of conceptual and mathematical test models 
allowing the identification and ranking of key processes in a quantitative, but also in a qualitative 
manner using expert judgement. Systematic model reduction can be applied to test the utility of the 
model components (e.g. Tarsitano et al., 2011). For the future, the verification of model predictions 
could better benefit from a comparison with observatory data. 
Within this research line, we intend to progress further towards process-based dynamic models. 
Process-based modelling is essential to demonstrate that scientifically justified impact and safety 
assessments can be made for future situations. The various empirically-based model parameters will 
be replaced by mathematical equations that describe the key physical, chemical and biological 
processes that govern radionuclide transfers. Properties specific to radionuclides and the biotic and 
abiotic components of each environment will be incorporated. A key issue is then to validate the model 
outcome in the field. Examples include: 
• relating the environmental mobility of radionuclides to their speciation resulting from the 
oxidising/reducing properties, pH, redox potentials, salinity, DOC, mineralogy, general 
chemical composition of environmental media or biological actors (e.g. microbial activity, 
presence of mycorrhiza);  
• advection-dispersion equations for describing flow kinetics in aquatic environments;  
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• simulating rates of water movement in porous media; and 
• metabolic theory for describing the biokinetics/toxicokinetics of contaminants in living 
organisms. 
In all cases, the objective will be to produce a set of physically and dimensionally consistent primary 
differential equations that represent the temporal and spatial dynamics of processes governing 
radionuclide transfers. The equations will, to the extent possible, incorporate the material properties 
of the radionuclides and environments and, ultimately, the basic laws of nature. Knowledge on 
associated processes has advanced for post-accident situations (Cs, Sr, I) but is generally deficient for 
other exposure situations and contexts (unforeseen events, decommissioning of nuclear facilities, 
urban context, industrial environment) and the majority of other radionuclides. For some recently 
emerging radionuclides such as medical radioisotopes, data are missing but scoping calculations 
related to potential dose contribution are required before setting of too complex modelling.  
It is important that the knowledge gained from the various research activities is rapidly assimilated and 
made available to the wider community. This is likely to require the development of flexible and open 
databases that do not ‘force’ the information into an over-constrained conceptual model framework, 
together with a platform (or platforms) for the modular development of mathematical models (as 
exemplified by recent work in the CONCERT-CONFIDENCE project (Brown et al., 2018; Lind et al., 2019). 
2.1.2.2. Acquire the data necessary for parameterisation of the key processes controlling the 
transfer of radionuclides 
Major data collection activities (such the IAEA handbooks of radioecological transfer parameters) have 
identified significant data gaps and limitations for many of the empirical parameters which underpin 
dose assessment models for humans and wildlife. The wide range of radionuclides, human foodstuffs 
and species of wildlife means that, pragmatically, we may never be in the position of having empirical 
data for everything. 
There is a need to consider alternative approaches to address this lack of data for model 
parameterisation in the most robust manner possible (rather than relying on highly conservative 
judgment to avoid analysing the problem in more depth, as is often the case currently). Extrapolating 
across the periodic table using chemical analogues is such an approach. For example, in the context of 
the Fukushima accident, it was proposed that estuarine reactivity of short-lived radioactive tellurium 
could be assessed based on the behaviour of its stable analogue. Other approaches, such as Bayesian 
statistics, allow a low number of empirical observations to be supported by inferences from more 
comprehensive, larger datasets (this approach has been used in the parameterisation of the ERICA 
Tool (Brown et al., 2016)). Some approaches to extrapolate data have been suggested for application 
across species (wildlife species or human food chain species) such as phylogeny (i.e. using ‘common 
ancestry’ to categorise transfer) and allometric (mass dependent) relationships. These approaches 
have started to be advanced by activities in the STAR, COMET, CONCERT-CONFIDENCE and TREE 
projects (see above).  
The data for model parameterisation will require focused laboratory-based work and field studies, as 
well as on-going reviews of published information from the wider scientific community (both at 
suitably-designated "observatory sites" and more generally from environmental monitoring). For 
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example, a preliminary inventory of databases acquired from observatories and monitoring sites at the 
European scale by the various STAR partners highlighted the richness of environmental data, especially 
their temporal and spatial distributions, even though heterogeneity and data gaps were identified. The 
Belgian NORM site (Alliance observatory intensely investigated in CONCERT- TERRITORIES) proved the 
benefit of establishing mechanistic investigations in controlled conditions to scientifically explore 
process-based models (Vives I Battle, 2019). The Upper Silesia Coal Basin (another European 
radioecological observatory) was also investigated in CONCERT-TERRITORIES in order to explore the 
conceptual scheme of processes occurring in a Polish lake displaying NORM, including the occurrence 
of early diagenesis process (Mora et al., 2019). Even if less exhaustively informative, long-term data 
series obtained along routine surveillance programs can also provide information for transfer 
modelling (Brimo et al., 2019). 
Some of the data gaps are expected to be filled by innovative analytical tool developments in both 
radioactive and non-radioactive metrology. For example, difficulties persist in quantifying the various 
radioactive decay products from the natural U-Th decay chains within the same sample at a given time. 
In this context, ICP-MS and AMS analyses offer potentially exciting solutions.  
To maximise opportunities for data acquisition whilst minimising the environmental impacts of our 
science, a strategic focus should be placed on the development and adoption of non-lethal 
methodologies (which do not require animals to be killed) for use in radioecological research.   
The ALLIANCE have highlighted the need for experimentalists and modellers to work together from 
project outset, in order to obtain the correct match and compatibility of models and the data necessary 
to parameterise them. 
2.1.2.3. Develop process-based transfer and exposure models that incorporate physical, 
chemical and biological interactions and associated kinetics, and enable predictions 
to be made spatially and temporally  
Accurate, process-based radioecological modelling reduces model conceptual uncertainty and can 
reduce the uncertainty of model predictions, leading to a greater confidence in the results. For 
example, the consideration of chemical and physical speciation of radionuclides and their effect on 
subsequent environmental transfer (e.g., Salbu, 2009b; Salbu et al., 2018; Mitchell et al., 1995) reduces 
the 1-order of magnitude discrepancy between the near-field and far-field Kd's in the assessment of 
plutonium releases from Sellafield. Likewise, assessments of the globally-circulating radionuclides 14C 
and 3H have been greatly improved by including the influence of stable carbon, nitrogen and hydrogen 
cycles in radionuclide transfers (e.g., Schell et al., 1974). Knowing the early dynamics of radionuclide 
distributions following atmospheric deposition and marine releases has already played a major part in 
understanding the consequences of the nuclear accident at Fukushima. These developments are also 
crucial in context of site and environmental remediation. Hence, process-based and mechanistic 
models are also expected to advance countermeasure strategies and optimize site remediation and 
restoration. 
The transfer models developed should be able to integrate radioactive contaminants into the general 
dynamics of ecological systems. An example is using pollutant-coupled soil-vegetation-atmosphere 
transport (SVAT) models to investigate the wider, long-term circulation patterns of radionuclides in 
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the geosphere-biosphere interface (e.g. ECOFOR forest modelling as used in CONCERT-TERRITORIES), 
taking into account the biogeochemical (re)cycling of radionuclides over very long time-scales, 
changing climate conditions and evolving ecosystems or the coupling of radionuclide transfer 
biokinetic modelling with short-range, (e.g. coastal) dispersion with long-range movement of water 
and sediment dynamics to identify the ultimate fate of radionuclides in the aquatic environment (see 
COMET-FRAME). Ahead in the future lies the further coupling of such modelling with the climate-
induced ocean global circulation patterns but also to include speciation in these dynamic models. 
Other understanding that should be improved includes the behaviour of radionuclides at interfaces 
(e.g., atmosphere-water surfaces, land-coastal, watershed-freshwater courses, saline-freshwater, 
geosphere-biosphere, oxic-anoxic, air and water and built environment) and the influence of co-
contaminants on radionuclide behaviour. Furthermore, progress is awaited on representing the redox 
behaviour in soil, influence of soil organisms on mobility and uptake by plants and other organisms in 
an integrated way, improving semi-mechanistic models such as the Absalom model. In addition, drivers 
of global change, such as climate variation and evolving hydrological and land use changes, will 
influence the transport, fate and effects of radionuclides in the environment, and therefore need to 
be considered. Ultimately, by using dispersion, transport and kinetic exchange equations and well-
defined boundary conditions, a dynamic, process-based understanding can be incorporated into our 
models, especially for systems which are outside their biogeochemical equilibrium, fundamental for 
the understanding of accidental situations and incidents but also in the context of NORM (decay chains 
seldom in equilibrium). An analysis that relates to fundamental processes becomes conceptually 
simpler. Moreover, it facilitates performing the necessary abstractions and simplifications a posteriori 
(by way of a simplified description of less important sub-processes) rather than a priori (by way of 
insufficiently justified transfer parameters). In addition, as stated previously, it should be more feasible 
to communicate, to the public, a process-based model than an empirical model based on aggregated 
parameters which contain a lot of implicit assumptions.  
Radioecology is particularly under-developed in analysing the interactions of substances with living 
organisms at the cell membrane level, as well as in considering the biokinetics of internally 
incorporated substances leading to their time-dependent distribution, assimilation and elimination. 
An expectation is that it will be possible to combine circulation, metabolism and elimination processes 
with toxicokinetics and consequently gain an understanding of the effects of internally deposited 
radionuclides (links with Challenge 2).  
There is a need to assess wildlife exposure more realistically by considering spatial as well as temporal 
variability in for instance, habitat utilisation, contaminant densities and interactions between 
organisms, all of which impact animal movement and hence exposure in heterogeneously 
contaminated environments. During various life stages, dynamic processes may change many 
characteristics of an individual organism, such as weight, food intake, metabolism, internal 
contaminant concentration and the habitat in which they reside. These factors all influence the amount 
of contaminant intake and/or external irradiation levels. By modelling exposure dynamically and 
mechanistically, these changes can be taken into account. By introducing spatial heterogeneity models, 
it will be possible to take into account the organism's movements (e.g., foraging behaviour, migration, 
burrowing or nesting in function of life history stages). An organism’s mobility in a heterogeneously 
contaminated area will contribute significantly to the variation in exposure observed between 
individuals. Recent studies in which GPS units and dosimeters were attached to free ranging animals 
show the potential impact of not taking these factors into account in assessments (Aramrun et al., 
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2019; Hinton et al., 2019). Advances in this area would have synergies with population modelling 
(Alonzo et al., 2016; Vives i Batlle et al., 2012) approaches being developed to better predict ecosystem 
level effects (links with Challenge 2). Animal mobility can be predicted using random or quasi-random 
walk models (Loos et al., 2006). A particular potential of this approach is its ability to determine what 
individuals or populations of a particular species are more at risk, rather than treating all the individuals 
of a species in a given ecosystem as having received the same exposure. In present exposure models, 
these aspects are not yet considered though the use of agent based random walk models and mass-
balance food-web approaches is currently being assessed11. 
Wildlife dosimetry is also in need of some advancements (e.g. Stark et al., 2017). Current wildlife 
dosimetry models are simplistic and generally describe organisms as single ellipsoid forms that are 
homogeneous in composition and contamination. We should evaluate, in connection with challenge 2 
on effects assessment, how important it is to incorporate radionuclide-specific heterogeneous 
distributions within the body and microdosimetry measurement to be able to account for differences 
in sensitivity among various organs and  to better assess the dose-response relationships in particular 
situations for improved future predictions.  Initial simplistic investigations on this topic were carried 
out during the FASSET and ERICA EURATOM projects whilst other work has explored the use of voxel 
phantoms (e.g. Ruedig et al., 2015). Comparison of voxel phantoms (detailed three dimensional models 
which represent individual organs/tissues and can cope with heterogeneous distribution) with the 
simplistic ellipsoid used in assessment models have tended to demonstrate that for regulatory 
assessment the ellipsoid approach is generally sufficient (Ruedig et al., 2015). Where voxel phantoms 
will be of value is in the analyses of effects data, perhaps most especially from contaminated field sites 
with a mixed radionuclide profile (e.g. the Chernobyl Exclusion Zone). Skewed dose distributions from 
internally incorporated radionuclides (macro-distribution of radionuclides within organisms, but also 
the micro-distribution within specific organs and tissues, especially for alpha or beta emitters and for 
radioactive particles) also represent a challenge as it can significantly influence radiotoxicity. Studies 
in this field should involve collaboration with EURADOS on advanced dose assessment techniques and 
dose monitoring tools (e.g. the notable developments in microdosimetry).  However, more basic 
improvement is also needed to reduce the uncertainties in environmental dosimetry, notably 
geometries used for plant are currently poor and do not necessarily consider the most exposed or 
sensitive plant parts (e.g. the geometry for a tree is represented by a section of trunk).  
The Observatory Sites initiated under COMET and continued to be assessed under CONCERT-
TERRITORIES (cf. 2.1.2.2) and with continued support of the ALLIANCE are excellent large-scale field 
laboratories with spatial variability. These site allow for multidisciplinary studies (radioecology, 
dosimetry, toxicology, hydrogeology, ecosystem approaches, etc.), long-term investigation of 
environmental processes, parameter value generation, modelling tool testing and validation within 
real systems.  Observatory sites have been established in Chernobyl and Fukushima but also NORM 
contaminated sites are established. The Observatory Sites will be receiving due attention and further 
development as an essential radioecological ‘infrastructure’ (see also section §4 - Strategic Agenda for 
Infrastructures).  
                                                          
11https://gnssn.iaea.org/RTWS/modaria/Shared%20Documents/MODARIA%20II/3rd%20MODARIA%20II%20Te
chnical%20Meeting/25th%20October%202018%20-%20TM%20Closing%20Plenary%20Presentations/06%20-
%20WG5%20TM3%20Closing%20Presentation%20(Beresford+Vives).pdf 
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2.1.2.4. Represent radionuclide transfer and exposure at a landscape or large geographic 
scale with an indication of the associated uncertainty  
The objective of this research line is to improve the current status by mapping radionuclide transfer 
and exposure at the European or global scale based on thematic maps, including spatial and temporal 
variability, using the newly developed process-based models. Since geographical distributions of 
radionuclides tend to be highly heterogeneous (Van der Perk et al., 1998), a detailed understanding is 
needed of radionuclide transfer processes at multiple scales. Within this research line we intend to 
design and implement a user-friendly, state-of-the-art GIS interface with the developed models, 
facilitating mapping of radionuclide transfer and exposure at a landscape level to identify sensitive 
environmental compartments/areas. An added benefit of such development could be the integration 
of knowledge at the European level (interaction with challenge 3). Improvements in spatial 
dimensioning are still needed by incorporating better process-based approaches. Such an approach 
was proposed by Gonze et al. (2016) who modelled at the landscape level air dose rates with a process-
based dynamic approach. This priority should be further developed in collaboration with NERIS), as 
they are of specific interest for post-accident situations. 
An important task here will be to bridge the previously-mentioned difference between the small scales 
at which radionuclide behaviour and transport are often studied and the larger scales often relevant 
for management decisions, also in context of site and environmental remediation. A GIS interface could 
include reference values (geochemical or anthropogenic backgrounds) and thus provide useful means 
to evaluate the level of exposure. The changing exposure conditions experienced by wildlife animals 
as they traverse and utilise various habitats with heterogeneous contamination could also be 
incorporated and visualised to improve our understanding of the exposure conditions and, as result, 
reduce uncertainties in the environmental assessment. Thematic maps of different terrestrial variables 
such as land use, soil type, leaf area index and crop coefficient, local climate, etc. will be linked to the 
radionuclide transport datasets. Such a system will enable robust environmental exposure predictions 
at various scales, allowing advanced visualisation of the complex interactions between radionuclides 
and the various environmental properties and processes. It would also enable the modelling (if 
appropriately parameterised) of countermeasures (as exemplified by Cox et al., 2005).  
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2.2. Challenge Two: To Determine Ecological Consequences under Realistic 
Exposure Conditions 
There is a growing awareness by the public of the importance of the global quality of environmental 
resources and biodiversity, with many examples of national regulations directed to the protection of 
the environment as a whole (e.g., nature conservation, uses of environmental resources, air, soil, and 
water quality). Even more significantly, human and ecosystem health are now recognised as strongly 
interconnected as evidenced, for example, by several principles and goals for sustainable development 
recently agreed upon in the 2030 development agenda of the United Nations (2015). 
This challenge is of high priority regarding new regulatory requirements for the radioprotection of the 
environment which has shifted during the last decade from an implicit to an explicit environmental 
protection. The IAEA’s Fundamental Safety Principles (IAEA, 2006), revised ICRP Recommendations 
(ICRP, 2007), the revised versions of the international Basic Safety Standards (BSS) (IAEA, 2011) and to 
a lesser extent, the Euratom BSS (European Commission 2013) promote developing guidance on wildlife 
radiological risk assessments and, as a consequence, espouse the need for ecological protection criteria 
of radioactively contaminated environments. Acquiring new scientific results on which decisions can be 
based is key to answering social concerns about (eco)toxic effects from ionising radiation and its 
ecological consequences.  
Over the last 20 years, international efforts have focused on new strategies for protecting the 
environment from radioactive substances e.g. by setting up an effects database for non-human species 
(FREDERICA) (Copplestone et al., 2008) and producing screening ecological benchmarks needed to 
implement a tiered Ecological Risk Assessment approach (ERA) [(FASSET (Williams, 2004), ERICA 
(Larsson, 2008), PROTECT (Howard et al., 2010)]. Whilst the ERA-type approach is a substantial 
advancement in radioecology, a lack of sufficient data prevents current ERA analyses from fully 
accounting for the realistic environmental conditions that organisms are actually exposed and ecological 
processes that are actually affected.  
Data are still insufficient to take into account low dose effects, variable dose rate regime, dose deposit 
heterogeneity (from molecular targets up to individuals and ecosystems), multi-contaminant scenarios 
(including the different exposures from external irradiation and internal contamination), species 
variation in radiation sensitivity due to life-history traits, community or ecosystem level effects. Such 
knowledge gaps are accounted for via extrapolation and the use of assessment factors (or safety factors) 
that add conservatism and increase uncertainties in predictive risk assessments. The vision of this SRA 
is to address such deficiencies (Figure 2). 
There exists still considerable scientific disagreement on the actual extent of the radiation effects on 
wildlife in contaminated areas. Many studies have reported no significant effects of radiation on 
wildlife (e.g. in the Chernobyl and Fukushima exclusion zones), whereas others reported significant 
radiation effects on different wildlife groups at very low dose rates (below natural background 
exposure) (Beresford et al., 2016; Chesser and Baker, 2006; Moller and Mousseau, 2009, 2016; 
Beresford et al., 2019; Fuller et al., 2019). This controversy challenges the ecological protection criteria 
published by research groups, as well as international organisations that issue guidance for radiological 
exposures. Several protection criteria with different ways of derivation and different protection 
purposes are established (UNSCEAR, 2008; ICRP, 2008; Anderson et al., 2009; Garnier-Laplace et al., 
2010); ICRP, 2014). 
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Figure 2. Schematic of the components and anticipated results of the Strategic Research Agenda 
concerned with challenge two: To Determine Ecological Consequences under the Realistic Conditions 
that Organisms are Actually Exposed. 
In the last decade the STAR, COMET and TREE programmes were large multi-institute programmes, in 
part designed to address these identified priorities. Whereas STAR initiated research on multiple 
stressors, the COMET project focussed on understanding the role of epigenetic processes in the trans-
generational effects of radiation (Saenen et al., 2017; Horemans et al., 2019; Beresford et al., 2019). The 
need to further resolve this important low dose rate controversy at Chernobyl (to understand the 
phenomenon, and in doing so enhance public confidence) was an important consideration in developing 
this SRA.  
In order to build new environmental radiation protection approaches and to understand and assess 
the effects of radiation on wildlife, radioecology will need to benefit and collaborate across different 
disciplines such as environmental sciences including ecology and ecotoxicology of chemical substances, 
stress ecology (Van Straalen, 2003) and other European research platforms such as MELODI with which 
it shares a number of challenges (e.g., for extrapolating from acute to chronic ecotoxicity, laboratory to 
field, one species to another, individual to populations) as well as methods, concepts, models, and tools. 
New approaches adopted by environmental sciences in general, and ecotoxicology and ecology in 
particular, emphasize that to properly determine the effects from any contaminant we must address 
the realistic environmental conditions in which organisms are actually exposed, including the 
consequences to ecosystem integrity (i.e. structure, composition, function). Realistic environmental 
conditions incorporate natural abiotic factors (e.g., climate change, temperature, flooding events, snow 
and ice) as well as biotic factors (e.g., physiological and life-history status of organisms; ecological 
processes such as competition, predation, and food availability). Adding this realism will aid at 
developing integrated exposure assessment approaches (including the development of proper tools for 
the dose calculation for wildlife species) that encompass the dynamics over time and space during the 
entire life cycle of organisms (links with Challenge 1). One operational outcome from this challenge, 
directly relevant to radioprotection of flora and fauna, is to establish sound-science protection criteria 
for ecosystems and their sub-organisational levels following exposure to radioactive substances, 
whatever the source term and the environmental situation.  
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2.2.1. Strategic vision for research  
Our strategic vision is that over the next 20 years radioecology will have gained a thorough mechanistic 
understanding of the processes inducing radiation effects at different levels of biological organisation, 
including the consequences on ecosystem integrity, and be able to accurately describe and predict 
effects under the realistic conditions in which organisms are actually exposed. 
2.2.2. Strategic agenda  
Similarly to Challenge one, the key research lines developed below are intended to be applied for all 
exposure situations, as described by the CONCERT Joint Roadmap scenarios: planned exposures 
situations under normal operation conditions (scenarios 2), existing environmental exposure scenarios 
with regard to legacy (scenario 4) and natural radiation (scenario 5), as well as long term exposures after 
accidents (scenario 6) and malevolent acts (scenario 7). To address these, studies will have to include 
an appropriate combination of laboratory studies conducted under controlled conditions and field 
studies and statistical data treatment and/or mathematical modelling. In connection with challenge 
one, common to all five research lines outlined below, is a crucial need for an improved dosimetric 
assessment to reduce uncertainty and enhance robustness of dose estimates and for the establishment 
of dose-response relationships, whatever the model used (e.g., logistic, hormetic, linear non threshold). 
Such response relationships constitute the basis for any predictive risk assessment. Specifically, the 
following five research lines will need to be addressed to achieve the vision. 
2.2.2.1. Mechanistically understand how processes link radiation induced effects in wildlife 
from molecular to individual levels of biological complexity 
This research line aims at identifying key molecular/cellular and individual characteristics driving 
radiation induced effects at the individual level. The use of advanced analytical methods from 
molecular biology including high-throughput screening technologies and computational models to 
extrapolate data at different levels of biological complexity, holds great promise for enhancing our 
mechanistic understanding of radiation induced responses at the sub-cellular levels and their 
consequences to individuals and is shared between human and other organisms (Mothersill et al., 
2018). One way of describing the links between molecular initiation of the response and the observed 
adverse effects is through the formulation of an Adverse Outcome Pathway (AOP) (Ankley et al., 2010; 
Groh et al.,., 2015). The formulation of a radiation specific AOP will form a framework within which 
data and knowledge coming from different organisms, different levels of biological complexity and 
even multiple stressors are synthesised in a way that is useful for risk assessment. The key molecular 
events (which may include epigenetic change) of an AOP might serve as a potential biomarker, once 
their response sensitivity and natural variability in populations are characterised. With validated 
biomarkers under field conditions and populations of native or non-native species (e.g., using caged 
animals in the environment), innovative biomonitoring in the field should be developed, with a 
preference to non-lethal methods and tools where possible. Field studies will be required to test the 
detectability of radiation induced changes used as biomarkers within complex realistic exposure 
situations (e.g., confounding factors such as seasonal variations, other contaminants, changes in 
habitats). A radiation-related AOP for different organisms together with specific biomarkers could 
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potentially be used in a regulatory setting to verify the results of impact assessments for operational 
facilities. 
In addition, coupled Biokinetics/Dynamic Energy Budget (DEB) approaches can aid in understanding 
the metabolic mode of actions at the individual level following radiological exposures. DEB theory 
(Kooijman, 2000) offers a single consistent framework to understand effects of stressors on growth, 
reproduction and survival in an integrated way. 
Examples of key issues are given to illustrate this research line: 
• How does the oxidative status of the cells (or tissue/organisms) modulate the responses? 
• How may those elementary mechanisms result in adverse outcomes at the cellular and 
individual levels (immune and neurological systems integrity, general metabolism, 
reproduction, growth, survival, behaviour, susceptibility to diseases)? 
• How do radiation type (α, β, γ), exposure duration (acute, chronic), pathways (external vs. 
internal irradiation) and cellular/biological characteristics modulate the quality and quantity of 
damages? Are those damages reversible? 
• Do specific modes of action or master genes exist for different types of radiation, and can they 
be used to develop specific biomarkers or biosensors or AOPs? 
2.2.2.2. Understand what causes intra-species and inter-species differences in radiosensitivity 
(i.e. among cell types, tissues, life stages, among contrasted life histories, influence of 
ecological characteristics including habitats, behaviour, feeding regime...) 
Even though the fundamental mechanisms that cause radiation damage seem universal, individual 
responses to radiation exposure vary tremendously, depending on factors such as type of radiation 
(variation up to ca. x50); acute versus chronic exposure (variation ca. 1-2 orders of magnitude); cell 
type; biological endpoint (e.g., reproduction versus mortality); life stage (embryos, larvae, and 
juveniles stages are the most sensitive); species (variation ca. 6 orders of magnitude); and level of 
biological organisation; simple laboratory experiments versus complex ecosystems (UNSCEAR, 2008). 
Some recent research suggests that current international protection benchmarks may not be 
protective of all organism groups (Raines, 2018). Some general parameters known to determine the 
sensitivity of an organism to radiation are: the DNA content (i.e. mean chromosome volume) of the 
cell; the efficiency and types of DNA repair/pathways; the cell repopulation capacity; and the ability of 
tissue and organs to regenerate (reviewed in Harrison and Anderson, 1996 and Adam-Guillermin et 
al.,., 2017).Differences in sensitivity between species also lie behind overall effects at higher levels 
(community, ecosystem). Understanding the mechanisms of inter-species radiation sensitivity may 
also help us understand mechanisms behind intra-species variation (Beresford et al., 2019). 
This research line will be strongly combined with the first one. It will highlight the key drivers for intra- 
and inter-species radiosensitivity differences. A combination with phylogeny/homology concepts as it 
exists in comparative toxicology could help to support inter-species extrapolation. This research line 
requires a long-term commitment and comprises fundamental key issues such as: 
• How do differences in DNA damage between different species, or the potential for DNA repair, 
explain the inter- intra-species differences in radiosensitivity? 
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• For internal contamination, how does uneven internal distribution of radionuclides and the 
subsequent dose heterogeneity in the cell/tissue/organ influence the biological response?  
• What is the variability in sensitivity / response between life stages and between species? 
• How do those findings, combined with a phylogeny/homology-type approach, support inter-
species extrapolation? 
• How do occupied habitats, organism behaviour and feeding regimes contribute to determining 
potentially exposed/critically sensitive life stages and species? 
2.2.2.3. In a broader exposure context, understand the interactions between ionising 
radiation effects and other co-stressors 
Exposure to multiple stressors may directly or indirectly modulate radiation effects. The environment 
is contaminated with low concentrations of complex mixtures (e.g., radionuclides, metals, pesticides, 
fire retardants and endocrine disruptors) and non-optimal or adverse environmental conditions (e.g. 
heat, drought) (Vanhoudt et al., 2012; Vandenhove et al., 2012; Mothersill et al., 2019). Studying a 
contaminant in isolation is necessary and provides critical information on the underlying mechanism 
resulting in detectable effects and can be used to test the specificity of biomarkers but cannot predict 
possible interactions among the many stressors to which organisms are exposed. Interactions can 
provide protective effects and reduce overall damage, or augment effects in negative, synergistic ways 
(SCHER, SCCS, SCENIHR, 2012). 
Modifying effects of multiple stressors can be the consequence of altering the bioaccumulation 
characteristics of radionuclides, or influencing the radiosensitivity of the species (e.g., Au et al., 1994; 
Sugg et al., 1996). Radiosensitivity is affected by exposure to other contaminants and a combination 
of stressors reduces the physiological fitness of organisms. Multiple stressors are included within our 
SRA because of the need to understand the potential for mixtures to cause antagonistic or synergistic 
interactions with radiation. 
Some research projects, including the EU funded STAR project, have been trying to answer the 
question of multi-contaminant/stressors (Gilbin et al., 2015; Gagnaire et al., 2017). While studies of 
stressor interactions are common in ecotoxicology, it has been difficult to derive general rules by which 
to predict how different species may be effected by a given combined stressor exposure (additive, 
greater than additive, less than additive) (Holmstrup et al., 2010; Vanhoudt et al., 2012). For many 
species, the limits of tolerance for some types of stressors (e.g. soil pH, temperature ranges) are 
known. Measurements of potential stressors along with radioecological measurements may identify 
those cases in which radionuclide exposures coincide with other stressful conditions helping to identify 
when multiple stressor effects may need to be taken in to account (Beresford et al., 2019.).). 
Research should be developed to understand radiation effects in the context of contaminant mixtures 
and multiple stressors. Emphasis will be placed on identifying combinations of mixtures and stressors 
that interact such that super-additive and sub-additive effects are likely to occur with radiation. The 
potential for interactions among stressors will be based on their modes of action and their cellular 
targets at the molecular level (e.g., oxidative stress, genotoxicity). This will also contribute to the 
understanding of radiotoxicity and chemotoxicity, and their delineation when it is relevant. Because of 
the multitude of potential stressors that exists in real exposure conditions, early research efforts will 
develop a scheme to prioritise hypotheses and maximise research efficacy (Escher et al., 2017). 
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Examples of key questions addressed in this research line are: 
• What are the combinations of mixtures situations or co-contaminants that are likely to show 
interacting effects with radiation? 
• What are the mechanisms underlying interacting effects of different co-contaminants and 
radiation or radionuclides? 
• At what level does interaction take place: for example at the exposure, uptake, internal 
redistribution of the radionuclides, at the site of damage or in regulation and signal 
transduction of the response of the organism towards radiation effects? 
2.2.2.4. In a broader ecological context, understand the mechanisms underlying multi-
generational responses to long-term ecologically relevant exposures (e.g., maternal 
effects, hereditary effects, adaptive responses, genomic instability, and epigenetic 
processes). 
A strong connection with evolutionary ecology is needed to study adaptive responses and modulation 
of effects at a multi-generation scale following exposures to radiation. Understanding long-term 
effects of radiation on the phenotypic and genetic characteristics of the population is crucial to assess 
the risk of population extinction and its consequence for the maintenance of both genetic biodiversity 
and species biodiversity. This is true whatever the radiation type and exposure pathways. 
The mechanisms involved in organism responses to chronic radiation exposure, both within and 
between generations, are the subject of an active debate in the scientific literature (e.g. Boubriak et al., 
2016; Carroll et al., 2007; Goodman et al., 2019; Horemans et al., 2019). Whilst adaptation of organisms 
to radiation within the Chernobyl Exclusion Zone (CEZ) has been suggested (Møller and Mousseau, 
2016; Boubriak et al., 2008), it has not yet been the focus of any comprehensive research programme. 
If it does occur, adaptation of specific populations could lead to adaptation of the ecosystem over time 
(e.g. the plant biome is thought to help plants cope with abiotic stress such as drought or salinity (Dodd 
and Pérez-Alfocea, 2012; Liu and Zhang, 2015)). If adaptation to chronic radiation exposure exists in the 
CEZ, it will have implications for the interpretation of studies comparing current effect and exposure 
levels. 
Radiation can directly affect DNA by ionisation of the molecules that form the double helix indirectly 
through formation of Reactive Oxygen Species (ROS) leading to molecular lesions (e.g., base 
degradation or deletion, single- or double-strand breaks, protein-DNA cross link). Indirect effects of 
oxidative stress can also alter protein, enzyme and lipid structure or function, resulting in disruption 
of general metabolism. Other alterations of the cellular genome can be induced by ionising radiation 
through changes in epigenetic mechanisms that cause changes in cell signalling processes [e.g., 
genomic instability (genomic damage expressed post-irradiation, after many cell cycles), bystander 
effects (where non-irradiated cells in proximity to irradiated cells exhibit effects similar to those that 
received the radiation), and reduced repair efficiency (e.g., Morgan, 2003; Mothersill et al., 2009]. 
Knowledge about genomic instability incorporating changes in the epigenetics and in the DNA 
sequence due to mutations and repaired double strand breaks should be improved to support the 
understanding and prediction of the evolutionary response of populations chronically exposed to 
ionising radiation (Horemans et al,., 2019). One novelty could be to associate an experimental 
approach (lab and field) with quantitative genetic methods to study the evolutionary response of a 
natural population to a rapid change in its environment. 
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Some of the major elementary key questions are: 
• What are the biological and evolutionary significance of genomic and epigenetic changes due 
to exposure to ionising radiation? How much do they contribute to transmission of genomic 
damage to offspring, through successive generations? 
• What is the influence of ionising radiation exposure on epigenetic changes in comparison with 
other environmental factors? 
• To what extent does multigenerational exposure make the consequences worse (or better)? 
Are populations that are exposed for several generations to ionising radiation more (or less) 
resistant to new environmental changes? What is the molecular basis of resistance (or 
vulnerability) in comparison to non-exposed populations? What is the impact of previous 
‘acute’ radiation exposure on organisms in contaminated environments now? 
2.2.2.5. Understand how radiation effects combine in a broader ecological context at higher 
levels of biological organisation (population dynamics, trophic interactions, indirect 
effects at the community level, and consequences for ecosystem functioning) 
Regardless of the stressor or type of contaminant, the vast majority of ecotoxicological data describe 
effects on individual traits of organisms at the cellular, tissue or individual levels. As demonstrated for 
chemicals, effects observed at these levels may propagate such that they have consequences at higher 
levels of biological organisation (population, community, ecosystem; e.g., Forbes and Calow, 2002a; 
Forbes et al., 2011). Our knowledge of radiation effects (and radiation protection) is based almost 
entirely on single species experiments, while in reality species are exposed as part of a multi-species 
assemblage. In radioecology, the importance of an ecosystem approach has been emphasised many 
times over the last decade. Several publications and international workshops have led to a number of 
recommendations and consensus statements (Bradshaw et al., 2014; Bréchignac et al., 2016; 
Mothersill et al., 2018, 2019).  
In the wild, species within the same environment are differentially exposed to radioactivity due to their 
specific habitat, behaviour, and feeding regime. Species also have different sensitivities to radiation. 
In an ecosystem, this means that the various responses of species to radiation will also alter the 
interactions between species and may affect aspects such as competition, predator-prey or parasite-
host interactions. This may lead to secondary effects that change community structure, composition 
and function. These secondary, indirect effects may impact a population to a larger extent than the 
direct effects of radiation. Such issues have been poorly addressed in radioecology and, for that matter 
in ecotoxicology, partly due to the complexity of studying multi-species assemblages in the laboratory 
or unravelling complexity in field situations. Recently, a literature review assessing the design and 
properties of multispecies effect-study experiments and their suitability for radioecology is currently 
in review (Haanes et al, submitted). A few experiments using microcosms (multispecies experiments) 
have clearly demonstrated such indirect effects (e.g., Doi et al., 2005; Fuma et al., 2010) at quite high 
doses. A recent microcosm study performed at dose rates similar to those at contaminated field sites 
(Hevrøy et al., 2019) allowed to isolate specific relationships between interacting species in an 
ecosystem and test the direct and indirect effects. Studies have investigated the effects of ionising 
radiation on wildlife from subcellular to community levels in the CEZ (e.g. Beresford et al., 2019) and 
increasingly in the Fukushima region. However, the consequences of increased ionising radiation levels 
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on key ecosystem processes such as plant production, the degradation of dead organic matter, and 
elemental cycling have received little attention.  
However, very few studies have actually measured effects at the higher levels. A few have attempted 
to extrapolate effects observed in individuals to what might occur in the population by using 
population dynamic models. Modelling the propagation of ionising radiation effects from individuals 
to populations has been addressed theoretically (Woodhead, 2003; Vives i Batlle et al., 2010), and 
based on experimental data, such as those acquired within the ERICA project by chronically exposing 
earthworms and daphnids (Alonzo et al., 2008) or more recently using available radiation effect data 
available in the FREDERICA database (Lance et al., 2012; Alonzo et al., 2016). Such models are a 
valuable, under-utilised method for predicting effects from environmental stressors, and thus are 
included within this SRA as they need to be further explored in radioecology. However, all models need 
to be tested in realistic systems (e.g., complex laboratory studies or in the natural environment) before 
accepting them as predictive tools. 
The propagation of effects from individuals to population depends on the characteristics of specific life 
histories. Understanding and accounting for the differences in life history traits among species will 
likely reduce our current uncertainties in predicting effects to populations of wildlife exposed to 
radiation. Recognising the importance of life history strategies is not unique to radioecology; Forbes 
and Calow (2002b) suggested that it was not feasible to identify a priori among growth, mortality and 
reproduction, the best predictors of population growth rate. This underlines the necessity for adequate 
experimental development to address the following questions for radioactive substances: (i) How 
sensitive is the population growth rate to changes in each of the life-history traits? Which life-history 
stage(s) is sufficiently sensitive to influence the population growth; (ii) To what extent do effects on 
life-history traits influence population growth rate? 
To extrapolate even further to communities or ecosystems, concerted collaborative effort is needed 
to carry out both controlled laboratory experiments on simple predator-prey relationships and more 
complex multi-species microcosms and field investigations/experiments, with a focus on ecosystem-
relevant endpoints covering both ecosystem structure and function. In addition, development of 
population and ecosystem models capable of integrating radiation effects with population dynamics 
would substantially advance the field. Assessing the consequences of radioactive substances on 
ecological integrity (i.e., structure, composition and function) is essential to optimize management of 
ecosystems resources (water, forest, agriculture...), as well as other natural goods and services 
provided to society. For example, recent studies (ALLIANCE, 2018) demonstrate shifts in 
developmental and reproductive endpoints (e.g. flowering time or sexual maturity) due to radiation 
exposure, that may be significant for ecological functioning (e.g., delayed production of pollinators and 
earlier flowering may mean no floral resources are available for pollinators). Key issues would include: 
• How does radiation affect food availability and quality (taxonomic composition, nutritional 
value) for predatory species? 
• How do radiation effects modulate under changing food conditions and varying environmental 
constraints such as predation, migration and natural mortality? 
• How do radiation effects alter trophic interactions such as competition, parasite/host 
relationships? 
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• How do radiation effects ultimately lead to changes in taxonomic composition, biological 
diversity and complexity, including delayed effects after multiple generations particularly in 
populations already subjected to environmental stress? 
• How does ionising radiation affect the ecological integrity (structure, composition) key 
ecosystem processes (function)? 
• How does ionising radiation affect the provision of goods and services provided by the 
environment of importance to humans (e.g. how species lifecycle dynamics may become 
uncoupled from the resources (e.g. food supply, nest sites, pollinators) on which they rely)? 
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2.3. Challenge Three: To Improve Human and Environmental Protection by 
Integrating Radioecology 
The risks posed by the presence of radionuclides in the environment require an efficient, balanced and 
adaptable assessment for protecting and managing exposed humans and environments. The individual 
contaminant-medium-pathway paradigm is changing towards a more integrated view of the 
environment as a whole. Radioecology’s position relative to this paradigm shift can be best maintained 
by embracing the concept of integration – integration of the underlying systems and methods of 
human and environmental protection, and integration of radioecology with other scientific disciplines, 
including social sciences and humanities (SSH) to provide necessary scientific basis for system and 
practice of radiation protection and to ensure proper answers on societal questions and challenges in 
different exposure situations. Thus, radioecology’s future success, broadly defined as meeting 
stakeholder needs, will require integration in several ways and from several different perspectives. 
This portion of the SRA identifies several integration challenges (Figure 3), as well as highlights the 
advantages gained by the science of radioecology in meeting the integration challenges: 
 
 
 
Figure 3. Five areas in challenge 3: To Improve Human and Environmental Protection by Integrating 
Radioecology. 
During the last decades, the need was recognised for explicit demonstration of the protection of the 
whole environment from the effects of radioactive contaminants, which also resulted in changes to 
international policy (ICRP, 2007; EU Directive 2013/59; ICRP, 2014). Significant effort has been 
expended in that regard and a system of environmental protection is emerging, along with the tools 
required to estimate exposure, evaluate risk and demonstrate protection (Larsson, 2008; Brechignac 
et al., 2016). In some important areas, however, the methodologies for human and environmental 
assessments still differ. This problem is exacerbated because human and environmental assessments 
are not complementary in terms of how they are conducted. The differences can cause difficulties for 
operators, stakeholders and regulators. An integration of the two radiation protection systems – both 
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in terms of the underlying philosophy and the practical application via appropriate tools and systems 
- offers significant benefits on many levels. 
Additionally, radionuclides and the risks posed by them to humans and the environment typically occur 
as part of a complex suite of co-contaminants and other stressors that may act as confounding 
variables, as exemplified by waste streams from nuclear and non-nuclear industries, complex legacy 
contamination and releases as a result of accidents. There is a clear and long-standing gap in our 
understanding of contaminant mixtures that include radioactive materials. Radioecological research 
integrated with other disciplines and directed towards better understanding of mixture effects, as well 
as adapted risk assessment methods, will make it possible to determine whether radiation protection 
criteria are robust in a multiple contaminant context.  
Radioactive contamination can occur as a result of a range of different scenarios, disparate in character 
and often specific in their actual or potential impacts, but often of great concern to the public. Societal 
perception of the technical capacity and resources required to prevent, mitigate or remediate impacts 
and ensure recovery of any contaminated area after a release should take into account the disparities 
and specificities inherent in the exposure scenarios, as they play a significant role in the assessment of 
consequences – in terms of economic considerations and from a societal perspective. A continuum of 
effects includes societal concerns, varying degrees of economic impact or loss of societal benefit, 
administrative disruption, health impacts or loss of life and impact on ecosystem services. In addition 
to these impacts, the measures taken to address them may, in turn, incur societal and environmental 
side effects. This complex interplay has been well demonstrated in the aftermaths of both the 
Chernobyl and Fukushima accidents and has been taken into consideration when developing the Joint 
Roadmap of radiation research platforms in 2017. 
Management approaches in planned, existing and emergency exposure situations can range from the 
minimal through ascending levels of complexity and detail. Although a significant amount of valuable 
knowledge exists for a wide range of exposure situations, it is fragmentary with respect to constituting 
an integrated strategy sufficient to deal with complex, dynamically changing conditions. In dealing with 
a range of actual or potential exposure situations, a gradient of integrated management approaches 
based on multi-criteria decision analyses (MCDA) and the means of creatively implementing them are 
required. The development of appropriate tools – Decision Support Systems (DSSs) – for best 
implementing such approaches must occur in tandem with the development of management 
objectives to ensure that maximum benefit is derived. The need for integrated, graded management 
approaches and the tools to implement them in handling the entire spectrum of possible effects of 
exposure and ensuring the productivity and societal benefit of impacted areas will be a primary driver 
for radioecological research in the coming decades. The recent events at Fukushima in Japan exemplify 
these problems and the existing challenges. Intrinsically bound to this need is the requirement for 
sound, fundamental and progressive science to underpin and derive maximum benefit from these 
efforts. 
2.3.1. Strategic vision for research  
Our strategic vision is that over the next 20 years radioecological research will develop the scientific 
foundation for the holistic integration of human and environmental protection, as well as their 
associated management systems. 
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2.3.2. Strategic agenda  
The following five research and integration lines will need to be addressed to achieve the vision. 
2.3.2.1. Integrate uncertainty and variability from transfer modelling, exposure assessment, 
and effects characterisation into risk characterisation 
Risk characterisation is the final step of risk assessment that integrates information from exposure 
assessment and effects characterization. 
Challenge 1 of this SRA identified that transfers and exposure have to be assessed at multiple spatial 
scales, from an emitting source to the landscape or even global scale. Challenge 2 emphasised that 
effects have to be characterised not only at the individual level, but also at higher levels of biological 
organisation (population, community, and ecosystem). This means that any risk assessment at such 
integrated scales should simultaneously take into account: (i) variability of doses, depending on spatial 
variability of radionuclide transfers, as well as behavioural heterogeneity among exposed species, (ii) 
and variability in radiosensitivity among species, including gender- and life stage-dependencies. 
Improvements in risk assessments, and the increased confidence in their results, require challenge 3 
to integrate all these sources of variability into a single calculation. 
In parallel, the temporal variability characterising transfers and exposure (cf. challenge 1) as well as 
effects, from age-dependent differences to multi-generational responses (cf. challenge 2) need to be 
integrated over the period of interest for risk assessment, depending on the context, from weeks in an 
emergency situation to thousands of years for radioactive waste repositories. 
Lastly, due to its inherent integrative power, risk characterisation is the ad hoc step to fully characterise 
the global uncertainty of a risk assessment, by incorporating uncertainty from exposure assessment 
and effects characterisation. Considering the multiple sources of uncertainty, including those 
mentioned in challenges 1 and 2, this final stage is the key to a real integrated ecological risk 
assessment. 
Some recent advances have been made in relation to characterising uncertainty and variability in 
transfer modelling and exposure assessment within EJP-CONCERT funded projects. From the 
CONCERT-TERRITORIES project, Urso et al. (2019) provide guidance for carrying out uncertainty 
analysis with experts’ knowledge specifically in the field of radioecology. Structured information about 
parameter uncertainty, conceptual model uncertainty, scenario uncertainty as well as role of variability 
are presented together with analytical, probabilistic and Bayesian approaches and methodologies to 
quantify and (where possible) to reduce these uncertainties. From the CONCERT-CONFIDENCE project, 
Brown et al. (2018) explore how information on parameter uncertainty can be used in the agricultural 
food-chain models commonly implemented within European post radiological emergency decision 
support systems, the aforementioned ARGOS and RODOS systems. These new developments provide 
initial steps towards fulfilling the objectives of this research line. Integrating the mentioned 
uncertainties and variability into the overall risk assessment would contribute to better reliability of 
dose assessments in general (this being one of the ICRP’s (2017) identified areas for which research is 
needed in order to support the system of radiological protection).  
Nonetheless, the requirement still remains to reduce uncertainties so that risks to biota and humans 
can be better quantified, whatever the situation (low, as well as high risk situations; planned, existing 
and emergency situations). Most of the research lines described in Challenges 1 and 2, as well as 
research lines described in related SRAs from other platforms), identify research that could contribute 
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to improved risk quantification. The strong links which are already being built between the ALLIANCE 
and existing radiation protection research platforms will help facilitate integration and reduce 
uncertainties  
2.3.2.2. Integrate human and environmental protection frameworks 
Risk assessments for ionizing radiation have historically been exclusively focussed on human risk but 
have expanded to gradually include ecological risk. This shift is reflected in recent high-level policy 
changes. It is recognised that the present framework of radiological protection should be changed to 
explicitly demonstrate rather than assume the protection of the environment, as stated in the general 
recommendations of the International Commission on Radiological Protection (ICRP, 2007), 
international Atomic Energy Agency (IAEA, 2014) and in the EURATOM (EC, 2013) Basic Safety 
Standards.  
Over the last decade, new drivers for integration of human and environmental protection frameworks 
have emerged, such as the increasing interest from society in environmental issues, requests to 
demonstrate the overall protection of the environment and aspirations to build public confidence 
through information and transparency. Human and ecosystem health are now recognized as strongly 
interconnected as evidenced, for example, by a number of principles and goals for sustainable 
development recently agreed in the 2030 development agenda of the United Nations (UN, 2015). 
Furthermore, according to the ICRP’s and IUR’s recommendations about the integration issue, more 
focus should be put on the development of an integrated view of all benefits and impacts that includes 
consideration of protection of people and ecosystems (Brechignac et al., 2016; Garnier-Laplace et al., 
2017).  Moreover, integrating environmental protection and human protection under one generalised 
system for radioprotection, would enhance efficiency and would be of great interest to regulators, 
industry and the public (Salomaa and Impens, 2016).  
. Some initial steps with regards to exploring the issue of integration were taken in the radiological 
sciences through the application of case studies (Copplestone et al., 2010). A step forward has been 
made by the development of a combined screening model for both human and non-human biota in 
the form of the CROMERICA tool (Mora et al., 2015).) Although, this integrated assessment platform 
provides alignment with respect to the advection and dispersion models used in modelling the 
behaviour and fate of radionuclides, the tool falls short of providing a satisfactory amalgamation of all 
methodologies employed.  More recently, Copplestone et al. (2018) has explored how an integrated 
approach might be applied in planned, existing and emergency situations. This was achieved by, for 
example, showing how simplified numeric criteria may be used in planned exposure situations that are 
protective of both the public and non-human biota.  
Nonetheless, these deliberations still fall some way short of being considered a full framework for 
integration of human and ecological risk assessments for radionuclides. Therefore, further 
consideration of the acceptable or optimal level of integration for assessment approaches is still 
needed. . Valuable insights for future research actions can be gained by recent developments that have 
occurred for the risk assessment of chemicals (Wilks et al., 2015; Ciffroy et al., 2016). Building of 
common exposure scenarios based on a tiered approach using cautious assumptions and simple 
deterministic models, developing tools to support the harmonization, sharing of human and 
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environmental exposure data and sampling designs are seen as further steps to be done through 
multidisciplinary research in order to develop an integrated system. 
The ALLIANCE is convinced that the scientific and pragmatic (application via appropriate tools) 
foundation for a holistic integration of human and environmental assessment should be addressed 
(Vandenhove et al., 2017). Further development, in the radiological sciences, of integrated 
methodologies for transfer, exposure and risk assessment, and the production of tools incorporating 
those methodologies for existing, emergency and planned exposure situations, remain a major step 
forward in ensuring efficient, adequate, demonstrable protection for both humans and the 
environment. Areas where active research towards integration is required include transfer/exposure 
and dosimetry. Currently, transfer/exposure studies for humans and biota are conducted separately 
using two dissimilar methodologies. It is evident that progress is still needed to gain fundamental 
knowledge (on underlying processes), validate tools and methods for performing realistic, integrated 
and graded impact and risk assessments for both humans and wildlife, across all ecosystems and 
exposure scenarios (Salomaa and Impens, 2016). 
This challenge, incorporating the knowledge generated in other strands of activity within the SRA, will 
focus on the scientific and practical integration of human and environmental transfer and exposure 
methodologies. By determining where harmonisation of approaches for humans and environment is 
justifiable and beneficial, the challenge will focus on developing integrated methods for assessment in 
the areas of transfer, exposure, dosimetry and risk. Future research initiatives in this area need to 
continue good links with MELODI and the work being carried out by the ICRP. 
2.3.2.3. Integrate the risk assessment frameworks for ionising radiation and chemicals 
Both human populations and wildlife in polluted environments of radiological concern may be exposed 
to a complex mixture of radioactive and chemical substances and various confounding factors; such 
combined exposure may sometimes cause adverse effects. The need to account for multiple stressors 
in experimental set-ups, effect analysis and risk assessment has been recognized and addressed in the 
SRA through several research lines, among others, by integration of the risk assessment frameworks 
for ionizing radiation and chemicals. 
Recently, new drivers that additionally implied the need for further development of integrated risk 
assessment frameworks emerged, such as the increased awareness by the public of the simultaneous 
presence of chemicals and ionizing radiation in the environment, their importance for ecological 
quality of environmental resources and for biodiversity, practical issues of assessors, operators and 
regulators related to the existence of separated approaches. Integration of environmental exposure 
assessment for ionizing radiation and other stressors and optimization of radiological protection have 
been identified as a common challenge and knowledge gap in the Joint Roadmap of the international 
radiation research platforms (MELODI, NERIS, EURAMED, ALLIANCE) (Impens, 2017; Vanhavere, 2018). 
The issue of multiple stressors in the risk assessment framework has recently been considered by  
studying the factors affecting the impact assessment of mixed waste disposal in the context of 
achieving an optimized waste management (BIOPROTA forum (2013, 2015); Thorne and Kautsky 
(2016;);); Thorne and Wilson (2015)). Although constraints such as missing data on stressors and 
endangered biota as well as the general complexity and diversity of existing mixed exposure scenarios, 
have been identified, steps for future alignment of the approaches by focussing on a relatively limited 
set of hazardous components (such as U, Pb, Cd, Cr and asbestos) have been proposed.  
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Furthermore, development of integrated multiple stressors risk assessment using species sensitivity 
distribution (SSD) in combination with mixture models (CA, RA, IA) allowed the derivation of an 
integrated proxy of ecological impact of radionuclide and stable stressors (msPAF, multisubstances 
potentially affected fraction of species) (Beaumelle et al., 2017; Beaugelin-Seiller et al., 2019). 
One of the recommendations from the CONCERT-TERRITORIES project, aimed to regulatory 
authorities, focuses on establishing and implementing an integrative approach in decision making 
under exposure situations involving multiple stressors and including NORM. 
 
In perspective, to meet the challenge of integration of risk assessment frameworks, the development 
process will require missing data collation, incorporation of overall uncertainty, sensitivity analysis, 
meta-analysis and integration of long time scales within the proposed tiered approach. 
2.3.2.4. Provide a multi-criteria perspective including decision support systems for an 
optimised decision-making 
In handling of existing, planned and emergency exposures, a gradient of integrated management 
approaches is required as well as the means of creatively planning environmental management 
(including waste disposal options, remediation and decommissioning strategies) and assessing their 
effectiveness prior to implementing them. Although the primary driver in choosing management 
options for radiation exposure situations will always be the reduction or prevention of dose, the 
problem is inherently multi-factorial and will involve many stakeholders. There are significant needs in 
other sectors - economic, infrastructural, social services, production – that should be considered when 
selecting management options. Thus, there is a need to transparent communication to optimise 
management approaches for radioactive contamination that go beyond the simple consideration of 
radiation dose vs. economic cost. Optimisation requires expertise in areas such as radioecology, urban 
planning, social and economic sciences, information technology, waste handling, environmental and 
agricultural sciences, and risk perception and communication. From a practical viewpoint, the 
optimisation process could be based on the integration of decision support systems (DSSs) associated 
with radiological sciences with knowledge data-bases and other decision-aid tools from different 
disciplines (e.g., urban planning, economics, sociology) so that contaminated environments are 
managed in a holistic way to the maximum benefit for society. Concerning DSSs, the following aspects 
of how integration will be of benefit for decision making are apparent: (i) integration of available 
radioecological DSSs, (ii) development of DSSs for integrated assessment and (iii) integrating DSSs for 
existing and planned with those for emergency exposures. 
As discussed above, integration of human and environmental protection systems and methodologies 
is a challenge for radioecology (and MELODI) with the potential for significant benefits which can only 
be fully realised if the means of efficiently implementing such systems are available to stakeholders, 
regulators and operators. The development of DSSs for integrated assessments of both man and 
environment is necessary in ensuring demonstrable protection in a manner accessible to stakeholders. 
Moving towards this goal serves to generate maximum benefit from the research and ensures an 
important feedback mechanism between radioecology research and stakeholders. In situations 
requiring decisions to be taken dealing with radioactive contamination, it is almost never the case that 
one criterion can be used in isolation when determining the actions to be taken. The results of joint 
European research projects clearly showed that apart from the radiological effectiveness and technical 
feasibility of the various management options, the acceptance of stakeholders and the public at large 
is at least as important. Multi-criteria analysis (Linkov and Moberg, 2012) provides a suitable 
theoretical framework that can be used to combine quantitative and qualitative factors and to guide 
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the decision process towards a satisfactory solution (since no global optimum exists in the presence of 
multiple, often conflicting criteria).  
Multi-Criteria Decision Analysis is often employed for the analysis of complex problems involving non-
commensurable, conflicting criteria that form the basis within which alternative decisions are 
assessed. This methodology promotes “a good decision-making process” (Keeney and Raiffa, 1972; 
Linkov and Moberg, 2012) by a clearer illustration of the different types of data and information items 
that go into decision-support, being able to deal in a structured and transparent way with multiple, 
conflicting objectives and value systems. At the same time, multi-criteria decision aid methods 
overcome the shortcomings of traditional decision support tools used in economy, such as Cost –
Benefit Analysis, especially when dealing with values that cannot be easily quantified (e.g., 
environmental issues), or translated in monetary terms due to their intangible nature (e.g., social, 
cultural or psychological issues). 
Proper site characterization, human and environmental exposure and impact assessments, safety 
assessments and evaluation of remediation and waste disposal options (in terms of technical 
performance, associated exposure reduction and social impact), constitute the basis for decision 
making and need to be underpinned by robust scientific and technological developments. At the same 
time, societal uncertainties and ethical implications must be seen as a constitutional part, of high 
importance, in every regulatory decision-making process. 
The integrative and participatory process between the research community and relevant stakeholders 
has been recently established in EJP CONCERT to provide a range of benefits and optimized decision 
making based on (i) better definition of radiation protection objectives, (ii) improvement of existing 
knowledge and (iii) support in challenges of regulatory authorities and TSO to (IV) choice of relevant 
measures, proper risk and uncertainty communication. Beyond EJP CONCERT, collaborative actions on 
I-IV as well as on further integration work on DSS and definition and development of multi-criteria for 
better decision making are foreseen as necessary. 
2.3.2.5. Towards better interaction and integration of radioecology with other disciplines, 
including social sciences and humanities (SSH)   
The system of radiological protection is underpinned by advanced research in numerous scientific 
disciplines including radioecology. At the European scale, efforts have been made in the last decade to 
establish and bring together European platforms for radiation protection research, namely MELODI, 
EURADOS, NERIS, ALLIANCE, EURAMED, as well as social sciences and humanities (SSH) researchers. A 
European Joint Programme for Radiation Protection Research CONCERT was organized (2015-2020) 
with the main objective being implementation of a joint activities in radiation protection research 
(ranging from organising open research calls to coordination and networking activities, including 
training, research infrastructure development and stakeholder involvement) (Impens et al., 2017).  
Main results of joint activities targeted current system and practice of radiation protection by giving 
the contribution to questions of general importance. Furthermore, improved answers to societal needs 
and challenges have been provided, as well as sharing and better use of state-of-the art- research 
infrastructure.  
Growing public awareness of the importance of the global quality of environmental resources and 
biodiversity nowadays covers various philosophical perspectives such as anthropocentrism (protection 
of resources), biocentrism (intrinsic value of organisms) and ecocentrism (intrinsic value on all living 
organisms and their natural environment). In these terms, integration of radioecology with other 
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disciplines, especially SSH, would help in mutual understanding, generation of trust and improvement 
of credibility by better linking scientific findings with different stakeholders and general public needs. 
Benefits from better integration of the fields of radioecology and SSH are numerous (Perko et al. 2019, 
CONCERT-TERRITORIES Deliverable 9.72) and can be of more general (1-3), but also of more specific 
nature (4-8). Some more prominent examples of future actions and related benefits could be as 
following: 
• bridging the gaps and/or improvement of the links and development of the tools for 
mediation between radioecology research and stakeholders, at more levels - from local, 
national to international; 
• collaboration for research prioritization; getting the scrutiny into radioecology research and 
assessment methodologies; 
• collaboration to develop the holistic approach for the governance of radiation risks; 
• collaboration to develop integrated assessment framework for multiple hazards and 
integrated protection frameworks for man and biota; 
• clarification of the stakeholders’ viewpoints on various issues (e.g. integration of risk 
assessment approaches for chemicals and radioactive substances, different factors in multi-
criteria decision making); 
• improved social understanding of the uncertainties related to exposure characterization and 
risk assessments in different exposure situations; 
• better risk communication on different levels (e.g., from better communication of modelled 
risk to better communication of knowledge-based intervention levels, remediation actions, 
etc. in relation to predicted but also perceived risk); 
• identification of social constraints related to decision making based on impact and risk 
assessments (such as remediation and decommissioning). 
Further close communication and collaboration between radioecology and related research 
disciplines, including social sciences concerned with issues of radiological protection, are foreseen as 
necessary to achieve the goals set in this SRA challenges 1, 2 and previously given lines in challenge 3. 
Regular dissemination and update of research achievements should also be planned as beneficial for 
future beyond EJP CONCERT. 
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3. Strategic Agenda for Education and Training 
Scientific research in radioecology and application of that knowledge in the radiation protection of 
man and the environment requires scientists and workers with adequate competence, appropriate 
skills. Research-based education and training depends on access to relevant infrastructures and 
facilities. The EC EURAC project (2005) and the Radioecology Master Programme at the Norwegian 
University of Life Sciences (2007) have been important steps in promoting environmental radioactivity 
as an academic discipline under the Bologna Model. This work continued in the Network of Excellence 
STAR, with increased participation of STAR network scientists as teachers, international students and 
professionals taking course modules, an increase in the number of radioecology graduates as well as 
interaction and joint courses with DoReMi (low-dose research) and CINCH (radiochemistry). STAR also 
solicited stakeholder engagement (industry, regulators, academics, educators, etc) in the development 
of a strategic agenda through supply and demand workshops linked to education and training (STAR 
Deliverable 6.1 Oughton et al., 2012). 
To secure the sustainability of education and training in radioecology internationally, potential funding 
mechanisms need to be discussed with the ALLIANCE, the Internal Union of Radioecology (IUR) and 
other relevant organizations, to maintain the Education and Training Platform developed in STAR and 
further developed under COMET/ OPERRA as well as under CONCERT-TERRITORIES.  
3.1. Challenge: To maintain and develop a skilled workforce in Europe and 
world-wide, through university candidates and professionals trained within 
radioecology. 
3.1.1. Strategic vision for Education and Training 
The strategic vision is to secure and further develop a sustainable, integrated European training and 
education platform in radioecology that attracts top-level graduates and provides a workforce that has 
the necessary skills to meet future scientific, economic and societal needs within radioecology and other 
nuclear and environmental sciences. 
3.1.2. Strategic agenda  
The following action lines will need to be addressed to achieve the vision. 
• Increasing student and teacher/researcher mobility requires sustainable funding mechanisms 
within radioecology. Actions such as travel grants for students and guest lecturer fees have a 
relatively low cost, but need to be maintained. The ALLIANCE will foster attendance of students 
at international radioecology conferences by offering small supportive grants. 
• Inclusion of bespoke E&T work packages in EU (and other large) funded projects with wide 
reaching outreach activities to deliver training across all levels from the public to researchers. 
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• Attachment of PhD, post doc or young researcher positions to EU (and other large) funded 
projects is encouraged. 
• Exploring joint EU MSc opportunities through the Erasmus Mundus programme and other 
activities under Horizon 2020 and Horizon Europe. This would include mechanisms to increase the 
number of ECTS courses in radioecology that are given by European Universities as well as to 
stimulate integration within the ALLIANCE. 
• Fostering links with other E&T programmes in nuclear and environmental sciences  (e.g., radiation 
protection, emergency management, radiochemistry, ecology, environmental chemistry) to 
maximize use of infrastructure and human resources by ensuring courses are compatible between 
different disciplines. Links with environmental sciences (e.g. via lectures on courses) should be 
made at all educational levels, from schools to post graduate. 
• Providing joint courses for students and professionals with both ECTS (academic credits) and 
ECVET (vocational credits) or equivalents. This will ensure student merits, efficient use of 
resources and offer important networking opportunities for students, both across countries and 
disciplines, as well as with potential employees. 
• Increasing stakeholder and employer involvement in education and training through student 
placements, sponsored courses or university positions, and development of specialized intensive 
courses to meet stakeholder needs. For professional training courses, particular focus will be 
placed on access to state-of-the-art methods and models. 
• Development of distance learning courses (including webinars) where applicable (e.g. modelling, 
impact and risk assessment), to increase the recruitment of students. 
• Development of novel educational materials and approaches, and promoting participation in 
science festivals to bring radioecology to the wider public. 
• Offering refresher courses and seminars at relevant regional and international conferences. 
• Organising summer schools and field training courses. 
  
  
page 49 of 61 
 
4. Strategic Agenda for Infrastructures 
Adequate infrastructures and capabilities are a necessary resource for state-of-the-art and excellence 
radioecological research, as well as for education and training activities in radioecology. Infrastructures 
and capabilities encompass the facilities, equipment, methods, databases and models, and also the 
expertise required to perform radioecological research. 
In the recent past, several EURATOM funded projects have performed activities to drive the 
improvement of the knowledge and use of radioecology infrastructures in Europe. Thus, in the 
Network of Excellence on Radioecology STAR an inventory of infrastructure, including databases and 
sample archives, available in the member organizations was created (STAR Deliverable 2.2). Also during 
the STAR project, with the subsequent support of COMET and the ALLIANCE, a virtual laboratory was 
developed to contribute to the harmonization of practices and protocols between the different 
radioecological facilities. 
The establishment of Radioecological Observatory sites12 was proposed as a tool for innovative 
research, research integration and sustainability (Initiated in STAR and fostered in COMET and 
CONCERT-TERRITORIES13 European projects, with the support of the ALLIANCE). 
Within the EJP-CONCERT the work package 6 is devoted to increase visibility of radiation protection 
infrastructures. To do so, a database (AIR2D2) and a bulletin (AIR2), on infrastructures have been 
created14.  
The approaches used to study and evaluate the behaviour and impacts of radiation and radionuclides 
on the living world are changing. Consequently the required infrastructures and capabilities are also 
changing. A robust long-term vision is essential to successfully and sustainably develop, construct and 
operate radioecological (and radiation protection) infrastructures and capabilities. Thus, a network of 
collaborations between organizations would allow advanced platforms to be utilized within the 
consortium, within Europe or internationally.  
                                                          
12 Radioecological Observatory sites are contaminated field sites that provide a focus for long-term joint field investigations. 
The development of a pooled, consolidated effort maximises the sharing of data and resources. The Observatories also 
provide excellent training and educational sites. 
13 https://territories.eu/ 
14 https://www.concert-h2020.eu/en/Concert_info/Access_Infrastructures 
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4.1. Challenge: To maintain and acquire the infrastructures and capabilities 
needed to accomplish the three scientific challenges, as well as to support 
the education and training challenge, of the SRA.  
4.1.1. Strategic vision for Infrastructures 
The strategic vision for the next 20 years is that radioecology will develop a sustainable, integrated 
network of infrastructures and capabilities, to best meet the needs of the radioecology community, 
both in research and in education and training activities. 
4.1.2. Strategic agenda  
The following four action lines will need to be addressed to achieve the vision. 
• Identify the requirements for infrastructures and capabilities and create the partnerships of 
excellence that bring together these required infrastructure and tools.  
• Maintain and keep up to date a web-based catalogue on physical infrastructures, e-infrastructures 
and capabilities to ensure an efficient and effective sustainable integration of resources and 
capacities at a European level and to show stakeholders the radioecology capabilities available. 
• Further development of the Radioecological Observatory Sites (ROS). The ROS are considered as 
field laboratories where experiments are conducted that support greater understanding of 
radioecological processes, enables model development, validations and improvement and 
forecasting of future radioecological conditions. The data collected at the ROS and the models 
developed will be made available and may be combined with other datasets or data collected in 
other studies to support the three challenges of the SRA. ROS are a unique tool for integration 
among different disciplines through common studies, shared data, and E&T activities.  Actually 
the ALLIANCE exploits ROS in the Chernobyl Exclusion Zone, the Fukushima Exclusion Zone and 
NORM-impacted sites in Belgium, Poland and France.   
• Promote the visibility and joint use of existing infrastructures. Encourage wider collaboration, not 
only in the field of radioecology, but also in the broader area of radiation protection and with 
other related disciplines, leading to a better use and development of infrastructures.   
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5. Value of a Strategic Research Agenda 
The acquisition of new scientific knowledge through research in radioecology is a crucial element in 
safeguarding humans and the environment against harmful consequences, as well as responding to 
stakeholders concerns regarding the presence of radionuclides in the environment. Such studies are 
important to society because over-estimation of exposures or effects could lead to unnecessary and 
costly restrictions; alternatively, under-estimation of the risks will result in injury to humans and the 
environment. 
The three scientific challenges presented above, with their 14 associated research lines, are 
incompletely studied because they are complex and complicated. Attempts to address them have been 
piecemeal. The only way to provide rapid and efficient solutions to these difficult problems is a 
focused, hypothesis-driven research program with clear common goals and resources shared among 
the international radioecology community. For society to obtain a significant contribution from the 
radioecology of the future, a long-term, multidisciplinary approach is needed that goes beyond 
national boundaries. 
Additionally, this updated version of the SRA contains important sections on education and training of 
radioecology and infrastructure for our research. Sustaining knowledge and educating new scientists 
is critical to the viability of radioecology and was a concern expressed by several stakeholders. 
It is our hope that a science-based SRA for radioecology will focus and prioritise our collective efforts, 
resulting in increased value and more rapid advancement in our understanding of environmental 
radioactivity, as well as an improved ability to predict its effects on humans and the environment. It is 
expected that further integration within the global radiation protection community and consideration 
of stakeholders will push towards maximal efficiency, completeness and societal relevancy.  
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Abstract
Reflecting a change in funding strategies for European research projects, and a
commitment to the idea of responsible research and innovation in radiological
protection (RP), a collective of research institutes and universities have
developed a prospective Strategic Research Agenda (SRA) for Social Sciences
and Humanities (SSH) in radiological protection. This is the first time such a
research agenda has been proposed. This paper identifies six research lines of
interest and concern: (1) Effects of social, psychological and economic aspects
on RP behaviour; (2) Holistic approaches to the governance of radiological
risks; (3) Responsible research and innovation in RP; (4) Stakeholder
engagement and participatory processes in RP research, development, policy
and practice; (5) Risk communication; and (6) RP cultures. These topics were
developed through broad stakeholder consultation, in conjunction with
activities carried out in the framework of various projects and initiatives (EU
H2020 CONCERT programme, the EU FP7 projects OPERRA, PREPARE
and EAGLE, the 2015–2018 RICOMET series of conferences, and the 2014
and 2016 International Symposia on Ethics of Environmental Health); as well
as through dialogues with members of the European radiation protection
research communities. The six research lines open opportunities to integrate a
range of key social and ethical considerations into RP, thereby expanding
research opportunities and programmes and fostering collaborative approaches
to research and innovation.
Keywords: radiological protection, social sciences and humanities, ethics,
strategic research agenda, responsible research and innovation
1. Introduction
In this article, we present the contours of a Strategic Research Agenda (SRA) for the Social
Sciences and Humanities (SSH) in radiological protection (RP). Despite an increased institutional
recognition of the need for SSH research in radiological protection, SSH involvement in the field
remains fleeting and dispersed (Van Oudheusden et al 2018). Building a more robust role for SSH
in RP would open opportunities for scientific research communities (e.g. experts in radiobiology,
dosimetry, radioecology) to integrate societal and ethical considerations into radiological pro-
tection work. Moreover, this would lead to expanding research options and the fostering of
collaborative and co-creative approaches to research and innovation.
In recent decades, SSH researchers in Europe and beyond have demonstrated how
social studies can fruitfully inform risk governance and clarify the societal understanding of
radiological protection issues, for instance in relation to public response to and engagement
in radioactive waste management (Jenkins-Smith et al 2011, Perko et al 2012, Dubreuil,
Baudé, and Mays 2013, Bergmans et al 2014, Schröder et al 2015). Other studies shed light
on public risk perception of industrial uses of ionising radiation, such as food sterilisation
(Turcanu and Perko 2014); identify societal constraints related to environmental remedia-
tion and decommissioning processes (Perko et al 2017a); and raise public awareness about
radon (Hevey 2017, Lofstedt 2018). Research has been undertaken to stimulate mutual
learning and contribute to radiation safety and security by identifying and addressing
mismatches between emergency management plans and practice (Malesic et al 2015,
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Liland and Raskob 2016, Prezelj et al 2016, Schneider et al 2016); pinpoint new security
challenges (Becker 2004); and to propose novel ways to manage informed consent in the
medical field (Friedrich-Nel and Munro 2015). Social studies—often in a comparative
perspective across risky objects or technologies, and/or cultural contexts—also clarify how
people interpret and take decisions in the presence of radiation related risks. This work
highlights, for instance, factors influencing public concern about ionising radiation
(Železnik et al 2016), such as the perception of uncontrollability, involuntariness, invisi-
bility and having potentially catastrophic consequences (Slovic et al 2000). The direct
contribution of SSH practitioners has been recognised to be valuable in the societal and
scientific governance of contentious issues related to radiation risks to human populations
and the environment, including in post-accidental exposure situations (OECD-NEA,
CRPPH 2003, OECD/NEA 2011, Bréchignac et al 2016).
These research studies ‘open up’ (Stirling 2008a) radiological protection to society by
questioning RP concepts, programmes and policies, and by incorporating social needs and
considerations into science, technology and innovation (Felt and Wynne 2007,
Stirling 2008b). More than simply a critique of radiological protection, social studies are an
invitation to develop avenues for systematic collaboration between natural scientists and
social scientists, and between technical and non-technical communities. The potential
contribution of SSH is acknowledged by the existing European RP research and technical
platforms18, by various projects in the radiological protection field, for instance RISKEDU19
(Wojcik et al 2018), and by CONCERT—the European Joint Programme for the Integration
of Radiological Protection Research. As stated in the Public Declaration following the
RICOMET 201620 Conference, ‘[m]any radiological protection fields could profit from social
science and humanities input, which could help cover knowledge gaps in complex radi-
ological issues. The practical role of ethics, education and economics in decision making also
needs further elaboration.’20
The aim of the SRA, therefore, is to contribute to the improvement of the radiological
protection system by coordinating SSH research in radiological protection; supporting edu-
cation and training; building stakeholder involvement, knowledge management and sharing;
and identifying SSH state of the art across disciplines. Enabling SSH research to play a fuller
and stronger role in RP through a coordinated SRA mechanism will ensure that societal
perspectives on research, policy and practice related to RP will be acknowledged and
accounted for.
The members of the collective which has authored the SRA (see appendix) share a
commitment to the ideals of Science with and for society and to Responsible Research and
Innovation, both of which emphasise the need for collective, inclusive and system-wide
governance involving all relevant stakeholders (Owen et al 2012). This development coin-
cides with increasing interest in the ethical aspects of radiological protection as reflected, for
instance, in the most recent publications of the International Commission on Radiological
Protection (ICRP 2018).
18 Multidisciplinary European Low Dose Initiative (MELODI), European Radioecology (ALLIANCE), European
Platform on Preparedness for Nuclear and Radiological Emergency Response and Recovery (NERIS), European
Radiation Dosimetry Group (EURADOS) and European Alliance for Medical Radiation Protection Research
(EURAMED), European radon association (ERA), The European NORM Association (ENA).
19 RISKEDU : How can teachers support the development of scientific literacy through teaching about risk and risk-
assessment; http://riskedu.se.
20 RICOMET : Conference on Risk Perception, Communication and Ethics of Exposures to Ionising Radiation
http://ricomet2019.sckcen.be/.
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The underlying principles that inform the SRA are that:
• SSH can support existing and future research, policy and practice, in all areas relating to
radiological protection, to better take into account the concerns, values and needs of a
wider range of stakeholders, including citizens;
• SSH research should be coordinated, shared and integrated into existing research and
development (R&D) on radiological protection; hence, collaboration with the European
radiological protection platforms and associations must be an integral component of the agenda;
• Research relating to RP should be conceived of as transdisciplinary and inclusive, integrating
citizen, science and stakeholder input into research and innovation from the start.
With these principles in mind, the SSH SRA identifies priorities for future European
Commission-supported SSH research, and beyond, in the field of radiological protection. The
SRA is structured along six research lines addressing issues that are relevant for all existing
European radiation protection research platforms (MELODI, ALLIANCE, NERIS, EUR-
ADOS and EURAMED), as well as topics of wider interest in the radiological protection area.
The SRA and will be regularly updated in light of changing stakeholder needs, as
identified by research performed by the collective’s members, under other platforms or in the
international research community. Effective adaptation will therefore require continuous
engagement of the SSH community in RP and ongoing interactions with all concerned parties,
particularly the technical and research platforms.
In the following sections, we outline the state of the art of SSH research on RP, briefly
describe the process of SRA development, and then present the scope and topics of the SRA,
subsequently identifying the initial top priorities. We conclude by emphasising the need for
ongoing and integrated SSH research on RP, for the benefit of society.
2. Current status of social sciences and humanities in radiological protection
research
The field of radiological protection is challenged by particularities of ionising radiation (e.g.
scientific and societal uncertainties, different perceptions of risks, societal trust issues) and the
evolving societal landscape (e.g. rise in social media, active citizenship). The assessment of health
effects from low radiation doses is confronted with the complexity of assessing causal and tem-
poral relationships, alongside sources of uncertainty. This is not only due to limits of the models
and data, but also to the inherent boundaries of radiation protection knowledge (Renn 2008).
While SSH research has been conducted for many years on multiple aspects of radiological
risk, this research is fragmented and often circumscribed by input from actors beyond the SSH
community (Lazo et al 2016). Therefore, SSH research has addressed in depth only some areas of
relevance, directly or indirectly, related to radiological protection, whereas many areas have
remained largely unexplored. Understanding how societies have engaged (or not) with nuclear
energy and radioactive waste management has been the object of several studies (Bergmans et al
2014). Recently the relationships between societies and actors in the nuclear energy sector, and
how these have changed over the course of the past 60 years, have been investigated from
historical and sociological perspectives (HONEST21). Linguistic and discursive analyses have
been conducted mainly in relation to nuclear emergencies (PREPARE22), while research on
techno-cultural questions on the preservation of records, knowledge and memory of nuclear
21 HONEST: History of nuclear energy and society, http://honest2020.eu.
22 PREPARE: Enhanced emergency preparedness and response for nuclear and radiological incidents https://eu-
neris.net/projects/prepare.html.
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waste across generations has been undertaken by the OECD Nuclear Energy Agency
(RK&M23). Extensive literature has addressed the perception of radiological risk and its
influence on trust, attitudes, or governance of ionising radiation applications and their life
cycle (Sjoberg 2004, Slovic 2012, Visschers and Siegrist 2013, Perko 2014, Perko et al
2015a, 2015b). However, there is a dearth of studies addressing these factors in specific long-
term exposure situations such as those relating to Naturally Occurring Radioactive Material
(NORM), radon in homes, legacy sites, or recent applications of ionising radiation in the
context of food sterilisation or security threats. In sum, while different SSH disciplines have
addressed some areas of RP to varying levels of detail, there remain large gaps in the
knowledge base and a lack of integration of knowledge across domains.
A gap is also observed between state-of-the-art SSH concepts, theories and outcomes and
their rate or rigor of application in the radiological protection field. Although a number of national
and international recommendations and legal requirements for stakeholder engagement in radi-
ological protection have been developed (e.g. Basic Safety Standards, Aarhus Convention, IRPA
guiding principles), there remain gaps between those policies and actual practice, as highlighted
for instance by the ‘Aarhus Convention in Nuclear’ initiative conducted by ANCCLI24 and
European Commission DG-ENER from 2009 to 2012 (UNECE 2013), and the FP7 European
projects EAGLE25 and PREPARE (Perko et al 2016c).
From a methodological perspective, there is insufficient dissemination of reliable and vali-
dated quantitative measurement scales for concepts relating to radiological protection. There is a
need to harmonise qualitative research protocols and disseminate already existing, systematic, and
transparent protocols for qualitative research. Such research protocols may concern, for instance,
media studies, living-laboratory observations, and ‘social laboratory workshops’. Currently, there
are no publicly accessible databases of methods or tools for SSH research on radiological pro-
tection. Hence, there is methodological development yet to be undertaken.
Social sciences and humanities can lend insight and method to bridge gaps between
technical experts and wider society in complex radiological issues (Perko 2014). SSH can
also facilitate the development of RP research programmes that take into account: responsible
research and innovation imperatives; citizen-centered RP governance (e.g. citizen science,
environmental citizenship); vulnerability and resilience of societies and individuals; and
cultural perspectives on technical solutions for radiological protection. The SSH SRA pre-
sented in section 4 addresses these and other areas and proposes new research lines and topics
with a view to improving the radiological protection of individuals and society.
3. Development of the SRA
The research topics to be included in the SRA were collected through several activities carried
out in the framework of the H2020 CONCERT project (http://concert-h2020.eu, specifically
WP 2.6) and the FP7 projects OPERRA26 (Perko et al 2015a), PLATENSO27 (Mes-
kens 2016), PREPARE (Schneider et al 2017), and EAGLE (Perko et al 2016b). The topics
23 RK&M: Preservation of Records, Knowledge and Memory across Generations https://oecd-nea.org/rwm/rkm/.
24 ANCCLI: The Association Nationale des Comités et Commissions Locales d’Information; http://www.anccli.
org/.
25 EAGLE: ENhancinG stAkeholder participation in the GovernancE of radiological risks for improved radiation
protection and informed decision-making; http://eagle.sckcen.be.
26 OPERRA: Open project for the European radiation research area; https://cordis.europa.eu/project/rcn/
109481/en.
27 PLATENSO: Building a platform for enhanced societal research related to nuclear energy in Central and Eastern
Europe; http://www.merience.eu/en/ortfolio-items/platenso-2013-2016.
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were further developed using a stakeholder consultation and dialogue approach. This process
was initiated by social scientists at the annual RICOMET conferences (2015, 2016, 2017 and
2018), and the International Symposia on Ethics of Environmental Health (2014 and 2016)
and included also other dialogues with members of the radiological protection research
platforms. The first meeting of the persons engaged in the SRA collective took place in June
2016 at the RICOMET conference in Bucharest and an outline SRA was produced. The
refinement of research topics identified through a series of dialogues was further discussed at
the September 2016 Radiation Protection Week in Oxford with members of the CONCERT
task group, SSH community and technical platforms, and resulted in an early draft of the SRA
document. Following these interactions, a consensus was formed through discussion as to the
most urgent topics for SSH research and the principles that would underlie the SRA work.
A systematic verification of the research priorities was conducted in June 2017 through
an email-based consultation of 1400 individuals from the RP field. Respondents were asked to
share their opinions, remarks and advice on the existing version of the SRA. They were,
moreover, invited to participate live or online in a dedicated discussion and debate at the 2017
RICOMET conference in Vienna. At that session, the collected comments and the existing
SRA version were discussed by 130 physically present delegates, and live streamed from the
IAEA venue using technology that allowed distance-attendees to submit further input in
real time.
Toward the end of 2017, the first steps to build a joint roadmap for radiological pro-
tection research were taken by the scientific platforms (Impens et al 2017). At this time, a
specific challenge for SSH was identified and integrated into the draft Joint Roadmap for
Radiation Protection Research: ‘Enhancing integration of radiation protection science with
society’ (Salomaa et al 2017).
By using a range of events and processes for engaging the SSH community and stake-
holders, a robust SRA has been developed. In the following section, we present the key
features of this Strategic Research Agenda, as agreed upon by the aforementioned con-
tributors and based on the priorities identified in the consultations.
4. Strategic research agenda (SRA) for social sciences and humanities (SSH) in
the radiological protection field (RP)
The SRA aligns with recent calls for more open and responsive modes of research and science
policy-making, and attends to four challenges put forward in contemporary EU-wide policy
discourses on Science with and for society and Responsible Research and Innovation
(EC 2018): health and wellbeing; secure, safe and resilient societies; communication, colla-
boration and citizenship; and integration, impact and reflexivity.
Firstly, health and wellbeing comprise the social, mental and physical health of indivi-
duals, as well as social factors such as the strength and diversity of social bonds within a
community and its capacity for autonomy within a healthy environment. Research in the field
of SSH can explicitly address these aspects in connection to radiological exposure situations,
with the aim of ensuring a good quality of life for all. Achieving health and wellbeing requires
investments on behalf of decision makers and research communities at a time of economic
restraint and the aging of populations across Europe and the world.
Secondly, on the topic of secure, safe and resilient societies, European nations face major
natural hazards and human-induced threats. SSH research seeks to make significant con-
tributions towards enhancing societal resilience and preparedness in the face of these threats
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by examining contemporary approaches to safety and security, and by opening a broader
societal debate on the kinds of resilience that can, and should, be achieved.
Thirdly, SSH research on communication, collaboration and citizenship advances our
understanding of how individuals and communities are included and excluded, and how
processes such as communication and collaboration foster novel forms of identity, sense
making and belonging. It does so with the aim of creating societies in which citizens thrive,
feel confident to express themselves and empowered to take decisions concerning radiological
risks and connected issues.
Finally, SSH research on integration, impact and reflexivity assesses the impact of
research activities on the values and choices made by researchers in their communities. This
includes giving due consideration to the societal and ethical implications of scientific research
agendas, processes, and outputs.
The SRA has six research lines that reflect areas for which the need for a concerted effort
has been identified as a prerequisite to addressing the contemporary societal challenges
outlined above. Each of these research lines includes a number of specific research topics
relevant to the future European research agenda in the field of radiological protection. Indeed,
we anticipate that the relevance extends beyond Europe. Exchanging views on these joint
challenges will be an integral part of developing and improving the SRA further, setting
priorities and initiating research projects.
4.1. Research line 1: effects of social, psychological and economic aspects on radiological
protection behaviour and actors’ choices
Research line 1 is geared towards understanding behavioural aspects related to radiological
risks, including the interrelation between behaviour, perception of risks, economic aspects,
knowledge, culture, historical memory and other factors.
Relevant topics include:
• Links between perception of radiological risk and radiological protection behaviour, or individual
strategies to cope with perceived risk in relation to radiological exposure. Using cross-sectional and
longitudinal studies, multiple aspects will be brought into focus:
different exposure contexts (e.g. workers, populations living in areas affected by radiological
contamination).
different time scales (e.g. different generations).
cultural contexts,
socio-economic issues.
Perceptions of radiological risk and environmental remediation actions in post-accident and existing
exposure situations (e.g. human ecology, psychology, epidemiology).
Media impacts (social media, traditional media) on perception of radiological risk and ideas of well-
being linked to radiological exposures. This includes the influence of citizen journalism on radi-
ological protection behaviour in different exposure situations and examining if, and how, citizen
science journalism can be integrated into RP.
The interplay of individual differences, such as psychological aspects associated with radioactivity,
social environment and radiological protection behaviour.
Capturing different understandings of ionising radiation concepts, risks and uncertainty as byr sta-
keholder group (e.g. practitioners, patients, local population) and the respective amplification or
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attenuation of radiological risks. Contexts are medical exposures, industrial applications, natural
radiation and nuclear or radiological accidents.
Perception of radiological risks by individuals and groups when exposed to low radiation doses,
accounting for cultural differences in routine, emergency and other exposure situations.
Socio-psychological and economic aspects of medical follow-up after accidental or other exposures.
Societal approaches to dealing with uncertainties and the potential for bridging the gap between
different concepts of uncertainty.
4.2. Research line 2: Holistic approaches to governance of radiological risks
The aim of this research line is to develop inclusive approaches for the governance of
radiological risk situations by integrating technical assessments and social assessments,
raising public awareness on the social scientific aspects and integrating these into knowledge
building, framing of issues and the decision-making process together with technical assess-
ments. Evaluation of radiological and non-radiological aspects by the various stakeholders
should serve as inputs for decision-making. Stakeholders comprise formal institutions, as well
as actors without a predefined institutional role that have to manage their own decision-
making processes, stakes, and expectations. A core emphasis here is on providing insights and
guidance on multi-dimensional, multi-actor and multi-institutional decision-making and
policy-making and on resolving emerging trade-offs in radiological protection. As radi-
ological protection is a burgeoning multidisciplinary field, special attention will be devoted to
the added value of SSH in relation to contributions from other fields and sciences.
Relevant topics include:
Assessment of the radiological and non-radiological effects of radiological accidents through trans-
disciplinary research, for instance in the case of a medical overexposure or in industrial radiology.
Holistic approaches to accident preparedness, management and recovery, taking into account multiple
risks, social, economic and psychological factors. These approaches should account for the devel-
opment of psychological support for evacuees as part of preparedness policies; socio-economic
aspects of preventive distribution of iodine tablets in different EU countries; and psychological
consequences of emergency management decisions. Inappropriate responses of individuals and
groups (e.g. voluntary evacuation when sheltering is advised) and how to avoid such responses is also
important.
Social, ethical and psychological issues related to preparedness and response to nuclear and radi-
ological terrorism and other criminal behaviour.
Ethical aspects of crisis situations, particularly ethical questions around evacuation, post-accident
management, and the transition from emergency to recovery radiological exposure situations.
Development of socio-economic valuation and multi-criteria decision methods as one approach to
formally structure the evaluation and integration of radiological and non-radiological factors for
different ionising radiation exposure situations.
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Decision making mechanisms in post-accident situations, with emphasis on local knowledge, values
and decision-making.
Analysis of existing policy and regulatory influence on the radiological protection field.
The development of joint actions with institutional and non-institutional actors in radiological
protection governance.
Analysis of the values and principles that inform radiological protection programmes and practices in
the medical field.
Assessment of how uncertainties are identified and managed in different professions, for instance
general practitioners, surgeons, food scientists, environmental scientists, publics.
The ethics of compensation for radiological risks in different countries.
Assessing values and expectations that come with the integration of SSH in radiological
protection.
4.3. Research line 3: Responsible Research and Innovation in Radiological Protection
Research line 3 aims at assessing how radiological protection research, development and
innovation is conducted, with the aim of inciting more socially responsive and ethically sound
processes and outcomes. The design of transdisciplinary activities is emphasised in this
research line, for example through co-creation agenda setting-processes that engage technical
and social scientists alongside publics.
Relevant topics include:
Enhancing the reflexive awareness of actors involved in technical R&D about the societal implica-
tions of nuclear technology applications and radiological exposure situations that require radiological
protection research.
Examining the social, cultural, and historical context of radiological protection research; the ratio-
nales, possibilities, and limitations of research approaches and methods; the social relevance of
research hypotheses.
Ascertaining conflicts of interest in radiological protection research and finding ways to manage such
conflicts.
Identifying and developing sound ethical principles and approaches to guide radiological protection
research in a socially responsive, inlcusive and responsible manner.
Operationalising, as well as problematising and developing, principles such as trans-disciplinarity,
which sustain the integration of SSH into radiological protection research.
Evaluating the institutional uptake of research projects and findings.
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Determining how to make SSH integration meaningful and effective for all stakeholders.
Developing methodologies and tools for the dynamic mapping of stakeholders’ concerns, views and
needs to identify R&D priorities in the radiological protection field.
4.4. Research line 4: stakeholder engagement in radiological protection research and
development, policy and practice
Research line 4 aims at fostering stakeholder engagement in radiological protection research,
policy and practice in ways that enhance responsiveness to societal needs and concerns. By
‘stakeholder’ we denote anyone who has a stake in radiological protection research, its
development or applications and/or is potentially affected by radiological protection R&D
and the outcomes it generates.
Relevant topics include:
Mediation and facilitation between authorities, scientists, publics and other stakeholders for different
exposure situations and nuclear applications, research and development. This implies giving due
attention to issues of representation and lessons learned.
Establishment of a collaborative framework for stakeholder engagement in radiological protection
research, policy and practice in ways that enhance responsiveness to societal needs and concerns.
Analysis and evaluation of societal needs to shape the legal requirements and governance frameworks
in ways that support access to information, public participation and access to justice.
Assessment and development of stakeholder and public participation tools and methodologies for
different radiological exposure situations; including roles, rules and responsibilities of stakeholders in
the engagement process, motivations, values and links between theory and practice.
Potential and limitations of involving citizens in the production of knowledge for radiological pro-
tection. Examples include citizen science, citizen journalism, and partnerships with local
communities.
Preservation of knowledge and experience of local stakeholders’ (e.g. local community, schools,
citizens) involvement and participation. Community research and tracing of the development of a
participation culture in relation to different exposure situations.
4.5. Research line 5: risk communication
This area covers issues related to communication of risk, how affect and trust influence risk
perception and behaviour, and how exchange or sharing of risk-related data, information and
knowledge between and among different parties (such as regulators, experts, consumers,
media, general public) can be provided. Research line 5 aims at developing research to
support communication about ionising radiation between different stakeholders and citizen-
centred risk communication, in order to clarify choices and options in a variety of exposure
situations. It also seeks to empower citizens and other stakeholders to make more informed
decisions.
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Relevant topics include:
Risk communication about radioactivity and radiological protection principles in medical applications
of ionising radiation, and the impact of communication on the radiological protection behaviour of
practitioners.
Improving decision-making through informed consent of patients for medical procedures involving
ionising radiation; by empowering patients in decision making; ethical issues and communication
about uncertainties; informed consent versus the right not to know.
Developing long-term communication models to improve radiological protection culture and public
well-being in long-term existing exposure situations.
Use and perception of technical information and risk estimates in communication with various publics
(lay people, experts, informed civil society).
Media communication about ionising radiation, in particular low radiation doses and related uncer-
tainties in the field of radiological protection including inter-media agenda setting in different
exposure situations.
Ethical basis and values underpinning risk communication about ionising radiation exposures.
Risk communication and stakeholder involvement in post-accident recovery in order to support
decision-making process related to daily life and improving public health.
Developing risk communication about low doses: Use of state of the art knowledge from socio-
psychological research with focus on low doses of ionising radiation and related uncertainties.
Ethical principles guiding deliberative processes on questions that cannot be decided by radiological
specialist alone: role of uninformed risk perceptions, applicability of informed consent, appro-
priateness of risk comparisons, dealing with refusal to communicate.
Perception and communication related to radiosensitivity and radiosusceptibility including mental
maps, ethical aspects.
4.6. Research line 6: radiological protection culture
Research line 6 involves research concerning the assessment and development of a radiological
protection culture among all RP stakeholders, in various exposure situations (planned, existing
and emergency), and for different categories of exposure (occupational, patient, general public).
The aim of this research line is to increase the understanding and application of radiological
protection principles, norms and standards; to enhance the decision-making processes concerning
the management of radiological exposure situations, and the identification and implementation of
RP actions. At the same time, it aims to enable individuals and collectivities to reflect on their own
protection and/or that of others; to consider consciously radiological protection aspects in their
activities or decisions; to make their own decisions with regard to their own protection against
ionising radiations; to participate in decision-making processes related to the management of
exposure situations. By enabling the dialogue between professionals in the RP field and other
stakeholders, Research line 6, contributes to enhancing the efficiency and reliability of the radi-
ological protection system and its capacity to effectively address the concerns of all stakeholders.
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Relevant topics include:
• Characterisation of RP culture, including
Specificities associated with exposure situations;
Organisational, social, political, economic, cultural and psychological aspects influencing RP culture
or RP behaviour;
Ethical frameworks and value judgments underlying RP cultures;
Interactions between the RP culture at the level of an organisation or community, and at individual or
sub-group level;
Impact of evolving RP technologies, knowledge, information, and communication technologies on
RP culture;
Relationships between RP culture and safety or security culture.
Analysis of processes of RP knowledge production, values and expectations.
Qualitative and quantitative evaluation of RP culture, at group and or individual level.
The role of RP culture for the implementation and improvement of the RP system; and the health and
well-being of populations.
Development of tools, methods, processes and guidelines to build, maintain, enhance and transmit RP
culture, taking into account the needs and concerns of various stakeholders regarding RP culture,
including future generations, and the specificities of RP fields (e.g. emergency and recovery pre-
paredness, NORM activities, radon exposures, paediatric imaging).
Social, psychological and economic aspects of radiological protection choices by different actors.
5. Research needs in short-term and medium-term
Social and ethical aspects in radiological protection research, policy and practice involves
research that must be addressed to numerous fields related to ionising radiation and its
applications, for example: medical exposures to ionising radiation, naturally occurring
radioactive materials, nuclear waste management, environmental remediation, emergency and
recovery management, and decommissioning. On the one hand, the Social Sciences and
Humanities community encourages multi-disciplinary approaches that ensure attention to
social and ethical considerations. On the other hand, the SSH community has its own SSH
SRA dedicated research priorities, which are not currently addressed by the research agendas
for RP produced by other, non-SSH disciplines.
A gap analysis was carried out in order to identify the top SSH research priorities to be
addressed by projects responding to the EURATOM NFRP28 2018 calls (Vanhavere 2018).
The gap analysis considered topics included in the SSH SRA (Perko et al 2016a, Perko et al
2017b) and/or defined as priorities by radiological protection stakeholders (Impens et al
2017). The analysis highlighted key topics that have been addressed to only a limited extent
in recent or ongoing EU projects, namely:
• Risk communication in medical exposures; impact of communication on RP behaviors of
practitioners.
• Risk communication on low doses and related uncertainties.
28 NFRP: Nuclear fission and radiation protection research.
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• Ethical basis and values underpinning risk communication exposures to ionising radiation.
• The understanding of ionising radiation concepts, risks and uncertainties by different
stakeholders in the context of planned, existing and emergency exposure situations.
• The interplay of psychological aspects associated with radioactivity, social environment
and radiological protection behaviour.
• Potential and pitfalls of citizen involvement in knowledge production for radiological risk
governance.
• Socio-economic valuation and multi-criteria decision-aiding methods to formally
structure the evaluation and integration of radiological and non-radiological factors.
• Enhancing the reflexive awareness of actors involved in radiological protection R&D as
to the societal implications of research.
• Democratic culture in RP in order to construct joint actions with institutional and non-
institutional actors.
• Mediation, facilitation and representation on the triangle scientists, public and other
stakeholders for different exposure situations.
• Collaborative framework for stakeholder engagement in RP research, policy and practice
in ways that enhance responsiveness to societal needs and concerns.
• Societal needs for and evaluation of legal instruments and governance frameworks supporting
access to information, public participation and access to justice in relation to RP issues.
• Stakeholder and public participation tools and methodologies for different exposure
situations. Roles and rules for stakeholders in the engagement process. Motivational
factors, ethics, and links between theory and practice.
• Characterisation of RP culture.
• The role of RP culture in the implementation and improvement of the protection system.
The SSH community encourages multi-disciplinary approaches that address one or more
of the above topics and facilitate the integration of social and ethical considerations into
radiological protection agendas and programmes at an early stage. This vision of priorities
will guide further development of the SRA with a view towards enhancing the role of SSH
research in RP for the mutual benefit of science and society.
6. Conclusions
In this article, we outlined a prospective Strategic Research Agenda for the Social Sciences and
Humanities in radiological protection. The SRA represents the views and commitments of a wide
range of stakeholders in the RP arena (researchers, policy makers, implementers, authorities, and
members of technical and research platforms). In line with European science policy appeals to
responsible research and innovation, the proposed SRA seeks to facilitate more socially responsive
science and technology processes by systematically integrating social and ethical considerations
into RP research programmes and policies. It extends, unifies and builds on previous European
efforts to integrate SSH into radiological protection research in fields such as medicine, radio-
ecology, energy, dosimetry, and waste, with due consideration to the social, political, ethical,
cultural and historical factors that shape research. Among the benefits of conducting scientific intra-
, inter-, multi- and trans-disciplinary research in radiological protection may be the fostering of
user-friendly technologies for radiological protection, helping citizens make informed decisions,
and improving radiological risk governance. As evidenced by numerous studies, SSH researchers
can fruitfully inform RP research and decision-making in these and related areas.
Far from a conclusive declaration, the SRA is intended as a dynamic document to
encourage debate on what are SSH research priorities in RP; provide guidance on what
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subjects could and should be covered in new research programmes on radiological protection
research (for example through PhD and postdoctoral programmes); and offer a list of key SSH
topics for research programmes on specific radiological protection subjects. The SRA will be
adapted in view of changing stakeholder needs, through ongoing interactions with all con-
cerned parties, including the technical and research platforms.
We anticipate that the SSH SRA presented here will have significant scientific and policy
impact in the intermediate and long run, as social scientists and humanities scholars
increasingly engage with RP stakeholders, policies and practices. These engagements open up
new possibilities to embed social and ethical considerations in RP research and development,
thereby expanding research options, addressing stakeholder needs and values, and fostering
forms of inter- and transdisciplinary research collaboration.
Now is the time for European research institutions, as well as national and international
authorities, including the European Commission, to invest resources in the identified research
lines and topics. This will facilitate the further development of SSH research, under a broad,
engaged, and reflexive agenda, whose effect will be to promote responsible RP practices and
benefits for both science and society.
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